Document:

EX-4.(A)

 Exhibit 4(a) 
  

 
  

 
  

CAMPBELL SOUP COMPANY 

INDENTURE 
 Dated as of
                    , 2014 
 WELLS
FARGO BANK, NATIONAL ASSOCIATION, 
 Trustee 
  

 
  
  

 

 TABLE OF CONTENTS 

 
  

 

							
	 	 	 	  	PAGE	 
	 ARTICLE 1
	   

	 DEFINITIONS AND OTHER PROVISIONS
OF GENERAL APPLICATION
	   

			
	 Section 1.01.
	 	Definitions	  	 	5	  
	 Section 1.02.
	 	Compliance Certificates and Opinions	  	 	13	  
	 Section 1.03.
	 	Form of Documents Delivered to Trustee	  	 	14	  
	 Section 1.04.
	 	Acts of Holders	  	 	14	  
	 Section 1.05.
	 	Notices, Etc., to Trustee and Company	  	 	17	  
	 Section 1.06.
	 	Notice to Holders; Waiver	  	 	17	  
	 Section 1.07.
	 	Language of Notices, Etc	  	 	18	  
	 Section 1.08.
	 	Conflict with Trust Indenture Act	  	 	18	  
	 Section 1.09.
	 	Effect of Headings and Table of Contents	  	 	18	  
	 Section 1.10.
	 	Successors and Assigns	  	 	19	  
	 Section 1.11.
	 	Separability Clause	  	 	19	  
	 Section 1.12.
	 	Benefits of Indenture	  	 	19	  
	 Section 1.13.
	 	Governing Law	  	 	19	  
	 Section 1.14.
	 	Legal Holidays	  	 	19	  
	 Section 1.15.
	 	Judgment Currency	  	 	19	  
	 Section 1.16.
	 	Immunity of Incorporators, Shareholders, Officers, Directors and Employees	  	 	20	  
	
	ARTICLE 2	  
	SECURITY FORMS	  
			
	 Section 2.01.
	 	Forms Generally	  	 	20	  
	 Section 2.02.
	 	Form of Trustee’s Certificate of Authentication	  	 	21	  
	 Section 2.03.
	 	Securities in Global Form	  	 	21	  
	 Section 2.04.
	 	Form of Legend for Book-Entry Securities	  	 	22	  
	
	ARTICLE 3	  
	THE SECURITIES	  
			
	 Section 3.01.
	 	Amount Unlimited; Issuable in Series	  	 	22	  
	 Section 3.02.
	 	Denominations	  	 	25	  
	 Section 3.03.
	 	Execution, Authentication, Delivery and Dating	  	 	25	  
	 Section 3.04.
	 	Temporary Securities	  	 	27	  
	 Section 3.05.
	 	Registration, Registration of Transfer and Exchange	  	 	29	  
	 Section 3.06.
	 	Mutilated, Destroyed, Lost and Stolen Securities	  	 	33	  
	 Section 3.07.
	 	Payment of Interest; Interest Rights Preserved	  	 	34	  
	 Section 3.08.
	 	Persons Deemed Owners	  	 	36	  
	 Section 3.09.
	 	Cancellation	  	 	37	  
	 Section 3.10.
	 	Computation of Interest	  	 	38	  
	 Section 3.11.
	 	Electronic Security Issuance	  	 	38	  
	 Section 3.12.
	 	CUSIP Numbers	  	 	38	  

  
 i 

							
	 	 	 	  	PAGE	 
	ARTICLE 4	  
	SATISFACTION AND DISCHARGE	  
			
	 Section 4.01.
	 	Satisfaction and Discharge of Indenture	  	 	38	  
	 Section 4.02.
	 	Application of Trust Money	  	 	39	  
	 Section 4.03.
	 	Discharge and Defeasance of Securities of any Series	  	 	40	  
	
	ARTICLE 5	  
	REMEDIES	  
			
	 Section 5.01.
	 	Events of Default	  	 	42	  
	 Section 5.02.
	 	Acceleration of Maturity; Rescission and Annulment	  	 	43	  
	 Section 5.03.
	 	Collection of Indebtedness and Suits for Enforcement by Trustee	  	 	44	  
	 Section 5.04.
	 	Trustee May File Proof of Claim	  	 	44	  
	 Section 5.05.
	 	Trustee May Enforce Claims Without Possession of Securities or Coupons	  	 	45	  
	 Section 5.06.
	 	Application of Money Collected	  	 	45	  
	 Section 5.07.
	 	Limitation on Suits	  	 	46	  
	 Section 5.08.
	 	Unconditional Right of Holders to Receive Principal, Premium and Interest	  	 	46	  
	 Section 5.09.
	 	Restoration of Rights and Remedies	  	 	46	  
	 Section 5.10.
	 	Rights and Remedies Cumulative	  	 	47	  
	 Section 5.11.
	 	Delay or Omission Not Waiver	  	 	47	  
	 Section 5.12.
	 	Control by Holders	  	 	47	  
	 Section 5.13.
	 	Waiver of Past Defaults	  	 	47	  
	 Section 5.14.
	 	Undertaking For Costs	  	 	48	  
	 Section 5.15.
	 	Waiver of Stay or Extension Laws	  	 	48	  
	
	ARTICLE 6	  
	THE TRUSTEE	  
			
	 Section 6.01.
	 	Certain Duties and Responsibilities	  	 	48	  
	 Section 6.02.
	 	Notice of Defaults	  	 	49	  
	 Section 6.03.
	 	Certain Rights of Trustee	  	 	50	  
	 Section 6.04.
	 	Not Responsible for Recitals or Issuance of Securities	  	 	51	  
	 Section 6.05.
	 	May Hold Securities	  	 	52	  
	 Section 6.06.
	 	Money Held in Trust	  	 	52	  
	 Section 6.07.
	 	Compensation and Reimbursement	  	 	52	  
	 Section 6.08.
	 	Disqualification; Conflicting Interests	  	 	52	  
	 Section 6.09.
	 	Corporate Trustee Required; Eligibility	  	 	53	  
	 Section 6.10.
	 	Resignation and Removal; Appointment of Successor	  	 	53	  
	 Section 6.11.
	 	Acceptance of Appointment by Successor	  	 	54	  
	 Section 6.12.
	 	Merger, Conversion, Consolidation or Succession to Business	  	 	55	  
	 Section 6.13.
	 	Preferential Collection of Claims Against Company	  	 	56	  
	 Section 6.14.
	 	Appointment of Authenticating Agent	  	 	56	  

  
 ii 

							
	 	 	 	  	PAGE	 
	ARTICLE 7	  
	HOLDERS’ LISTS AND REPORTS BY TRUSTEE AND COMPANY	  
			
	 Section 7.01.
	 	Company to Furnish Trustee Names and Addresses of Holders of Registered Securities	  	 	58	  
	 Section 7.02.
	 	Preservation of Information; Communications to Holders	  	 	58	  
	 Section 7.03.
	 	Reports by Trustee	  	 	59	  
	 Section 7.04.
	 	Reports by Company	  	 	59	  
	
	ARTICLE 8	  
	CONSOLIDATION, MERGER, CONVEYANCE, TRANSFER OR LEASE	  
			
	 Section 8.01.
	 	Company May Consolidate, Etc., Only on Certain Terms	  	 	60	  
	 Section 8.02.
	 	Successor Substituted	  	 	61	  
	
	ARTICLE 9	  
	SUPPLEMENTAL INDENTURES	  
			
	 Section 9.01.
	 	Supplemental Indentures Without Consent of Holders	  	 	61	  
	 Section 9.02.
	 	Supplemental Indentures With Consent of Holders	  	 	62	  
	 Section 9.03.
	 	Execution of Supplemental Indentures	  	 	64	  
	 Section 9.04.
	 	Effect of Supplemental Indentures	  	 	64	  
	 Section 9.05.
	 	Conformity with Trust Indenture Act	  	 	64	  
	 Section 9.06.
	 	Reference in Securities to Supplemental Indentures	  	 	64	  
	
	ARTICLE 10	  
	COVENANTS	  
			
	 Section 10.01.
	 	Payment of Principal, Premium and Interest	  	 	64	  
	 Section 10.02.
	 	Maintenance of Office or Agency	  	 	65	  
	 Section 10.03.
	 	Money For Security Payments to Be Held in Trust	  	 	66	  
	 Section 10.04.
	 	Restrictions on Secured Debt	  	 	67	  
	 Section 10.05.
	 	Restrictions on Sales and Leasebacks	  	 	69	  
	 Section 10.06.
	 	Statement as to Compliance	  	 	70	  
	 Section 10.07.
	 	Corporate Existence	  	 	71	  
	 Section 10.08.
	 	Waiver of Certain Covenants	  	 	71	  
	 Section 10.09.
	 	Additional Amounts	  	 	71	  
	 Section 10.10.
	 	Calculation of Original Issue Discount	  	 	72	  
	
	ARTICLE 11	  
	REDEMPTION OF SECURITIES	  
			
	 Section 11.01.
	 	Applicability of This Article	  	 	72	  
	 Section 11.02.
	 	Election to Redeem; Notice to Trustee	  	 	72	  
	 Section 11.03.
	 	Selection by Trustee of Securities to be Redeemed	  	 	72	  
	 Section 11.04.
	 	Notice of Redemption	  	 	73	  
	 Section 11.05.
	 	Deposit of Redemption Price	  	 	74	  
	 Section 11.06.
	 	Securities Payable on Redemption Date	  	 	74	  
	 Section 11.07.
	 	Securities Redeemed in Part	  	 	75	  

  
 iii 

							
	 	 	 	  	PAGE	 
	ARTICLE 12	  
	SINKING FUNDS	  
			
	 Section 12.01.
	 	Applicability of Article	  	 	75	  
	 Section 12.02.
	 	Satisfaction of Sinking Fund Payments with Securities	  	 	75	  
	 Section 12.03.
	 	Redemption of Securities for Sinking Fund	  	 	76	  
	
	ARTICLE 13	  
	MEETINGS OF HOLDERS OF SECURITIES	  
			
	 Section 13.01.
	 	Purposes for which Meetings may be Called	  	 	76	  
	 Section 13.02.
	 	Call, Notice and Place of Meetings	  	 	76	  
	 Section 13.03.
	 	Persons Entitled to Vote at Meetings	  	 	77	  
	 Section 13.04.
	 	Quorum; Action	  	 	77	  
	 Section 13.05.
	 	Determination of Voting Rights; Conduct and Adjournment of Meetings	  	 	78	  
	 Section 13.06.
	 	Counting Votes and Recording Action of Meetings	  	 	79	  
	 Section 13.07.
	 	U.S.A. Patriot Act	  	 	79	  

  
 iv 

 INDENTURE, dated as of
                    , 2014, from CAMPBELL SOUP COMPANY, a New Jersey corporation (hereinafter called the “Company”) having its
principal office at Campbell Place, Camden, New Jersey 08101-0391 to WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking corporation (hereinafter called the “Trustee”). 

RECITALS OF THE COMPANY 

The Company has duly authorized the execution and delivery of this Indenture to provide for the issuance from time to time of its unsecured
debentures, notes or other evidences of indebtedness (hereinafter called the “Securities”), to be issued in one or more series as in this Indenture provided. 

All things necessary to make this Indenture a valid agreement of the Company, in accordance with its terms, have been done. 

NOW, THEREFORE, THIS INDENTURE WITNESSETH: 

For and in consideration of the premises and the purchase of the Securities by the Holders thereof, it is mutually covenanted and agreed, for
the equal and proportionate benefit of all Holders of the Securities or of a series thereof, as follows: 
 ARTICLE 1 

DEFINITIONS AND OTHER PROVISIONS OF GENERAL
APPLICATION 
 Section 1.01. Definitions. For all purposes of this Indenture, except as otherwise expressly
provided or unless the context otherwise requires: 
 (a) the terms defined in this Article have the meanings assigned to them in this
Article, and include the plural as well as the singular, 
 (b) all other term used herein which are defined in the Trust Indenture Act,
either directly or by reference therein, have the meanings assigned to them therein; 
 (c) all accounting terms not otherwise defined
herein have the meanings assigned to them in accordance with generally accepted accounting principles in the United States, and, except as otherwise herein expressly provided, the term “generally accepted accounting principles” with
respect to any computation required or permitted hereunder shall mean such accounting principles which are generally accepted in the United States at the date or time of such computation; and 

(d) the words “herein,” “hereof” and “hereunder” and other words of similar import refer to
this Indenture as a whole and not to any particular Article, Section or other subdivision. 
 Certain terms, used principally in Article
Six, are defined in that Article. 

  
 5 

 “Act”, when used with respect to any Holder, has the meaning specified in
Section 1.04. 
 “Affiliate” of any specified Person means any other Person directly or indirectly controlling or
controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control” when used with respect to any specified Person means the power to direct the management and policies
of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. 

“Attributable Debt” means, as to any particular lease under which any Person is at the time liable and at any date as of
which the amount thereof is to be determined, the total net amount of rent required to be paid by such Person under such lease during the remaining primary term thereof, discounted from the respective due dates thereof to such date at the actual
percentage rate inherent in such arrangement as determined in good faith by the Company. The net amount of rent required to be paid under any such lease for any such period shall be the aggregate amount of the rent payable by the lessee with respect
to such period after excluding amounts required to be paid on account of maintenance and repairs, insurance, taxes, assessments, water rates and similar charges. In the case of any lease which is terminable by the lessee upon the payment of a
penalty, such net amount shall also include the amount of such penalty, but no rent shall be considered as required to be paid under such lease subsequent to the first date upon which it may be so terminated. 

“Authenticating Agent” means any Person authorized by the Trustee pursuant to Section 6.14 to act on behalf of the Trustee to
authenticate Securities of one or more series. 
 “Authorized Newspaper” means a newspaper, in the English language or in
an official language of the country of publication, customarily published on each Business Day, whether or not published on Saturdays, Sundays or holidays, and of general circulation in the place in connection with which the term is used or in the
financial community of such place. Where successive publications are required to be made in Authorized Newspapers, the successive publications may be made in the same or in different newspapers in the same city meeting the foregoing requirements and
in each case on any Business Day. 
 “Authorized Officer”, when used with respect to the Company, means the Chairman of the
Board, the Vice Chairman of the Board, the President, the chief financial officer, the chief legal officer, the Treasurer, a Deputy Treasurer, an Assistant Treasurer, the Controller, an Assistant Controller, the Secretary or an Assistant Secretary
of the Company. 
 “Bearer Security” means any Security substantially in the form for Bearer Securities set forth in
Exhibit B or established pursuant to Section 2.01 which is payable to bearer. 

  
 6 

 “Board of Directors” means either the board of directors of the Company or any
duly authorized committee of that board. 
 “Board Resolution” means a copy of a resolution certified by the Secretary or
an Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification, and delivered to the Trustee. 

“Book-Entry Security” means a Security bearing the legend specified in Section 2.04, evidencing all or part of a series of
Securities, issued to the Depository for such series or its nominee, and registered in the name of such Depository or such nominee. Book-Entry Securities shall not be deemed to be Securities in global form for purposes of Sections 2.01 and 2.03 and
Article 3 of the Indenture. 
 “Business Day”, when used with respect to any Place of Payment or any other particular
location referred to in the Indenture or in the Securities, means each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in that Place of Payment or other location are authorized or obligated by law or
executive order to close, unless otherwise specified for a particular series of Securities. 
 “Capital Stock”, as applied
to the stock of any corporation, means the capital stock of every class whether now or hereafter authorized, regardless of whether such capital stock shall be limited to a fixed sum or percentage with respect to the rights of the holders thereof to
participate in dividends and in the distribution of assets upon the voluntary or involuntary liquidation, dissolution or winding up of such corporation. 

“Clearstream” means Clearstream Banking, société anonyme, or its successor. 

“Commission” means the Securities and Exchange Commission, as from time to time constituted, created under the Exchange Act,
or if at any time after the execution of this instrument such Commission is not existing and performing the duties now assigned to it under the Trust Indenture Act, then the body performing such duties at such time. 

“Common Depository” has the meaning specified in Section 3.04. 

“Company” means the Person named as the “Company” in the first paragraph of this instrument until a
successor Person shall have become such pursuant to the applicable provisions of this Indenture, and thereafter “Company” shall mean such successor Person. 

“Company Request” and “Company Order” mean, respectively, a written request or order signed in the name of
the Company by two Authorized Officers of the Company, and delivered to the Trustee. 
 “Consolidated Net Assets” means
total assets after deducting therefrom all current liabilities as set forth on the most recent balance sheet of the Company and its consolidated subsidiaries and computed in accordance with generally accepted accounting principles. 

  
 7 

 “Corporate Trust Office” means the designated office of the Trustee at which at
any time its corporate trust business shall be administered, which office at the date hereof is located at 150 East 42nd Street, 40th Floor, New York, New York 10017, Attention: Corporate Trust Services – Administrator for Campbell Soup
Company, or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the designated corporate trust office of any successor Trustee (or such other address as such successor Trustee may designate
from time to time by notice to the Holders and the Company). 
 “coupon” means any interest coupon appertaining to a Bearer
Security. 
 “Defaulted Interest” has the meaning specified in Section 3.07. 

“Depository” means with respect to the Securities of any series issuable or issued in whole or in part in the form of one or
more Book-Entry Securities, the clearing agency registered under the Exchange Act, specified for that purpose contemplated by Section 3.01. 

“Dollar” or “$” means a dollar or other equivalent unit in such coin or currency of the United States as at
the time shall be legal tender for the payment of public and private debts. 
 “Euroclear” means the operator of the
Euroclear System. 
 “Event of Default” has the meaning specified in Section 5.01. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and as it may be further amended from time to time.

 “Exchange Date” has the meaning specified in Section 3.04. 

“Funded Debt” means (i) all indebtedness for money borrowed having a maturity of more than 12 months from the date as of
which the determination is made or having a maturity of 12 months or less but by its terms being renewable or extendible beyond 12 months from such date at the option of the borrower and (ii) rental obligations payable more than 12 months from
such date under leases which are capitalized in accordance with generally accepted accounting principles (such rental obligations to be included as Funded Debt at the amount so capitalized and to be included for the purposes of the definition of
Consolidated Net Assets both as an asset and as Funded Debt at the amount so capitalized). 
 “Holder” means in the case of
a Registered Security the Person in whose name the Security is registered in the Security Register and in the case of a Bearer Security, or any related coupon, the bearer thereof. 

“Indenture” means this instrument as originally executed or as it may from time to time be supplemented or amended by one or
more indentures supplemental hereto entered into pursuant to the applicable provisions hereof and shall include the terms of a particular series of Securities established as contemplated by Section 3.01. 

  
 8 

 “interest”, when used with respect to an Original Issue Discount Security which
by its terms bears interest only after Maturity, means interest payable after Maturity. 
 “Interest Payment Date”, when
used with respect to any Security, means the Stated Maturity of an installment of interest on such Security. 
 “Judgment
Currency” has the meaning specified in Section 1.15. 
 “Maturity”, when used with respect to any Security, means
the date on which the principal of such Security or an installment of principal becomes due and payable as therein or, herein provided, whether at the Stated Maturity or by declaration of acceleration, call for redemption or otherwise. 

“New York Business Day” means any day which is not a Saturday, Sunday, or a day on which commercial banking institutions are
authorized or obligated by law, regulation or executive order to be closed in the City of New York. 
 “Officers’
Certificate” means a certificate signed by two Authorized Officers of the Company and delivered to the Trustee. 
 “Opinion
of Counsel” means a written opinion of counsel, who may be an employee of or counsel to the Company reasonably satisfactory to the Trustee. 

“Original Issue Discount Security” means any Security which provides for an amount less than the principal amount thereof to
be due and payable upon a declaration of acceleration of the Stated Maturity thereof pursuant to Section 5.02. 

“Outstanding”, when used with respect to Securities of all Series or Securities of any series means, as of the date of
determination, all such Securities theretofore authenticated and delivered under this Indenture, except: 
 (i) Such
Securities theretofore cancelled by the Trustee or delivered to the Trustee for cancellation; 
 (ii) Such Securities or
portions thereof for whose payment or redemption (a) money in the necessary amount has been theretofore deposited in trust with the Trustee or any Paying Agent (other than the Company) or set aside and segregated in trust by the Company (if the
Company shall act as its own Paying Agent) for the Holders of such Securities and any coupons appertaining thereto or (b) U.S. Government Obligations as contemplated by Section 4.03 in the necessary amount have been theretofore deposited in
satisfaction of the requirements of Section 4.03 with the Trustee (or another trustee satisfying the requirements of Section 6.09) in trust for the Holders of such Securities and any coupons thereto appertaining in accordance with Section 4.02;
provided that, if such Securities are to be redeemed, notice of such redemption has been duly given pursuant to this Indenture or provision therefor satisfactory to the Trustee has been made; and 

  
 9 

 (iii) Such Securities which have been paid pursuant to Section 3.06 or in
exchange for or in lieu of which other Securities have been authenticated and delivered pursuant to this Indenture other than any such Securities in respect of which there shall have been presented to the Trustee proof satisfactory to it that such
Securities are held by a bona fide purchaser in whose hands such Securities are valid obligations of the Company; 
 provided, however,
that in determining whether the Holders of the requisite principal amount of such Outstanding Securities have given any request, demand, authorization direction, notice, consent or waiver hereunder or whether a quorum is present at a meeting of
Holders of such Securities, (i) the principal amount of an Original Issue Discount Security that shall be deemed to be Outstanding shall be the amount of the principal thereof that would be due and payable as of the date of such determination
upon acceleration of the Stated Maturity thereof pursuant to Section 5.02, (ii) the principal amount of Securities denominated in more than one currency (including composite currencies) shall be the U.S. Dollar equivalent (determined,
unless otherwise provided as contemplated by Section 3.01, on the basis of the spot rate of exchange, on the date of such determination, for any currency other than Dollars as determined by the Company or by an authorized exchange rate agent and
evidenced to the Trustee by an Officers’ Certificate) of the principal amount (or, in the case of an Original Issue Discount Security, the U.S. Dollar equivalent on the date of such determination of the amount determined as provided in
(i) above) of such Securities, and (iii) Securities owned by the Company or any other obligor upon the Securities or any Affiliate of the Company or such other obligor shall be disregarded and deemed not to be Outstanding, except that, in
determining whether the Trustee shall be protected in relying upon any such request, demand, authorization, direction, notice, consent or waiver, or upon any such determination as to the presence of a quorum only Securities which a Responsible
Officer of the Trustee actually knows to be so owned shall be so disregarded. Securities so owned which have been pledged in good faith may be regarded as Outstanding if the pledgee establishes to the satisfaction of the Trustee the pledgee’s
right so to act with respect to such Securities and that the pledgee is not the Company or any other obligor upon the Securities or any Affiliate of the Company or such other obligor. For purposes of clause (ii) above, an exchange rate agent
may be authorized in advance or from time to time by the Company, and may be the Trustee. Any such determination by the Company or by any such exchange rate agent shall be conclusive and binding on all Holders of Securities and related coupons, if
any, and the Trustee, and neither the Company nor such exchange rate agent shall be liable therefor in the absence of willful misconduct; and 

“Paying Agent” means any Person (including the Company) authorized by the Company to pay the principal of (and premium, if
any) or interest, if any, of any Securities on behalf of the Company. 

  
 10 

 “Person” means any individual, corporation, partnership, joint venture,
association, joint-stock company, trust, unincorporated organization or government or any agency or political subdivision thereof. 

“Place of Payment”, when used with respect to any series of Securities or any coupons, means the place or places where,
subject to the provisions of Section 10.02, the principal of (and premium, if any) and interest, if any, on the Securities of that series are payable as specified as contemplated by Section 3.01. 

“Predecessor Security” of any particular Security means every previous Security evidencing all or a portion of the same debt
as that evidenced by such particular Security, and, for the purposes of this definition, any Security authenticated and delivered under Section 3.06 in exchange for or in lieu of a mutilated, destroyed, lost or stolen Security or the Security to
which the mutilated, destroyed, lost or stolen coupon appertains, as the case may be, shall be deemed to evidence the same debt as the mutilated, destroyed, lost or stolen Security or the Security to which the mutilated, destroyed, lost or stolen
coupon appertains, as the case may be. 
 “Principal Property” means (a) any manufacturing or processing plant or warehouse
owned at the date hereof or hereafter acquired by the Company or any Restricted Subsidiary of the Company which is located within the United States of America and the gross book value (including related land and improvements thereon and all
machinery and equipment included therein without deduction of any depreciation reserves) of which on the date as of which the determination is being made exceeds 2% of Consolidated Net Assets, other than (i) any property which in the opinion of
the Board of Directors is not of material importance to the total business conducted by the Company as an entirety or (ii) any portion of a particular property which is similarly found not to be of material importance to the use or operation of
such property. 
 “Realty Subsidiary” means a Subsidiary of the Company engaged primarily in the development and sale or
financing of real property. 
 “Redemption Date”, when used with respect to any Security to be redeemed, means the date
fixed for such redemption by or pursuant to this Indenture. 
 “Redemption Price”, when used with respect to any Security
to be redeemed, means the price at which it is to be redeemed pursuant to this Indenture or in such Security (including any premium with respect thereto). 

“Registered Security” means any Security substantially in the form for Registered Securities set forth in Exhibit A or
established pursuant to Section 2.01 which is registered in the Security Register. 
 “Regular Record Date” for the
interest payable on any Interest Payment Date on the Registered Securities of any series means the date specified for that purpose as contemplated by Section 3.01. 

“Required Currency” has the meaning specified in Section 1.15. 

  
 11 

 “Responsible Officer”, when used with respect to the Trustee, means any officer
within the corporate trust department of the Trustee (or any successor group of the Trustee) including any vice president, assistant vice president, assistant treasurer, assistant secretary or any other officer or assistant officer of the Trustee
customarily performing functions similar to those performed by the persons who at the time shall be such officers, respectively, or to whom any corporate trust matter is referred at the Trustee’s principal Corporate Trust Office because of his
knowledge of and familiarity with the particular subject. 
 “Restricted Subsidiary” means a Subsidiary of the Company
(i) substantially all the property of which is located, or substantially all the business of which is carried on, within the United States of America and (ii) which owns a Principal Property, but does not include a Realty Subsidiary. 

“Securities” has the meaning stated in the first recital of this Indenture and more particularly means any Securities
authenticated and delivered under this Indenture. 
 “Security Register” and “Security Registrar” have the
respective meanings specified in Section 3.05. 
 “Special Record Date” for the payment of any Defaulted Interest on the
Registered Securities of any series means a date fixed by the Trustee pursuant to Section 3.07. 
 “Stated Maturity”, when
used with respect to any Security or any installment of principal thereof or interest thereon, means the date specified in such Security or a coupon representing such installment of interest as the fixed date on which the principal of such Security
or such installment of principal or interest is due and payable. 
 “Subsidiary” means any corporation more than 50% of the
outstanding Voting Stock of which at the time of determination is owned, directly or indirectly, by the Company and/or one or more other Subsidiaries. 

“Trustee” means the Person named as the “Trustee” in the first paragraph of this instrument until a
successor trustee shall have become such pursuant to the applicable provisions of this Indenture, and thereafter “Trustee” shall mean or include each Person who is then a Trustee hereunder, and if at any time there is more than one
such Person, “Trustee” as used with respect to the Securities of any series shall mean the Trustee with respect to Securities of that series. 

“Trust Indenture Act” means the Trust Indenture Act of 1939, as amended, and as it may be further amended from time to time.

 “United States” means the United States of America (including the States and the District of Columbia), its territories
and possessions and other areas subject to its jurisdiction. 

  
 12 

 “United States Alien” means any Person who, for United States Federal income tax
purposes, is a foreign corporation, a non-resident alien individual, a non-resident alien fiduciary of a foreign estate or trust, or a foreign partnership one or more of the members of which is, for United States Federal income tax purposes, a
foreign corporation, a non-resident alien individual or non-resident alien fiduciary of a foreign estate or trust. 
 “U.S.
Government Obligations” means securities which are (i) direct obligations of the United States of America for the payment of which its full faith and credit is pledged or (ii) obligations of a Person controlled or supervised by
and acting as an agency or instrumentality of the United States of America the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America, which, in either case, are not callable or
redeemable at the option of the issuer thereof, and shall also include a depository receipt issued by a bank or trust company as custodian with respect to any such obligation evidenced by such depository receipt or a specific payment of interest on
or principal of any such obligation held by such custodian for the account of the holder of a depository receipt; provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the
holder of such depository receipt from any amount received by the custodian in respect of the obligation set forth in (i) or (ii) above or the specific payment of interest on or principal of such obligation evidenced by such depository
receipt. 
 “Voting Stock” means Capital Stock of a corporation of the class or classes having general voting power under
ordinary circumstances to elect at least a majority of the board of directors, managers or trustees of such corporation (irrespective of whether or not at the time stock of any other class or classes shall have or might have voting power upon the
occurrence of any contingency). 
 Section 1.02. Compliance Certificates and Opinions. Upon any application or request by the
Company to the Trustee to take any action under any provision of this Indenture, the Company shall furnish to the Trustee an Officers’ Certificate stating that all conditions precedent, if any, provided for in this Indenture relating to the
proposed action have been complied with and an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent, if any, have been complied with, except that in the case of any such application or request as to which the
furnishing of such documents is specifically required by any provision of this Indenture relating to such particular application or request, no additional certificate or opinion need be furnished. 

Every certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture shall include: 

(a) a statement that each individual signing such certificate or opinion has read such condition or covenant and the definitions herein
relating thereto; 
 (b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or
opinions contained in such certificate or opinion are based; 

  
 13 

 (c) a statement that, in the opinion of each such individual, he has made such examination or
investigation as is necessary to enable him to express an informed opinion as to whether or not such condition or covenant has been complied with; and 

(d) a statement as to whether, in the opinion of each such individual, such condition or covenant has been complied with. 

Section 1.03. Form of Documents Delivered to Trustee. In any case where several matters are required to be certified by, or
covered by an opinion of, any specified Person, it is not necessary that all such matters be certified by, or covered by the opinion of, only one such Person, or that they be so certified or covered by only one document, but one such Person may
certify or give an opinion with respect to some matters and one or more other such Persons as to other matters, and any such Person may certify or give an opinion as to such matters in one or several documents. 

Any certificate or opinion of an officer of the Company may be based, insofar as it relates to legal matters, upon a certificate or opinion
of, or representations by, counsel, unless such officer knows, or in the exercise of reasonable care should know, that the certificate or opinion or representations with respect to the matters upon which his certificate or opinion is based are
erroneous. 
 Any such certificate or Opinion of Counsel may be based, insofar as it relates to factual matters, upon a certificate or
opinion of, or representations by, an Authorized Officer or Authorized Officers, of the Company stating that the information with respect to such factual matters is in the possession of the Company, unless such counsel knows, or in the exercise of
reasonable care should know, that the certificate or opinion or representations with respect to such matters are erroneous. 
 Where any
Person is required to make, give or execute two or more applications, requests, consents, certificates, statements, opinions or other instruments under this Indenture, they may, but need not, be consolidated and form one instrument. 

Section 1.04. Acts of Holders. (a) Any request, demand, authorization, direction, notice, consent, waiver or other
action provided by this Indenture to be given or taken by Holders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Holders in person or by an agent duly appointed in writing. If Securities of
a series are issuable as Bearer Securities, any request, demand, authorization, direction, notice, consent, waiver or other action provided by this Indenture to be given or taken by Holders of such series may, alternatively, be embodied in and
evidenced by the record of Holders of Securities of such series voting in favor thereof, either in person or by proxies duly appointed in writing, at any meeting of Holders of Securities of such series duly called and held in accordance with the
provisions of Article Thirteen, or a combination of such instruments and any such record. Except as herein otherwise expressly provided, such action shall become effective when such instrument or instruments or record, or both, are delivered to the
Trustee and, where it is hereby expressly required, to the Company. Such instrument or instruments and any such record (and the action embodied therein and evidenced thereby) are herein sometimes referred to 

  
 14 

 
as the “Act” of the Holders signing such instrument or instruments or so voting at any such meeting. Proof of execution of any such instrument or of a writing appointing any
such agent or proxy, or of the holding by any Person of a Security, shall be sufficient for any purpose of this Indenture and (subject to Section 6.01) conclusive in favor of the Trustee and the Company and any agent of the Company, if made in the
manner provided in this Section. The record of any meeting of Holders of Securities shall be proved in the manner provided in Section 13.06. 

(b) The fact and date of the execution by any Person of any such instrument or writing may be proved by the affidavit of a witness of such
execution or by a certificate of any notary public or other officer authorized by law to take acknowledgments of deeds, certifying that the individual signing such instrument or writing acknowledged to him the execution thereof. Where such execution
is by an officer of a corporation or association or a member of a partnership, or an official of a public or governmental body, on behalf of such corporation, association, partnership or public or governmental body or by a fiduciary, such
certificate or affidavit shall also constitute sufficient proof of his authority. The fact and date of the execution by any Person of any such instrument or writing, or the authority of the Person executing the same, may also be proved in any other
manlier which shall be satisfactory to the Trustee. 
 (c) The principal amount and serial numbers of Registered Securities held by any
Person, and the date of holding the same, shall be proved by the Security Register. 
 (d) The principal amount and serial numbers of Bearer
Securities held by any Person, and the date of holding the same, may be proved by the production of such Bearer Securities or by a certificate executed, by any trust company, bank, banker or other depositary, as depositary, wherever situated, if
such certificate shall be satisfactory to the Trustee, showing that at the date therein mentioned such Person had on deposit with such depositary, or exhibited to it, the Bearer Securities therein described; or such facts may be proved by the
certificate or affidavit of the Person holding such Bearer Securities, if such certificate or affidavit shall be satisfactory to the Trustee. The Trustee and the Company may assume that such ownership of any Bearer Security continues until
(i) another certificate or affidavit bearing a later date issued in respect of the same Bearer Security is produced, or (ii) such Bearer Security is produced to the Trustee by some other Person, or (iii) such Bearer Security is
surrendered in exchange for a Registered Security, or (iv) such Bearer Security is no longer Outstanding. The principal amount and serial numbers of Bearer Securities held by any Person, and the date of holding the same, may also be proved in
any other manner which shall be satisfactory to the Trustee. 
 (e) Any request, demand, authorization, direction, notice, consent, waiver
or other action by the Holder of any Security shall bind every future Holder of the same Security and the Holder of every Security issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof in respect of anything
done or suffered to be done by the Trustee or the Company in reliance thereon, whether or not notation of such action is made upon such Security. 

  
 15 

 (f) With respect to the Securities of any Series, upon receipt by the Trustee of
(i) any written notice directing the time, method or place of conducting any proceeding or exercising any trust or power pursuant to Section 5.12 with respect to Securities of such series or (ii) any written demand, request or notice with
respect to any matter of which the Holders of Securities of such series are entitled to act under this Indenture, in each case from Holders of less than, or proxies representing less than, the requisite principal amount of Outstanding Securities of
such series entitled to give such demand, request or notice, the Trustee shall promptly notify the Company in writing that it has received such demand, request or notice, and the Company shall establish a record date for determining Holders of
Outstanding Securities of such series entitled to join in such demand, request or notice, which record date shall be the close of business on the day the Trustee received such demand, request or notice. The Holders on such record date, or their duly
designated proxies, and only such Persons, shall be entitled to join in such demand, request or notice whether or not such Holders remain Holders after such record date; provided, however, that unless the Holders of the requisite
principal amount of Outstanding Securities of such series shall have joined in such demand, request or notice prior to the day which is the ninetieth day after such record date, such demand, request or notice shall automatically and without further
action by any Holder be canceled and of no further effect. Nothing in this paragraph shall prevent a Holder, or a proxy of a Holder, from giving, (i) after the expiration of such 90-day period, a new demand, request or notice identical to a
demand, request or notice which has been cancelled pursuant to the proviso to the preceding sentence or (ii) during any such 90-day period, a new demand, request or notice which has been cancelled pursuant to the proviso to the preceding
sentence or (iii) during any such 90-day period, a new demand, request or notice contrary to or different from such demand, request or notice, in any of which events a new record date shall be established pursuant to the provisions of this
clause. 
 (g) The Company may set any day as the record date for the purpose of determining the Holders of Outstanding Securities of
any series entitled to give or take any request, demand, authorization, direction, notice, consent, waiver or other action provided or permitted by this Indenture to be given or taken by Holders of Securities of such series. With regard to any
record date set pursuant to this paragraph, the Holders of Outstanding Securities of the relevant series on such record date (or their duly appointed agents), and only such Persons, shall be entitled to give or take the relevant action, whether or
not such Holders remain Holders after such record date. With regard to any action that may be given or taken hereunder only by Holders of a requisite principal amount of Outstanding Securities of any series (or their duly appointed agents) and for
which a record date is set pursuant to this paragraph, the Company may, at its option, set an expiration date after which no such action purported to be given or taken by any Holder shall be effective hereunder unless given or taken on or prior to
such expiration date by Holders of the requisite principal amount of Outstanding Securities of such series on such date (or their duly appointed agents). On or prior to any expiration date set pursuant to this paragraph, the Company may, on one or
more occasions at its option, extend such date to any later date. Nothing in this paragraph shall prevent any Holder (or any duly appointed agent thereof) from giving or taking, after any expiration date, any action identical to, or, at any time,
contrary to or different from, any action, given or taken, or purported to have been given or taken, hereunder by a Holder on or prior to 

  
 16 

 
such date, in which event the Company may set a record date in respect thereof pursuant to this paragraph. Notwithstanding the foregoing or the Trust Indenture Act, the Company shall not set a
record date for, and the provisions of this paragraph shall not apply with respect to, any action to be given or taken by Holders pursuant to Section 5.01, 5.02 or 5.12. 

Section 1.05. Notices, Etc., to Trustee and Company. Any request, demand, authorization, direction, notice, consent, waiver
or Act of Holders or other document provided or permitted by this Indenture to be made upon, given or furnished to, or filed with, 

(a) the Trustee by any Holder or by the Company shall be sufficient for every purpose hereunder if made, given, furnished or filed in writing
to or with the Trustee at its Corporate Trust Office; or 
 (b) the Company by the Trustee or by any Holder shall be sufficient for
every purpose hereunder (unless otherwise herein expressly provided) if in writing and mailed, first-class postage prepaid, to the Company addressed to it at the address of its principal office specified in the first paragraph of this instrument, to
the attention of the Corporate Secretary or at any other address previously furnished in writing to the Trustee by the Company; provided, however, that such instrument will be considered properly given if submitted by facsimile. 

Notwithstanding the foregoing, the Trustee agrees to accept and act upon instructions or directions pursuant to this Indenture sent by
unsecured e-mail, facsimile transmission or other similar unsecured electronic methods; provided, however, that (a) the party providing such written instructions, subsequent to such transmission of written instructions, shall provide the
originally executed instructions or directions to the Trustee in a timely manner, and (b) such originally executed instructions or directions shall be signed by an authorized representative of the party providing such instructions or directions. If
the party elects to give the Trustee e-mail or facsimile instructions (or instructions by a similar electronic method) and the Trustee in its discretion elects to act upon such instructions, the Trustee’s understanding of such instructions
shall be deemed controlling. The Trustee shall not be liable for any losses, costs or expenses arising directly or indirectly from the Trustee’s reliance upon and compliance with such instructions notwithstanding such instructions conflict or
are inconsistent with a subsequent written instruction. The party providing electronic instructions agrees to assume all risks arising out of the use of such electronic methods to submit instructions and directions to the Trustee, including without
limitation the risk of the Trustee acting on unauthorized instructions, and the risk or interception and misuse by third parties. 

Section 1.06. Notice to Holders; Waiver. Except as otherwise expressly provided herein, where this Indenture provides for
notice to Holders of any event, 
 (a) such notice shall be sufficiently given to Holders of Registered Securities if in writing and
mailed, first-class postage prepaid, to each Holder of a Registered Security affected by such event, at his address as it appears in the Security Register, not later than the latest date, and not earlier than the earliest date, prescribed for the
giving of such notice; 

  
 17 

 (b) such notice shall be sufficiently given to Holders of Bearer Securities if published in an
Authorized Newspaper in the City of New York and in such other city or cities as may be specified in such Securities on a Business Day at least once, the first such publication to be not earlier than the earliest date, and not later than the latest
date, prescribed for the giving of such notice. 
 If, by reason of the suspension of regular mail service, it shall be impracticable to
mail notice of any event to Holders of Registered Securities when such notice is required to be given pursuant to any provision of this Indenture, then such manner of giving such notice as shall be acceptable to the Trustee shall constitute
sufficient giving of such notice. In any case where notice to Holders of Registered Securities is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to any particular Holder of a Registered Security shall
affect the sufficiency of such notice with respect to other Holders of Registered Securities or the sufficiency of any notice with respect to Holders of Bearer Securities given as provided herein. 

If, by reason of the suspension of publication of any Authorized Newspaper or Authorized Newspapers or by reason of any other cause it shall
be impracticable to publish any notice to Holders of Bearer Securities as provided above, then such notification to Holders of Bearer Securities as shall be given in a manner satisfactory to the Trustee shall constitute sufficient notice to such
Holders for every purpose hereunder. Neither the failure to give notice by publication to Holders of Bearer Securities as provided above, nor any defect in any notice so published, shall affect the sufficiency of any notice to Holders of Registered
Securities given as provided herein. 
 Where this Indenture provides for notice in any manner, such notice may be waived in writing by the
Person entitled to receive such notice, either before or after the event, and such waiver shall be the equivalent of such notice. Waivers of notice by Holders shall be filed with the Trustee, but such filing shall not be a condition precedent to the
validity of any action taken in reliance upon such waiver. 
 Section 1.07. Language of Notices, Etc. Any request,
demand, authorization, direction, notice, consent, waiver, Act of Holders or other document required or permitted under this Indenture shall be in the English language, except that any published notice may be in an official language of the country
of publication. 
 Section 1.08. Conflict with Trust Indenture Act. If any provision hereof limits, qualifies or
conflicts with another provision hereof which is required to be included in this Indenture by any of the provisions of the Trust Indenture Act, such required provision shall control.  

Section 1.09. Effect of Headings and Table of Contents. The Article and Section headings herein and the Table of Contents
are for convenience only and shall not affect the construction hereof. 

  
 18 

 Section 1.10. Successors and Assigns. All covenants and agreements in this
Indenture by the Company shall bind its successors and assigns, whether so expressed or not. 
 Section 1.11. Separability
Clause. In case any provision in this Indenture or the Securities or coupons shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

 Section 1.12. Benefits of Indenture. Nothing in this Indenture or the Securities or coupons, expressed or implied,
shall give to any Person, other than the parties hereto, their successors hereunder and the Holders of Securities or coupons, any benefit or any legal or equitable right, remedy or claim under this Indenture. 

Section 1.13. Governing Law. This Indenture and the Securities and any coupons shall be governed by and construed in accordance
with the laws of the State of New York without giving effect to the conflicts of laws provisions thereof. 
 Section 1.14.
Legal Holidays. In any case where any Interest Payment Date, Redemption Date, sinking fund payment date or Stated Maturity or Maturity of any Security shall not be a Business Day at any Place of Payment, then (notwithstanding any other
provision of this Indenture or of the Securities or coupons other than a provision in the Securities of any series which specifically states that such provision shall apply in lieu of this Section) payment of principal (and premium, if any) or
interest, if any, need not be made at such Place of Payment on such date, but may be made on the next succeeding Business Day at such Place of Payment with the same force and effect as if made on the Interest Payment Date or Redemption Date, or at
the Stated Maturity or Maturity, provided that no interest shall accrue on the amount so payable for the period from and after such Interest Payment Date, Redemption Date, Stated Maturity or Maturity, as the case may be to such succeeding
business day. 
 Section 1.15. Judgment Currency. The Company agrees, to the fullest extent that it may
effectively do so under applicable law, that (a) if for the purpose of obtaining judgment in any court it is necessary to convert the sum due on the Securities of any series from the currency in which such sum is payable in accordance with the
terms of such Securities (the “Required Currency”) into a currency in which a judgment will be rendered (the “Judgment Currency”), the rate of exchange used shall be the rate at which in
accordance with normal banking procedures the Trustee could purchase in the City of New York the Required Currency with the Judgment Currency on the New York Business Day preceding that on which a final unappealable judgment is rendered and (b) its
obligations under this Indenture to make payments in the Required Currency (i) shall not be discharged or satisfied by any tender, or any recovery pursuant to any judgment (whether or not entered in accordance with subsection (a)), in any
currency other than the Required Currency, except to the extent that such tender or recovery shall result in the actual receipt, by the payee, of the full amount of the Required Currency expressed to be payable in respect of such payments,
(ii) shall be enforceable as an alternative or additional cause of action for the purpose of recovering in the Required Currency the  

  
 19 

 
amount, if any, by which such actual receipt shall fall short of the full amount of the Required Currency so expressed to be payable and (iii) shall not be affected by judgment being
obtained for any other sum due under this Indenture. 
 Section 1.16. Immunity of Incorporators, Shareholders, Officers,
Directors and Employees. (a) No recourse under or upon any obligation, covenant or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect thereof, shall be had against any incorporator,
shareholder, officer, director or employee, as such, past, present or future, of the Company or of any successor corporation, either directly or through the Company, whether by virtue of any constitution, statute or rule of law, or by the
enforcement of any assessment or penalty or otherwise; it being expressly understood that this Indenture and the obligations issued hereunder are solely corporate obligations of the Company, and that no such personal liability whatever shall attach
to, or is or shall be incurred by, the incorporators, shareholders, officers, directors or employees, as such, of the Company or of any successor corporation, or any of them, because of the creation of the indebtedness hereby authorized, or under or
by reason of the obligations or agreements contained in this Indenture or in any of the Securities or implied therefrom; and that any and all such personal liability, either at common law or in equity or by constitution or statute, of, and any and
all such rights and claims against, every such incorporator, shareholder, officer, director or employee, as such, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations or agreements contained in this
Indenture or in any of the Securities or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issue of such Securities. 

(b) All payments of interest and other amounts, if any, to be made by the Trustee hereunder shall be made only from the money deposited with
the Trustee and only to the extent that the Trustee shall have sufficient income or proceeds to make such payments in accordance with the terms of this Indenture, and each Holder hereof, by its acceptance of a Security, agrees that it will look
solely to the income and proceeds deposited by the Company with the Trustee to the extent available for distribution to the Holder thereof as provided and that the Trustee is not personally liable in any manner to the Holder hereof for any amounts
payable or any liability under this Indenture of any Security. 
 ARTICLE 2 

SECURITY FORMS 

Section 2.01. Forms Generally. The Registered Securities, if any, of each series and the Bearer Securities, if any, of each
series and related coupons, if any, shall be in substantially the form set forth in Exhibit A and Exhibit B to this Indenture, respectively, or in such other form (including temporary or permanent global form) as shall be established in one or more
indentures supplemental hereto or approved from time to time by or pursuant to a Board Resolution in accordance with Section 3.01, in each case with such appropriate insertions, omissions, substitutions and other variations as are required or
permitted by this Indenture and may have such letters, numbers or other marks of identification and such legends or endorsements placed thereon as may be required to  

  
 20 

 
comply with the rules of any securities exchange or as may, consistently herewith, be determined by the officers executing such Securities and coupons, if any, as evidenced by their execution of
the Securities and coupons, if any. If the forms of Securities and coupons, if any, of any series (or the form of any such temporary or permanent global Security) are established by action taken pursuant to a Board Resolution, a copy of an
appropriate record of such action shall be certified by the Secretary or an Assistant Secretary of the Company and delivered to the Trustee at or prior to the delivery of the Company Order contemplated by Section 3.03 for the authentication and
delivery of such Securities or coupons (or any such temporary or permanent global Security). 
 Unless otherwise provided as contemplated by
Section 3.01 with respect to any series of Securities, the Securities of each series shall be issuable in registered form without coupons. If so provided as contemplated by Section 3.01, the Securities of a series also shall be issuable in bearer
form, with interest coupons, if any, attached. 
 The definitive Securities and coupons, if any, shall be printed, lithographed or engraved
or produced by any combination of these methods on steel engraved borders or may be produced in any other manner permitted by the rules of any securities exchange on which the Securities may be listed, all as determined by the officers executing
such Securities and coupons, if any, as evidenced by their execution of such Securities and coupons, if any. 
 Section 2.02.
Form of Trustee’s Certificate of Authentication. The Trustee’s certificate of authentication shall be in substantially the following form: 

This is one of the Securities of the series designated herein referred to in the within mentioned Indenture. 

 

			
	 WELLS FARGO BANK, NATIONAL

    ASSOCIATION, as Trustee

		
	By:	 	  

		 	Authorized Signatory

 Section 2.03. Securities in Global Form. If Securities of a series are issuable in
global form, as specified as contemplated by Section 3.01, then, notwithstanding clause (h) of Section 3.01 and the provisions of Section 3.02, any such Security shall represent such of the Outstanding Securities of such series as shall be specified
therein and may provide that it shall represent the aggregate amount of Outstanding Securities from time to time endorsed thereon and that the aggregate amount of Outstanding Securities represented thereby may from time to time be reduced to reflect
exchanges. Any endorsement of a Security in global form to reflect the amount, or any decrease in the amount, of Outstanding Securities represented thereby shall be made by the Trustee in such manner and upon instructions given by such Person or
Persons as shall be specified therein or in the Company Order to be delivered to the Trustee pursuant to Section 3.03  

  
 21 

 
or 3.04. Subject to the provisions of Section 3.03 and, if applicable, Section 3.04, the Trustee shall deliver and redeliver any Security in permanent global form in the manner and upon
instructions given by the Person or Persons specified therein or in the applicable Company Order. If a Company Order pursuant to Section 3.03 or 3.04 has been, or simultaneously is, delivered, any instructions by the Company with respect to
endorsement or delivery or redelivery of a Security in global form shall be in writing but need not comply with Section 1.02 and need not be accompanied by an Opinion of Counsel. 

The provisions of the last sentence of Section 3.03 shall apply to any Security represented by a Security in global form if such Security was
never issued and sold by the Company, and the Company delivers to the Trustee the Security in global form together with written instructions in the form of an Officers’ Certificate upon which the Trustee may conclusively rely, and which need
not be accompanied by an Opinion of Counsel, with regard to the reduction in the principal amount of Securities represented thereby, together with the Officers’ Certificate contemplated by the last sentence of Section 3.03. 

Notwithstanding the provisions of Sections 2.01 and 3.07, payment of principal of (and premium, if any) and interest, if any, on any Security
in permanent global form shall be made to the Person in whose name such Security is registered in the Trustee’s Security Register. 

Notwithstanding the provisions of Section 3.08, the Company, the Trustee and any agent of the Company and the Trustee shall treat as the
Holder a Person in whose name such Security is registered in the Trustee’s Security Register or, in the case of a permanent global Security in bearer form, a Person specified in a written statement of Euroclear or Clearstream, which is produced
to the Trustee by such Person. 
 Section 2.04. Form of Legend for Book-Entry Securities. Any Book-Entry Security
authenticated and delivered hereunder shall bear a legend in substantially the following form: 
 If a Book-Entry Security –
“This Security is a Book-Entry Security within the meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a Depository. This Security is exchangeable for Securities registered in the name
of a Person other than the Depository or its nominee only in the limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of this Security as a whole by the Depository to a nominee of the Depository
or by a nominee of the Depository to the Depository or another nominee of the Depository) may be registered except in such limited circumstances.” 

ARTICLE 3 
 THE
SECURITIES 
 Section 3.01. Amount Unlimited; Issuable in Series. The aggregate principal amount of
Securities which may be authenticated and delivered under this Indenture is unlimited. 

  
 22 

 The Securities may be issued in one or more series. There shall be established in or pursuant to
a Board Resolution, and, subject to Section 3.03, set forth in an Officers’ Certificate, or established in one or more indentures supplemental hereto, prior to the issuance of Securities of any series, 

(a) the title of the Securities of the series (which shall distinguish the Securities of the series from all other Securities); 

(b) any limit upon the aggregate principal amount of the Securities of the series which may be authenticated and delivered under this
indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of the series pursuant to Sections 3.04, 3.05, 3.06, 9.06 or 11.07 and except for any Securities
which, pursuant to Section 3.03 are deemed never to have been authenticated and delivered hereunder); 
 (c) the date or dates, or the
method by which such date or dates will be determined or extended, on which the principal of the Securities of the series is payable; 
 (d)
the rate or rates (which may be fixed or floating) at which the Securities of the series shall bear interest, if any, the date or dates from which such interest shall accrue, the Interest Payment Dates on which such interest shall be payable and the
Regular Record Date for the interest payable on Registered Securities on any Interest Payment Date or the formula or method by which such rate or rates, or date or dates may be determined; 

(e) the place or places where, subject to the provisions of Section 10.02, the principal of (and premium, if any) and interest, if any, on
Securities of the series shall be payable, any Registered Securities of the series may be surrendered for registration of transfer, Securities of the series may be surrendered for exchange and notices and demands to or upon the Company in respect of
the Securities of the series and this Indenture may be served; 
 (f) the period or periods within which, the price or prices at which and
the terms and conditions upon which Securities of the series may be redeemed, in whole or in part, at the option of the Company; 
 (g) the
obligation, if any, of the Company to redeem or purchase Securities of the series pursuant to any sinking fund or analogous provisions or at the option of a Holder thereof and the period or periods within which, the price or prices at which and the
terms and conditions upon which Securities of the series shall be redeemed or purchased, in whole or in part, pursuant to such obligation; 

(h) the denominations in which any Registered Securities of the series shall be issuable, if other than denominations of $1,000 and any
integral multiple thereof, and the denomination or denominations in which any Bearer Securities of the series shall be issuable, if other than the denomination of $5,000; 

  
 23 

 (i) if other than the principal amount thereof, the portion of the principal amount of Securities
of the series which shall be payable upon declaration of acceleration of the Stated Maturity thereof pursuant to Section 5.02; 
 (j) any
paying agents, transfer agents, registrars or any other agents with respect to the Securities of the series; 
 (k) the currency or
currencies, including composite currencies, in which payment of the principal of (and premium, if any) and interest, if any, on such Securities shall be payable if other than the currency of the United States; 

(l) if the principal of (and premium, if any), or interest, if any, on such Securities are to be payable, at the election of the Company or
any Holder thereof, in a coin or currency or currencies, including composite currencies, other than that or those in which such Securities are stated to be payable, the coin or currency or currencies, including composite currencies, in which payment
of the principal of (and premium, if any), or interest, if any, on Securities of such series as to which such election is made shall be payable, and the period or periods within which, and the terms and conditions upon which, such election may be
made; 
 (m) if such Securities are to be denominated in more than one currency, including composite currencies, the basis of determining
the equivalent price in the currency of the United States (if other than as set forth in the definition of Outstanding) for purposes of determining the voting rights of Holders of such Securities under this Indenture; 

(n) if the amount of payments of principal of (and premium, if any), or portions thereof, or interest, if any, on such Securities may be
determined with reference to an index, formula or other method, the manner in which such amounts shall be determined; 
 (o) whether
Securities of the series are to be issuable as Registered Securities, Bearer Securities or both, whether any Securities of the series are to be issuable initially in temporary global form and whether any Securities of the series are to be issuable
in permanent global form and, if so, whether beneficial owners of interests in any such permanent global Security may exchange such interests for Securities of such series and of like tenor of any authorized form and denomination and the
circumstances under which any such exchanges may occur, if other than in the manner provided in Section 3.05; 
 (p) the applicability of
Section 4.03 of this Indenture to the Securities of such series; 
 (q) any deletions from, modifications of or additions to the Events of
Default or covenants of the Company with respect to Securities of the series, whether or not such Events of Default or covenants are consistent with the Events of Default or covenants, as the case may be, set forth herein; 

  
 24 

 (r) whether the Securities of the series shall be issued upon original issuance in whole or in
part in the form of one or more Book-Entry Securities and, in such case (a) the Depository with respect to such Book-Entry Security or Securities; and (b) the circumstances under which any such Book-Entry Security may be exchanged for
Securities registered in the name of, and any transfer of such Book-Entry Security may be registered to, a Person other than such Depository or its nominee, if other than as set forth in Section 3.05; and 

(s) any other terms of or provisions applicable to the series (which terms and provisions shall not be inconsistent with the provisions of
this Indenture). 
 All Securities of any one series and any coupons appertaining thereto shall be substantially identical except, in the
case of Registered Securities, as to denomination and except in the case of any series of Securities, as may otherwise be provided in or pursuant to such Board Resolution referred to above and (subject to Section 3.03) set forth in such
Officers’ Certificate or in any such indenture supplemental hereto. All Securities of one series need not be issued at the same time and, unless otherwise provided, a series may be reopened for issuances of additional Securities of such series.
Securities may differ between series in respect of any matters. 
 If any of the terms of the Securities of any series are established by
action taken pursuant to a Board Resolution, a copy of an appropriate record of such action shall be certified by the Secretary or an Assistant Secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officers’
Certificate setting forth the terms of the Securities of such series. 
 Section 3.02. Denominations. Unless otherwise provided
as contemplated by Section 3.01 with respect to the Securities of any series, any Registered Securities of such series shall be issuable in denominations of $1,000 and any integral multiple thereof and any Bearer Securities of such series shall be
issuable in the denomination of $5,000. 
 Section 3.03. Execution, Authentication, Delivery and Dating. The Securities
shall be executed on behalf of the Company by its chairman of the board, its president, its chief financial officer, its treasurer or its deputy treasurer, attested by its secretary or one of its assistant secretaries. The signature of any of these
officers on the Securities may be manual or facsimile. Coupons shall bear the facsimile signature of the treasurer, deputy treasurer or any assistant treasurer of the Company. 

Securities and coupons bearing the manual or facsimile signatures of individuals who were at any time the proper officers of the Company shall
bind the Company, notwithstanding that such individuals or any of them have ceased to hold such offices prior to the authentication and delivery of such Securities or did not hold such offices at the date of such Securities. 

At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities of any series,
together with any coupons appertaining thereto, executed by the Company to the Trustee for authentication, together 

  
 25 

 
with a Company Order for the authentication and delivery of such Securities, and the Trustee in accordance with the Company Order shall authenticate and deliver such Securities; provided,
however, that, in connection with its original issuance, no Bearer Security shall be mailed or otherwise delivered to any location in the United States; and provided, further, that a Bearer Security may be delivered in connection with its
original issuance only if the Person entitled to receive such Bearer Security shall have furnished a certificate in the form set forth in Exhibit C-1 to this Indenture, dated no earlier than 15 days prior to the earlier of the date on which such
Bearer Security is delivered and the date on which any temporary global Security first becomes exchangeable for such Bearer Security in accordance with the terms of such temporary global Security and this Indenture. If any Security shall be
represented by a permanent global Bearer Security, then, for purposes of this Section and Section 3.04, the notation of a beneficial owner’s interest therein upon original issuance of such Security or upon exchange of a portion of a temporary
global Security shall be deemed to be delivery in connection with its original issuance of such beneficial owner’s interest in such permanent global Security. Except as permitted by Section 3.06 the Trustee shall not authenticate and deliver
any Bearer Security unless all appurtenant coupons for interest then matured have been detached and cancelled. 
 If the forms or terms of
the Securities of the series and any related coupons have been established in or pursuant to one or more Board Resolutions as permitted by Sections 2.01 and 3.01, in authenticating such Securities, and accepting the additional responsibilities under
this Indenture in relation to such Securities, the Trustee shall receive, and (subject to Section 6.01) shall be fully protected in relying upon, an Opinion of Counsel stating: 

(a) if the forms of such Securities and any coupons have been established by or pursuant to a Board Resolution as permitted by Section 2.01,
that such forms have been established in conformity with the provisions of this Indenture; 
 (b) if the terms of such Securities and any
coupons have been established by or pursuant to a Board Resolution as permitted by Section 3.01, that such terms have been established in conformity with the provisions of this Indenture; 

(c) that all conditions precedent in the Indenture to the issuance and authentication of the Securities have been complied with by the
Company; and 
 (d) that such Securities, together with any coupons appertaining thereto, when authenticated and delivered by the Trustee
and issued by the Company in the manner and subject to customary qualifications specified in such Opinion of Counsel, will constitute valid and legally binding obligations of the Company, enforceable in accordance with their terms, subject, as to
enforcement to bankruptcy, insolvency, reorganization and other laws of general applicability relating to or affecting the enforcement of creditors’ rights and to general equity principles. If such forms or terms have been so established, the
Trustee shall not be required to authenticate such Securities if the issue of such Securities pursuant to this Indenture will affect the Trustee’s own rights, duties or immunities under the Securities and this Indenture or will otherwise affect
the Trustee in a manner which is not reasonably acceptable to the Trustee. 

  
 26 

 Notwithstanding the provisions of Section 3.01 and of the preceding paragraph, if all Securities
of a series are not to be originally issued at one time, it shall not be necessary to deliver the Officers’ Certificate otherwise required pursuant to Section 3.01 or the Company Order and Opinion of Counsel otherwise required pursuant to such
preceding paragraph at or prior to the time of authentication of each Security of such series if such documents are delivered at or prior to the authentication upon original issuance of the first Security of such series to be issued. 

A Company Order delivered in the circumstances set forth in the preceding paragraph may provide that Securities which are the subject thereof
will be authenticated and delivered by the Trustee on original issue from time to time upon the written order of persons designated in such Company Order, and that such persons are authorized to determine, consistent with the Officers’
Certificate referred to in Section 3.01 or any applicable supplemental indenture, such terms and conditions of said Securities as are specified in such Company Order, provided the foregoing procedure is acceptable to the Trustee. 

Each Registered Security shall be dated the date of its authentication. Each Bearer Security of a series shall be dated as of the date of the
initial issuance of Securities of such series. 
 No Security or any related coupon shall be entitled to any benefit under this Indenture or
be valid or obligatory for any purpose unless there appears on such Security, or the Security to which such coupon appertains, a certificate of authentication substantially in the form provided for herein executed by the Trustee by manual signature,
and such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Security has been duly authenticated and delivered hereunder and that such Security and any related coupon are entitled to the benefits of this
Indenture. Notwithstanding the foregoing, if any Security shall have been authenticated and delivered hereunder but never issued and sold by the Company, and the Company shall deliver such Security to the Trustee for cancellation as provided in
Section 3.09 together with an Officers’ Certificate (which need not be accompanied by an Opinion of Counsel) stating that such Security has never been issued and sold by the Company, for all purposes of this Indenture such Security shall be
deemed never to have been authenticated and delivered hereunder and shall never be entitled to the benefits of this Indenture. 

Section 3.04. Temporary Securities. Pending the preparation of definitive Securities of any series, the Company may
execute, and upon Company Order the Trustee shall authenticate and deliver, temporary Securities which are printed, lithographed, typewritten, mimeographed or otherwise produced, in any authorized denomination, substantially of the tenor of the
definitive Securities in lieu of which they are issued, in registered form or, if authorized, in bearer form with one or more coupons or without coupons, and with such appropriate insertions, omissions, substitutions and 

  
 27 

 
other variations as the officers executing such Securities may determine, as evidenced by their execution of such Securities. In the case of Bearer Securities of any series, such temporary
Securities may be in global form, representing all of the Outstanding Bearer Securities of such series. A temporary Bearer Security shall be delivered only in compliance with the conditions set forth in Section 3.03. 

Except in the case of temporary Securities in global form (which shall be exchanged in accordance with the provisions of the following
paragraphs), if temporary Securities of any series are issued, the Company will cause definitive Securities of that series to be prepared without unreasonable delay. After the preparation of definitive Securities of such series, the temporary
Securities of such series shall be exchangeable for definitive Securities of such series upon surrender of the temporary Securities of such series at the office or agency of the Company maintained pursuant to Section 10.02 in a Place of Payment for
that series, without charge to the Holder. Upon surrender for cancellation of any one or more temporary Securities of any series (accompanied by any unmatured coupons appertaining thereto) the Company shall execute and the Trustee shall authenticate
and deliver in exchange therefor a like aggregate principal amount of definitive Securities of the same series and of like tenor of authorized denominations; provided, however, that no definitive Bearer Security shall be delivered in
exchange for a temporary Registered Security; and provided, further, that a definitive Bearer Security shall be delivered in exchange for a temporary Bearer Security only in compliance with the conditions set forth in Section 3.03.
Until so exchanged the temporary Securities of any series shall in all respects be entitled to the same benefits under this Indenture as definitive Securities of such series. 

If temporary Securities of any series are issued in global form, any such temporary global Security shall, unless otherwise provided therein,
be delivered to the London office of a depository or common depository (the “Common Depository”), for the benefit of Euroclear and Clearstream, for credit to the respective accounts of the beneficial owners of such Securities (or to
such other accounts as they may direct). 
 Without unnecessary delay but in any event not later than the date specified in, or determined
pursuant to the terms of, any such temporary global Security of a series (the “Exchange Date”), the Company shall deliver to the Trustee definitive Securities of such series in aggregate principal amount equal to the principal
amount of such temporary global Security, executed by the Company. On or after the Exchange Date, such temporary global Security shall be surrendered by the Common Depository to the Trustee, as the Company’s agent for such purpose, to be
exchanged, in whole or from time to time in part, for definitive Securities of such series without charge and the Trustee shall authenticate and deliver, in exchange for each portion of such temporary global Security, a like aggregate principal
amount of definitive Securities of the same series of authorized denominations and of like tenor as the portion of such temporary global Security to be exchanged; provided, however, that, unless otherwise specified in such temporary
global Security, upon such presentation by the Common Depository, such temporary global Security is accompanied by a certificate dated the Exchange Date or a subsequent date and signed by Euroclear as to the portion of such temporary global Security
held for its account then to be exchanged and a certificate dated the Exchange Date or a subsequent 

  
 28 

 
date and signed by Clearstream as to the portion of such temporary global Security held for its account then to be exchanged, each in the form set forth in Exhibit C.2 to this Indenture. The
definitive Securities to be delivered in exchange for any such temporary global Security shall be in bearer form, registered form, permanent global bearer form or permanent global registered form, or any combination thereof, as specified as
contemplated by Section 3.01, and, if any combination thereof is so specified, as requested by the beneficial owner thereof; provided, however, that definitive Bearer Securities shall be delivered in exchange for a portion of a
temporary global Security only in compliance with the requirements of Section 3.03. 
 Unless otherwise specified in such temporary global
Security, the interest of a beneficial owner of Securities of a series in a temporary global Security shall be exchanged for definitive Securities of the same series and of like tenor following the Exchange Date when the account holder instructs
Euroclear or Clearstream, as the case may be, to request such exchange on his behalf and delivers to Euroclear or Clearstream, as the case may be, a certificate in the form set forth in Exhibit C.1 to this Indenture, dated no earlier than 15 days
prior to the Exchange Date, copies of which certificate shall be available from the offices of Euroclear and Clearstream, the Trustee and each Paying Agent. Unless otherwise specified in such temporary global Security, any such exchange shall be
made free of charge to the beneficial owners of such temporary global Security, except that a Person receiving definitive Securities must bear the cost of insurance, postage, transportation and the like in the event that such Person does not take
delivery of such definitive Securities in person at the offices of Euroclear or Clearstream. Definitive Securities in bearer form to be delivered in exchange for any portion of a temporary global Security shall be delivered only outside the United
States. 
 Until exchanged in full as hereinabove provided, the temporary Securities of any series shall in all respects be entitled to the
same benefits under this Indenture as definitive Securities of the same series and of like tenor authenticated and delivered hereunder, except that, unless otherwise specified as contemplated by Section 3.01, interest payable on a temporary global
Security on an Interest Payment Date for Securities of such series occurring prior to the applicable Exchange Date shall be payable to Euroclear and Clearstream on such Interest Payment Date upon delivery by Euroclear and Clearstream to the Trustee
of a certificate or certificates in the form set forth in Exhibit C.3 to this Indenture, for credit without further interest on or after such Interest Payment Date to the respective accounts of the Persons who are the beneficial owners of such
temporary global Security on such Interest Payment Date and who have each delivered to Euroclear or Clearstream, the case may be, a certificate in the form set forth in Exhibit C.4 to this Indenture. Any interest so received by Euroclear and
Clearstream and not paid as herein provided shall be returned to the Trustee immediately prior to the expiration of two years after such Interest Payment Date in order to be repaid to the Company in accordance with Section 10.03. 

Section 3.05. Registration, Registration of Transfer and Exchange. The Company shall cause to be kept at the Corporate
Trust Office of the Trustee a register (the register maintained in such office and in any other office or agency to be maintained by the Company in accordance with Section 10.02 being herein sometimes collectively 

  
 29 

 
referred to as the “Security Register”) in which, subject to such reasonable regulations as it may prescribe, the Company shall provide for the registration of Registered
Securities and of transfers of Registered Securities. The Trustee is hereby appointed “Security Registrar” for the purpose of registering Registered Securities and transfers of Registered Securities as herein provided. 

Upon due surrender for registration of transfer of any Registered Security of any series at the office or agency maintained pursuant to
Section 10.02 for such purpose in a Place of Payment for that series, the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the designated transferee or transferees, one or more new Registered Securities of the
same series, of any authorized denominations and of a like aggregate principal amount and tenor. 
 At the option of the Holder, Registered
Securities of any series may be exchanged for other Registered Securities of the same series, of any authorized denominations and of a like aggregate principal amount and tenor, upon surrender of the Securities to be exchanged at such office or
agency. Bearer Securities may not be issued in exchange for Registered Securities. 
 At the option of the Holder, Bearer Securities of any
series may be exchanged for Registered Securities of the same series of any authorized denominations and of a like aggregate principal amount and tenor, upon surrender of the Bearer Securities to be exchanged at any such office or agency, with all
unmatured coupons and all matured coupons in default thereto appertaining. If the Holder of a Bearer Security is unable to produce any such unmatured or matured coupon or coupons in default, such exchange may be effected if the Bearer Securities are
accompanied by payment in funds acceptable to the Company in an amount equal to the face amount of such missing coupon or coupons, or the surrender of such missing coupon or coupons may be waived by the Company or jointly by the Company and the
Trustee if there is furnished to them such security or indemnity as they may require to save each of them and any Paying Agent harmless. If thereafter the Holder of such Security shall surrender to any Paying Agent any such missing coupon in respect
of which such a payment shall have been made, such Holder shall be entitled to receive the amount of such payment; provided, however, that, except as otherwise provided in Section 10.02, interest represented by coupons shall be payable
only upon presentation and surrender of those coupons at an office or agency located outside the United States. Notwithstanding the foregoing, in case a Bearer Security of any series is surrendered at any such office or agency in exchange for a
Registered Security of the same series and like tenor after the close of business at such office or agency on (i) any Regular Record Date and before the opening of business at such office or agency on the relevant Interest Payment Date, or
(ii) any Special Record Date and before the opening of business at such office or agency on the related proposed date for payment of Defaulted Interest, such Bearer Security shall be surrendered without the coupon relating to such Interest
Payment Date or proposed date for payment, as the case may be, and interest or Defaulted Interest as the case may be, will not be payable on such Interest Payment Date or proposed date for payment, as the case may be, in respect of the Registered
Security issued in exchange for such Bearer Security, but will be payable only to the Holder of such coupon when due in accordance with the provisions of this Indenture. 

  
 30 

 Whenever any Securities are so surrendered for exchange, the Company shall execute, and the
Trustee shall authenticate and deliver, the Securities which the Holder making the exchange is entitled to receive. 
 Notwithstanding the
foregoing, except as otherwise specified as contemplated by Section 3.01, any permanent global Security shall be exchangeable only as provided in this paragraph. If the beneficial owners of interest in a permanent global Security are entitled to
exchange such interests for Securities of such series and of like tenor and principal amount of another authorized form and denomination, as specified as contemplated by Section 3.01, then without unnecessary delay but in any event not later than
the earliest date on which such interests may be so exchanged, the Company shall deliver to the Trustee definitive Securities of that series in aggregate principal amount equal to the principal amount of such permanent global Security, executed by
the Company. On or after the earliest date on which such interests may be so exchanged, such permanent global Security shall be surrendered by the Common Depository or such other depositary as shall be specified in the Company Order with respect
thereto to the Trustee as the Company’s agent for such purpose, to be exchanged, in whole or from time to time in part, for definitive Securities of the same series without charge and the Trustee shall authenticate and deliver, in exchange for
each portion of such permanent global Security, a like aggregate principal amount of definitive Securities of the same series of authorized denominations and of like tenor as the portion of such permanent global Security to be exchanged which,
unless the Securities of the series are not issuable both as Bearer Securities and as Registered Securities, as specified as contemplated by Section 3.01, shall be in the form of Bearer Securities or Registered Securities, or any combination
thereof, as shall be specified by the beneficial owner thereof, provided, however, that no such exchanges may occur during a period beginning at the opening of business 15 days before any selection of Securities of that series to be
redeemed and ending on the relevant Redemption Date; and provided, further, that no Bearer Security delivered in exchange for a portion of a permanent global Security (or, if specified as contemplated by Section 3.01, in exchange for
Registered Securities) shall be mailed or otherwise delivered to any location in the United States. Promptly following any such exchange in part and any endorsement thereon to reflect the amount represented by such exchange, such permanent global
Security shall be returned by the Trustee to the Common Depository or such other depositary or Common Depository referred to above in accordance with the instructions of the Company referred to above. If a Registered Security is issued in exchange
for any portion of a permanent global Security after the close of business at the office or agency where such exchange occurs on (i) any Regular Record Date and before the opening of business at such office or agency on the relevant Interest
Payment Date, or (ii) any Special Record Date and before the opening of business at such office or agency on the related proposed date for payment of Defaulted Interest, interest or Defaulted Interest, as the case may be, will not be payable on
such Interest Payment Date or proposed date for payment, as the case may be, in respect of such Registered Security, but will be payable on such Interest Payment Date or proposed date for payment, as the case may be, only to the Person to whom
interest in respect of such portion of such permanent global Security is payable in accordance with the provisions of this Indenture. 

  
 31 

 Notwithstanding the foregoing and except as otherwise specified or contemplated by Section 3.01,
any Book-Entry Security shall be exchangeable pursuant to this Section 3.05 or Sections 3.04, 9.06 and 11.07 for Securities registered in the name of, and a transfer of a Book-Entry Security or any series may be registered to, any Person other than
the Depository for such Security or its nominee only if (i) such Depository notifies the Company that it is unwilling or unable to continue as Depository for such Book-Entry Security or if at any time such Depository ceases to be a clearing
agency registered under the Exchange Act, (ii) the Company executes and delivers to the Trustee a Company Order that such Book-Entry Security shall be so exchangeable and the transfer thereof so registrable or (iii) there shall have
occurred and be continuing an Event of Default, or an event which after notice or lapse of time would be an Event of Default, with respect to the Securities of such series. Upon the occurrence in respect of any Book-Entry Security of any series of
any one or more of the conditions specified in clauses (i), (ii) or (iii) of the preceding sentence or such other conditions as may be specified as contemplated by Section 3.01 for such series, such Book-Entry Security may be exchanged for
Securities registered in the names of, and the transfer of such Book-Entry Security may be registered to, such Persons (including Persons other than the Depository with respect to such series and its nominees) as such Depository shall direct.
Notwithstanding any other provision of this Indenture, any Security authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, any Book-Entry Security shall also be a Book-Entry Security and shall bear the
legend specified in Section 2.04 except for any Security authenticated and delivered in exchange for, or upon registration of transfer of, Book-Entry Security pursuant to the preceding sentence. 

All Securities issued upon any registration of transfer or exchange of Securities shall be the valid obligations of the Company, evidencing
the same debt, and entitled to the same benefits under this Indenture, as the Securities surrendered upon such registration of transfer or exchange. 

Every Registered Security presented or surrendered for registration of transfer or for exchange shall (if so required by the Company or the
Trustee or any transfer agent) be duly endorsed, or be accompanied by a written instrument of transfer in form satisfactory to the Company, the Trustee and the Security Registrar or any transfer agent duly executed, by the Holder thereof or his
attorney duly authorized in writing. 
 No service charge shall be made for any registration of transfer or exchange of Securities, but the
Company may require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in connection with any registration of transfer or exchange of Securities, other than exchanges pursuant to Sections 3.04, 9.06 and
11.07 not involving any transfer. 
 The Company shall not be required (i) to issue, register the transfer of or exchange Securities of
any series during a period beginning at the opening of business 15 days before any selection of Securities of that series to be redeemed and ending at the 

  
 32 

 
close of business on (A) if Securities of the series are issuable only as Registered Securities, the day of the mailing of the relevant notice of redemption and (B) if Securities of the
series are issuable as Bearer Securities, the day of the first publication of the relevant notice of redemption or, if Securities of the series are also issuable as Registered Securities and there is no publication, the mailing of the relevant
notice of redemption, (ii) to register the transfer of or exchange any Registered Security so selected for redemption in whole or in part, except the unredeemed portion of any Security being redeemed in part, or (iii) to exchange any
Bearer Security so selected for redemption except that such a Bearer Security may be exchanged for a Registered Security of that series and like tenor, provided that such Registered Security shall be simultaneously surrendered for redemption.

 Notwithstanding anything in this Indenture or in the terms of a Security to the contrary, the exchange of Bearer Securities for
Registered Securities will be subject to satisfaction of the provisions of the United States Federal income tax laws in effect at the time of such exchange. None of the Company, the Trustee or any Authenticating Agent of the Company or the Trustee
(any of which, other than the Company, shall rely on an Officers’ Certificate and an Opinion of Counsel) shall be required to exchange any Bearer Security for a Registered Security if as a result thereof and in the Company’s reasonable
judgment, the Company would incur adverse consequences under then applicable United States Federal income laws. No Registered Security may be exchanged for a Bearer Security. 

Each Holder of a Security agrees to indemnify the Company and the Trustee against any liability that may result from the transfer, exchange or
assignment of such Holder’s Security in violation of any provision of this Indenture and/or applicable United States Federal or state securities law. The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance
with any restrictions on transfer imposed under this Indenture or under applicable law with respect to any transfer of any interest in any Security (including any transfers between or among Depositary Participants or beneficial owners of interests
in any Global Security) other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to
determine substantial compliance as to form with the express requirements hereof. 
 Section 3.06. Mutilated, Destroyed, Lost
and Stolen Securities. If any mutilated Security or a Security with a mutilated coupon appertaining thereto is surrendered to the Trustee, the Company shall execute, and the Trustee shall authenticate and deliver in exchange therefor, a new
Security of the same series and of like tenor and principal amount and bearing a number not contemporaneously outstanding, with coupons corresponding to the coupons, if any, appertaining to the surrendered Security. 

If there shall have been delivered to the Company and the Trustee (i) evidence to their satisfaction of the destruction, loss or theft of
any Security or coupon, and (ii) such security or indemnity as may be required by them to save each of them harmless, then, in the absence of notice to the Company or the Trustee that such Security or coupon has

  
 33 

 
been acquired by a bona fide purchaser, the Company shall execute and upon its written request the Trustee shall authenticate and deliver, in lieu of any such destroyed, lost or stolen
Security or in exchange for the Security to which a destroyed, lost or stolen coupon appertains (with all appurtenant coupons not destroyed, lost or stolen), a new Security of the same series and of like tenor and principal amount and bearing a
number not contemporaneously outstanding, with coupons corresponding to the coupons, if any, appertaining to such destroyed, lost or stolen Security or to the Security to which such destroyed, lost or stolen coupon appertains. 

In case any such mutilated, destroyed, lost or stolen Security or coupon has become or is about to become due and payable, the Company in its
discretion may, instead of issuing a new Security, pay such Security or coupon; provided however, that principal of (and premium, if any) and interest, if any, on Bearer Securities shall, except as otherwise provided in Section 10.02, be payable
only at an office or agency located outside the United States; and provided, further, that, unless otherwise specified as contemplated by Section 3.01 with respect to any series of Securities, interest on Bearer Securities (but not any
additional amounts payable as provided in Section 10.09), shall be payable only upon presentation and surrender of the coupons appertaining thereto. 

Upon the issuance of any new Security under this Section, the Company may require the payment of a sum sufficient to cover any tax or other
governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith. 

Every new Security of any series with its coupons, if any, issued pursuant to this Section in lieu of any destroyed, lost or stolen Security,
or in exchange for a Security to which a destroyed, lost or stolen coupon appertains, shall constitute an original additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Security and its coupons, if any, or
the destroyed, lost or stolen coupon shall be at any time enforceable by anyone, and any such new Security and coupons, if any, shall be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of
that series and their coupons, if any, duly issued hereunder. 
 The provisions of this Section are exclusive and shall preclude (to the
extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities or coupons. 

Section 3.07. Payment of Interest; Interest Rights Preserved. Unless otherwise specified as contemplated by Section 3.01
with respect to any series of Securities, interest on any Registered Security which is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the Person in whose name that Security (or one or more
Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest; provided, however, that each installment of interest on any Registered Security may at the Company’s option be paid by
(i) mailing a check for such interest, payable to the Person entitled thereto pursuant to Section 3.08, to the address of such Person as it appears on the Security Register or (ii) transfer to an account maintained by such Person inside
the United States; provided, however, that if payment is  

  
 34 

 
to be made pursuant to (ii) above, the Trustee shall have received written wire instructions by no later than the Regular Record Date preceding such Interest Payment Date. 

Unless otherwise provided as contemplated by Section 3.01, every permanent global Security or Book-Entry Security will provide that interest,
if any, payable on any Interest Payment Date will be paid to The Depository Trust Company, Euroclear and or Clearstream, as the case may be, with respect to that portion of such permanent global Security held for its account by Cede & Co.
or the Common Depository, as the case may be, for the purpose of permitting such party to credit the interest received by it in respect of such permanent global Security or Book-Entry Security to the accounts of the beneficial owners thereof. 

Unless otherwise specified as contemplated by Section 3.01 with respect to any series of Securities, any interest due on Bearer Securities on
or before Maturity shall be payable only upon presentation and surrender of the several coupons for such interest installments as are evidenced thereby as severally mature. 

Notwithstanding the foregoing and unless otherwise provided as contemplated by Section 3.01 with respect to the Securities of any series,
payment of interest may be made, in the case of a Bearer Security, by transfer to an account maintained by the payee with a bank located outside the United States upon surrender of the coupon for such payment. 

In case a Bearer Security of any series is surrendered in exchange for a Registered Security of such series after the close of business (at an
office or agency in a Place of Payment for such series) on any Regular Record Date for such Registered Security and before the opening of business (at such office or agency) on the next succeeding Interest Payment Date, such Bearer Security shall be
surrendered without the coupon relating to such Interest Payment Date and interest will not be payable on such Interest Payment Date in respect of the Registered Security issued in exchange for such Bearer Security, but will be payable only to the
Holder of such coupon when due in accordance with the provisions of this Indenture. 
 Any interest on any Registered Security of any series
which is payable, but is not punctually paid or duly provided for, on any Interest Payment Date (herein called “Defaulted Interest”) shall forthwith cease to be payable to the Holder on the relevant Regular Record Date by virtue of
having been such Holder, and such Defaulted Interest may be paid by the Company, at its election in each case, as provided in clause (a) or (b) below. 

(a) The Company may elect to make payment of any Defaulted Interest to the Persons in whose names the Registered Securities of such series (or
their respective Predecessor Securities) are registered at the close of business on a Special Record Date for the payment of such Defaulted Interest, which shall be fixed in the following manner. The Company shall notify the Trustee in writing of
the amount of Defaulted Interest proposed to be paid on each Registered Security of such series and the date of the 

  
 35 

 
proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or
shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this Clause
provided. Thereupon the Trustee shall fix a Special Record Date for the payment of such Defaulted Interest which shall be not more than 15 days and not less than 10 days prior to the date of the proposed payment and not less than 10 days after the
receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly notify the Company of such Special Record Date and, in the name and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted
Interest and the Special Record Date therefor (i) to be mailed, first-class postage prepaid, to each Holder of Registered Securities of such series at his address as it appears in the Security Register, not less than 10 days prior to such
Special Record Date, and (ii) with respect to Bearer Securities of such series, to be published as provided for in Section 1.06. The Trustee may, in addition, in the name and at the expense of the Company, cause a similar notice to be published
at least once in a newspaper published in the English language customarily published on each Business Day and of general circulation in the Borough of Manhattan, the City of New York, but such publication shall not be a condition precedent to the
establishment of such Special Record Date. Notice of the proposed payment of such Defaulted Interest and the Special Record Date therefor having been mailed as aforesaid, such Defaulted Interest shall be paid to the Persons in whose names the
Registered Securities of such series (or their respective Predecessor Securities) are registered at the close of business on such Special Record Date and shall no longer be payable pursuant to the following clause (b). 

(b) The Company may make payment of any Defaulted Interest on the Registered Securities of any series in any other lawful manner not
inconsistent with the requirements of any securities exchange on which such Securities may be listed, and upon such notice as may be required by such exchange, if, after notice is given by the Company to the Trustee of the proposed payment pursuant
to this Clause, such manner of payment shall be deemed practicable by the Trustee. 
 Subject to the foregoing provisions of this Section
and Section 3.05, each Security delivered under this Indenture upon registration of transfer of or in exchange for or in lieu of any other Security shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such
other Security. 
 Section 3.08. Persons Deemed Owners. Prior to due presentment of a Registered Security for
registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name such Registered Security is registered as the owner of such Registered Security for the purpose of receiving payment of
principal of (and premium, if any) and (subject to Sections 3.05 and 3.07) interest, if any, on such Security and for all other purposes whatsoever, whether or not such Security be overdue, and neither the Company, the Trustee nor any agent of the
Company or the Trustee shall be affected by notice to the contrary. 

  
 36 

 Title to any Bearer Security and any coupons appertaining thereto shall pass by delivery. The
Company, the Trustee and any agent of the Company or the Trustee may treat the bearer of any Bearer Security and the bearer of any coupon as the absolute owner of such Bearer Security or coupon for the purpose of receiving payment thereof or art
account thereof and for all other purposes whatsoever, whether or not such Bearer Security or coupon be overdue, and neither the Company, the Trustee nor any agent of the Company or the Trustee shall be affected by notice to the contrary. 

Except as provided in Section 3.05, owners of beneficial interests in a Book-Entry Security shall not be entitled to have Securities
represented by such Book-Entry Security registered in their names, shall not receive or be entitled to receive physical delivery of Securities in certificated form and shall not be considered the Holders thereof for any purpose under this Indenture.
Members or participants in the Depository shall have no rights under this Indenture with respect to any Book-Entry Security held on their behalf by the Depository, and such Depository may be treated by the Company, the Trustee and any agent of the
Company or the Trustee as the Holder of such Book-Entry Security under this Indenture. Notwithstanding the foregoing, with respect to any Book-Entry Security, nothing herein shall prevent the Company, the Trustee, or any agent of the Company or the
Trustee, from giving effect to any written certification, proxy or other authorization furnished by the Depository, as a Holder, with respect to such Book-Entry Security or impair, as between the Depository and owners of beneficial interests in such
Book-Entry Security, the operation of customary practices governing the exercise of the rights of the Depository (or its nominee) as Holder of such Book-Entry Security. 

None of the Company, the Trustee, any Paying Agent or the Security Registrar will have any responsibility or liability for any aspect of the
records relating to or payments made on account of beneficial ownership interests of a Book-Entry Security or for maintaining, supervising or reviewing any records relating to such beneficial ownership interests or for the delivery to any member of
or participants in the Depository of any notice permitted or required to be given to the Holders of the Securities under this Indenture. 

Section 3.09. Cancellation. All Securities and coupons surrendered for payment, redemption, registration of transfer or exchange
or for credit against any sinking fund payment shall, if surrendered to any Person other than the Trustee, be delivered to the Trustee and such Securities and coupons shall be promptly cancelled by the Trustee. The Company may at any time deliver to
the Trustee for cancellation any Securities previously authenticated and delivered hereunder which the Company may have acquired in any manner whatsoever, and all Securities so delivered shall be promptly cancelled by the Trustee. No Securities
shall be authenticated in lieu of or in exchange for any Securities cancelled as provided in this Section, except as expressly permitted by this Indenture. All cancelled Securities and coupons held by the Trustee shall be destroyed by the Trustee
unless other instructions are furnished to the Trustee by a Company Order. 
 Notwithstanding the foregoing, with respect to any Book-Entry
Security, nothing shall prevent the Company, the Trustee or any agent of the Company or the Trustee, from giving effect to any written certification, proxy or other authorization furnished by a 

  
 37 

 
Depository or impair, as between a Depository and holders of beneficial interests in any Book-Entry Security, the operation of customary practices governing the exercise of the rights of the
Depository (or its nominee) as Holder of such Book-Entry Security. 
 Section 3.10. Computation of Interest. Except as
otherwise specified as contemplated by Section 3.01 for the Securities of any series, interest, if any on the Securities of each series shall be Computed on the basis of a 360-day year of twelve 30-day months. 

Section 3.11. Electronic Security Issuance. The Securities may, pursuant to a Board Resolution and Officers’
Certificate complying with Section 3.01 hereof, be issued by means of an electronic issuance system. Any such Security issuance instructions may specify the name, address and taxpayer identification number of the Holder, the principal amount and
Maturity of the Security, the interest rate to be borne by the Security and any other terms not inconsistent with such Board Resolution and Officers’ Certificate. Nothing in this Section 3.11 shall be construed as prohibiting the Company from
issuing Securities by any means not inconsistent with the provisions of this Indenture. 
 Section 3.12. CUSIP Numbers.
The Company in issuing the Securities may use “CUSIP” numbers (if then generally in use), and, if so, the Trustee shall use CUSIP numbers in notices of redemption as a convenience to Holders; provided that any such notice may state
that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of a redemption and that a reliance may be placed only on the other identification numbers printed on the
Securities, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company will promptly notify the Trustee in writing of any change in the CUSIP numbers. 

ARTICLE 4 

SATISFACTION AND DISCHARGE 

Section 4.01. Satisfaction and Discharge of Indenture. This Indenture shall upon Company Request cease to be of further
effect with respect to any series of Securities (except as to any surviving rights of registration of transfer or exchange of Securities of such series herein expressly provided for the form of Security for such series and any right to receive
additional amounts, as provided in Section 10.09), and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging satisfaction and discharge of this Indenture as to such series: when 

(a) either 
 (i)
all Securities of such series theretofore authenticated and delivered and all coupons, if any, appertaining thereto (other than (A) coupons appertaining to Bearer Securities surrendered for exchange for Registered Securities and maturing after
such exchange, whose surrender is not required or has been waived as provided in Section 3.05, (B) Securities of such series and coupons appertaining thereto which have been destroyed, lost or stolen and which have

  
 38 

 
been replaced or paid as provided in Section 3.06, (C) coupons appertaining to Securities of such series called for redemption and maturing after the relevant Redemption Date, whose
surrender has been waived as provided in Section 11.06 and (D) Securities of such series and coupons appertaining thereto for whose payment money has theretofore been deposited in trust or segregated and held in trust by the Company and
thereafter repaid to the Company or discharged from such trust, as provided in Section 10.03) have been delivered to the Trustee for cancellation; or 

(ii) all such Securities of such series and, in the case of (A) or (B) below, any coupons appertaining thereto not
theretofore delivered to the Trustee for cancellation 
 (A) have become due and payable, or 

(B) will become due and payable at their Stated Maturity within one year, or 

(C) are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of
redemption by the Trustee in the name, and at the expense, of the Company, 
 and the Company, in the case of (A), (B) or (C) above, has deposited
or caused to be deposited with the Trustee as trust funds in trust for the purpose an amount sufficient to pay and discharge the entire indebtedness on such Securities and coupons not theretofore delivered to the Trustee for cancellation, for
principal (and premium, if any) and interest, if any, to the date of such deposit (in the case of Securities which have become due and payable), or to the Stated Maturity or the Redemption Date, as the case may be; 

(b) the Company has paid or caused to be paid all other sums payable hereunder by the Company with respect to such series; and 

(c) the Company has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that, with respect to such
series, all conditions precedent herein provided for relating to the satisfaction and discharge of this Indenture have been complied with. 

Notwithstanding the satisfaction and discharge of this Indenture with respect to such series, the obligations of the Company to the Trustee
with respect to such series under Section 6.07, and, if money shall have been deposited with the Trustee pursuant to subclause (ii) of clause (a) of this Section, the obligations of the Trustee under Section 4.02 and the last paragraph of
Section 10.03, shall survive. 
 Section 4.02. Application of Trust Money. Subject to the provisions of the last
paragraph of Section 10.03, all money deposited with the Trustee pursuant to Section 4.01 and all money and U.S. Government Obligations deposited with the Trustee (or a  

  
 39 

 
successor trustee satisfying the requirements of Section 6.09) pursuant to Section 4.03 shall be held in trust and shall be applied by it, in accordance with the provisions of the series of
Securities and this Indenture, to the payment, either directly or through any Paying Agent as the Trustee may determine, to the Persons entitled thereto, of all sums due and to become due thereon in respect of the principal of (and premium, if any)
and interest, if any, on the Securities for which payment such money has been deposited with the Trustee or to make mandatory sinking fund payments or analogous payments as contemplated by Section 4.03. 

Section 4.03. Discharge and Defeasance of Securities of any Series. If this Section 4.03 is specified, as contemplated by
Section 3.01, to be applicable to the Securities of any series, then, notwithstanding the provisions of Section 4.01, the Company shall be deemed to have paid and discharged the entire indebtedness on all the Outstanding Securities of any such
series on the 91st day after the date of the deposit referred to in subparagraph (d) hereof, and the provisions of this Indenture, as it relates to such Outstanding Securities, shall no longer be in effect (and the Trustee, at the expense of the
Company, shall upon Company Request, execute proper instruments acknowledging the same), except as to: 
 (a) the rights of Holders of
Securities of such series to receive, from the trust funds described in subparagraph (d) hereof, (i) payment of the principal of (and premium, if any) and each installment of principal of (and premium, if any) or interest, if any, on the
Outstanding Securities of such series on the Stated Maturity of such principal or installment of principal or interest and (ii) any mandatory sinking fund payments or analogous payments applicable to the Securities of such series on the day on
which such payments are due and payable in accordance with the terms of this Indenture and such Securities; and 
 (b) the rights, powers,
trusts, duties and immunities of the Trustee hereunder with respect to such series, including those set forth in Section 6.07; and 
 (c)
either (i) if this Section 4.03(c)(i) is specified, as contemplated by Section 3.01, to be applicable to the Securities of any series, the Company’s obligations with respect to the Securities of such series under Sections 3.04, 3.05, 3.06,
10.02 and 10.03; or, alternatively, (ii) if this Section 4.03(c)(ii) is specified, as contemplated by Section 3.01, to be applicable to the Securities of any series, the Company’s obligations with respect to such Securities under Sections
3.04, 3.05, 3.06, 10.01, 10.02 and 10.03; 
 provided that, the following conditions shall have been satisfied: 

(d) the Company shall have irrevocably deposited or caused to be deposited (in accordance with Section 4.02) with the Trustee (or another
trustee satisfying the requirements of Section 6.09) as trust funds in trust specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the Securities of that series, with reference to this Section 4.03
(i) money in an amount, or (ii) U.S. Government Obligations which through the payment of interest and principal in respect thereof in accordance with their terms will provide not later than one Business Day before the due

  
 40 

 
date of any payment referred to in clause (A) or (B) of this subparagraph (d) money in an amount, or (iii) a combination thereof, sufficient, in the opinion of a nationally
recognized firm of independent certified public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge (A) the principal of (and premium, if any) and each installment of principal of (and
premium, if any) and interest, if any, on the Outstanding Securities of such series on the Stated Maturity of such principal or installment of principal or interest or on the applicable Redemption Date and (B) any mandatory sinking fund
payments or analogous payments applicable to the Securities of such series on the day on which such payments are due and payable in accordance with the terms of this Indenture and of such Securities; 

(e) such deposit shall not cause the Trustee with respect to the Securities of such series to have a conflicting interest as defined in
Section 6.08 or for purposes of the Trust Indenture Act with respect to the Securities of any series; 
 (f) such deposit will not result in
a breach or violation of, or constitute a default under, any applicable laws, this Indenture or any other agreement or instrument to which the Company is a party or by which it is bound; 

(g) if this Section 4.03(g) is specified, as contemplated by Section 3.01, to be applicable to the Securities of any series, such provision
would not cause any Outstanding Securities of such series then listed on the New York Stock Exchange or other nationally recognized securities exchange to be de-listed as a result thereof; 

(h) no Event of Default or event which with the giving of notice or lapse of time or both would become an Event of Default with respect to the
Securities of that series shall have occurred and be continuing on the date of such deposit or at any time during the period ending on the 91st day after such date; 

(i) if this Section 4.03(i) is specified, as contemplated by Section 3.01, to be applicable to the Securities of any series, the Company has
delivered to the Trustee an Opinion of Counsel to the effect that, based upon applicable Federal income tax law or a ruling published by the Internal Revenue Service (which opinion, for the purposes contemplated by Section 4.03(c)(i), must be based
on a change in applicable Federal income tax law after the date of this Indenture or a ruling published by the Internal Revenue Service after the date of this Indenture), the Holders of the Securities of such series will not recognize income, gain
or loss for Federal income tax purposes as a result of such deposit, defeasance and discharge and will be subject to Federal income tax on the same amount and in the same manner and at the same times, as would have been the case if such deposit,
defeasance and discharge had not occurred; and 
 (j) the Company has delivered to the Trustee an Officers’ Certificate and an Opinion
of Counsel, each stating that all conditions precedent relating to the defeasance contemplated by this Section have been complied with. 

  
 41 

 ARTICLE 5 

REMEDIES 

Section 5.01. Events of Default. “Event of Default”, wherever used herein with respect to
Securities of any series, means any one of the following events (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any
court or any order, rule or regulation of any administrative or governmental body): 
 (a) default in the payment of any installment
of interest upon any Security of that series when it becomes due and payable, and continuance of such default for a period of 30 days; or 

(b) default in the payment of the principal of (or premium, if any, on) any Security of that series at its Maturity; or 

(c) default in the deposit of any sinking fund payment, when and as due by the terms of a Security of that series; or 

(d) default in the performance or breach of any covenant or warranty of the Company in this Indenture (other than a covenant or warranty a
default in whose performance or whose breach is elsewhere in this Section specifically dealt with or which has expressly been included in this Indenture solely for the benefit of a particular series of Securities other than that series) and
continuance of such default or breach for a period of 90 days after there has been given, by registered or certified mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in principal amount of the
Outstanding Securities of that series a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a “Notice of Default” hereunder; or 

(e) the entry by a court having jurisdiction in the premises of (A) a decree or order for relief in respect of the Company in an
involuntary case in respect of the Company under any applicable bankruptcy, insolvency, reorganization or other similar law now or hereafter in effect, or (B) a decree or order appointing a receiver, liquidator, assignee, custodian, trustee,
sequestrator (or similar official) of the Company or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs and such decree or order shall remain unstayed and in effect for a period of 60 consecutive days;
or 
 (f) the commencement by the Company of a voluntary case under any applicable bankruptcy, insolvency, reorganization or other similar
law now or hereafter in effect or the consent by it to the entry of an order for relief in an involuntary case in respect of it under any such law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee,
trustee, custodian, sequestrator (or similar official) of the Company or for any substantial part of its property, or the making by it of any general assignment for the benefit of creditors; or 

  
 42 

 (g) any other Event of Default provided with respect to Securities of that series. 

Section 5.02. Acceleration of Maturity; Rescission and Annulment. If an Event of Default with respect to Securities of any
series at the time Outstanding occurs and is continuing, then and in any such case the Trustee or the Holders of not less than 25% in principal amount of the Outstanding Securities of that series may declare the principal amount (or, if the
Securities of that series are Original Issue Discount Securities, such portion of the principal amount of such Securities as may be specified in the terms thereof) of all of the Securities of that series to be due and payable immediately, by a
notice in writing to the Company (and to the Trustee if given by Holders), and upon any such declaration such principal amount (or specified amount) shall become immediately due and payable. 

At any time after such a declaration of acceleration with respect to Securities of any series has been made and before a judgment or decree
for payment of the money due has been obtained by the Trustee as hereinafter in this Article provided, the Holders of a majority in principal amount of the Outstanding Securities of that series, by written notice to the Company and the Trustee, may
rescind and annul such declaration and its consequences if 
 (a) the Company has paid or deposited with the Trustee a sum sufficient to pay

 (i) all overdue installments of interest on all Securities of that series, 

(ii) the principal of (and premium, if any, on) any Securities of that series which have become due otherwise than by such
declaration of acceleration and interest, if any, thereon at the rate or rates prescribed therefor in such Securities, 

(iii) to the extent that payment of such interest is lawful interest upon any overdue installments of interest at the rate or
rates prescribed therefor in such Securities, and 
 (iv) all sums paid or advanced by the Trustee hereunder and the
compensation, expenses, disbursements and advances of the Trustee, its agents and counsel; and 
 (b) all Events of Default with respect to
Securities of that series, other than the nonpayment of the principal of Securities of that series which have become due solely by such declaration of acceleration, have been cured or waived as provided in Section 5.13. 

No such rescission shall affect any subsequent default or impair any right consequent thereon. 

  
 43 

 Section 5.03. Collection of Indebtedness and Suits for Enforcement by Trustee. The Company
covenants that if 
 (a) default is made in the payment of any installment of interest on any Security when such interest becomes due and
payable and such default continues for a period of 30 days, or 
 (b) default is made in the payment of the principal of (or premium, if
any, on) any Security at its Maturity, 
 the Company will, upon demand of the Trustee, pay to it, for the benefit of the Holders of such Securities and
coupons, the whole amount then due and payable on such Securities and coupons for principal (and premium, if any) and interest, if any, and, to the extent that payment of such interest shall be legally enforceable, interest on the overdue principal
(and premium, if any) and on any overdue installments of interest, at the rate or rates prescribed therefor in such Securities and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection,
including the compensation, expenses, disbursements and advances of the Trustee, its agents and counsel. 
 If the Company fails to pay such
amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust, may institute a judicial proceeding for the collection of the sums so due and unpaid, may prosecute such proceeding to judgment or final decree and
may enforce the same against the Company or any other obligor upon such Securities and collect the moneys adjudged or decreed to be payable in the manner provided by law out of the property of the Company or any other obligor upon such Securities,
wherever situated. 
 If an Event of Default with respect to Securities of any series occurs and is continuing, the Trustee may in its
discretion proceed to protect and enforce its rights and the rights of the Holders of Securities of such series and any related coupons by such appropriate judicial proceedings as the Trustee shall deem most effectual to protect and enforce any such
rights, whether for the specific enforcement of any covenant or agreement in this Indenture or in aid of the exercise of any power granted herein, or to enforce any other proper remedy. 

Section 5.04. Trustee May File Proof of Claim. In case of the pendency of any receivership, insolvency, liquidation,
bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding relative to the Company or any other obligor upon the Securities or the property of the Company or of such other obligor or their creditors, the Trustee
(irrespective of whether the principal of the Securities shall then be due and payable as therein expressed or by declaration or otherwise and irrespective of whether the Trustee shall have made any demand on the Company for the payment of overdue
principal or interest) shall be entitled and empowered, by intervention in such proceeding or otherwise, 
 (a) to file and prove a
claim for the whole amount of principal (and premium, if any) and interest, if any, owing and unpaid in respect of the Securities and to file such other papers or documents as may be necessary or advisable in order to have the claims of the Trustee
(including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and of the Holders of Securities and coupons allowed in such judicial proceeding, and 

  
 44 

 (b) to collect and receive any moneys or other property payable or deliverable on any such claims
and to distribute the same; 
 and any receiver, assignee, custodian, trustee, liquidator, sequestrator or other similar official in any such judicial
proceeding is hereby authorized by each Holder of Securities and coupons to make such payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders of Securities and coupons, to pay
to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 6.07. 

Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder of a
Security or coupon any plan of reorganization, arrangement, adjustment or composition affecting the Securities or coupons or the rights of any Holder thereof or to authorize the Trustee to vote in respect of the claim of any Holder of a Security or
coupon in any such proceeding. 
 Section 5.05. Trustee May Enforce Claims Without Possession of Securities or Coupons.
All rights of action and claims under this Indenture or the Securities or coupons may be prosecuted and enforced by the Trustee without the possession of any of the Securities or coupons or the production thereof in any proceeding relating thereto,
and any such proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment shall, after provision for the payment of the reasonable compensation, expenses, disbursements and
advances of the Trustee, its agents and counsel, be for the ratable benefit of the Holders of the Securities and coupons in respect of which such judgment has been recovered. 

Section 5.06. Application of Money Collected. Any money collected by the Trustee pursuant to this Article shall be applied
in the following order, at the date or dates fixed by the Trustee and, in case of the distribution of such money on account of principal (or premium, if any) or interest, if any, upon presentation of the Securities or coupons or both and the
notation thereon of the payment if only partially paid and upon surrender thereof if fully paid:  
 First: To the payment of all
amounts due the Trustee under Section 6.07; 
 Second: To the payment of then due and unpaid for principal of (and premium, if any) and
interest, if any, on the Securities and coupons in respect of which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities and
coupons for principal (and premium, if any) and interest, if any, respectively; and 
 Third: The balance, if any, to the Company. 

  
 45 

 Section 5.07. Limitation on Suits. No Holder of any Security of any series or
any related coupons shall have any right to institute any proceeding, judicial or otherwise, with respect to this Indenture, or for the appointment of a receiver or trustee, or for any other remedy hereunder: unless 

(a) such Holder has previously given written notice to the Trustee of a continuing Event of Default with respect to the Securities of that
series; 
 (b) the Holders of not less than 25% in principal amount of the Outstanding Securities of that series shall have made written
request to the Trustee to institute proceedings in respect of such Event of Default in its own name as Trustee hereunder; 
 (c) such Holder
or Holders have offered to the Trustee indemnity satisfactory to the Trustee against the costs, expenses and liabilities to be incurred in compliance with such request; 

(d) the Trustee for 60 days after its receipt of such notice, request and offer of indemnity has failed to institute any such proceeding; and

 (e) no direction inconsistent with such written request has been given to the Trustee during such 60-day period by the Holders of a
majority in principal amount of the Outstanding Securities of that series; 
 it being understood and intended that no one or more of Holders of Securities
of such series shall have any right in any manner whatever by virtue of, or by availing of, any provision of this Indenture to affect, disturb or prejudice the rights of any other such Holders of, or to obtain or to seek to obtain priority or
preference over any other such Holders or to enforce any right under this Indenture, except in the manner herein provided and for the equal and ratable benefit of all such Holders. 

Section 5.08. Unconditional Right of Holders to Receive Principal, Premium and Interest. Notwithstanding any other
provision in this Indenture, the Holder of any Security or coupon shall have the right, which is absolute and unconditional, to receive payment of the principal of (and premium, if any) and (subject to Sections 3.05 and 3.07) interest, if any, on
such security or payment of such coupon on the Stated Maturity or Maturities expressed in such Security or coupon (or, in the case of redemption, on the Redemption Date) and to institute suit for the enforcement of any such payment and such rights
shall not be impaired without the consent of such Holder. 
 Section 5.09. Restoration of Rights and Remedies. If the
Trustee or any Holder of any Security or coupon has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has been discontinued or abandoned for any reason, or has been determined adversely to the Trustee
or to such Holder, then and in every such case the Company, the Trustee and the Holders of such Securities and coupons shall, subject to any determination in such proceeding, be restored severally and respectively to their former positions
hereunder, and thereafter all rights and remedies of the Trustee and the Holders shall continue as though no such proceeding had been instituted. 

  
 46 

 Section 5.10. Rights and Remedies Cumulative. Except as otherwise provided
with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities or coupons in the last paragraph of Section 3.06, no right or remedy herein conferred upon or reserved to the Trustee or to the Holders of Securities or
coupons is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or
in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right or remedy. 

Section 5.11. Delay or Omission Not Waiver. No delay or omission of the Trustee or of any Holder of any Security or coupon
to exercise any right or remedy accruing upon any Event of Default shall impair any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article or by law to the
Trustee or to the Holders of Securities or coupons may be exercised from time to time, and as often as may be deemed expedient, by the Trustee or by the Holders of Securities or coupons as the case may be. 

Section 5.12. Control by Holders. Subject to Section 6.03(e), the Holders of a majority in principal amount of the
Outstanding Securities of any series shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the
Securities of such series, provided that 
 (a) such direction shall not be in conflict with any rule of law or with this
Indenture, and 
 (b) the Trustee may take any other action deemed proper by the Trustee which is not inconsistent with such direction. 

Section 5.13. Waiver of Past Defaults. The Holders of not less than a majority in principal amount of the Outstanding
Securities of any series may on behalf of the Holders of all the Securities of such series and any related coupons waive any past default hereunder with respect to the Securities of such series and its consequences, except a default: 

(a) in the payment of the principal of (or premium, if any) or interest, if any, on any Securities of such series, or 

(b) with respect to a covenant or provision hereof which under Article Nine cannot be modified or amended without the consent of the Holder of
each Outstanding Security of such series affected. 

  
 47 

 Upon any such waiver, such default shall cease to exist, and any Event of Default arising
therefrom shall be deemed to have been cured, for every purpose of this Indenture; but no such waiver shall extend to any subsequent or other default or impair any right consequent thereon. 

Section 5.14. Undertaking For Costs. All parties to this Indenture agree, and each Holder of any Security or coupon by his
acceptance thereof shall be deemed to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken, suffered or
omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees, against any party
litigant in such suit, having due regard for the merits and good faith of the claims or defenses made by such party litigant; but the provisions of this Section shall not apply to any suit instituted by the Trustee, or to any suit instituted by any
Holder, or group of Holders, holding in the aggregate more than 10% in principal amount of the Outstanding Securities of any series, or to any suit instituted by any Holder of any Security or coupon for the enforcement of the payment of the
principal of (or premium, if any) or interest, if any, on any Security or the payment of any coupon on or after the Stated Maturity or Maturities expressed in such Security or coupon (or, in the case of redemption, on or after the Redemption Date).

 Section 5.15. Waiver of Stay or Extension Laws. The Company covenants (to the extent that it may lawfully do so) that it will
not at any time insist upon, or plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay or extension law wherever enacted, now or at any time hereafter in force, which may affect the covenants or the performance of
this Indenture; and the Company (to the extent that it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and covenants that it will not hinder, delay or impede the execution of any power herein granted to the
Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted. 
 ARTICLE 6 

THE TRUSTEE 

Section 6.01. Certain Duties and Responsibilities. (a) Except during the continuance of an Event of Default with respect to
the Securities of any series, 
 (i) the Trustee undertakes to perform such duties and only such duties as are specifically
set forth in this Indenture with respect to such series, and the Trustee shall not be liable except for the performance of such duties and obligations as are specifically set forth in this Indenture, and no implied covenants or obligations shall be
read into this Indenture against the Trustee; and 
 (ii) in the absence of willful misconduct on its part, the Trustee may
conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee 

  
 48 

 
and conforming to the requirements of this Indenture; but in the case of any such certificates or opinions which by any provisions hereof are specifically required to be furnished to the Trustee,
the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture. 
 (b)
In case an Event of Default has occurred with respect to Securities of any series and is continuing, the Trustee shall exercise such of the rights and powers vested in it by this Indenture with respect to such series of Securities, and use the same
degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct of his own affairs. 

(c) No provision of this Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent
failure to act, or its own willful misconduct: except that 
 (i) this Subsection shall not be construed to limit the
effect of Subsection (a) of this Section; 
 (ii) the Trustee shall not be liable for any error of judgment made in good
faith by a Responsible Officer, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts; 

(iii) the Trustee shall not be liable with respect to any action taken, suffered or omitted to be taken by it in good faith in
accordance with the direction of the Holders of a majority in principal amount of the Outstanding Securities of any series, determined as provided in Section 5.12, relating to the time, method and place of conducting any proceeding for any remedy
available to the Trustee, or exercising any trust or power conferred upon the Trustee, under this Indenture with respect to the Securities of such series; and 

(iv) no provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur any financial
liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk or liability is not
reasonably assured to it. 
 (d) Whether or not therein expressly so provided, every provision of this Indenture relating to the conduct or
affecting the liability of or affording protection to the Trustee shall be subject to the provisions of this Section. 
 Section 6.02.
Notice of Defaults. Within 90 days after the occurrence of any default hereunder with respect to the Securities of any series, the Trustee shall transmit in the manner and to the extent provided in Section 7.03(c), notice of such default
hereunder actually known to a Responsible Officer of the Trustee, unless such default shall have been cured or waived; provided, however, that, except in the case of a default in the payment of the principal of (or premium, if any) or
interest, if any, on any Security of such series, or in the payment of any sinking fund installment with respect to Securities 

  
 49 

 
of such series, the Trustee shall be protected in withholding such notice if and so long as it in good faith determines that the withholding of such notice is in the interest of the Holders of
Securities of such series, and provided, further, that in the case of any default of the character specified in Section 5.01(d) with respect to Securities of such series, no such notice to Holders shall be given until at least 60 days after
the occurrence thereof. For the purpose of this Section, the term “default” means any event which is, or after notice or lapse of time or both would become, an Event of Default with respect to Securities of such series. 

Section 6.03. Certain Rights of Trustee. Except as otherwise provided in Section 6.01: 

(a) the Trustee may rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement, instrument,
opinion, report, notice, request, direction, consent, order, bond, debenture, note, coupon, other evidence of indebtedness or other paper or document believed by it to be genuine and to have been signed or presented by the proper party or parties;

 (b) any request or direction of the Company mentioned herein shall be sufficiently evidenced by a Company Request or Company Order or as
otherwise expressly provided herein and any resolution of the Board of Directors may be sufficiently evidenced by a Board Resolution; 
 (c)
whenever in the administration of this Indenture the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee (unless other evidence be herein specifically
prescribed) may, in the absence of willful misconduct on its part, rely upon an Officers’ Certificate and such Officers’ Certificate, in the absence of negligence or willful misconduct on the part of the Trustee, shall be full warrant to
the Trustee for any action taken, suffered or omitted by it under the provisions of this Indenture upon the faith thereof; 
 (d) the
Trustee may consult with counsel and the written advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in
reliance thereon; 
 (e) the Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at
the request or direction of any of the Holders pursuant to this Indenture, unless such Holders of Securities of any series or related coupons shall have offered to the Trustee security or indemnity against the costs, expenses and liabilities which
might be incurred by it in compliance with such request or direction; 
 (f) the Trustee shall not be bound to make any investigation into
the facts or matters stated in any resolution, certificate, statement, calculation or quotation, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, coupon, other evidence of indebtedness or other paper or
document, but the Trustee 

  
 50 

 
may make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be
entitled to examine the books, records and premises of the Company, personally or by agent or attorney; 
 (g) the Trustee may execute any
of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due
care by it hereunder; 
 (h) in no event shall the Trustee be responsible or liable for special, indirect, or consequential loss or damage
of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action; 

(i) the Trustee shall not be deemed to have notice of any Default or Event of Default unless a Responsible Officer of the Trustee has actual
knowledge thereof or unless written notice of any event which is in fact such a default is received by the Trustee at the Corporate Trust Office of the Trustee, and such notice references the Securities and this Indenture; 

(j) the rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be
indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed by the Trustee to act hereunder; and 

(k) in no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising
out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and
interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee shall use reasonable efforts which are consistent with accepted practices in the banking industry to
resume performance as soon as practicable under the circumstances. 
 Section 6.04. Not Responsible for Recitals or Issuance of
Securities. The recitals contained herein and in the Securities, except the Trustee’s certificates of authentication, shall be taken as the statements of the Company, and the Trustee assumes no responsibility for their correctness. The
Trustee makes no representations as to the validity or sufficiency of this Indenture or of the Securities or the coupons, except that the Trustee represents that it is duly authorized to execute and deliver this Indenture, authenticate the
Securities and perform its obligations hereunder and that the statements made by it in its Statements of Eligibility on Form T-1 supplied to the Company are true and accurate. The Trustee or any Authenticating Agent shall not be accountable for the
use or application by the Company of Securities or the proceeds thereof. 

  
 51 

 Section 6.05. May Hold Securities. The Trustee, any Paying Agent, any Security
Registrar or any other agent of the Company, in its individual or any other capacity, may become the owner or pledgee of Securities or coupons and, subject to Sections 6.08 and 6.13, may otherwise deal with the Company with the same rights it would
have if it were not Trustee, Paying Agent, Security Registrar or such other agent. 
 Section 6.06. Money Held in Trust. Money
held by the Trustee in trust hereunder need not be segregated from other funds except to the extent required by law. The Trustee shall be under no liability for interest on any money received by it hereunder except as otherwise agreed with the
Company. 
 Section 6.07. Compensation and Reimbursement. The Company agrees: 

(a) to pay to the Trustee from time to time compensation for all services rendered by it hereunder (which compensation shall not be limited by
any provision of law in regard to the compensation of a trustee of an express trust); 
 (b) except as otherwise expressly provided herein,
to reimburse the Trustee upon its request for all expenses, disbursements and advances incurred or made by the Trustee in accordance with any provision of this Indenture (including the compensation and the expenses and disbursements of its agents
and counsel), except any such expense, disbursement or advance as may be attributable to its negligence or willful misconduct; and 
 (c) to
indemnify the Trustee, its agents and counsel for, and to hold them harmless against, any loss, liability or expense incurred without negligence or willful misconduct on their part, arising out of or in connection with the acceptance or
administration of the trust or trusts hereunder, including the costs and expenses of defending themselves against any claim or liability in connection with the exercise or performance of any of their powers or duties hereunder. 

The obligations of the Company under this Section shall constitute additional indebtedness hereunder and shall survive the satisfaction and
discharges of this Indenture. Such additional indebtedness shall be a senior claim to that of the Securities upon all property and funds held or collected by the Trustee as such, except funds held in trust for the benefit of the Holders of
particular Securities, and the Securities are hereby subordinated to such senior claim. 
 When the Trustee incurs expenses or renders
services after an Event of Default specified in Section 5.01(e) or (f) occurs, the expenses and the compensation for the services (including the fees and expenses of its agents and counsel) are intended to constitute expenses of administration under
any Bankruptcy Law. 
 Section 6.08. Disqualification; Conflicting Interests. If the Trustee has or shall acquire a conflicting
interest within the meaning of the Trust Indenture Act, the Trustee shall either eliminate such interest or resign, to the extent and in the manner provided by, and subject to Section 310(b) of the Trust Indenture Act and this Indenture. 

  
 52 

 Section 6.09. Corporate Trustee Required; Eligibility. There shall at all times be a
Trustee hereunder which shall be a corporation organized and doing business under the laws of the United States of America or of any State or the District of Columbia, authorized under such laws to exercise corporate trust powers, having a combined
capital and surplus of at least $50,000,000, subject to supervision or examination by Federal, State or District of Columbia authority and having its Corporate Trust Office in the Borough of Manhattan, the City of New York. If such corporation
publishes reports of condition at least annually, pursuant to law or to the requirements of the aforesaid supervising or examining authority, then for the purposes of this Section, the combined capital and surplus of such corporation shall be deemed
to be its combined capital and surplus as set forth in its most recent report of condition so published. If at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, it shall resign immediately in the
manner and with the effect hereinafter specified in this Article. 
 Section 6.10. Resignation and Removal; Appointment of
Successor. (a) No resignation or removal of the Trustee and no appointment of a successor Trustee pursuant to this Article shall become effective until the acceptance of appointment by the successor Trustee under Section 6.11. 

(b) The Trustee may resign at any time with respect to the Securities of one or more series by giving written notice thereof to the Company.
If the instrument of acceptance by a successor Trustee required by Section 6.11 shall not have been delivered to the Trustee within 30 days after the giving of such notice of resignation, the resigning Trustee may petition any court of competent
jurisdiction for the appointment of a successor Trustee with respect to the Securities of such series. 
 (c) The Trustee may be removed at
any time with respect to the Securities of any series by Act of the Holders of a majority in principal amount of the Outstanding Securities of such series delivered to the Trustee and to the Company. 

(d) If at any time: 

(i) the Trustee shall fail to comply with Section 310(b) of the Trust Indenture Act after written request therefor by the
Company or by any Holder who has been a bona fide Holder of a Security for at least six months; or 
 (ii) the Trustee
shall cease to be eligible under Section 6.09 and shall fail to resign after written request therefor by the Company or by any such Holder; or 

(iii) the Trustee shall become incapable of acting or shall be adjudged a bankrupt or insolvent or a receiver of the Trustee or
of its property shall be appointed or any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation, 

then, in any such case, (i) the Company by a Board Resolution may remove the Trustee with respect to all Securities, or (ii) subject to Section
5.14, any Holder who has been a 

  
 53 

 
bona fide Holder of a Security for at least six months may, on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the removal of the
Trustee with respect to all Securities and the appointment of a successor Trustee or Trustees. 
 The Company may also remove the Trustee
with or without cause if the Company so notifies the Trustee six months in advance and if no Event of Default occurs during the six-month period. 

(e) If the Trustee shall resign, be removed or become incapable of acting, or if a vacancy shall occur in the office of Trustee for any cause,
with respect to the Securities of one or more series, the Company, by a Board Resolution, shall promptly appoint a successor Trustee or Trustees with respect to the Securities of that or those series (it being understood that any such successor
Trustee may be appointed with respect to the Securities of one or more or all of such series and that at any time there shall be only one Trustee with respect to the Securities of any particular series) and shall comply with the applicable
requirements of Section 6.11. If, within one year after such resignation, removal or incapability, or the occurrence of such vacancy, a successor Trustee with respect to the Securities of any series shall be appointed by Act of the Holders of a
majority in principal amount of the Outstanding Securities of such series delivered to the Company and the retiring Trustee, the successor Trustee so appointed shall, forthwith upon its acceptance of such appointment in accordance with the
applicable requirements of Section 6.11, become the successor Trustee with respect to the Securities of such series and to that extent supersede the successor Trustee appointed by the Company. If no successor Trustee with respect to the Securities
of any series shall have been so appointed by the Company or the Holders of Securities of that series and accepted appointment in the manner required by Section 6.11, any Holder of a Security who has been a bona fide Holder of a Security of
such series for at least six months, subject to Section 5.14, may, on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the appointment of a successor Trustee with respect to the Securities of such
series. 
 (f) The Company shall give notice of each resignation and each removal of the Trustee with respect to the Securities of any
series and each appointment of a successor Trustee with respect to the Securities of any series in the manner provided in Section 1.06. Each notice shall include the name of the successor Trustee with respect to the Securities of such series and the
address of its Corporate Trust Office. 
 Section 6.11. Acceptance of Appointment by Successor. (a) In case of the
appointment hereunder of a successor Trustee with respect to all Securities, every such successor Trustee so appointed shall execute, acknowledge and deliver to the Company and to the retiring Trustee an instrument accepting such appointment, and
thereupon the resignation or removal of the retiring Trustee shall become effective and such successor Trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee;
but, on request of the Company or the successor Trustee, such retiring Trustee shall, upon payment of the charges due it pursuant to Section 6.07, execute and deliver an instrument transferring to such successor

  
 54 

 
Trustee all the rights, powers and trusts of the retiring Trustee, and shall duly assign, transfer and deliver to such successor Trustee all property and money held by such retiring Trustee
hereunder. Upon request of any such successor Trustee, the Company shall execute any and all instruments for more fully and certainly vesting in and confirming to such successor Trustee all such rights, powers and trusts. 

(b) In case of the appointment hereunder of a successor Trustee with respect to the Securities of one or more (but not all) series, the
Company, the retiring Trustee and each successor Trustee with respect to the Securities of one or more series shall execute and deliver an indenture supplemental hereto wherein each successor Trustee shall accept such appointment and which
(i) shall contain such provisions as shall be necessary or desirable to transfer and confirm to, and to vest in, each successor Trustee all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or
those series to which the appointment of such successor Trustee relates, (ii) if the retiring Trustee is not retiring with respect to all Securities, shall contain such provisions as shall be deemed necessary or desirable to confirm that all
the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series as to which the retiring Trustee is not retiring shall continue to be vested in the retiring Trustee, and (iii) shall add to or
change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, it being understood that nothing herein or in such supplemental indenture shall
constitute such Trustees co-trustees of the same trust and that each such Trustee shall be trustee of a trust or trusts hereunder separate and apart from any trust or trusts hereunder administered by any other such Trustee; and upon the execution
and delivery of such supplemental indenture the resignation or removal of the retiring Trustee shall become effective to the extent provided therein and each such successor Trustee, without any further act, deed or conveyance, shall become vested
with all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series to which the appointment of such successor Trustee relates; but, on request of the Company or any successor Trustee, such
retiring Trustee shall duly assign, transfer and deliver to such successor Trustee all property and money held by such retiring Trustee hereunder with respect to the Securities of that or those series to which the appointment of such successor
Trustee relates. 
 (c) Upon request of any such successor Trustee, the Company shall execute any and all instruments for more fully and
certainly vesting in and confirming to such successor Trustee all such rights, powers and trusts referred to in paragraph (a) or (b) of this Section, as the case may be. 

(d) No successor Trustee shall accept its appointment unless at the time of such acceptance such successor Trustee shall be qualified and
eligible under this Article. 
 Section 6.12. Merger, Conversion, Consolidation or Succession to Business. Any corporation into
which the Trustee may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation succeeding to all or substantially
all of the corporate trust business of the Trustee, shall be the successor of 

  
 55 

 
the Trustee hereunder, provided such corporation shall be otherwise qualified and eligible under this Article, without the execution or filing of any paper or any further act on the part of any
of the parties hereto. In a case any Securities shall have been authenticated, but not delivered, by the Trustee then in office, any successor by merger, conversion or consolidation to such authenticating Trustee may adopt such authentication and
deliver the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities. 

Section 6.13. Preferential Collection of Claims Against Company. If and when the Trustee shall be or become a creditor of the
Company (or any other obligor upon the Securities), the Trustee shall be subject to the provisions of the Trust Indenture Act regarding the collection of claims against the Company (or any such other obligor). A Trustee who has resigned or been
removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent provided therein. 
 Section 6.14.
Appointment of Authenticating Agent. The Trustee may appoint an Authenticating Agent or Agents with respect to one or more series of Securities which shall be authorized to act on behalf of the Trustee to authenticate Securities of such
series issued upon original issue or upon exchange, registration of transfer or partial redemption thereof or pursuant to Section 3.06, and Securities so authenticated shall be entitled to the benefits of this Indenture and shall be valid and
obligatory for all purposes as if authenticated by the Trustee hereunder. Wherever reference is made in this Indenture to the authentication and delivery of Securities by the Trustee or the Trustee’s certificate of authentication such reference
shall be deemed to include authentication and delivery on behalf of the Trustee by an Authenticating Agent and a certificate of authentication executed on behalf of the Trustee by an Authenticating Agent. Each Authenticating Agent shall be
acceptable to the Company. If such Authenticating Agent publishes reports of condition at least annually, pursuant to law or to the requirements of said supervising or examining authority, then for the purposes of this Section, the combined capital
and surplus of such Authenticating Agent shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. If at any time an Authenticating Agent shall cease to be eligible in accordance with
the provisions of this Section, such Authenticating Agent shall resign immediately in the manner and with the effect specified in this Section. 

Any corporation into which an Authenticating Agent may be merged or converted or with which it may be consolidated, or any corporation
resulting from any merger, conversion or consolidation to which such Authenticating Agent shall be a party, or any corporation succeeding to the corporate agency or corporate trust business of such Authenticating Agent, shall continue to be an
Authenticating Agent provided such corporation shall be otherwise eligible under this Section, without the execution or filing of any paper or any further act on the part of the Trustee or such Authenticating Agent. 

An Authenticating Agent may resign at any time by giving written notice thereof to the Trustee and to the Company. The Trustee may at any time
terminate the agency of an Authenticating Agent by giving written notice thereof to such Authenticating Agent and to the Company. Upon receiving such a notice of resignation or upon such a 

  
 56 

 
termination, or in case at any time such Authenticating Agent shall cease to be eligible in accordance with the provisions of this Section, the Trustee may appoint a successor Authenticating
Agent which shall be acceptable to the Company and shall promptly give notice of such appointment to all Holders of Securities pursuant to Section 1.06. Any successor Authenticating Agent upon acceptance of its appointment hereunder shall become
vested with all the rights, powers and duties of its predecessor hereunder with like effect as if originally named as an Authenticating Agent. No successor Authenticating Agent shall be appointed unless eligible under the provisions of this Section.

 The Company agrees to pay to each Authenticating Agent from time to time reasonable compensation for its services under this Section.

 If an appointment with respect to one or more series is made pursuant to this Section, the Securities of such series may have endorsed
thereon, in addition to the Trustee’s certificate of authentication, an alternative certificate of authentication in the following form: 

This is one of the Securities of the series designated therein referred to in the within mentioned Indenture. 

 

			
	 WELLS FARGO BANK, NATIONAL

   ASSOCIATION, as Trustee

		
	By:	 	  

		 	Authenticating Agent
		
	By:	 	  

		 	Authorized Signatory

 If the Trustee does not have an office capable of authenticating Securities upon original issuance
located in a Place of Payment where the Company wishes to have Securities of such series authenticated upon original issuance, the Trustee, if so requested by the Company in writing (which writing need not comply with Section 102 and need not
be accompanied by an Opinion of Counsel), shall appoint (at the expense of the Company) in accordance with this Section an Authenticating Agent having an office in a Place of Payment designated by the Company with respect to such series of
Securities. 

  
 57 

 ARTICLE 7 

HOLDERS’ LISTS AND REPORTS BY TRUSTEE
AND COMPANY 
 Section 7.01. Company to Furnish Trustee Names and Addresses of Holders of Registered
Securities. The Company will furnish or cause to be furnished to the Trustee with respect to the Registered Securities of each series: 

(a) semi-annually, not more than fifteen days after each Regular Record Date, or in the case of any series of Securities on which semi-annual
interest is not payable, not more than 15 days after such semi-annual dates as may be specified by the Trustee, a list, in such form as the Trustee may reasonably require, of the names and addresses of the Holders of such Registered Securities as of
such Regular Record Date or such semiannual date, as the case may be, and 
 (b) at such other times as the Trustee may request in
writing, within 30 days after the receipt by the Company of any such request, a list of similar form and content as of a date not more than 15 days prior to the time such list is furnished, provided, however, that so long as the Trustee is
the Security Registrar, no such list need be furnished. 
 Section 7.02. Preservation of Information; Communications
to Holders. (a) The Trustee shall preserve, in as current a form as is reasonably practicable, the names and addresses of Holders of Registered Securities (a) contained in the most recent list furnished to the Trustee as provided in Section
7.01, (b) received by the Trustee in its capacity as Security Registrar (or Paying Agent, if so acting) and (c) filed with it during the two preceding years pursuant to Section 7.03(c). The Trustee may destroy any list furnished to it as provided in
Section 7.01 upon receipt of a new list so furnished. 
 (b) If three or more Holders of Securities of any series (hereinafter
referred to as “applicants”) apply in writing to the Trustee, and furnish to the Trustee reasonable proof that each such applicant has owned a Security for a period of at least six months preceding the date of such application, and such
application states that the applicants desire to communicate with other Holders of Securities of such series with respect to their rights under this Indenture or under the Securities of such series and is accompanied by a copy of the form of proxy
or other communication which such applicants propose to transmit, then the Trustee shall within five business days after the receipt of such application, at its election, either 

(i) afford such applicants access to the information preserved at the time by the Trustee in accordance with Section 7.02(a),
or 
 (ii) inform such applicants as to the approximate number of Holders of Registered Securities of such series whose names
and addresses appear in the information preserved at the time by the Trustee in accordance with Section 7.02(a), and as to the approximate cost of mailing to such Holders of Registered Securities of such series the form of proxy or other
communication, if any, specified in such application. 
 If the Trustee shall elect not to afford such applicants access to such
information, the Trustee shall, upon the written request of such applicants, mail to each Holder of Registered Securities of such series whose name and address appears in the information preserved at the time by the Trustee in accordance with
Section 7.02(a), a copy of the form of proxy or other communication which is specified in such request, with reasonable promptness after a tender to the Trustee of the material to be mailed and of payment, or provision for the payment, of the
reasonable expenses of mailing, unless within five days 

  
 58 

 
after such tender, the Trustee shall mail to such applicants and file with the Commission, together with a copy of the material to be mailed, a written statement to the effect that, in the
opinion of the Trustee, such mailing would be contrary to the best interests of the Holders of Registered Securities of such series or would be in violation of applicable law. Such written statement shall specify the basis of such opinion. If the
Commission, after opportunity for a hearing upon the objections specified in the written statement so filed, shall enter an order refusing to sustain any of such objections or if, after the entry of an order sustaining one or more of such
objections, the Commission shall find, after notice and opportunity for hearing, that all the objections so sustained have been met and shall enter an order so declaring, the Trustee shall mail copies of such material to all such Holders of
Registered Securities of such series with reasonable promptness after the entry of such order and the renewal of such tender; otherwise the Trustee shall be relieved of any obligation or duty to such applicants respecting their application. 

(c) Every Holder of Securities or coupons, by receiving and holding the same, agrees with the Company and the Trustee that neither the Company
nor the Trustee, nor any agent of the Company or the Trustee shall be held accountable by reason of the disclosure of any such information as to the names and addresses of the Holders of Registered Securities in accordance with Section 7.02(b),
regardless of the source from which such information was derived, and that the Trustee shall not be held accountable by reason of mailing any material pursuant to a request made under Section 7.02(b). 

Section 7.03. Reports by Trustee. (a) The Trustee shall transmit to Holders such reports concerning the Trustee and
its actions under this Indenture as may be required pursuant to the Trust Indenture Act at the times and in the manner provided pursuant thereto. If required by Section 313(a) of the Trust Indenture Act, the Trustee shall, within 60 days after
each September 1 following the date of this Indenture deliver to Holders a report, dated as of such September 1, which complies with the provisions of such Section 313(a).  

(b) The Trustee shall comply with Sections 313(b) and 313(c) of the Trust Indenture Act. 

(c) A copy of such report shall, at the time of such transmission to the Holders of Securities, be filed by the Trustee with the Company, with
each securities exchange upon which any of the Securities are listed (if so listed) and also with the Commission. The Company agrees to notify the Trustee when any Securities become listed on any stock exchange or market center. 

Section 7.04. Reports by Company. The Company will: 

(a) file with the Trustee, within 15 days after the Company is required to file the same with the Commission, copies of the annual reports and
of the information, documents and other reports (or copies of such portions of any of the foregoing as the Commission may from time to time by rules and regulations prescribe) which the Company may be required to file with the Commission pursuant to
Section 13 or Section 15(d) of the Exchange Act; or, if the Company is not required to file 

  
 59 

 
information, documents or reports pursuant to either of said Sections, then it will file with the Trustee and the Commission, in accordance with rules and regulations prescribed from time to
time by the Commission, such of the supplementary and periodic information, documents and reports which may be required pursuant to Section 13 of the Exchange Act in respect of a security listed and registered on a national securities exchange
as may be prescribed from time to time in such rules and regulations; provided that the Company shall be deemed to have filed with the Trustee any annual report, information, document or other report that the Company shall have filed with the
Commission that is publicly available via the Commission’s Electronic Data Gathering, Analysis and Retrieval (EDGAR) system or any successor thereto; provided further that the Trustee shall have no obligation whatsoever to determine
whether or not such information, documents or reports have been filed pursuant to the EDGAR system (or its successor). 
 (b) file
with the Trustee and the Commission, in accordance with rules and regulations prescribed from time to time by the Commission, such additional information, documents, and reports with respect to compliance by the Company with the conditions and
covenants of this Indenture as may be required from time to time by such rules and regulations; and 
 (c) transmit by mail to all Holders,
within 30 days after the filing thereof with the Trustee, in the manner and to the extent provided in Section 7.03(c) with respect to reports pursuant to Section 7.03(a), such summaries of any information, documents and reports required to be filed
by the Company pursuant to paragraphs (a) and (b) of this Section as may be required by rules and regulations prescribed from time to time by the Commission. 

Delivery of such reports, information and documents referenced above to the Trustee is for informational purposes only and the Trustee’s
receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is
entitled to rely exclusively on Officers’ Certificates). 
 ARTICLE 8 

CONSOLIDATION, MERGER, CONVEYANCE, TRANSFER OR LEASE

 Section 8.01. Company May Consolidate, Etc., Only on Certain Terms. 

The Company shall not consolidate with or merge into any other Person or sell, convey, transfer or lease its properties and assets
substantially as an entirety to any Person unless: 
 (a) the Person formed by such consolidation or into which the Company is merged or the
Person which acquires by sale, conveyance, transfer or lease the properties and assets of the Company substantially as an entirety shall expressly assume, by an indenture supplemental hereto, executed and delivered to the Trustee, in form
satisfactory 

  
 60 

 
to the Trustee, the due and punctual payment of the principal of (and premium, if any) and interest, if any (including all additional amounts, if any, payable pursuant to Section 10.09), on all
the Securities and the performance of every covenant of this Indenture on the part of the Company to be performed or observed; 
 (b)
immediately after giving effect to such transaction, and treating any indebtedness which becomes an obligation of the Company or a Subsidiary as a result of such transaction as having been incurred by the Company or such Subsidiary at the time of
such transaction no Event of Default, and no event which, after notice or lapse of time, or both, would become an Event of Default, shall have happened and be continuing; and 

(c) the Company has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel each stating that such consolidation,
merger, sale, conveyance, transfer or lease and, if a supplemental indenture is required in connection with such transaction, such supplemental indenture comply with this Article and that all conditions precedent herein provided for relating to such
transaction have been complied with. 
 Section 8.02. Successor Substituted. Upon any consolidation or merger by the
Company with or into any other Person, or any sale, conveyance, transfer or lease by the Company of the properties and assets of the Company substantially as an entirety to any Person in accordance with Section 8.01, the successor Person formed by
such consolidation or into which the Company is merged or to which such sale, conveyance, transfer or lease is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same
effect as if such successor Person had been named as the Company herein; and thereafter, the Company (which term shall for this purpose mean the Person named as the “Company” in the first paragraph of this Indenture or any successor Person
which shall theretofore become such in the manner described in Section 8.01) shall be discharged from all obligations and covenants under this Indenture and the Securities and coupons, and may be dissolved and liquidated.  

ARTICLE 9 

SUPPLEMENTAL INDENTURES 

Section 9.01. Supplemental Indentures Without Consent of Holders. Without the consent of any Holder of Securities, the
Company, when authorized by or pursuant to a Board Resolution, and the Trustee, at any time and from time to time, may enter into one or more indentures supplemental hereto, in form satisfactory to the Trustee, for any of the following purposes:

 (a) to evidence the succession of another Person to the Company and the assumption by any such successor of the covenants of the
Company herein and in the Securities contained; or 
 (b) to add to the covenants of the Company, for the benefit of the Holders of all or
any series of Securities (and if such covenants are to be for the benefit of less than all series of Securities, stating that such covenants are expressly being included solely for the benefit of such series) or to surrender any right or power
herein conferred upon the Company; or 

  
 61 

 (c) to add any additional Events of Default (and if such Events of Default are to be for the
benefit of less than all series of Securities, stating that such Events of Default are expressly being included solely for the benefit of such series); or 

(d) to add to or change any of the provisions of this Indenture to provide that Bearer Securities may be registrable as to principal,
to change or eliminate any restrictions on the payment of principal (or premium, if any) or interest, if any, on Bearer Securities, to permit Bearer Securities to be issued for Bearer Securities of other authorized denominations or to permit the
issuance of Securities in uncertificated form, provided that any such action shall not adversely affect the interests of the Holders of Securities of any series or any related coupons in any material respect; or 

(e) to change or eliminate any of the provisions of this Indenture, provided that any such change or elimination shall become
effective only when there is no Security Outstanding of any series created prior to the execution of such supplemental indenture which is entitled to the benefit of such provision; or 

(f) to secure the Securities and related coupons; or 

(g) to establish the form or terms of Securities of any series and related coupons as permitted by Section 2.01 and 3.01; or 

(h) to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more
series and/or to add or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, pursuant to the requirements of Section 6.11(b); or 

(i) to cure any ambiguity, to correct or supplement any provision herein which may be defective or inconsistent with any other
provision herein; or to make any other provisions with respect to matters or questions arising under this Indenture, provided that such action shall not adversely affect the interests of the Holders of Securities of any series or any related
coupons in any material respect; or 
 (j) to conform the text of this Indenture or any Security issued hereunder to any provision of
the registration statement (including any prospectus, prospectus supplement or free writing prospectus filed with the Commission pursuant thereto) pursuant to which Securities were or may be sold to the extent such provision in the registration
statement (including any prospectus, prospectus supplement or free writing prospectus filed with the Commission pursuant thereto) was intended to be a verbatim recitation of a provision in this Indenture or such Securities, as set forth in an
Officers’ Certificate. 
 Section 9.02. Supplemental Indentures With Consent of Holders. With the consent of the
Holders of not less than a majority in principal amount of the Outstanding Securities of each series affected by such supplemental indenture, by Act of said Holders  

  
 62 

 
delivered to the Company and the Trustee, the Company, when authorized by a Board Resolution, and the Trustee may enter into an indenture or indentures supplemental hereto for the purpose of
adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of modifying in any manner the rights of the Holders of Securities of such series and any related coupons under this Indenture; provided,
however, that no such supplemental indenture shall, without the consent of the Holder of each Outstanding Security affected thereby: 

(a) change the Stated Maturity of the principal of, or any installment of principal of or any interest on, any Security, or reduce the
principal amount thereof or any rate of interest thereon or any premium payable upon the redemption thereof, or change any obligation of the Company to pay additional amounts pursuant to Section 10.09 (except as contemplated by Section 8.01(a) and
permitted by Section 9.01(a)), or reduce the amount of the principal of an Original Issue Discount Security that would be due and payable upon a declaration of acceleration of the Stated Maturity thereof pursuant to Section 5.02, or change the
method in which amounts of payments of principal or any interest thereon are determined, or change any Place of Payment, or change the coin or currency in which any Security or any premium or any interest thereon is payable, or impair the right to
institute suit for the enforcement of any such payment on or after the Stated Maturity thereof (or, in the case of redemption, on or after the Redemption Date); or 

(b) reduce the percentage in principal amount of the Outstanding Securities of any series, the consent of whose Holders is required for any
such supplemental indenture, or the consent of whose Holders is required for any waiver (or compliance with certain provisions of this Indenture or certain defaults hereunder and their consequences) provided for in this Indenture; or 

(c) modify any of the provisions of this Section, Section 5.13 or Section 10.08, except to increase any such percentage or to provide
that certain other provisions of this Indenture cannot be modified or waived without the consent of the Holder of each Outstanding Security affected thereby, provided, however, that this clause shall not be deemed to require the consent of
any Holder of a Security or coupon with respect to changes in the references to “the Trustee” and concomitant changes in this Section and Section 10.08, or the deletion of this proviso, in accordance with the requirements of Section
6.11(b) and Section 9.01(h); or 
 (d) change any obligation of the Company to maintain an office or agency in the places and for the
purposes specified in Section 10.02. 
 A supplemental indenture which changes or eliminates any covenant or other provision of this
Indenture which has expressly been included solely for the benefit of one or more particular series of Securities, or which modifies the rights of the Holders of Securities of such series with respect to such covenant or other provision, shall be
deemed not to affect the rights under this Indenture of the Holders of Securities of any other series. 

  
 63 

 It shall not be necessary for any Act of Holders under this Section to approve the particular
form of any proposed supplemental indenture, but it shall be sufficient if such Act shall approve the substance thereof. 

Section 9.03. Execution of Supplemental Indentures. In executing, or accepting the additional trusts created by, any
supplemental indenture permitted by this Article or the modifications thereby of the trusts created by this Indenture, the Trustee shall be entitled to receive, and (subject to Section 6.01) shall be fully protected in relying upon, an
Officers’ Certificate and Opinion of Counsel stating that the execution of such supplemental indenture is authorized or permitted by this Indenture, and that such supplemental indenture, when executed and delivered by the Company, will
constitute a valid and binding obligation of the Company enforceable in accordance with its terms. The Trustee may, but shall not be obligated to, enter into any such supplemental indenture which affects the Trustee’s own rights, duties or
immunities under this Indenture or otherwise. 
 Section 9.04. Effect of Supplemental Indentures. Upon the
execution of any supplemental indenture under this Article, this Indenture shall be modified in accordance therewith, and such supplemental indenture shall form a part of this Indenture for all purposes; and every Holder of Securities theretofore or
thereafter authenticated and delivered hereunder and of any coupons appertaining thereto shall be bound thereby. 

Section 9.05. Conformity with Trust Indenture Act. Every supplemental indenture executed pursuant to this Article shall
conform to the requirements of the Trust Indenture Act as then in effect. 
 Section 9.06. Reference in Securities to
Supplemental Indentures. Securities of any series authenticated and delivered after the execution of any supplemental indenture pursuant to this Article may, and shall if required by the Trustee, bear a notation in form acceptable to the Trustee
as to any matter provided for in such supplemental indenture. If the Company shall so determine, new Securities of any series so modified as to conform, in the opinion of the Company, to any such supplemental indenture may be prepared and executed
by the Company and authenticated and delivered by the Trustee in exchange for Outstanding Securities of such Series. 
 ARTICLE 10

 COVENANTS 

Section 10.01. Payment of Principal, Premium and Interest. The Company covenants and agrees for the benefit of each series
of Securities that it will duly and punctually pay the principal of (and premium, if any) and interest, if any, on the Securities of that series in accordance with the terms of such series of Securities, any coupons appertaining thereto and this
Indenture. Unless otherwise specified as contemplated by Section 3.01 with respect to any series of Securities, any interest due on Bearer Securities on or before Maturity shall be payable only upon presentation and surrender of the several coupons
for such interest installments as are evidenced thereby as they severally mature. 

  
 64 

 Section 10.02. Maintenance of Office or Agency. If Securities of a series are
issuable as or exchangeable for Registered Securities, the Company will maintain in each Place of Payment for such series an office or agency where Securities of that series may be presented or surrendered for payment where Securities of that series
may be surrendered for registration of transfer or exchange and where notices and demands to or upon the Company with respect to the Securities of that series and this Indenture may be served, any one or more of which offices or agencies may be the
same for one or more series of Securities. 
 If Securities of a series are issuable as Bearer Securities, the Company will maintain
(a) in the Borough of Manhattan, the City of New York, an office or agency where any Registered Securities of that series may be presented or surrendered for payment, where any Registered Securities of that series may be surrendered for
registration of transfer, where Securities of that series may be surrendered for exchange, where notices and demands to or upon the Company in respect of the Securities of that series and this Indenture may be served and where Bearer Securities of
that series and related coupons may be presented or surrendered for payment in the circumstances described in the following paragraph (and not otherwise), (b) subject to any laws or regulations applicable thereto, in a Place of Payment for that
series which is located outside the United States, an office or agency where Bearer Securities of that series, and related coupons may be presented and surrendered for payment (including payment of any additional amounts payable on Securities of
that series pursuant to Section 10.09); provided, however, that if the Securities of that series are listed on the International Stock Exchange of the United Kingdom and the Republic of Ireland Limited, the Luxembourg Stock Exchange or any
other stock exchange located outside the United States and such securities exchange shall so require, the Company will maintain a Paying Agent for the Securities of that series in London, Luxembourg or any other required city located outside the
United States, as the case may be, so long as the Securities of that series are listed on such exchange, and (c) subject to any laws or regulations applicable thereto, in a Place of Payment for that series located outside the United States an
office or agency where any Registered Securities of that series may be surrendered for registration of transfer, where Securities of that series may be surrendered for exchange and where notices and demands to or upon the Company in respect of the
Securities of that series and this Indenture may be served. 
 The Company will give prompt written notice to the Trustee and prompt notice
to the Holders of Securities of such series, as provided in Section 1.06 of the location, and of any change in the location, of any such office or agency. If at any time the Company shall fail to maintain any such required office or agency in
respect of any series of Securities or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee, except that Bearer Securities
of that series and the related coupons may be presented and surrendered for payment (including payment of any additional amounts payable on Bearer Securities of that series pursuant to Section 10.09) at any Place of Payment for such series located
outside the United States and the Company hereby appoints the Trustee its agent to receive all such presentations, surrenders, notices and demands. 

  
 65 

 No payment of principal, premium or interest on Bearer Securities shall be made at any office or
agency of the Company in the United States or by check mailed to any address in the United States or by transfer to an account maintained with a bank located in the United States; provided, however, that, if the Securities of a series are
denominated and payable in Dollars, payment of principal of and any premium and interest on any Bearer Security (including any additional amounts payable on Securities of such series pursuant to Section 10.09) and payment of any coupon related
thereto shall be made at the office of the Company’s Paying Agent in the United States, if (but only if) payment in Dollars of the full amount of such principal, premium, interest or additional amounts, the case may be, at all offices or
agencies outside the United States maintained for the purpose by the Company in accordance with this Indenture is illegal or effectively precluded by exchange controls or other similar restrictions. 

The Company may also from time to time designate one or more other offices or agencies (in or outside any Place of Payment) where the
Securities of one or more series and any related coupons may be presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided, however, that no such designation or rescission shall in any
manner relieve the Company of its obligation to maintain an office or agency for Securities of any series and related coupons for such purposes. The Company will give prompt written notice to the Trustee of any such designation or rescission and of
any change in the location of any such other office or agency. 
 Section 10.03. Money For Security Payments to Be Held in
Trust. If the Company shall at any time act as its own Paying Agent with respect to any series of Securities, it will, on or before each due date of the principal of (and premium, if any) or interest, if any, on any of the Securities of that
series, segregate and hold in trust for the benefit of the Persons entitled thereto a sum sufficient to pay the principal (and premium, if any) or interest, if any, so becoming due until such sums shall be paid to such Persons or otherwise disposed
of as herein provided and will promptly notify the Trustee of its action or failure so to act. 
 Whenever the Company shall have one
or more Paying Agents for any series of Securities, it will, prior to each due date of the principal of (and premium, if any) or interest, if any, on any Securities of that series, deposit with a Paying Agent a sum sufficient to pay the principal
(and premium, if any) or interest, if any, so becoming due, such sum to be held in trust for the benefit of the Persons entitled to such principal, premium or interest, and (unless such Paying Agent is the Trustee) the Company will promptly notify
the Trustee of its action or failure so to act. 
 The Company will cause each Paying Agent for any series of Securities other than the
Trustee to execute and deliver to the Trustee an instrument in which such Paying Agent shall agree with the Trustee, subject to the provisions of this Section, that such Paying Agent will: 

(a) hold all sums held by it for the payment of the principal of (and premium, if any) or interest, if any, on Securities of that series in
trust for the benefit of the Persons entitled thereto until such sums shall be paid to such Persons otherwise disposed of as herein provided; 

  
 66 

 (b) give the Trustee notice of any default by the Company (or any other obligor upon the
Securities of that series) in the making of any payment of principal (and premium, if any) or interest, if any, on the Securities of that series; and 

(c) at any time during the continuance of any such default, upon the written request of the Trustee, forthwith pay to the Trustee all sums so
held in trust by such Paying Agent. 
 The Company may at any time, for the purpose of obtaining the satisfaction and discharge of this
Indenture or for any other purpose, pay, or by Company Order direct any Paying Agent to pay, to the Trustee all sums held in trust by the Company or such Paying Agent, such sums to be held by the Trustee upon the same trusts as those upon which such
sums were held by the Company or such Paying Agent; and, upon such payment by any Paying Agent to the Trustee, such Paying Agent shall be released from all further liability with respect to such money. 

Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of the principal of (and
premium, if any) or interest, if any, on any Security of any series or the payment of any related coupon and remaining unclaimed for two years after such principal (and premium, if any) or interest, if any, has become due and payable shall, unless
otherwise required by mandatory provisions of applicable escheat, or abandoned or unclaimed property law, be paid to the Company on Company Request, or (if then held by the Company) shall be discharged from such trust; and the Holder of such
Security or any coupon appertaining thereto shall thereafter, as an unsecured general creditor, look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability
of the Company as trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense of the Company cause to be published once, in an
Authorized Newspaper in each Place of Payment, notice that such money remains unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such publication, any unclaimed balance of such money then
remaining will unless otherwise required by mandatory provisions of applicable escheat, or abandoned or unclaimed property law, be repaid to the Company. 

Section 10.04. Restrictions on Secured Debt. The Company covenants and agrees for the benefit of each series of Securities,
other than any series established by or pursuant to a Board Resolution or in one or more supplemental indentures hereto which specifically provides otherwise, that it will not itself, and will not permit any Restricted Subsidiary to, incur, issue,
assume, or guarantee any loans, whether or not evidenced by negotiable instruments or securities, or any notes, bonds, debentures or other similar evidences of indebtedness for money borrowed (loans, and notes, bonds, debentures or other similar
evidences of indebtedness for money borrowed being hereinafter in this Section 10.04 called “Debt”), secured after the date hereof by pledge of, or mortgage  

  
 67 

 
or lien on, any Principal Property of the Company or any Restricted Subsidiary or any shares of Capital Stock of or Debt of any, Restricted Subsidiary (mortgages, pledges and liens being
hereinafter in this Section 10.04 called “Mortgage” or “Mortgages”), without effectively providing that the Securities other than Securities of a series not entitled to the benefits of this covenant (together with, if the Company
shall so determine, any other Debt of the Company or such Restricted Subsidiary then existing or thereafter created which is not subordinate to the Securities) shall be secured equally and ratably with (or, at the option of the Company, prior to)
such secured Debt, so long as such secured Debt shall be so secured, unless, after giving effect thereto, the aggregate amount of all such secured Debt plus all Attributable Debt of the Company and its Restricted Subsidiaries with respect to sale
and leaseback transactions to which Section 10.05 is applicable would not exceed 10% of Consolidated Net Assets; provided, however, that this Section 10.04 shall not apply to, and there shall be excluded from secured Debt in any computation
under this Section 10.04, Debt secured by:  
 (a) Mortgages on property of, or on any shares of Capital Stock of or Debt of, any
corporation existing at the time such corporation becomes a Restricted Subsidiary; 
 (b) Mortgages in favor of the Company or any
Restricted Subsidiary; 
 (c) Mortgages in favor of any governmental body to secure progress, advance or other payments pursuant to any
contract or provision of any statute; 
 (d) Mortgages on property, shares of Capital Stock or Debt existing at the time of acquisition
thereof (including acquisition through merger or consolidation) or to secure the payment of all or any part of the purchase price thereof or construction thereon or to secure any Debt incurred prior to, at the time of, or within 180 days after the
later of the acquisition of such property, shares of Capital Stock or Debt or the completion of construction for the purpose of financing all or any part of the purchase price thereof or construction thereon; 

(e) Mortgages securing obligations issued by a State, territory or possession of the United States, any political subdivision of any of the
foregoing, or the District of Columbia, or any instrumentality of any of the foregoing to finance the acquisition or construction of property, and on which the interest is not, in the opinion of tax counsel of recognized standing or in accordance
with a ruling issued by the Internal Revenue Service, includible in gross income of the holder by reason of Section 103(a) of the Internal Revenue Code (or any successor to such provision) as in effect at the time of the issuance of such
obligations; 
 (f) Mechanics’, materialmen’s, carriers’ or other like liens arising in the ordinary course of business
(including construction of facilities) in respect of obligations which are not due or which are being contested in good faith; 
 (g) Any
mortgage arising by reason of deposits with, or the giving of any form of security to, any governmental agency or any body created or approved by law or governmental regulations which is required by law or governmental regulation as a condition to
the transaction of any business, or the exercise of any privilege, franchise or license; 

  
 68 

 (h) Mortgages for taxes, assessments or governmental charges or levies not yet delinquent, or
mortgages for taxes, assessments or governmental charges or levies already delinquent but the validity of which is being contested in good faith; 

(i) Mortgages (including judgment liens) arising in connection with legal proceedings so long as such proceedings are being contested in good
faith and, in the case of judgment liens, execution thereon is stayed; and 
 (j) Any extension, renewal or replacement (or successive
extensions, renewals or replacements), as a whole or in part, of any Mortgage referred to in the foregoing clauses (a) to (i), inclusive; provided, however, that such extension, renewal or replacement Mortgage shall be limited to all or
part of the same property, shares of Capital Stock or Debt that secured the Mortgage extended, renewed or replaced (plus improvements on such property). 

Section 10.05. Restrictions on Sales and Leasebacks. The Company covenants and agrees for the benefit of each series of
Securities, other than any series established by or pursuant to a Board Resolution or in one or more supplemental indentures hereto which specifically provides otherwise, that it will not itself, and will not permit any Restricted Subsidiary to,
enter into any transaction after the date hereof with any bank, insurance company or other lender or investor, or to which any such bank, company, lender or investor is a party, providing for the leasing by the Company or a Restricted Subsidiary of
any Principal Property which has been or is to be sold or transferred by the Company or such Restricted Subsidiary to such bank, company, lender or investor, or to any person to whom funds have been or are to be advanced by such bank, company,
lender or investor on the Security of such Principal Property (herein referred to as a “sale and leaseback transaction”) unless, after giving effect thereto, the aggregate amount of all Attributable Debt with respect to all such
transactions plus all secured Debt to which Section 10.04 is applicable would not exceed 10% of Consolidated Net Assets. This covenant shall not apply to, and there shall be excluded from Attributable Debt in any computation under this Section
10.05, Attributable Debt with respect to any sale and leaseback transaction if: 
 (a) the lease in such sale and leaseback
transaction is for a period, including renewal rights, of not in excess of five years; or 
 (b) the Company or a Restricted
Subsidiary, within 180 days after the sale or transfer shall have been made by the Company or by a Restricted Subsidiary applies an amount equal to the greater of the net proceeds of the sale of the Principal Property leased pursuant to such
arrangement or the fair market value of the Principal Property so leased at the time of entering into such arrangement (as determined in any manner approved by the Board of Directors) to (i) the retirement of the Securities or other Funded Debt
of the Company ranking on a parity with or senior to the Securities, or the retirement of the securities or other Funded Debt of a Restricted Subsidiary; provided, however, that the  

  
 69 

 
amount to be applied to the retirement of such Funded Debt of the Company or a Restricted Subsidiary shall be reduced by (x) the principal amount of any Securities (or other notes or
debentures constituting such Funded Debt) delivered within such 180-day period to the Trustee or other applicable trustee for retirement and cancellation and (y) the principal amount of such Funded Debt, other than items referred to in the
preceding clause (x), voluntarily retired by the Company or a Restricted Subsidiary within 180 days after such sale; and provided, further, that, notwithstanding the foregoing, no retirement referred to in this clause (i) may be effected
by payment at maturity or pursuant to any mandatory sinking fund payment or any mandatory prepayment provision, or (ii) the purchase of other property which will constitute a Principal Property having a fair market value, in the opinion of the
Board of Directors, at least equal to the fair market value of the Principal Property leased in such sale and leaseback transaction; or 

(c) such sale and leaseback transaction is entered into prior to, at the time of, or within 180 days after the later of the acquisition of the
Principal Property or the completion of construction thereon; or 
 (d) the lease in such sale and leaseback transaction secures or relates
to obligations issued by a State, territory or possession of the United States, or any political subdivision of any of the foregoing, the District of Columbia, or any instrumentality of any of the foregoing to finance the acquisition or construction
of property, and on which the interest is not, in the opinion of tax counsel of recognized standing or in accordance with a ruling issued by the Internal Revenue Service, includible in gross income of the holder by reason of Section 103(a) of
the Internal Revenue Code (or other successor to such provision) as in effect at the time of the issuance of such obligations; or 
 (e)
such sale and leaseback transaction is entered into between the Company and a Restricted Subsidiary or between Restricted Subsidiaries. 

Section 10.06. Statement as to Compliance. The Company will deliver to the Trustee, within 120 days after the end of each
fiscal year of the Company ending after the date of the first issuance of Securities hereunder, an Officers’ Certificate, stating, as to each signer thereof, that 

(a) a review of the activities of the Company during such year and of performance under this Indenture has been made under his supervision and

 (b) to the best of his knowledge, based on such review, the Company is not in default in the fulfillment of any of its obligations under
this Indenture, or specifying each such default known to him and the nature and status thereof. 
 The Company shall, so long as any of the
Notes are outstanding, deliver to a Responsible Officer of the Trustee, within five (5) Business days after the chief financial officer, the Treasurer, or the Controller obtains actual knowledge of any Default or Event of Default, an
Officers’ Certificate specifying such Default or Event of Default. 

  
 70 

 Section 10.07. Corporate Existence. Subject to Article Eight, the Company will
do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence. 

Section 10.08. Waiver of Certain Covenants. The Company may omit in any particular instance to comply with any term,
provision, covenant or condition set forth in Sections 10.04 and 10.05, inclusive, if before the time for such compliance the Holders of at least a majority in principal amount of the Outstanding Securities of each series shall, by Act of such
Holders, either waive such compliance in such instance or generally waive compliance with such term, provision, covenant or condition, but no such waiver shall extend to or affect such term, provision, covenant or condition except to the extent so
expressly waived, and, until such waiver shall become effective, the obligations of the Company and the duties of the Trustee with respect to any such term, provision, covenant or condition shall remain in full force and effect. 

Section 10.09. Additional Amounts. If the Securities of a series provide for the payment of additional amounts, the Company
will pay to the Holder of any Security of such series or any coupon appertaining thereto additional amounts as provided therein. Whenever in this Indenture there is mentioned, in any context, the payment of the principal of or any premium or
interest on, or in respect of, any Security of any series or payment of any related coupon or the net proceeds received on the sale or exchange of any Security of any series, such mention shall be deemed to include mention of the payment of
additional amounts provided for in this Section to the extent that, in such context, additional amounts are, were or would be payable in respect thereof pursuant to the provisions of this Section and express mention of the payment of additional
amounts (if applicable) in any provisions hereof shall not be construed as excluding additional amounts in those provisions hereof where such express mention is not made. 

If the Securities of a series provide for the payment of additional amounts, at least 10 days prior to the first Interest Payment Date with
respect to that series of Securities (or if the Securities of that series will not bear interest prior to Maturity, the first day on which a payment of principal and any premium is made), and at least 10 days prior to each date of payment of
principal and any premium or interest if there has been any change with respect to the matters set forth in the below-mentioned Officers’ Certificate, the Company will furnish the Trustee and the Company’s principal Paying Agent or Paying
Agents, if other than the Trustee, with an Officers’ Certificate instructing the Trustee and such Paying Agent or Paying Agents whether such payment of principal of and any premium or interest on the Securities of that series shall be made to
Holders of Securities of that series or any related coupons who are United States Aliens without withholding for or on account of any tax, assessment or other governmental charge described in the Securities of that series. If any such withholding
shall be required, then such Officers’ Certificate shall specify by country the amount, if any, required to be withheld on such payments to such Holders of Securities or coupons and the Company will pay to the Trustee or such Paying Agent the
additional amounts required by this Section. The Company covenants to indemnify the Trustee and any Paying Agent for, and to hold them harmless against, any loss, liability or expense incurred without negligence or willful misconduct on their part
arising out of or in connection with actions taken or omitted by any of them in reliance on any Officers’ Certificate furnished pursuant to this Section. 

  
 71 

 Section 10.10. Calculation of Original Issue Discount. If any series is issued
with Original Issue Discount, the Company shall file with the Trustee promptly at the end of each calendar year or written notice specifying the amount of original issue discount (including daily rates and accrual periods) accrued on Outstanding
Securities as of the end of such year. 
 ARTICLE 11 

REDEMPTION OF SECURITIES 

Section 11.01. Applicability of This Article. Securities of any series which are redeemable before their stated Maturity
shall be redeemable in accordance with their terms and (except as otherwise specified as contemplated by Section 3.01 for Securities of any series) in accordance with this Article. 

Section 11.02. Election to Redeem; Notice to Trustee. The election of the Company to redeem any Securities shall be
evidenced by a Board Resolution. In case of any redemption at the election of the Company of less than all the Securities of any series, the Company shall, at least 60 days prior to the Redemption Date fixed by the Company (unless a shorter notice
shall be satisfactory to the Trustee), notify the Trustee of such Redemption Date and of the principal amount of Securities of such series to be redeemed and the redemption price for such Securities, such notice to be accompanied by a written
statement signed by an Authorized Officer of the Company stating that no defaults in the payment of interest or Events of Default with respect to the Securities of that series have occurred (which have not been waived or cured). In the case of any
redemption of Securities (i) prior to the expiration of any restriction on such redemption provided in the terms of such Securities or elsewhere in this Indenture, or (ii) pursuant to an election of the Company which is subject to a
condition or computation specified in the terms of such Securities, the Company shall furnish the Trustee with an Officers’ Certificate evidencing compliance with such restriction, condition or computation. 

In the event that any election by the Company necessitates the retention of any agent by the Trustee, the Company agrees that such retention
shall be at the sole expense of the Company. 
 Section 11.03. Selection by Trustee of Securities to be Redeemed. If less
than all the Securities of any series are to be redeemed, the particular Securities to be redeemed shall be selected not more than 60 days prior to the Redemption Date by the Trustee, from the Outstanding Securities of such series not previously
called for redemption by lot or by such other method as the Trustee shall deem fair and appropriate (and in accordance with the procedures of the Depository) and which may provide for the selection for redemption of portions (equal to the minimum
authorized denomination for Securities of that series or any integral multiple thereof) of the principal amount of Securities of such series of a denomination larger than the minimum authorized denomination for Securities of that series or of
portions of the principal amount of global Securities of such series. 

  
 72 

 The Trustee shall promptly notify the Company in writing of the Securities selected for
redemption and, in the case of any Securities selected for partial redemption, the principal amount thereof to be redeemed. 
 For all
purposes of this Indenture, unless the context otherwise requires, all provisions relating to the redemption of Securities shall relate, in the case of any Securities redeemed or to be redeemed only in part, to the portion of the principal amount of
such Securities which has been or is to be redeemed. 
 Section 11.04. Notice of Redemption. Notice of redemption shall
be given in the manner provided in Section 1.06 not less than 30 and not more than 60 days prior to the Redemption Date, to the Holders of Securities to be redeemed. 

All notices of redemption shall include the CUSIP number and state: 

(a) the Redemption Date; 
 (b)
the Redemption Price and any accrued interest; 
 (c) if less than all Outstanding Securities of any series are to be redeemed, the
identification (and, in the case of partial redemption, the principal amounts) of the particular Securities to be redeemed; 
 (d) that on
the Redemption Date the Redemption Price, and any accrued interest thereon will become due and payable upon each such Security to be redeemed and that interest thereon shall cease to accrue from and after said date; 

(e) the place or places where such Securities are, together in the case of Bearer Securities with all coupons appertaining thereto, if any,
maturing after the Redemption Date, to be surrendered for payment of the Redemption Price and any accrued interest thereon; 
 (f) if such
be the case, that the installment of interest on Registered Securities whose Stated Maturity is the Redemption Date is payable to the Persons in whose names such Registered Securities are registered at the close of business on the Regular Record
Date immediately preceding the Redemption Date; and 
 (g) that the redemption is for a sinking fund, if such is the case. 

Notice of redemption of Securities to be redeemed shall be given by the Company or, at the Company’s request, by the Trustee in the name
and at the expense of the Company. In the event that the Company shall request that the Trustee send out a notice of redemption on its behalf, it shall make such request and provide the form of the notice of redemption to the Trustee at least 5
Business Days before such notice of redemption is to be sent. 

  
 73 

 Section 11.05. Deposit of Redemption Price. Prior to the opening of business
on any Redemption Date, the Company shall deposit with the Trustee or with a Paying Agent (or, if the Company is acting as its own Paying Agent, segregate and hold in trust as provided in Section 10.03) an amount of money sufficient to pay the
Redemption Price of, and (except if the Redemption Date shall be an Interest Payment Date) any accrued interest on, all the Securities which are to be redeemed on that date. 

Section 11.06. Securities Payable on Redemption Date. Notice of Redemption having been given as aforesaid, the Securities
so to be redeemed shall, on the Redemption Date, become due and payable at the Redemption Price therein specified together with any accrued interest thereon and from and after such date (unless the Company shall default in the payment of the
Redemption Price and accrued interest) such Securities shall cease to bear interest and the coupons for such interest appertaining to any Bearer Securities so to be redeemed, except to the extent provided below, shall be void. Upon surrender of any
such Securities for redemption in accordance with said notice, such Securities shall be paid by the Company at the Redemption Price, together with any accrued interest to the Redemption Date; provided, however, that any installments of
interest on Bearer Securities whose Stated Maturity is on or prior to the Redemption Date shall be payable only at an office or agency located outside the United States (except as otherwise provided in Section 10.02) and, unless otherwise specified
as contemplated by Section 3.01, only upon presentation and surrender of coupons for such interest, and provided, further, that, unless otherwise specified as contemplated by Section 3.01, installments of interest on Registered Securities
whose Stated Maturity is on or prior to the Redemption Date shall be payable to the Holders of such Securities, or one or more Predecessor Securities, registered as such at the close of business on the relevant Record Dates according to their terms
and the provisions of Section 3.07. 
 If any Bearer Security which is to be redeemed in whole or in part (as set forth in Section
11.07), surrendered for redemption shall not be accompanied by all appurtenant coupons maturing after the Redemption Date, such Security may be paid after deducting from the Redemption Price an amount equal to the face amount of all such missing
coupons, or the surrender of such missing coupon or coupons may be waived by the Company or jointly by the Company and the Trustee if there be furnished to them such security or indemnity as they may require to save each of them and any Paying Agent
harmless. If thereafter Holder shall surrender to the Trustee or any Paying Agent any such missing coupon in respect of which a deduction shall have been made from the Redemption Price, such Holder shall be entitled to receive the amount so
deducted; provided, however, that interest represented by coupons shall be payable only upon presentation and surrender of those coupons at an office or agency located outside of the United States except as otherwise provided in Section
10.02. 
 If the Company shall default in the payment of the Redemption Price and accrued interest on any Security called for redemption,
the principal (and premium, if any) of such Security shall, until paid or until payment is provided for in accordance herewith, bear interest for the Redemption Date at the rate, if any, prescribed therefor in the Security. 

  
 74 

 So long as it is known to the Trustee that an Event of Default is continuing hereunder, the
Trustee shall not redeem any Securities of any series pursuant to this Article (unless all Outstanding Securities of such series are to be redeemed) or mail or give any notice of redemption of Securities except that, where the mailing of notice of
redemption of any Securities shall theretofore have been made, the Trustee shall redeem or cause to be redeemed such Securities provided that it shall have received from the Company a sum sufficient for such redemption. Except as aforesaid, any
monies theretofore or thereafter received by the Trustee shall, during the continuance of such Event of Default, be deemed to have been collected under Article Five and held for the payment of all such Securities. In case such Event of Default shall
have been waived as provided in Section 5.13 or the default cured on or before the sixtieth day preceding the Redemption Date, such monies shall hereafter be applied in accordance with the provisions of this Article. 

Section 11.07. Securities Redeemed in Part. Any Security which is to be redeemed only in part shall be surrendered at any
Place of Payment therefor (with, if the Company or the Trustee so requires, due endorsement by, or a written instrument of transfer in form satisfactory to the Company and the Trustee duly executed by, the Holder thereof or his attorney duly
authorized in writing) together, in the case of Bearer Securities, with all coupons appertaining thereto maturing after the Redemption Date and the Company shall execute and the Trustee shall authenticate and deliver to the Holder of such Security
without service charge, a new Security or Securities of the same series and of like tenor, of any authorized denomination as requested by the Holder, in an aggregate principal amount equal to and in exchange for the unredeemed portion of the
principal of the Security so surrendered. 
 ARTICLE 12 

SINKING FUNDS 

Section 12.01. Applicability of Article. The provisions of this Article shall be applicable to any sinking fund for the
retirement of Securities of a series except as otherwise specified as contemplated by Section 3.01 for the Securities of such series. 

The minimum amount of any sinking fund payment provided for by the terms of Securities of any series is herein referred to as a
“mandatory sinking fund payment”, and any payment in excess of such minimum amount provided for by the terms of the Securities of any series is herein referred to as an “optional sinking fund payment”. If provided for by the
terms of the Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided in Section 12.02. Each sinking fund payment made on the Securities of a series shall be applied to the redemption of the
Securities of such series as provided for by the terms of the Securities of such series. 
 Section 12.02. Satisfaction of
Sinking Fund Payments with Securities. The Company (a) may deliver Outstanding Securities of a series (other than any previously called for redemption), together in the case of any Bearer Securities of such series with all unmatured coupons
appertaining thereto and (b) may apply as a credit the Securities of a series which have been redeemed either at the election of the Company pursuant to the  

  
 75 

 
terms of such Securities or through the application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of all or any part of
any sinking fund payment with respect to the Securities of such series required to be made pursuant to the terms of such Securities as provided for by the terms of such Securities; provided that such Securities have not been previously so
credited. Such Securities shall be received and credited for such purpose by the Trustee at the Redemption Price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be
reduced accordingly. 
 Section 12.03. Redemption of Securities for Sinking Fund. Not less than 60 days or such
other shorter period as may be acceptable to the Trustee prior to each sinking fund payment date for any series of Securities, the Company will deliver to the Trustee an Officers’ Certificate specifying the amount of the next ensuing sinking
fund payment for that series pursuant to the terms of that series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any, which is to be satisfied by delivering and crediting Securities of that
series pursuant to Section 12.02 and will also deliver to the Trustee any Securities to be so delivered. Not less than 30 days before each such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking fund
payment date in the manner specified in Section 11.03 and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in Section 11.04. Such notice having been duly given, the redemption
of such Securities shall be made upon the terms and in the manner stated in Sections 11.06 and 11.07. 
 ARTICLE 13 

MEETINGS OF HOLDERS OF SECURITIES 

Section 13.01. Purposes for which Meetings may be Called. If any Securities of a series are issuable as Bearer Securities,
a meeting of Holders of Securities of such series may be called at any time and from time to time pursuant to this Article to make, give or take any request, demand, authorization direction, notice, consent, waiver or other action provided by this
Indenture to be made, given or taken by Holders of Securities of such series.  
 Section 13.02. Call, Notice and
Place of Meetings. (a) The Trustee may at any time call a meeting of Holders of Securities of any series issuable as Bearer Securities or as Bearer Securities and Registered Securities for any purpose specified in Section 13.01, to be held
at such time and at such place in the Borough of Manhattan, the City of New York, or in London as the Trustee shall determine. Notice of every meeting of Holders of Securities of any series, setting forth the time and the place of such meeting and
in general terms the action proposed to be taken at such meeting, shall be given, in the manner provided in Section 1.06, not less than 21 nor more than 180 days prior to the date fixed for the meeting. 

(b) In case at any time the Company, pursuant to a Board Resolution, or the Holders of at least 10% in principal amount of the Outstanding
Securities of any series 

  
 76 

 
issuable as Bearer Securities or as Bearer Securities and Registered Securities shall have requested the Trustee to call a meeting of the Holders of Securities of such series for any purpose
specified in Section 13.01, by written request setting forth in reasonable detail the action proposed to be taken at the meeting, and the Trustee shall not have made the first publication of the notice of such meeting within 21 days after receipt of
such request or shall not thereafter proceed to cause the meeting to be held as provided herein, then the Company or the Holders of Securities of such series in the amount above specified, as the case may be, may determine the time and the place in
the Borough of Manhattan, the City of New York, or in London for such meeting and may call such meeting for such purposes by giving notice thereof as provided in subsection (a) of this Section. 

Section 13.03. Persons Entitled to Vote at Meetings. To be entitled to vote at any meeting of Holders of Securities of any
series, a Person shall be (a) a Holder of one or more Outstanding Securities of such series, or (b) a Person appointed by an instrument in writing as proxy for a Holder or Holders of one or more Outstanding Securities of such series by
such Holder or Holders. The only Persons who shall be entitled to be present or to speak at any meeting of Holders of Securities of any series shall be the Persons entitled to vote at such meeting and their counsel, any representatives of the
Trustee and its counsel and any representatives of the Company and its counsel. 
 Section 13.04. Quorum; Action.
The Persons entitled to vote a majority in principal amount of the Outstanding Securities of a series shall constitute a quorum for a meeting of Holders of Securities of such series; provided, however, that if any action is to be taken at
such meeting with respect to a consent or waiver which this Indenture or the terms of such series expressly provides may be given by the Holders of not less than a specified percentage of the principal amount of the Outstanding Securities of a
series, the Persons entitled to vote such specified percentage in principal amount of the Outstanding Securities of such series shall constitute a quorum. In the absence of a quorum within 30 minutes of the time appointed for any such meeting, the
meeting shall, if convened at the request of Holders of Securities of such series, be dissolved. In any other case the meeting may be adjourned for a period of not less than 10 days as determined by the chairman of the meeting prior to the
adjournment of such meeting. In the absence of a quorum at any such adjourned meeting, such adjourned meeting may be further adjourned for a period of not less than 10 days as determined by the chairman of the meeting prior to the adjournment of
such adjourned meeting. Notice of the reconvening of any adjourned meeting shall be given as provided in Section 13.02(a), except that such notice need be given only once not less than five days prior to the date on which the meeting is scheduled to
be reconvened. Notice of the reconvening of an adjourned meeting shall state expressly the percentage, as provided above, of the principal amount of the Outstanding Securities of such series which shall constitute a quorum. 

Except as limited by the proviso to Section 9.02, any resolution presented to a meeting or adjourned meeting duly reconvened at which a quorum
is present as aforesaid may be adopted by the affirmative vote of the Holders of a majority in principal amount of the Outstanding Securities of that series; provided, however, that, except as limited by the proviso to Section 9.02, any
resolution with respect to any request, demand, authorization, direction, notice, consent, waiver or other action which this Indenture or 

  
 77 

 
the terms of such series expressly provides may be made, given or taken by the Holders of a specified percentage in principal amount of the Outstanding Securities of a series may be adopted at a
meeting or an adjourned meeting duly reconvened and at which a quorum is present as aforesaid by the affirmative vote of the Holders of such specified percentage in principal amount of the Outstanding Securities of that series. 

Any resolution passed or decision taken at any meeting of Holders of Securities of any series duly held in accordance with this Section shall
be binding on all the Holders of Securities of such series and the related coupons, whether or not present or represented at the meeting. 

Section 13.05. Determination of Voting Rights; Conduct and Adjournment of Meetings. (a) Notwithstanding any other
provisions of this Indenture, the Trustee may make such reasonable regulations as it may deem advisable for any meeting of Holders of Securities of a series in regard to proof of the holding of Securities of such series and of the appointment of
proxies and in regard to the appointment and duties of inspectors of votes, the submission and examination of proxies, certificates and other evidence of the right to vote, and such other matters concerning the conduct of the meeting as it shall
deem appropriate. Except as otherwise permitted or required by any such regulations, the holding of Securities shall be proved in the manner specified in Section 1.04 and the appointment of any proxy shall be proved in the manner specified in
Section 1.04 or by having the signature of the person executing the proxy witnessed or guaranteed by any trust company, bank or banker authorized by Section 1.04 to certify to the holding of Bearer Securities. Such regulations may provide that
written instruments appointing proxies, regular on their face, may be presumed valid and genuine without the proof specified in Section 1.04 or other proof. 

(b) The Trustee shall, by an instrument in writing, appoint, a temporary chairman of the meeting, unless the meeting shall have been called by
the Company or by Holders of Securities as provided in Section 13.02(b), in which case the Company or the Holders of Securities of the series calling the meeting, as the case may be, shall in like manner appoint a temporary chairman. A permanent
chairman and a permanent secretary of the meeting shall be elected by vote of the Persons entitled to vote a majority in principal amount of the Outstanding Securities of such series represented at the meeting. 

(c) At any meeting each Holder of a Security of such series or proxy shall be entitled to one vote for each $1,000 principal amount of
the Outstanding Securities of such series held or represented by him; provided, however, that no vote shall be cast or counted at any meeting in respect of any Security challenged as not Outstanding and ruled by the chairman of the meeting to
be not Outstanding. The chairman of the meeting shall have no right to vote, except as a Holder of a Security of such series or proxy. 

(d) Any meeting of Holders of Securities of any series duly called pursuant to Section 13.02 at which a quorum is present may be adjourned
from time to time by Persons entitled to vote a majority in principal amount of the Outstanding Securities of such series represented at the meeting; and the meeting may be held as so adjourned without further notice. 

  
 78 

 Section 13.06. Counting Votes and Recording Action of Meetings. The vote upon
any resolution submitted to any meeting of Holders of Securities of any series shall be by written ballots on which shall be subscribed the signatures of the Holders of Securities of such series or of their representatives by proxy and the principal
amounts and serial numbers of the Outstanding Securities of such series held or represented by them. The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the meeting for or against any
resolution and who shall make and file with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting. A record, at least in duplicate, of the proceedings of each meeting of Holders of Securities of
any series shall be prepared by the secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by ballot taken thereat and affidavits by one, or more persons having knowledge of
the facts setting forth a copy of the notice of the meeting and showing that said notice was given as provided in Section 13.02 and, if applicable, Section 13.04. Each copy shall be signed and verified by the affidavits of the permanent chairman and
secretary of the meeting and one such copy shall be delivered to the Company, and another to the Trustee to be preserved by the Trustee, the latter to have attached thereto the ballots voted at the meeting. Any record so signed and verified shall be
conclusive evidence of the matters therein stated. 
 Section 13.07. U.S.A. Patriot Act. The parties hereto
acknowledge that in accordance with Section 326 of the U.S.A. Patriot Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record
information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. The parties to this Indenture agree that they will provide the Trustee with such information as it may reasonably request
in order for the Trustee to satisfy the requirements of the U.S.A. Patriot Act. 
 This instrument may be executed in any number of
counterparts, each of which so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument. 

  
 79 

 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed, and their
respective corporate seals to be hereunto affixed and at attested, all as of the day and year first above written. 
  

			
	CAMPBELL SOUP COMPANY
		
	By:	 	  

		 	Name:
		 	Title:
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	 WELLS FARGO BANK, NATIONAL

    ASSOCIATION, as Trustee

		
	By:	 	  

		 	Name:
		 	Title:

  
 80 

 EXHIBIT A 

[FORM OF REGISTERED SECURITY]1 

[Form of Face of Security] 

[If an Original Issue Discount Security, insert any legend required by the Internal Revenue Code and the Regulations thereunder.] 

[If a Book-Entry Security – “THIS SECURITY IS A BOOK-ENTRY SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED
TO AND IS REGISTERED IN THE NAME OF A DEPOSITORY OR A NOMINEE OF A DEPOSITORY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITORY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN
THE INDENTURE, AND NO TRANSFER OF THIS SECURITY (OTHER THAN A TRANSFER OF THIS SECURITY AS A WHOLE BY THE DEPOSITORY TO A NOMINEE OF THE DEPOSITORY OR BY A NOMINEE OF THE DEPOSITORY TO THE DEPOSITORY OR ANOTHER NOMINEE OF THE DEPOSITORY) MAY BE
REGISTERED EXCEPT IN SUCH LIMITED CIRCUMSTANCES.”] 
 CAMPBELL SOUP COMPANY 

[TITLE OF SECURITY] 
  

					
	No. [R-]                     	  	 	[U.S.$]                    	  
		  	 	CUSIP No.                      	  
		  	 	ISIN No.                      	  

 [If the Security is to bear interest at a fixed rate, insert – CAMPBELL SOUP COMPANY, a
corporation duly organized and existing under the laws of New Jersey (herein called the “Company”, which term includes any successor Person under the Indenture referred to on the reverse hereof), for value received, hereby promises
to pay to Cede & Co. or registered assigns, the principal sum of [—] U.S. DOLLARS ($[—]) on
[—] and to pay interest thereon from [—], or from the most recent Interest Payment Date to which interest has been paid or duly provided for as
set forth in the Indenture, semi-annually in arrears on [—] and [—] in each year (each an “Interest Payment Date”), commencing
on [—] at the rate of [—]% per annum, until the principal hereof is paid or made available for payment as set forth in the Indenture. The
interest so payable, and punctually paid or duly provided for as set forth in the Indenture, on any Interest Payment Date will, as provided in such Indenture, be paid to the Holder in whose name this Security (or one or more Predecessor Securities)
is registered at the close of business on the Regular Record Date for such interest, which shall be the [—] or [—] (whether or not a Business
Day) preceding such Interest Payment Date.] 
  

	1 	To be completed and supplemented to reflect the terms of any series of Securities. 

  
 A-1 

 [If the Security is to bear interest at a floating rate, insert – CAMPBELL
SOUP COMPANY, a corporation duly organized and existing under the laws of New Jersey (herein called the “Company”, which term includes any successor Person under the Indenture referred to on the reverse hereof), for
value received, hereby promises to pay to Cede & Co. or registered assigns, the principal sum of [—] U.S. DOLLARS ($[—]) on [—] (the “Final Maturity Date”) or any earlier Redemption Date fixed in accordance with the terms of this Security as to the principal repayable on such date. In addition,
the Company promises to pay interest on principal amount quarterly in arrears on [—], [—],
[—], and [—] (each a “Interest Payment Date”), commencing on
[—], subject to the Business Day Convention, and until the outstanding principal amount of this Security is fully repaid or duly provided for as set forth in the Indenture. Interest payable on any
Interest Payment Date, the Final Maturity Date or, if applicable, any Redemption Date shall be the amount accrued from, and including, the immediately preceding Interest Payment Date in respect of which interest has been paid or duly provided for as
set forth in the Indenture (or from [—], if no interest has been paid or duly provided for as set forth in the Indenture) to, but excluding, such Interest Payment Date, Final Maturity Date, or
Redemption Date, as the case may be. If the Final Maturity Date or, if applicable, the Redemption Date is not a New York Business Day, the payment of principal and interest shall be made on the next following New York Business Day, and no further
interest shall accrue in respect of the delay in such payment. This Security shall cease to bear interest upon, and no interest shall be payable in respect of, the earlier of the Final Maturity Date and, if applicable, the Redemption Date, unless
the Company defaults in making payment in full of all amounts due on any such date. 
 The interest rate for the period
beginning on, and including, [—] and ending on, but not including, the earlier of the first Interest Payment Date or, if applicable, the Redemption Date (the “Initial Interest
Period”) shall be [—]%. The interest rate for each Interest Period subsequent to the Initial Interest Period shall be the three-month U.S. dollar London Interbank Offered Rate
(“LIBOR”), as determined on the applicable Interest Determination Date by the Calculation Agent in accordance with the provisions of the Indenture, plus [—] basis points (0.[—]%). The interest so payable, and punctually paid or duly provided for as set forth in the Indenture, on any Interest Payment Date will, as provided in such Indenture, be paid to the Holder in whose
name this Security (or one or more Predecessor Securities) is registered at the close of business on the fifteenth calendar day prior to such Interest Payment Date (whether or not a New York Business Day), each a Regular Record Date with respect to
this Security. 
 “Business Day Convention” means if any Interest Payment Date (other than the Final
Maturity Date or, if applicable, the Redemption Date) is not a New York Business Day, then such Interest Payment Date shall be postponed to the next succeeding New York Business Day unless that New York Business Day is in the next succeeding
calendar month, in which case the Interest Payment Date shall be the immediately preceding New York Business Day. If any such Interest Payment Date (other than the Final Maturity Date or, if applicable, the Redemption Date) is postponed or brought
forward as described in the preceding sentence, the interest amount shall be adjusted accordingly and the Holder shall be entitled to more or less interest, respectively. 

  
 A-2 

 “Calculation Agent” means [Wells Fargo Bank, National
Association], or any other successor appointed from time to time by the Company acting as calculation agent in respect of this Security. 

“Designated LIBOR Page” means (1) the Reuters screen “LIBOR01” or such other page as may
replace the Reuters screen “LIBOR01” on that service or (2) if, on any Interest Determination Date, the three-month U.S. dollar LIBOR does not appear or is not available on such date on the designated Reuters screen described in
clause (1) of this definition, the designated LIBOR page shall be Bloomberg L.P. page “BBAM” or such other page as may replace Bloomberg L.P. page “BBAM” on that service. 

“Interest Determination Date” means, for each Interest Reset Date, the second London Business Day preceding
such Interest Reset Date. 
 “Interest Period” means the period beginning on, and including an Interest
Payment Date and ending on, but not including, the following Interest Payment Date, except that the final Interest Period shall be the period beginning on, and including, the Interest Payment Date immediately preceding the Final Maturity Date or the
Redemption Date (if such Redemption Date occurs subsequent to the first Interest Payment Date) in respect of such Security, and ending on, but not including, the Final Maturity Date or such Redemption Date. 

“Interest Reset Date” means, for each Interest Period other than the Initial Interest Period, the first day of
such Interest Period. 
 “London Business Day” means any day which is not a Saturday, Sunday, or a day on
which commercial banking institutions are authorized or obligated by law, regulation or executive order to be closed in London.] 
 Except
as otherwise provided in the Indenture, any such interest not so punctually paid or duly provided for as set forth in the Indenture will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in
whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of
Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be
listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 
 Payment of principal of
(and premium, if any) and interest on this Security may be made at the office or agency of the Company maintained for that purpose in New York, New York. 

[If the Security is to bear interest at a fixed rate and is to be optionally redeemable by the Company at a “make-whole” premium,
insert – At any time and from time to time, the Securities of this series shall be redeemable, in whole or in part, at the  

  
 A-3 

 
Company’s option, at a Redemption Price equal to the greater of (i) 100% of the principal amount of such Securities, or (ii) as determined by a Quotation Agent, the sum of the
present values of the remaining scheduled payments of principal and interest thereon (not including any portion of such payments of interest accrued as of the Redemption Date) discounted to the Redemption Date on a semi-annual basis (assuming a
360-day year consisting of twelve 30-day months) at the Adjusted Treasury Rate plus [—] basis points; plus accrued interest on such Securities to, but excluding, the Redemption Date. 

Notice of any such redemption shall be given by mail to Holders of the Securities to be redeemed, not less than 30 days nor more than 60 days
prior to the Redemption Date, all as provided in the Indenture. 
 On and after the Redemption Date for the Securities or any portion
thereof called for redemption, as applicable, interest shall cease to accrue on such Securities or any portion thereof called for redemption, unless the Company defaults in the payment of the Redemption Price and accrued interest, if any. On or
before the Redemption Date for such Securities or any portion thereof called for redemption, the Company shall deposit with the Trustee or a Paying Agent, funds sufficient to pay the Redemption Price of such Securities to be redeemed on the
Redemption Date, and (except if the Redemption Date shall be an Interest Payment Date) accrued interest, if any. 
 If less than all of the
Securities of this series are to be redeemed, the Depository shall select the Securities to be redeemed in accordance with its operational arrangements. If the Securities are not Global Notes held by the Depository, the Securities to be redeemed
shall be selected by the Trustee by such method as the Trustee deems fair and appropriate; provided, however, that in no event shall Securities of a principal amount of $2,000 or less be redeemed in part. 

“Adjusted Treasury Rate” means, with respect to any Redemption Date, the rate per annum equal to the
semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such Redemption Date. 

“Comparable Treasury Issue” means the United States Treasury security selected by a Quotation Agent as having
a maturity comparable to the remaining term of the Securities to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable
maturity to the remaining term of such Securities. 
 “Comparable Treasury Price” means, with respect to any
Redemption Date, (1) the average of the Reference Treasury Dealer Quotations for such Redemption Date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (2) if the Company obtains fewer than three such
Reference Treasury Dealer Quotations, the average of all such Reference Treasury Dealer Quotations. 

  
 A-4 

 “Quotation Agent” means the Reference Treasury Dealer appointed
by the Company. 
 “Reference Treasury Dealer” means (1)
[—], [—] and [—] and their respective successors; provided, however, that if any of
the foregoing shall cease to be a primary U.S. Government securities dealer in the State of New York or the State of Connecticut (a “Primary Treasury Dealer”), the Company shall substitute therefor another Primary Treasury Dealer;
and (2) any other Primary Treasury Dealer selected by the Company. 
 “Reference Treasury Dealer
Quotations” means, with respect to each Reference Treasury Dealer and any Redemption Date, the average, as determined by the Company, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of
its principal amount) quoted in writing to the Company by such Reference Treasury Dealer at 5:00 p.m. on the third New York Business Day preceding such Redemption Date.] 

Reference is hereby made to the further provisions of this Security set forth on the reverse side hereof, which further provisions shall for
all purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has been executed by the
Trustee referred to on the reverse hereof, directly or through an Authenticating Agent, by manual signature of an authorized signatory, this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.

  
 A-5 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its
corporate seal. 

Dated:                     

 

			
	CAMPBELL SOUP COMPANY
		
	By:	 	  

		 	Name:
		 	Title:
		
	By:	 	  

		 	Name:
		 	Title:

 [seal] 
 Attest: 

 

	
	  
 Name:

	Title:

  
 A-6 

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated herein referred to in the within mentioned Indenture. 

 

			
	 WELLS FARGO BANK, NATIONAL
ASSOCIATION, as Trustee

		
	By:	 	  

		 	Authorized Signatory

  
 A-7 

 [REVERSE OF SECURITY] 

This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to
be issued in one or more series under an indenture, dated as of                     , 2014 (the “Indenture”), between the Company
and Wells Fargo Bank, National Association, a national banking association, as trustee (the “Trustee,” which term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto
reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be,
authenticated and delivered. This Security is one of the series designated on the face hereof. 
 [The Securities of this series are subject
to optional redemption, as further described in the Indenture and on the face hereof. There is no mandatory redemption applicable to the Securities of this series.] 

[The Securities of this series are not entitled to the benefit of, or subject to, any sinking fund.] 

If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series
may be declared due and payable in the manner and with the effect provided in the Indenture. Upon payment (i) of the amount of principal so declared due and payable and (ii) of interest on any overdue principal and overdue interest (in
each case to the extent that the payment of such interest shall be legally enforceable), all of the Company’s obligations in respect of the payment of the principal of and interest, if any, on the Securities of this series shall terminate. 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations
of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee, with, except in specified cases, the consent of the Holders of a majority in principal
amount of the Securities at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time Outstanding (with
each series voting as a separate class in certain cases specified in the Indenture, or with all series voting as one class, in certain other cases specified in the Indenture), on behalf of the Holders of all Securities of such series, to waive
compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and
upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notification of such consent or waiver is made upon this Security. 

  
 A-8 

 As set forth in, and subject to, the provisions of the Indenture, no Holder of any Security of
this series will have any right to institute any proceeding with respect to the Indenture or for any remedy thereunder, unless such Holder shall have previously given to the Trustee written notice of a continuing Event of Default with respect to
this series, the Holders of not less than 25% in principal amount of the Outstanding Securities of this series shall have made written request, and offered reasonable indemnity, to the Trustee to institute such proceeding as Trustee, and the Trustee
shall not have received from the Holders of a majority in principal amount of the Outstanding Securities of this series a direction inconsistent with such request and shall have failed to institute such proceedings within 60 days; provided,
however, that such limitations do not apply to a suit instituted by the Holder hereof for the enforcement of payment of the principal of (and premium, if any) or interest on this Security on or after the respective due dates expressed herein.

 No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of (and premium, if any) and interest on this Security at the times, places and rate, and in the coin or currency, herein prescribed. 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the
Security Register upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of (and premium, if any) and interest on such Security are payable, duly endorsed by, or
accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities of this series
and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 

The Securities of this series are issuable only in registered form, without coupons, in denominations of $2,000 and any integral multiple of
$1,000 in excess of $2,000. As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a
different authorized denomination, as requested by the Holder surrendering the same. 
 No service charge shall be made for any such
registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security is overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 

  
 A-9 

 The Indenture and the Securities shall be governed by and construed in accordance with the laws
of the State of New York, without giving effect to the conflicts of laws provisions thereof. 
 All terms used in this Security which are
defined in the Indenture shall have the meanings assigned to them in the Indenture. 

  
 A-10 

 EXHIBIT B 

[FORM OF BEARER SECURITY AND 

FORM OF RELATED COUPON]2 

[Form of Face of Security] 

ANY UNITED STATES PERSON WHO HOLDS THIS OBLIGATION WILL BE SUBJECT TO LIMITATIONS UNDER THE UNITED STATES INCOME TAX LAWS, INCLUDING THE
LIMITATIONS PROVIDED IN SECTIONS 165(j) AND 1287(a) OF THE INTERNAL REVENUE CODE [If an Original Issue Discount Security, insert any legend required by the Internal Revenue Code and the Regulations thereunder.] 

Campbell Soup Company 
  

 
  

			
	No. B                     	  	[U.S.$                     ]

 CAMPBELL SOUP COMPANY, a corporation duly organized and existing under the laws of New Jersey (herein called the
“Company”, which term includes any successor Person under the Indenture referred to on the reverse hereof), for value received, hereby promises to pay to bearer upon presentation and surrender of this Security the principal sum of
             [United States dollars] on                      [if the Security is
interest-bearing, insert –, and to pay interest thereon, from the date hereof, [semi-annually in arrears on              and
             in each year] [annually in arrears on              in each year], commencing
                    , 20    , at the rate of     % per annum, until the principal hereof is paid or made
available for payment [if applicable, insert –, and (to the extent that the payment of such interest shall be legally enforceable) at the rate of     % per annum on any overdue principal and premium and on any overdue
installment of interest)]. 
 [If the Security is not to bear interest prior to Maturity. insert – The principal of this Security shall not bear
interest except in the case of a default in payment of principal upon acceleration, upon redemption or at Stated Maturity, and in such case the overdue principal of this Security shall bear interest at the rate of     % per annum
(to the extent that the payment of such interest shall be legally enforceable), which shall accrue from the date of such default in payment to the date payment of such principal has been made or duly provided for. Interest on any overdue principal
shall be payable on demand. Any such interest on any overdue principal that is not so paid on demand shall bear interest at the rate of     % per annum (to the extent that the payment of such interest shall be legally
enforceable), which shall accrue from the date of such demand for payment to the date payment of such interest has been made or duly provided for, and such interest shall also be payable on demand.] Such payments [(including premium, if any)] shall
be made, subject to any laws or regulations applicable thereto and to the right of the Company 
  

	2 	To be completed and supplemented to reflect the terms of any series of Securities. 

  
 B-1 

 
(limited as provided in the Indenture) to rescind the designation of any such Paying Agent, at the [main] office of              in
            ,              in             , in
            ,              in              and
             in             , or at such other offices or agencies outside the United States (as defined below) as the Company
may designate, at the option of the Holder, by [United States dollar] check drawn on a bank in the City of New York or by transfer of [United States dollars] to an account maintained by the payee with a bank located outside the United States. [If
the Security is interest-bearing, insert – Interest on this Security due on or before Maturity shall be payable only upon presentation and surrender at such an office or agency of the interest coupons hereto attached as they severally
mature.] No payment of principal[, or] [premium] [or interest)] on this Security shall be made at any office or agency of the Company in the United States or by check mailed to any address in the United States or by transfer to an account maintained
with a bank located in the United States [if Security is denominated and payable in United Sates dollars, insert –; provided, however, that payment of principal of [(and premium, if any)] and [any] interest on this Security
(including any additional amounts which may be payable as provided below) shall be made at the office of the Company’s Paying Agent in the United States of America, if (but only if) payment in United States dollars of the full amount of such
principal[, premium] [, interest] or additional amounts, as the case may be, at all offices or agencies outside the United States maintained for the purpose by the Company in accordance with the Indenture is illegal or effectively precluded by
exchange controls or other similar restrictions, as determined by the Company). 
 The Company will pay to the Holder of this Security
[if the Security is interest-bearing insert – or any coupon appertaining hereto] who is a United States Alien (as defined below) such additional amounts as may be necessary in order that [If the Security is interest-bearing,
insert – every net payment of the principal of [(and premium if any)] and interest on this Security] [if the Security is not to bear interest prior to Maturity, insert – (i) the net payment of principal of (and interest
on overdue principal, if any, on) this Security and (ii) the net proceeds from the sale or exchange of this Security, including, in each case, amounts received in respect of original issue discount), after deduction or withholding for or on
account of any present or future tax, assessment or other governmental charge imposed by the United States or any political subdivision or taxing authority thereof or therein upon or as a result of such payment [if the Security is not to bear
interest prior to Maturity, insert – or as a result of such sale or exchange], will not be less than the amount provided for in this Security [if the Security is interest-bearing, insert – or in such coupons] to be then due and payable
[if the Security is not to bear interest prior to Maturity, insert – or, in the case of a sale or exchange, the amount of the net proceeds from the sale or exchange before any such tax, assessment or other governmental charge];
provided, however, that the foregoing obligation to pay additional amounts will not apply to any one or more of the following: 

(a) any tax, assessment or other governmental charge which would not have been so imposed but for (i) the existence of any
present or former connection between such Holder (or between a fiduciary, settlor, beneficiary or member of, or possessor of a power over, such Holder, if such Holder is an estate, a trust or a 

  
 B-2 

 
partnership) and the United States, including, without limitation, such Holder (or such fiduciary, settlor, beneficiary, member or possessor) being or having been a citizen or resident or treated
as a resident thereof, or being or having been engaged in trade or business or present therein, or having or having had a permanent establishment therein, or (ii) such Holder’s present or former status as a personal holding company, a
foreign personal holding company, a controlled foreign corporation for United States tax purposes or a corporation which accumulates earnings to avoid United States federal income tax; 

(b) any tax, assessment or other governmental charge imposed [if the Security is interest-bearing, insert – on
interest received by a Person holding, actually or constructively, 10% or more of the total combined voting power of all classes of stock of the Company entitled to vote)] [if the Security is not to bear interest prior to Maturity, insert
– by reason of such Holder’s past or present status as the actual or constructive owner of 10% or more of the total combined voting power of all classes of stock of the Company entitled to vote]; 

(c) any tax, assessment or other governmental charge which would not have been imposed but for the failure to comply with any
certification, identification or other reporting requirements concerning the nationality, residence, identity or connection with the United States of the Holder or beneficial owner of this Security [if the Security is interest-bearing, insert
– or any coupon appertaining hereto], if compliance is required by statute or by regulation of the United States Treasury Department as a precondition to exemption from such tax, assessment or other governmental charge; 

(d) any estate inheritance, gift, sales, transfer, personal property or any similar tax, assessment or governmental charge;

 (e) any tax, assessment or other governmental charge which is payable otherwise than, by deduction or withholding from
payments of [if the Security is interest-bearing, insert – principal of [(and premium, if any)] or interest on this Security.] [If the Security is not to bear interest prior to Maturity, insert – principal of (or interest on
overdue principal, if any, on) this Security or from payments from the proceeds of a sale or exchange of this Security]; or 

(f) any tax, assessment or other governmental charge which would not have been so imposed but for the presentation by the
Holder of this Security [if Security is interest-bearing insert – or any coupon appertaining hereto] for payment on a date more than 15 days after the date on which such payment became due and payable or the date on which payment thereof
is duly provided for, whichever occurs later, 
 nor will additional amounts be paid with respect to any payment of [if the Security is interest-bearing
insert – principal of [(and premium, if any)] or interest on this Security] [if the Security is not to bear interest prior to Maturity, insert – principal of (or interest on overdue principal, if any, on) this Security or of the
proceeds of any sale or exchange of 

  
 B-3 

 
this Security to any United States Alien who is a fiduciary or partnership or other than the sole beneficial owner of any such payment to the extent that a beneficiary or settlor with respect to
such fiduciary, a member of such a partnership or the beneficial owner would not have been entitled to the additional amounts had such beneficiary, settlor, member or beneficial owner been the Holder of this Security [If the Security is
interest-bearing insert – or any coupon appertaining hereto]. The term “United States Alien” means any Person who, for United States federal income tax purposes, is a foreign corporation, a non-resident alien individual, a
nonresident alien fiduciary of a foreign estate or trust, or a foreign partnership one or more of the members of which is, for United States federal income tax purposes, a foreign corporation, a non-resident alien individual or a non-resident alien
fiduciary of a foreign estate or trust, and the term “United States” means the United States of America (including the States and the District of Columbia), its territories, its possessions and other areas subject to its
jurisdiction. 
 [Notwithstanding the foregoing, if and so long as a certification identification or other reporting requirement referred to
in the [fourth] [fifth] paragraph on the reverse hereof would be fully satisfied by payment of a backup withholding tax or similar charge, the Company may elect, by so stating in the Determination Notice (as defined in such paragraph), to have the
provisions of this paragraph apply in lieu of the provisions of such paragraph. In such event, the Company will pay as additional amounts such amounts as may be necessary so that every net payment made following the effective date of such
requirements outside the United States by the Company or any of its Paying Agents of principal [(and premiums, if any)] [if the Security is interest-bearing, insert – or interest] due in respect of any Bearer Security [if the Security
is interest bearing, insert – or any coupon] of which the beneficial owner is a United States Alien (but without any requirement that the nationality, residence or identity of such beneficial owner be disclosed to the Company, any Paying
Agent or any governmental authority), after deduction or withholding for or on account of such backup withholding tax or similar charge other than a backup withholding tax or similar charge which is (i) the result of a certification,
identification or other reporting requirement described in the second parenthetical clause of such paragraph, or (ii) imposed as a result of the fact that the Company or any of its Paying Agents has actual knowledge that the beneficial owner of
such Bearer Security [if the Security is interest-bearing, insert – or coupon] is within the category of Persons described in clause (a) of the [third] paragraph of this Security, or (iii) imposed as a result of presentation of
such Bearer Security [if the Security is interest-bearing insert – or coupon) for payment more than 15 days after the date on which such payment becomes due and payable or on which payment thereof is duly provided for, whichever occurs
later, will not be less than the amount provided for in such Bearer Security [if the Security is interest-bearing, insert – or coupon) to be then due and payable.] 

Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all
purposes have the same effect as if set forth at this place. 
 Unless the certificate of authentication hereon has been executed by the
Trustee referred to on the reverse hereof, directly or through an authenticating agent, by manual 

  
 B-4 

 
signature of an authorized signatory, neither this Security, nor any coupon appertaining hereto, shall be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its corporate seal and coupons bearing the facsimile
signature of [its Treasurer] [one of its Assistant Treasurers] to be annexed hereto. 
 Dated as of
                     20     
  

			
	CAMPBELL SOUP COMPANY
		
	By:	 	  

  

	
	Attest:
	
	  

  
 B-5 

 [Form of Reverse of Security] 

This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to
be issued in one or more series under an Indenture, dated as of                     , 2014 (herein called the “Indenture”), between
the Company and Wells Fargo Bank, National Association, as Trustee (herein called the “Trustee”, which term includes any successor trustee under the Indenture), to which Indenture and all indentures supplemental thereto reference is
hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities and any coupons appertaining thereto and of the terms upon which the
Securities are, and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof [, limited in aggregate principal amount to [U.S.$]
            . The Securities of this series are issuable as Bearer Securities, with interest coupons attached, in the denomination of [U.S.$]
            [, and as Registered Securities, without coupons, in denominations of [U.S.$]             and any integral multiple
thereof]. [As provided in the Indenture and subject to certain limitations therein set forth, Bearer Securities and Registered Securities of this series are exchangeable for a like aggregate principal amount of Registered Securities of this series
and of like tenor of any authorized denominations, as requested by the Holder surrendering the same, upon surrender of the Security or Securities to be exchanged, with all unmatured coupons and all matured coupons in default thereto appertaining, at
any office or agency described below where Registered Securities of this series may be presented for registration of transfer, provided, however, that Bearer Securities surrendered in exchange for Registered Securities between a Record Date
and the relevant Interest Payment Date shall be surrendered without the coupon relating to such Interest Payment Date. Bearer Securities may not be issued in exchange for Registered Securities.] 

[If applicable, insert – The Securities of this series are subject to redemption [(1)) [if applicable, insert – on
(1)             in any year commencing with the year             and ending with the year
            through operation of the sinking fund for this series at a Redemption Price equal to [100% of the principal amount] [or insert formula for determining the amount], and
(2)] [If applicable insert – at any time [on or after             , 20    ), as a whole or in part, at the election of the Company, at the following
Redemption Prices (expressed as percentages of the principal amount): If redeemed [or before             ,     %, and if redeemed] during the 12-month period beginning
                    of the years indicated, 
  

							
	 Year
	 	 Redemption
Price
	 	 Year
	  	Redemption
Price
		 		 		  	
		 		 		  	

 and thereafter at a Redemption Price equal to     % of the principal amount,] [and
(            )] (under the circumstances described in the next [two] succeeding paragraph[s] at a Redemption Price equal to [100% of the principal amount] [or insert formula for
determining the amount] [if the Security is interest-bearing, insert – , together in the case 

  
 B-6 

 
of any such redemption [if applicable insert – (whether through operation of the sinking fund or otherwise)] with accrued interest to the Redemption Date; provided, however,
that interest installments on this Security whose Stated Maturity is on or prior to such Redemption Date will be payable only upon presentation and surrender of coupons for such interest (at an office or agency located outside the United States,
except as herein provided otherwise)].] 
 [If applicable, insert – The Securities of this series are subject to redemption
(1) on                      in any year commencing with the year
                     and ending with the year
                     through operation of the sinking fund for this series at the Redemption Prices for redemption through operation of the sinking
fund (expressed as percentages of the principal amount) set forth in the table below, and (2) at any time [on or after                     ,
20    ], as a whole or in part, at the election of the Company, at the Redemption Prices for redemption otherwise than through operation of the sinking fund (expressed as percentages of the principal amount) set forth in the
table below: If redeemed during the 12-month period beginning                      of the years indicated. 

 

					
	 Year
	 	 Redemption Price for

Redemption Through

Operation of the Sinking

Fund
	 	 Redemption Price for

Redemption Otherwise
 Than
Through Operation
 of the Sinking Fund

		 		 	
		 		 	

 and thereafter at a Redemption Price equal to     % of the principal amount, and (3) under the
circumstances described in the next [two] succeeding paragraph[s] at a Redemption Price equal to 100% of the principal amount [or insert formula for determining the amount] [if the Security is interest-bearing insert – , together
in the case of any such redemption (whether through operation of the sinking fund or otherwise) with accrued interest to the Redemption Date; provided, however, that interest installments on this Security whose Stated Maturity is on or
prior to such Redemption Date will be payable only upon presentation and surrender of coupons for such interest (at an office or agency located outside the United States, except as herein provided otherwise)].] 

[Partial redemption must be in an amount not less than [U.S. $5,000] principal amount of Securities.] [Notwithstanding the foregoing, the
Company may not, prior to             , redeem any Securities of this series as contemplated by Clause [(2)] above as a part of, or in anticipation of, any refunding operation by the
application, directly or indirectly, of moneys borrowed having an interest cost to the Company (calculated in accordance with generally accepted financial practice) of less than     % per annum.] 

[The Securities may be redeemed, as a whole but not in part, at the option of the Company, at a Redemption Price [equal to 100% of their
principal amount] [determined as set forth in the preceding paragraph]. [If the Security is interest-bearing, insert – , together with interest accrued to the date fixed for redemption,] if, as a result of any

  
 B-7 

 
amendment to, or change in, the laws or regulations of the United States or any political subdivision or taxing authority thereof or therein affecting taxation, or any amendment to or change in
an official interpretation or application of such laws or regulations, which amendment or change is effective on or after                     ,
20    , the Company will become obligated to pay additional amounts (as described on the face hereof) [if the Security is interest-bearing, insert – on the next succeeding Interest Payment Date] [if the Security is
not to bear interest prior to Maturity, insert – at Maturity or upon the sale or exchange of any Security] at the time such notice is given, such obligation to pay such additional amounts remains in effect. 

[If applicable, insert – In addition, if the Company determines, based upon a written opinion of independent counsel, that any
payment made outside the United States by the Company or any of its Paying Agents of the full amount of principal [(, premium, if any)] or interest due with respect to any Bearer Security or coupon would, under any present or future laws or
regulations of the United States, be subject to any certification, identification or other reporting requirement of any kind, the effect of which requirement is the disclosure to the Company, any Paying Agent or any governmental authority of the
nationality, residence or identity of a beneficial owner of such Bearer Security or coupon who is a United States Alien (as defined on the face hereof) (other than such a requirement (a) which would not be applicable to a payment made by the Company
or any one of its Paying Agents (i) directly to the beneficial owner or (ii) to any custodian, nominee or other agent of the beneficial owner, or (b) which can be satisfied by the custodian, nominee or other agent certifying that the
beneficial owner is a United States Alien, provided in each case referred to in clauses (a) (ii) and (b) that payment by such custodian, nominee or other agent of such beneficial owner is not otherwise subject to any such requirement), the
Company at its election will either (x) redeem the Securities as a whole but not in part, at a Redemption Price [equal to 100% of their principal amount,] [determined as set forth in the next preceding paragraph,] together with interest accrued
to the date fixed for redemption, or (y) if and so long as the conditions of the [third] paragraph on the face of this Security are satisfied, pay the additional amounts specified in such paragraph. The Company will make such determination and
election and notify the Trustee thereof as soon as practicable, and the Trustee will promptly give notice of such determination in the manner provided below (the “Determination Notice”), in each case stating the effective date of
such certification, identification or other reporting requirement, whether the Company will redeem the Securities or will pay the additional amounts specified in such paragraph and (if applicable) the last date by which the redemption of the
Securities must take place. If the Company elects to redeem the Securities, such redemption shall take place on such date, not later than one year after publication of the Determination Notice, as the Company elects by notice to the Trustee at least
[60] days before such date, unless shorter notice is acceptable to the Trustee. Notwithstanding the foregoing, the Company will not so redeem the Securities if the Company, based upon an opinion of independent counsel, subsequently determines, not
less than [30] days prior to the date fixed for redemption, that subsequent payments would not be subject to any such requirement, in which case the Company will notify the Trustee, which will promptly give notice of that determination in the manner
provided below, and any earlier redemption notice will thereupon be revoked and of no further effect. If the Company elects as provided in clause (y) above to pay additional amounts, 

  
 B-8 

 
and as long as the Company is obligated to pay such additional amounts, the Company may subsequently redeem the Securities, at any time, as a whole but not in part, at a Redemption Price [equal
to 100% of their principal amount] [determined as set forth in the next preceding paragraph,] together with interest accrued to the date fixed for redemption, but without reduction for applicable United States withholding taxes.] 

[If applicable, insert – In addition, if the Company determines, based upon a written opinion of independent counsel, that any
payment made outside the United States by the Company or any of its Paying Agents of the full amount due with respect to any Bearer Security would, under any present or future laws or regulations of the United States, be subject to any
certification, identification or other reporting requirement of any kind, the effect of which requirement is the disclosure to the Company, any Paying Agent or any governmental authority of the nationality, residence or identity of a beneficial
owner of such Bearer Security who is a United States Alien (as defined on the face hereof) (other than such a requirement (a) which would not be applicable to a payment made by the Company or any one of its Paying Agents (i) directly to the
beneficial owner or (ii) to any custodian, nominee or other agent of the beneficial owner, or (b) which can be satisfied by the custodian, nominee or other agent certifying to the effect that such beneficial owner is a United States Alien,
provided in each case referred to in clauses (a)(ii) and (b) that payment by such custodian, nominee or other agent of such beneficial owner is not otherwise subject to any such requirement), the Company at its election will either (x) permit
any Holder of a Bearer Security to present such Bearer Security for redemption within 90 days of notice of such redemption, at a Redemption Price determined as set forth in the next preceding paragraph, or (y) if and so long as the conditions
of the [fifth] paragraph on the face of this Security are satisfied, pay the additional amounts specified in such paragraph. The Company will make such determination and election and notify the Trustee thereof as soon as practicable, and the Trustee
will promptly give notice of such determination in the manner provided below (the “Determination Notice”), in each case stating the effective date of such certification, identification or other reporting requirement, whether the
Company has elected to permit redemption of the Bearer Securities or to pay the additional amounts specified in such paragraph and (if applicable) the last day by which the Company may publish any notice of redemption. If the Company elects to
permit redemption of the Bearer Securities, notice of the redemption will be given not more than 268 days following the Determination Notice and will specify the date fixed for redemption. The Bearer Securities will be redeemed on the day 97 days
after notice of the redemption has been given. Notwithstanding the foregoing, the Company will not permit redemption of the Bearer Securities if the Company, based upon an opinion of independent counsel, subsequently determines, not less than 30
days prior to the date fixed for redemption, that no payment would be subject to any such requirement, in which case the Company will promptly notify the Trustee, which will promptly give notice of that determination in the manner described below,
and any earlier redemption notice will thereupon be revoked and of no further effect.] 
 [The sinking fund for this series provides for the
redemption on                      in each year, beginning with the year
                    , and ending with the year
                    , of [not less than] [U.S.$]..... [(“mandatory sinking fund”) and not more than [U.S.$].]

  
 B-9 

 
aggregate principal amount of Securities of this series. [Securities of this series acquired or redeemed by the Company otherwise than through [mandatory] sinking fund payments may be credited
against subsequent [mandatory] sinking fund payments otherwise required to be made – in the inverse order in which they become due).] 

[Notice of redemption will be given by publication in an Authorized Newspaper in the City of New York and, if the Securities of this series
are then listed on [The Stock Exchange of the United Kingdom and the Republic of Ireland] [the Luxembourg Stock Exchange] [or] any [other] stock exchange located outside the United States and such stock exchange shall so require, in [London]
[Luxembourg] [or] in any [other] required city outside the United States or, if not practicable, elsewhere in Europe, [and by mail to Holders of Registered Securities] not less than 30 nor more than 60 days prior to the date fixed for redemption,
all as provided in the Indenture.] 
 If an Event of Default with respect to Securities of this series shall occur and be continuing, [the]
[if an Original Issue Discount Security, insert – an amount of] principal of the Securities of the series may be declared due and payable in the manner and with the effect provided in the Indenture [the] [if an Original Issue Discount
Security, insert – such amount shall be equal to – insert formula for determining the amount. Upon payment (i) of the amount of principal so declared due and payable and (ii) of interest on any overdue principal and
overdue interest (in each case to the extent that the payment of such interest shall be legally enforceable), all of the Company’s obligations in respect of the payment of the principal of and interest, if any, on the Securities of this series
shall terminate.] 
 The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the
rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected [if the Securities of the series are interest-bearing insert – and any related coupons] under the Indenture at any time
by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified
percentages in principal amount of the Securities of each series at the time Outstanding (with each series voting as a separate class in certain other cases specified in the Indenture or with all series voting as one class, in certain other cases
specified in the Indenture), on behalf of the Holders of all Securities of such series [if the Securities of the series are interest-bearing, insert – and any related coupons], to waive compliance by the Company with certain provisions
of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and any
coupon appertaining hereto and of any Security issued in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security. 

As set forth in, and subject to, the provisions of the Indenture, no Holder of any Security of this series [if the Security is interest-bearing, insert
– or any related coupon] will have any right to institute any proceeding with respect to the Indenture or for any remedy 

  
 B-10 

 
thereunder, unless such Holder shall have previously given to the Trustee written notice of a continuing Event of Default with respect to this series, the Holders of not less than 25% in
principal amount of the Outstanding Securities of this series shall have made written request, and offered reasonable indemnity, to the Trustee to institute such proceeding as trustee, and the Trustee shall not have received from the Holders of a
majority in principal amount of the Outstanding Securities of this series a direction inconsistent with such request and shall have failed to institute such proceeding within 60 days; provided, however, that such limitations do not apply to a
suit instituted by the Holder hereof [if the Security is interest-bearing insert – or any related coupon] for the enforcement of payment of the principal of [(and premium, if any)] or [any] interest on this Security [if the Security
is interest-bearing, insert - or payment of such coupon] on or after the respective due dates expressed herein [if the Security is interest-bearing, insert -or in such coupon]. 

No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of [(and premium, if any)] and [any] interest (including additional amounts, as described on the face hereof) on this Security at the times, places and rate, and in the coin or
currency, herein prescribed. 
 Title to [Bearer] Securities and coupons shall pass by delivery. [As provided in the Indenture and subject
to certain limitations therein set forth, the transfer of Registered Securities is registrable in the Security Register, upon surrender of a Registered Security for registration of transfer at the [Corporate Trust Office of the Trustee or such
other] office or agency of the Company in any place where the principal of (premium, if any) and interest, if any, on such Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company
and the Security Registrar duly executed by, the Holder thereof or his attorney duly authorized in writing, and thereupon one or more new [Registered] Securities of this series and of like tenor, of authorized denominations and for the same
aggregate principal amount, will be issued to the designated transferee or transferees.] 
 [No service charge shall be made for any such
[registration of transfer or] exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith.] 

The Company, the Trustee and any agent of the Company or the Trustee may treat the bearer of a Bearer Security of any series [if the
Securities of the series are interest-bearing, insert - and any coupon appertaining thereto] [, and prior to due presentment of a Registered Security for registration of transfer, the Company, the Trustee and any agent of the Company or the
Trustee may treat the Person in whose name such Security is registered,] as the owner thereof for all purposes, whether or not such Security. [if the Securities of the series are interest-bearing insert – or such coupon] is overdue, and
neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. 

  
 B-11 

 The Indenture, the Securities and any coupons appertaining thereto shall be governed by and
construed in accordance with the laws of the State of New York without giving effect to the conflicts of laws provisions thereof. All terms used in this Security which are defined in the Indenture shall have the meanings assigned to them in the
Indenture. 
 [Form of Face of Coupon] 

ANY UNITED STATES PERSON WHO HOLDS THIS OBLIGATION WILL BE SUBJECT TO LIMITATIONS UNDER THE UNITED STATES INCOME TAX LAWS, INCLUDING THE
LIMITATIONS PROVIDED IN SECTIONS 165(j) AND 1287(a) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED. 
  

			
		 	[R-]                
		
	 CAMPBELL SOUP COMPANY
	 	[U.S.$]            
		
		 	Due                    

  
  

Unless the Security to which this coupon appertaining shall have been called for previous redemption and payment thereof duly provided for on
the date set forth hereon. CAMPBELL SOUP COMPANY (herein called the “Company”) will pay to bearer, upon surrender hereof, the amount shown hereon (together with any additional amounts in respect thereof which the Company may be
required to pay according to the terms of said Security and the Indenture referred to therein) [at the initial Paying Agents set out on the reverse hereof or at such other offices or agencies (which, except as otherwise provided in the Security to
which this coupon appertaining, shall be located outside the United States of America (including the States and the District of Columbia), its territories, its possessions and other areas subject to its jurisdiction (the “United
States”)) as the Company may designate from time to time,] at the option of the Holder, by [United States dollar check] drawn on a bank in the City of New York or by transfer of [United States dollars] to an account maintained by the payee
with a bank located outside the United States, being [one year’s] interest then payable on said Security. 
  

			
	CAMPBELL SOUP COMPANY
		
	By:	 	  

  
 B-12 

 
	
	[Reverse of Coupon]3
	
	  

	
	  

	
	  

	
	  

	
	  

  

	3 	Insert names and addresses of Initial Paying Agents located outside the United States. 

  
 B-13 

 EXHIBIT C-1 

[FORM OF CERTIFICATE TO BE GIVEN BY 

PERSON ENTITLED TO RECEIVE BEARER SECURITY] 

CERTIFICATE 
 Whenever any
provision of this Indenture or the forms of Security contemplates that certification be given by a Person entitled to receive a Bearer Security, such certification shall be provided substantially in the form of the following certificate, with only
such changes as shall be approved by the Company: 
 [Insert title or sufficient description 

of Securities to be delivered] 

This is to certify that the above-captioned Security is not being acquired by or on behalf of a United States person, or for offer to resell
or for resale to a United States person or any person inside the United States, or, if a beneficial interest in the Security is being acquired by a United States person, that such person is a financial institution within the meaning of Section
l.165-12(c)(1)(v) of the United States Treasury Regulations or is acquiring through such a financial institution, and in either case that the Security is held by a financial institution that has agreed in writing to comply with the requirements of
Section 165(j)(3)(A), (B) or (C) of the Internal Revenue Code of 1986, as amended, and the regulations thereunder and is not purchasing for offer to resell or for resale inside the United States. If this certificate is being provided
by a clearing organization, it is based on statements provided to it by its member organizations. As used herein, “United States” means the United States of America (including the States and the District of Columbia), its
territories and possessions and other areas subject to its jurisdiction, and “United States person” means any citizen or resident of the United States, any corporation, partnership or other entity created or organized in or under
the laws of the United States or any political subdivision thereof and any estate or trust the income of which is subject to United States Federal income taxation regardless of its source. If the undersigned is a dealer, the undersigned agrees to
obtain a similar certificate from each person entitled to delivery of any of the above-captioned Securities in bearer form purchased from it; provided, however, that, if the undersigned has actual knowledge that the information
contained in such a certificate is false (and, absent documentary evidence that the beneficial owner of such Security is not a United States person, the undersigned will be, deemed to have actual knowledge that such beneficial owner, other than a
financial institution described above, is a United States person if the undersigned has a United States address for such beneficial owner), the undersigned will not deliver a Security in temporary or definitive bearer form to the person who signed
such certificate notwithstanding the delivery of such certificate to the undersigned. 
 We undertake to advise you by telex if the above
statement as to beneficial ownership is not correct on the date of delivery of the above-captioned Securities in bearer form as to all of such Securities. 

  
 C-1-1 

 We understand that this certificate is required in connection with certain securities and tax
legislation in the United States. If administrative or legal proceedings are commenced or threatened in connection with which this certificate is or would be relevant, we irrevocably authorize you to produce this certificate or a copy thereof to any
interested party in such proceedings.] 
  

					
	Dated:                    , 20    	 		 	  

  
 C-1-2 

 EXHIBIT C-2 

[FORM OF CERTIFICATE TO BE GIVEN BY EUROCLEAR AND 

CLEARSTREAM IN CONNECTION WITH THE EXCHANGE OF A PORTION 

OF A TEMPORARY GLOBAL SECURITY 

Whenever any provision of this Indenture or the forms of Security contemplates that certification be given by Euroclear or Clearstream in
connection with the exchange of a portion of a temporary global Security, such certification shall be provided substantially in the form of the following certificate, with only such changes as shall be approved by the Company:] 

CERTIFICATE 
 [Insert title or
sufficient description 
 of Securities to be delivered] 

This is to certify with respect to U.S. $[—] principal amount of the above-captioned
Securities (i) that we have received from each of the persons appearing in our records as persons entitled to a portion of such principal amount (our “Qualified Account Holders”) a certificate with respect to such portion
substantially in the form attached hereto, and (ii) that we are not submitting herewith for exchange any portion of the temporary global Security representing the above-captioned Securities excepted in such certificates. 

We further certify that as of the date hereof we have not received any notification from any of our Qualified Account Holders to the effect
that the statements made by such Qualified Account Holders with respect to any portion of the Principal amount submitted herewith for exchange are no longer true and cannot be relied upon as of the date hereof. 

We understand that this certificate may be required in connection with certain securities and tax legislation in the United States. If
administrative or legal proceedings are commenced or threatened in connection with which this certificate is or would be relevant, we irrevocably authorize you to produce this certificate or a copy thereof to any interested party in such
proceedings. 
 Dated:                     ,
20     
 [To be dated no earlier than 
 the
Exchange Date] 
  

			
	 [EUROCLEAR BANK S.A./N.V., as

Operator of the Euroclear System]
 [CLEARSTREAM BANKING,
SOCIETE
 ANONYME]

		
	 By:
	 	  

  
 C-2-1 

 EXHIBIT C-3 

[FORM OF CERTIFICATE TO BE GIVEN BY EUROCLEAR AND 

CLEARSTREAM TO OBTAIN INTEREST PRIOR TO AN EXCHANGE DATE 

Whenever any provision of this indenture or the forms of Security contemplates that certification be given by Euroclear or Clearstream to
obtain interest prior to an Exchange Date, such certification shall be provided substantially in the form of the following certificate, with only such changes as shall be approved by the Company:] 

CERTIFICATE 
  

 
 [Insert title
or sufficient description of Securities] 
 We confirm that the interest payable on the Interest Payment Date on [Insert Date]
will be paid to each of the persons appearing in our records as being entitled to interest payable on such date from whom we have received a written certification, dated not earlier than such Interest Payment Date, substantially in the form attached
hereto. We undertake to retain certificates received from our member organizations in connection herewith for four years from the end of the calendar year in which such certificates are received. 

We undertake that any interest received by us and not paid as provided above shall be returned to the Trustee for the above Securities
immediately prior to the expiration of two years after such Interest Payment Date in order to be repaid by such Trustee to the above issuer at the end of two years after such Interest Payment Date. 

Dated:                     , 20    

 [To be dated on or after 
 the relevant Interest 

Payment Date] 
  

			
	 [EUROCLEAR BANK S.A./N.V., as

Operator of the Euroclear System]
 [CLEARSTREAM BANKING,
SOCIETE
 ANONYME]

		
	 By:
	 	  

  
 C-3-1EX-10.1

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
 CREDIT AGREEMENT 

dated as of March 12, 2014 
 by
and between 
 UNILIFE MEDICAL SOLUTIONS, INC., 

as the Borrower, 
 and 

ROS ACQUISITION OFFSHORE LP, 
 as
the Lender 
  
  

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 TABLE OF CONTENTS 

 

					
	 	  	Page	 
		
	 ARTICLE I DEFINITIONS AND ACCOUNTING TERMS
	  	 	1	  
	 SECTION 1.1 Defined Terms
	  	 	1	  
	 SECTION 1.2 Use of Defined Terms
	  	 	24	  
	 SECTION 1.3 Cross-References
	  	 	24	  
	 SECTION 1.4 Accounting and Financial Determinations
	  	 	24	  
	 SECTION 1.5 Interpretation
	  	 	24	  
	 SECTION 1.6 Conversion of Currencies
	  	 	25	  
		
	 ARTICLE II COMMITMENT AND BORROWING PROCEDURES
	  	 	26	  
	 SECTION 2.1 Commitment
	  	 	26	  
	 SECTION 2.2 Borrowing Procedure
	  	 	26	  
	 SECTION 2.3 Funding
	  	 	26	  
	 SECTION 2.4 Reduction of the Commitment Amounts
	  	 	26	  
		
	 ARTICLE III REPAYMENTS, PREPAYMENTS, INTEREST AND FEES
	  	 	26	  
	 SECTION 3.1 Repayments and Prepayments; Application
	  	 	26	  
	 SECTION 3.2 Repayments and Prepayments
	  	 	26	  
	 SECTION 3.3 Interest Rate
	  	 	27	  
	 SECTION 3.4 Default Rate
	  	 	27	  
	 SECTION 3.5 Payment Dates
	  	 	27	  
	 SECTION 3.6 Repayment Premium
	  	 	28	  
		
	 ARTICLE IV LIBO RATE AND OTHER PROVISIONS
	  	 	28	  
	 SECTION 4.1 Increased Costs, Etc.
	  	 	28	  
	 SECTION 4.2 Increased Capital Costs
	  	 	28	  
	 SECTION 4.3 Taxes
	  	 	29	  
	 SECTION 4.4 Payments, Computations; Proceeds of Collateral, Etc.
	  	 	33	  
	 SECTION 4.5 Setoff
	  	 	33	  
	 SECTION 4.6 LIBO Rate Not Determinable
	  	 	34	  
		
	 ARTICLE V CONDITIONS TO MAKING THE LOANS
	  	 	34	  
	 SECTION 5.1 Credit Extensions
	  	 	34	  
	 SECTION 5.2 Secretary’s Certificate, Etc.
	  	 	34	  
	 SECTION 5.3 Australian Requirements
	  	 	35	  
	 SECTION 5.4 Closing Certificate
	  	 	35	  
	 SECTION 5.5 Payment of Outstanding Indebtedness, Etc.
	  	 	35	  
	 SECTION 5.6 Delivery of Note
	  	 	35	  
	 SECTION 5.7 Financial Information, Etc. The Lender shall have received
	  	 	36	  
	 SECTION 5.8 Compliance Certificate
	  	 	36	  

  
 -i- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

					
	 SECTION 5.9 Solvency, Etc.
	  	 	36	  
	 SECTION 5.10 Guarantee
	  	 	36	  
	 SECTION 5.11 Security Agreement
	  	 	36	  
	 SECTION 5.12 Intellectual Property Security Agreements
	  	 	37	  
	 SECTION 5.13 Royalty Agreement
	  	 	37	  
	 SECTION 5.14 Australian Security Documents
	  	 	37	  
	 SECTION 5.15 Opinions of Counsel
	  	 	38	  
	 SECTION 5.16 Insurance
	  	 	38	  
	 SECTION 5.17 Metro Bank and Pennsylvania Loans. The Lender shall have received:
	  	 	38	  
	 SECTION 5.18 [Reserved]
	  	 	39	  
	 SECTION 5.19 Acknowledgement Agreements
	  	 	39	  
	 SECTION 5.20 Mortgaged Property
	  	 	39	  
	 SECTION 5.21 Flood Determinations; Flood Insurance
	  	 	39	  
	 SECTION 5.22 Closing Fees, Expenses, Etc.
	  	 	39	  
	 SECTION 5.23 Anti-Terrorism Laws
	  	 	39	  
	 SECTION 5.24 Satisfactory Legal Form
	  	 	39	  
	 SECTION 5.25 Loan Request and Disclosure Schedules
	  	 	39	  
	 SECTION 5.26 Post-Closing Commitments
	  	 	39	  
	 SECTION 5.27 Mortgage Post-Closing Commitments
	  	 	40	  
	 SECTION 5.28 MELF and Bank Account Post-Closing Commitments
	  	 	40	  
	 SECTION 5.29 Acknowledgement Agreements Post-Closing Commitments
	  	 	40	  
		
	 ARTICLE VI REPRESENTATIONS AND WARRANTIES
	  	 	41	  
	 SECTION 6.1 Organization, Etc.
	  	 	41	  
	 SECTION 6.2 Due Authorization, Non-Contravention, Etc.
	  	 	41	  
	 SECTION 6.3 Government Approval, Regulation, Etc.
	  	 	41	  
	 SECTION 6.4 Validity, Etc.
	  	 	42	  
	 SECTION 6.5 Financial Information
	  	 	42	  
	 SECTION 6.6 No Material Adverse Change
	  	 	42	  
	 SECTION 6.7 Litigation, Labor Matters and Environmental Matters
	  	 	42	  
	 SECTION 6.8 Subsidiaries
	  	 	43	  
	 SECTION 6.9 Ownership of Properties
	  	 	43	  
	 SECTION 6.10 Taxes
	  	 	43	  
	 SECTION 6.11 Benefit Plans, Etc.
	  	 	43	  
	 SECTION 6.12 Accuracy of Information
	  	 	44	  
	 SECTION 6.13 Regulations U and X
	  	 	44	  
	 SECTION 6.14 Solvency
	  	 	44	  
	 SECTION 6.15 Intellectual Property
	  	 	44	  
	 SECTION 6.16 Material Agreements
	  	 	46	  
	 SECTION 6.17 Permits
	  	 	46	  
	 SECTION 6.18 Regulatory Matters
	  	 	46	  

  
 -ii- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

					
	 SECTION 6.19 Transactions with Affiliates
	  	 	49	  
	 SECTION 6.20 Investment Company Act
	  	 	50	  
	 SECTION 6.21 OFAC
	  	 	50	  
	 SECTION 6.22 Deposit and Disbursement Accounts
	  	 	50	  
	 SECTION 6.23 Customer and Trade Relations
	  	 	50	  
	 SECTION 6.24 Holding Companies; Excluded Subsidiary
	  	 	51	  
	 SECTION 6.25 Hikma Collateral
	  	 	51	  
		
	 ARTICLE VII AFFIRMATIVE COVENANTS
	  	 	52	  
	 SECTION 7.1 Financial Information, Reports, Notices, Etc.
	  	 	52	  
	 SECTION 7.2 Maintenance of Existence; Compliance with Contracts, Laws, Etc.
	  	 	55	  
	 SECTION 7.3 Maintenance of Properties
	  	 	55	  
	 SECTION 7.4 Insurance
	  	 	55	  
	 SECTION 7.5 Books and Records
	  	 	56	  
	 SECTION 7.6 Environmental Law Covenant
	  	 	56	  
	 SECTION 7.7 Use of Proceeds
	  	 	56	  
	 SECTION 7.8 Future Guarantors, Security, Etc.
	  	 	56	  
	 SECTION 7.9 Obtaining of Permits, Etc.
	  	 	57	  
	 SECTION 7.10 Product Licenses
	  	 	57	  
	 SECTION 7.11 Maintenance of Regulatory Authorizations, Contracts, Intellectual Property, Etc.
	  	 	58	  
	 SECTION 7.12 Inbound Licenses
	  	 	58	  
	 SECTION 7.13 Cash Management
	  	 	59	  
	 SECTION 7.14 Subsequent Agreement
	  	 	59	  
		
	 ARTICLE VIII NEGATIVE COVENANTS
	  	 	60	  
	 SECTION 8.1 Business Activities
	  	 	60	  
	 SECTION 8.2 Indebtedness
	  	 	60	  
	 SECTION 8.3 Liens
	  	 	61	  
	 SECTION 8.4 Financial Covenants
	  	 	62	  
	 SECTION 8.5 Investments
	  	 	63	  
	 SECTION 8.6 Restricted Payments, Etc.
	  	 	63	  
	 SECTION 8.7 Consolidation, Merger; Permitted Acquisitions, Etc.
	  	 	63	  
	 SECTION 8.8 Permitted Dispositions
	  	 	64	  
	 SECTION 8.9 Modification of Certain Agreements
	  	 	64	  
	 SECTION 8.10 Transactions with Affiliates
	  	 	64	  
	 SECTION 8.11 Restrictive Agreements, Etc.
	  	 	64	  
	 SECTION 8.12 Sale and Leaseback
	  	 	65	  
	 SECTION 8.13 Product Agreements
	  	 	65	  
	 SECTION 8.14 Change in Name, Location or Executive Office or Executive Management; Change in Fiscal Year
	  	 	65	  
	 SECTION 8.15 Benefit Plans and Agreements
	  	 	65	  
	 SECTION 8.16 Holding Companies
	  	 	66	  
	 SECTION 8.17 Hikma Collateral
	  	 	67	  

  
 -iii- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

					
		
	 ARTICLE IX EVENTS OF DEFAULT
	  	 	67	  
	 SECTION 9.1 Listing of Events of Default
	  	 	67	  
	 SECTION 9.2 Action if Bankruptcy
	  	 	71	  
	 SECTION 9.3 Action if Other Event of Default
	  	 	71	  
		
	 ARTICLE X MISCELLANEOUS PROVISIONS
	  	 	71	  
	 SECTION 10.1 Waivers, Amendments, Etc.
	  	 	71	  
	 SECTION 10.2 Notices; Time
	  	 	71	  
	 SECTION 10.3 Payment of Costs and Expenses
	  	 	72	  
	 SECTION 10.4 Indemnification
	  	 	72	  
	 SECTION 10.5 Survival
	  	 	73	  
	 SECTION 10.6 Severability
	  	 	73	  
	 SECTION 10.7 Headings
	  	 	73	  
	 SECTION 10.8 Execution in Counterparts, Effectiveness, Etc.
	  	 	73	  
	 SECTION 10.9 Governing Law; Entire Agreement
	  	 	73	  
	 SECTION 10.10 Successors and Assigns
	  	 	74	  
	 SECTION 10.11 Other Transactions
	  	 	74	  
	 SECTION 10.12 Forum Selection and Consent to Jurisdiction
	  	 	74	  
	 SECTION 10.13 Waiver of Jury Trial
	  	 	75	  
	 SECTION 10.14 Confidential Information
	  	 	75	  
	 SECTION 10.15 Exceptions to Confidentiality
	  	 	76	  

 SCHEDULES: 
  

			
	Schedule 1.01(a)	  	Pennsylvania Real Property
	Schedule 6.7(a)	  	Litigation
	Schedule 6.8	  	Existing Subsidiaries
	Schedule 6.15(a)	  	Intellectual Property
	Schedule 6.15(e)	  	Infringement Notices
	Schedule 6.16	  	Material Agreements
	Schedule 6.19	  	Transactions with Affiliates
	Schedule 6.22	  	Deposit and Disbursement Accounts
	Schedule 7.7	  	Use of Proceeds
	Schedule 8.2(b)	  	Indebtedness to be Paid
	Schedule 8.2(c)	  	Existing Indebtedness
	Schedule 8.3(c)	  	Existing Liens
	Schedule 8.5(a)	  	Investments
	Schedule 10.2	  	Notice Information

  
 -iv- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBITS: 
  

					
	Exhibit A	 	-	  	Form of Promissory Note
	Exhibit B	 	-	  	Form of Loan Request
	Exhibit C	 	-	  	Form of Compliance Certificate
	Exhibit D	 	-	  	Form of Guarantee
	Exhibit E	 	-	  	Form of Security Agreement
	Exhibit F	 	-	  	Form of Mortgage
	Exhibit G-1	 	-	  	Form of Hikma Acknowledgement and Agreement
	Exhibit G-2	 	-	  	Form of MedImmune Acknowledgement and Agreement

  
 -v- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 CREDIT AGREEMENT 

THIS CREDIT AGREEMENT dated as of March 12, 2014 (as amended, supplemented or otherwise modified from time to time, this
“Agreement”), is by and between UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the “Borrower”) and ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (together with its Affiliates,
successors, transferees and assignees, the “Lender”). The Borrower and the Lender are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. 

W I T N E S S E T H: 

WHEREAS, the Borrower has requested that the Lender provide a senior secured term loan facility to the Borrower in an aggregate principal
amount of $60,000,000 (with $40,000,000 funded on the Closing Date and $10,000,000 funded on each of December 15, 2014 and June 15, 2015, subject to the terms and conditions set forth herein); and 

WHEREAS, the Lender is willing, on the terms and subject to the conditions hereinafter set forth, to extend the Commitment and make the Loans
to the Borrower; 
 NOW, THEREFORE, the parties hereto agree as follows. 

ARTICLE I 
 DEFINITIONS AND
ACCOUNTING TERMS 
 SECTION 1.1 Defined Terms. The following terms (whether or not underscored) when used in this Agreement,
including its preamble and recitals, shall, except where the context otherwise requires, have the following meanings (such meanings to be equally applicable to the singular and plural forms thereof): 

“$” means U.S. Dollars. 

“Affiliate” of any Person means any other Person which, directly or indirectly, Controls, is Controlled by or is under common
Control with such Person. “Control” (and its correlatives) by any Person means (i) the power of such Person, directly or indirectly, (x) to vote 15% or more of the Voting Securities (determined on a fully diluted basis) of
another Person, or (y) to direct or cause the direction of the management and policies of such other Person (whether by contract or otherwise), and (ii) in addition and without limiting the foregoing (i), in respect of any Australian
Subsidiary, (x) the meaning given in section 50AA of the Corporations Act, and (y) the direct or indirect power to directly or indirectly direct the management or policies of the Australian Subsidiary or control the membership or
voting of the board of directors or other governing body of the Australian Subsidiary (whether or not the power has statutory, legal or equitable force or arises by means of statutory, legal or equitable rights or trusts, agreements, arrangements,
understandings, practices, the ownership of any interest in ‘marketable securities’ (as defined in the Corporations Act), bonds or instruments of the entity or otherwise). 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Agreement” is defined in the preamble. 

“Applicable Margin” means 9.25%. 

“ASX” means Australian Securities Exchange. 

“Australian Security Documents” means any document governed by the laws of any state or territory of Australia, which as at
the date of this Agreement includes the General Security Deed. 
 “Australian Subsidiary” means any Subsidiary incorporated
under the laws of Australia, which as at the date of this Agreement includes (i) Unilife Medical Solutions Pty Limited ACN 008 071 403, and (ii) Unitract Syringe Pty Ltd ACN 101 059 723. 

“Australian Withholding Tax” means any Australian Tax required to be withheld or deducted from any interest or other payment
under Division 11A of Part III of the Income Tax Assessment Act 1936 (Cth). 
 “Authorized Officer” means, relative to
Holdings, the Borrower or any of the Subsidiaries, those of its officers, general partners or managing members (as applicable) whose signatures and incumbency shall have been certified to the Lender pursuant to Section 5.2. 

“Benefit Plan” means any employee benefit plan, within the meaning of section 3(3) of ERISA, that either: (i) is a
“multiemployer plan,” as defined in section 3(37) of ERISA, (ii) is subject to section 412 of the Code, section 302 of ERISA or Title IV of ERISA, or (iii) provides welfare benefits to terminated employees, other than to the
extent required by section 4980B(f) of the Code and the corresponding provisions of ERISA. 
 “BLA” means a Biologics
License Application filed with the FDA or an equivalent application to any Regulatory Authority requesting Regulatory Authorization for a new product. 

“Borrower” is defined in the preamble. 

“Business Day” means any day which is neither a Saturday or Sunday nor a legal holiday on which banks are authorized or
required to be closed in New York, Luxembourg or the Cayman Islands. 
 “Capital Securities” means, with respect to
any Person, all shares of, interests or participations in, or other equivalents in respect of (in each case however designated, whether voting or non-voting), of such Person’s equity interests, whether now outstanding or issued after the
Closing Date. 
 “Capitalized Lease Liabilities” means, with respect to any Person, all monetary obligations of such Person
and its Subsidiaries under any leasing or similar arrangement which 

  
 -2- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
have been (or, in accordance with GAAP, should be) classified as capitalized leases, and for purposes of each Loan Document the amount of such obligations shall be the capitalized amount thereof,
determined in accordance with GAAP, and the stated maturity thereof shall be the date of the last payment of rent or any other amount due under such lease prior to the first date upon which such lease may be terminated by the lessee without payment
of a premium or a penalty. 
 “Cash Equivalent Investment” means, at any time: 

(a) any direct obligation of (or unconditionally guaranteed by) the United States (or any agency or political subdivision
thereof, to the extent such obligations are supported by the full faith and credit of the United States) maturing not more than one year after such time; 

(b) commercial paper maturing not more than 270 days from the date of issue, which is issued by a corporation (other than an
Affiliate of Holdings, the Borrower or any of the Subsidiaries) organized under the laws of any state of the United States or of the District of Columbia and rated A-1 or higher by S&P or P-1 or higher by Moody’s; or 
 (c) any certificate of deposit, time deposit or
bankers acceptance, maturing not more than 180 days after its date of issuance, which is issued by any bank organized under the laws of the United States (or any state thereof) and which has (x) a credit rating of A2 or higher from Moody’s
or A or higher from S&P and (y) a combined capital and surplus greater than $500,000,000. 
 “Casualty Event”
means the damage, destruction or condemnation, as the case may be, of property of any Person or any of its Subsidiaries. 

“cGMP” means the current good manufacturing practices and regulatory requirements, as specified in regulations promulgated
from time to time by the Regulatory Authorities for the manufacture and testing of products. 
 “Change in Control” means
and shall be deemed to have occurred if (i) any “person” or “group” (within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934 as in effect on the date hereof) shall
own, directly or indirectly, beneficially or of record, determined on a fully diluted basis, more than 40% of the Voting Securities of Holdings; (ii) a majority of the seats (other than vacant seats) on the board of directors (or equivalent) of
Holdings shall at any time be occupied by persons who were neither (x) nominated by the board of directors of Holdings nor (y) appointed by directors so nominated, or (iii) Holdings shall cease to directly or indirectly own,
beneficially and of record, 100% of the issued and outstanding Capital Securities of the Borrower and the Subsidiaries. 
 “Change
in Law” means the occurrence, after the date of this Agreement, of any of the following: (i) the adoption or taking effect of any law, rule, regulation or treaty, (ii) any change 

  
 -3- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (iii) the making or issuance of any
request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority; provided that, notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection
Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking
Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a “Change in Law”, regardless of the date enacted, adopted
or issued. 
 “Clinical Investigation Application” means an application for authorization of a clinical investigation filed
with any Regulatory Authority in the European Union. 
 “Closing Date” means the date of the making of the Initial Loan
hereunder, which in no event shall be later than March 12, 2014. 
 “Closing Certificate” means a closing certificate
executed and delivered by an Authorized Officer of the Borrower in form and substance satisfactory to the Lender. 
 “CMS”
means the U.S. Center for Medicare and Medicaid Services. 
 “Code” means the Internal Revenue Code of 1986, and the
regulations thereunder, in each case as amended from time to time. 
 “Collateral” has the meaning given such term in the
Security Agreement. 
 “Commitment” means the Lender’s obligations (if any) to make Loans hereunder. 

“Commitment Amount” means the Initial Commitment Amount plus the Delayed Draw Commitment Amount. 

“Compliance Certificate” means a certificate duly completed and executed by an Authorized Officer of the Borrower,
substantially in the form of Exhibit C hereto, together with such changes thereto as the Lender may from time to time request for the purpose of monitoring the Borrower’s compliance with the financial covenants contained herein.

 “Corporations Act” means the Corporations Act 2001 (Cth). 

“Confidential Information” means any and all information or material (whether written or oral, or in electronic or other
form) that, at any time before, on or after the Closing Date, has been or is provided or communicated to the Receiving Party by or on behalf of the Disclosing Party pursuant to this Agreement or in connection with the transactions contemplated
hereby, and shall include the existence and terms of this Agreement. 

  
 -4- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Contingent Liability” means any agreement, undertaking or arrangement by
which any Person guarantees, endorses or otherwise becomes or is contingently liable upon (by direct or indirect agreement, contingent or otherwise, to provide funds for payment, to supply funds to, or otherwise to invest in, a debtor, or otherwise
to assure a creditor against loss) the Indebtedness of any other Person (other than by endorsements of instruments in the course of collection), or guarantees the payment of dividends or other distributions upon the Capital Securities of any other
Person. The amount of any Person’s obligation under any Contingent Liability shall (subject to any limitation set forth therein) be deemed to be the outstanding principal amount of the debt, obligation or other liability guaranteed thereby.

 “Control” is defined within the definition of “Affiliate”. 

“Controlled Account” is defined in Section 7.13(a). 

“Copyrights” means all copyrights, whether statutory or common law, and all exclusive and nonexclusive licenses from third
parties or rights to use copyrights owned by such third parties, along with any and all (i) renewals, revisions, extensions, derivative works, enhancements, modifications, updates and new releases thereof, (ii) income, royalties, damages,
claims and payments now and hereafter due and/or payable with respect thereto, including, without limitation, damages and payments for past, present or future infringements thereof, (iii) rights to sue for past, present and future infringements
thereof, and (iv) foreign copyrights and any other rights corresponding thereto throughout the world. 
 “Copyright Security
Agreement” means any Copyright Security Agreement executed and delivered by Holdings, the Borrower or any of the Subsidiaries in substantially the form of Exhibit C to the Security Agreement, as amended, supplemented, amended and restated
or otherwise modified from time to time. 
 “Covered Agreements” means each of (i) the Hikma Security Agreement, the
Hikma LDSA, and the definitive separate Supply Agreement and Quality Agreement (as referenced in the Hikma LDSA), (ii) the Sanofi Supply Agreement, (iii) the Medimmune Agreement and (iv) the Subsequent Agreement; provided that any of
(i), (ii), (iii) or (iv) above may be replaced, for purposes of this Agreement, by a separate agreement (or agreements) with a major pharmaceutical or biotechnology company that has equal or greater value to Holdings, the Borrower and its
Subsidiaries (the value of the agreements in clauses (i), (ii) and (iii) above determined as of the date hereof), as determined by the Lender in its sole discretion, and with respect to which the Lender has received an acknowledgement
agreement (similar to the other such acknowledgement agreements delivered hereunder) in form and substance satisfactory to the Lender. 

“Credit Agreement Termination Date” means the date on which all Obligations (other than Obligations arising under or in
connection with the Royalty Agreement) have been paid in full in cash and the Commitment shall have terminated. 

  
 -5- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Credit Obligor” means individually and “Credit Obligors”
means collectively, Holdings, the Borrower and the Subsidiaries that are party to any Loan Document. 
 “Default” means any
Event of Default or any condition, occurrence or event which, after notice or lapse of time or both, would constitute an Event of Default. 

“Delayed Draw Closing Dates” means December 15, 2014 and June 15, 2015. 

“Delayed Draw Commitment Amount” means $20,000,000. 

“Delayed Draw Loan” is defined in Section 2.1. 

“Designated Jurisdiction” means any country or territory to the extent that such country or territory is the subject of any
Sanction. 
 “Device” means any instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other
similar or related article, including any component, part, or accessory, which is (a) recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them, (b) intended for use in the diagnosis of
disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or (c) intended to affect the structure or any function of the body of man or other animals; and which does not achieve its
primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes. 

“Device Approval Application” means a premarket approval application (PMA) submitted under Section 515 of the FD&C
Act (21 U.S.C. § 360e), a de novo request submitted under Section 513(f) of the FD&C Act (21 U.S.C. § 360c(f)), or premarket notification submitted under Section 510(k) of the FD&C Act (21 U.S.C. § 360(k))
(“510(k)”), as defined in the FD&C Act, or any corresponding foreign application in the Territory (as defined in the Royalty Agreement), including, with respect to the European Union, a submission to a Notified Body for a
Certificate of Conformity with an applicable Council Directive. 
 “Disclosing Party” means the Party disclosing
Confidential Information. 
 “Disposition” (or similar words such as “Dispose”) means any sale, transfer,
lease, license, contribution or other conveyance (including by way of merger) of, or the granting of options, warrants or other rights to, any of Holdings’, the Borrower’s or the Subsidiaries’ assets (including any accounts receivable
and including Capital Securities of Subsidiaries) to any other Person (other than to Holdings, the Borrower or any of the Guarantors) in a single transaction or series of transactions. 

“Disqualified Capital Securities” shall mean any Capital Securities that, by their terms (or by the terms of any security or
other Capital Securities into which they are convertible or for 

  
 -6- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
which they are exchangeable) or upon the happening of any event or condition, (a) mature or are mandatorily redeemable (other than solely for Qualified Capital Securities), pursuant to a
sinking fund obligation or otherwise (except as a result of a Change in Control or asset sale so long as any rights of the holders thereof upon the occurrence of a Change in Control or asset sale event shall be subject to the prior repayment in full
of the Loans and all other Obligations that are accrued and payable and the termination of the Commitment), (b) are redeemable at the option of the holder thereof (other than solely for Qualified Capital Securities) (except as a result of a
Change in Control or asset sale so long as any rights of the holders thereof upon the occurrence of a Change in Control or asset sale event shall be subject to the prior repayment in full of the Loans and all other Obligations that are accrued and
payable and the termination of the Commitment), in whole or in part, (c) provide for the scheduled payment of dividends in cash or (d) are or become convertible into or exchangeable for Indebtedness or any other Capital Securities that
would constitute Disqualified Capital Securities, in each case, prior to the date that is one hundred and eighty-one (181) days after the Maturity Date; provided that if such Capital Securities are issued pursuant to a plan for the
benefit of employees of Holdings, the Borrower or any of the Subsidiaries, or by any such plan to such employees, such Capital Securities shall not constitute Disqualified Capital Securities solely because they may be required to be repurchased by
Holdings, the Borrower or the Subsidiaries in order to satisfy applicable statutory or regulatory obligations. 
 “EMA”
means the European Medicines Agency or any successor entity. 
 “Environmental Laws” means all federal, state, local or
international laws, statutes, rules, regulations, codes, directives, treaties, requirements, ordinances, orders, decrees, judgments, injunctions, or binding notices or agreements issued, promulgated or entered into by any Governmental Authority,
relating in any way to the environment, natural resources, Hazardous Material or health and safety matters. 
 “Environmental
Liability” means any liability, loss, claim, suit, action, investigation, proceeding, damage, commitment or obligation, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines, penalties or
indemnities), of or affecting Holdings, the Borrower or any Subsidiary directly or indirectly arising from, in connection with or based upon (i) any Environmental Law or Environmental Permit, (ii) the generation, use, handling,
transportation, storage, treatment, recycling, presence, disposal, Release or threatened Release of, or exposure to, any Hazardous Materials, or (iii) any contract, agreement, penalty, order, decree, settlement, injunction or other arrangement
(including operation of law) pursuant to which liability is assumed, entered into, inherited or imposed with respect to any of the foregoing. 

“Environmental Permit” is defined in Section 6.7(c). 

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended from time to time. 

  
 -7- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “ERISA Affiliate” means, as applied to any Person, (i) any corporation
that is a member of a controlled group of corporations within the meaning of section 414(b) of the Code of which that Person is a member, (ii) any trade or business (whether or not incorporated) that is a member of a group of trades or
businesses under common control within the meaning of section 414(c) of the Code of which that Person is a member, and (iii) any member of an affiliated service group within the meaning of section 414(m) or 414(o) of the Code of which that
Person is a member. 
 “Event of Default” is defined in Section 9.1. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“Excluded Accounts” means (i) bank accounts owned by any Australian Subsidiary and held with an ADI (as defined in the
Banking Act 1959 (Cth)), in which not more than $350,000 (or the equivalent, if such account is denominated in a currency other than in U.S. Dollars) in the aggregate for all such accounts is held in such accounts at any one time; (ii) deposit
accounts that are zero balance accounts and are used exclusively for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of a Credit Obligor’s employees, (iii) the bank account that the Borrower has
with CIC Industriel provided that not more than €25,000 is held in such account at any time, and (iv) the certificates of deposits that the Borrower has with [***] for the purpose of securing credit card facilities with those lenders,
respectively (so long as such accounts continue to be used for such purposes), provided that not more than $76,000, $36,000, $135,000 and AU$35,000, respectively, is held in such accounts at any time. 

“External Administrator” means an administrator, controller or managing controller (each as defined in the Corporations Act),
trustee, provisional liquidator, liquidator or any other person (however described) holding or appointed to an analogous office or acting or purporting to act in an analogous capacity. 

“FATCA” means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version
that is substantively comparable and not materially more onerous to comply with), any intergovernmental agreements with respect thereto, any current or future regulations or official interpretations thereof, and any agreements entered into pursuant
to Section 1471(b)(1) of the Code. 
 “FDA” means the U.S. Food and Drug Administration and any successor entity. 

“FD&C Act” means the U.S. Food, Drug and Cosmetic Act (or any successor thereto), as amended from time to time, and the
rules, regulations, guidelines, guidance documents and compliance policy guides issued or promulgated thereunder. For purposes of this Agreement, “FD&C Act” includes provisions of the Public Health Services Act that apply to biological
products and products derived from human tissue. 

  
 -8- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Fiscal Quarter” means a quarter ending on the last day of March, June,
September or December. 
 “Fiscal Year” means any period of twelve consecutive calendar months ending on June 30;
references to a Fiscal Year with a number corresponding to any calendar year (e.g., the “2013 Fiscal Year”) refer to the Fiscal Year ending on June 30 of such calendar year. 

“F.R.S. Board” means the Board of Governors of the Federal Reserve System or any successor thereto. 

“FTC Act” means the Federal Trade Commission Act. 

“GAAP” means generally accepted accounting principles in the United States. 

“General Security Deed” means the general security deed dated on or about the date of this Agreement granted by each of
Holdings, Unilife Medical Solutions Pty Limited and Unitract Syringe Pty Ltd in favor of the Lender (as “collateral agent” under the Loan Documents for and on behalf of each party to which any of the Credit Obligors may owe any
Obligations) and to which the Lender and ROS are also a party. 
 “Governmental Authority” means any national,
supranational, federal, state, county, provincial, local, municipal or other government or political subdivision thereof (including any Regulatory Agency), whether domestic or foreign, and any agency, authority, commission, ministry,
instrumentality, regulatory body, court, tribunal, arbitrator, central bank or other Person exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to any such government. 

“GST Group” has the meaning given in the A New Tax System (Goods and Services Tax) Act 1999 (Cth). 

“Guarantee” means the guarantee executed and delivered by an Authorized Officer, or in relation to any Australian Subsidiary
two directors or a director and a company secretary, of each Guarantor, substantially in the form of Exhibit D hereto, as amended, supplemented, amended and restated or otherwise modified from time to time. 

“Guarantors” means, collectively, Holdings, the Australian Subsidiaries and the U.S. Subsidiaries existing on the Closing
Date and each Subsidiary from time to time required to execute a Guarantee pursuant to Section 7.8. 
 “Hazardous
Material” means any material, substance, chemical, mixture or waste which is capable of damaging or causing harm to any living organism, the environment or natural resources, including all explosive, special, hazardous, polluting, toxic,
industrial, dangerous, biohazardous, medical, infectious or radioactive substances, materials or wastes, noise, odor, electricity or heat, and including petroleum or petroleum products, byproducts or distillates,

  
 -9- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
asbestos or asbestos-containing materials, urea formaldehyde, polychlorinated biphenyls, radon gas, ozone-depleting substances, greenhouse gases, and all other substances or wastes of any nature
regulated pursuant to any Environmental Law or as to which any Governmental Authority requires investigation, reporting or remedial action. 

“Hedging Obligations” means, with respect to any Person, all liabilities of such Person under currency exchange agreements,
interest rate swap agreements, interest rate cap agreements and interest rate collar agreements, and all other agreements or arrangements designed to protect such Person against fluctuations in interest rates or currency exchange rates. 

“Hikma” means Hikma Pharmaceuticals LLC. 

“Hikma Agreements” means each contract or agreement to which Holdings, the Borrower or any Subsidiary, on the one hand, and
Hikma Pharmaceuticals, LLC or any of its Affiliates, on the other hand, is a party, including the Hikma LDSA and the Hikma Security Agreement. 

“Hikma Collateral” has the meaning given to such term in the Security Agreement. 

“Hikma LDSA” means that certain Binding License, Development and Supply Agreement, dated November 18, 2013, between the
Borrower and Hikma. 
 “Hikma Security Agreement” means the Security Agreement, dated as of December 18, 2013, by and
among Unitract Syringe Pty Ltd, the Borrower and Hikma. 
 “Holdings” means Unilife Corporation, a Delaware corporation.

 “IDE” means an application, including an application filed with a Regulatory Authority, for authorization to commence
human clinical studies, including (a) an Investigational Device Exemption as defined in the FD&C Act or any successor application or procedure filed with the FDA, (b) an abbreviated IDE as specified in FDA regulations in 21 C.F.R.
§ 812.2(b), (c) any equivalent of a United States IDE in other countries or regulatory jurisdictions, including Clinical Investigations Applications, (d) all amendments, variations, extensions and renewals thereof that may be filed
with respect to the foregoing and (e) all related documents and correspondence thereto, including documents and correspondence with Institutional Review Boards (IRBs) or IECs. 

“Impermissible Qualification” means any qualification or exception to the opinion or certification of any independent public
accountant as to any financial statement of the Borrower (i) that relates to the limited scope of examination of matters relevant to such financial statement, or (ii) that relates to the treatment or classification of any item in such
financial statement and which, as a condition to its removal, would require an adjustment to such item the effect of which would be to cause the Borrower to be in Default. 

“IECs” means independent ethics committees. 

  
 -10- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Indebtedness” of any Person means: 

(a) all obligations of such Person for borrowed money or advances and all obligations of such Person evidenced by bonds,
debentures, notes or similar instruments; 
 (b) all obligations, contingent or otherwise, relative to the face amount of all
letters of credit, whether or not drawn, and banker’s acceptances issued for the account of such Person; 
 (c) all
Capitalized Lease Liabilities of such Person and all obligations of such Person arising under Synthetic Leases; 
 (d) net
Hedging Obligations of such Person; 
 (e) all obligations of such Person in respect of Disqualified Capital Securities; 

(f) whether or not so included as liabilities in accordance with GAAP, all obligations of such Person to pay the deferred
purchase price of property or services (excluding trade accounts payable in the ordinary course of business which are not overdue for a period of more than 90 days or, if overdue for more than 90 days, as to which a dispute exists and adequate
reserves in conformity with GAAP have been established on the books of such Person), and indebtedness secured by (or for which the holder of such indebtedness has an existing right, contingent or otherwise, to be secured by) a Lien on property owned
or being acquired by such Person (including indebtedness arising under conditional sales or other title retention agreements), whether or not such indebtedness shall have been assumed by such Person or is limited in recourse; and 

(g) all Contingent Liabilities of such Person in respect of any of the foregoing. 

The Indebtedness of any Person shall include the Indebtedness of any other Person (including any partnership in which such Person is a general partner) to the
extent such Person is liable therefor as a result of such Person’s ownership interest in or other relationship with such other Person, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor. 

“Indemnified Liabilities” is defined in Section 10.4. 

“Indemnified Parties” is defined in Section 10.4. 

“Infringement” and “Infringes” mean the misappropriation or other violation of know-how, trade secrets,
confidential information, and/or Intellectual Property. 
 “Initial Commitment Amount” means $40,000,000. 

  
 -11- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Initial Loan” is defined in Section 2.1. 

“Insolvency Event” means, in respect of a Person, any of the following occurring: 

(a) it becomes insolvent within the meaning of section 95A, or is taken to have failed to comply with a statutory demand under
section 459F(1), or must be presumed by a court to be insolvent under section 459C(2), or is the subject of a circumstance specified in section 461 (whether or not an application to court has been made under that section) or, if the person is a Part
5.7 body, is taken to be unable to pay its debts under section 585, of the Corporations Act; 
 (b) except with the
Lender’s consent: 
 (i) it is the subject of a Liquidation, or an order or an application is made for its Liquidation;
or 
 (ii) an effective resolution is passed or meeting summoned or convened to consider a resolution for its Liquidation;

 (c) an External Administrator is appointed to it or any of its assets or a step is taken to do so or its Related Party
requests such an appointment; 
 (d) if a registered corporation under the Corporations Act, a step is taken under section
601AA, 601AB or 601AC of the Corporations Act to cancel its registration; 
 (e) an analogous or equivalent event to any
listed above occurs in any jurisdiction; or 
 (f) it stops or suspends payment to all or a class of creditors generally.

 “Intellectual Property” means in the United States and anywhere else in the world all (i) Patents and all
applications, registrations of any sort whatsoever and renewals thereof; (ii) Trademarks and all applications, registrations and renewals thereof; (iii) Copyrights and other works of authorship (registered or unregistered), and all
applications, registrations and renewals thereof; (iv) Product Authorizations; (v) Product Agreements; (vi) computer software, databases, data and documentation; (vii) trade secrets and confidential business information, whether
patentable or unpatentable and whether or not reduced to practice, know-how, inventions, manufacturing processes and techniques, research and development information, data and other information included in or supporting Regulatory Authorizations;
(viii) financial, marketing and business data, pricing and cost information, business, finance and marketing plans, customer and prospective customer lists and information, and supplier and prospective supplier lists and information;
(ix) other intellectual property or similar proprietary rights; (x) copies and tangible embodiments of any of the foregoing (in whatever form or medium); and (xi) any and all improvements, developments, refinements, additions or
subtractions to any of the foregoing which is owned, assigned to, or, is assignable pursuant to the terms of the relevant contract, to Holdings, the Borrower, the Subsidiaries or any of their agents. 

  
 -12- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Interest Period” means, (a) initially, the period beginning on (and
including) the date on which the Initial Loan is made hereunder pursuant to Section 2.3 and ending on (and including) the last day of the Fiscal Quarter in which the Initial Loan was made, and (b) thereafter, the period beginning on
(and including) the first day of each succeeding Fiscal Quarter and ending on the earlier of (and including) (x) the last day of such Fiscal Quarter and (y) the Maturity Date. 

“Investment” means, relative to any Person, (i) any loan, advance or extension of credit made by such Person to any
other Person, including the purchase by such Person of any bonds, notes, debentures or other debt securities of any other Person, (ii) Contingent Liabilities in favor of any other Person, and (iii) any Capital Securities held by such
Person in any other Person. The amount of any Investment shall be the original principal or capital amount thereof less all returns of principal or equity thereon and shall, if made by the transfer or exchange of property other than cash, be deemed
to have been made in an original principal or capital amount equal to the fair market value of such property at the time of such Investment. 

“IP Licensing Arrangements” means collectively, (i) that certain Intra-Group IP License Agreement, by and between
Unitract Syringe Pty Ltd and Unilife Medical Solutions Pty Limited, dated as of November 12, 2009, with an effective date of July 1, 2003, as amended by that certain Deed of Variation relating to Intra-Group IP License Agreement, by and
between Unitract Syringe Pty Ltd and Unilife Medical Solutions Pty Limited, dated as of August 1, 2013, with an effective date of January 27, 2010; and (ii) that certain Exclusive IP Sub-License Agreement, by and between Unilife
Medical Solutions Pty Limited, the Borrower and Unitract Syringe Pty Ltd, dated as of August 1, 2013, with an effective date of January 28, 2010, as amended by that certain Deed of Variation relating to Exclusive IP Sub-License Agreement,
by and between Unilife Medical Solutions Pty Limited, the Borrower and Unitract Syringe Pty Ltd, dated as of November 1, 2013, with a date of variation of September 3, 2013. 

“Key Permits” means all Permits relating to the Products, including all Regulatory Authorizations. 

“knowledge” of the Borrower means the actual knowledge of any officer of Holdings, the Borrower or any Subsidiary, after due
inquiry. 
 “Lender” is defined in the preamble. 

“LIBO Rate” means the three-month London Interbank Offered Rate for deposits in U.S. Dollars at approximately 11:00 a.m.
(London, England time), quoted by the Lender from the appropriate Bloomberg or Telerate page selected by the Lender (or any successor thereto or similar source determined by the Lender from time to time), which shall be that three-month London
Interbank Offered Rate for deposits in U.S. Dollars in effect two Business Days prior to 

  
 -13- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
the last Business Day of the relevant Fiscal Quarter, adjusted for any reserve requirement and any subsequent costs arising from a change in governmental regulation, such rate to be rounded up to
the nearest 1/16 of 1% and such rate to be reset quarterly as of the first Business Day of each Fiscal Quarter. If the Initial Loan is advanced other than on the first Business Day of a Fiscal Quarter, the initial LIBO Rate shall be that three-month
London Interbank Offered Rate for deposits in U.S. Dollars in effect two Business Days prior to the date of the Initial Loan, which rate shall be in effect until (and including) the last Business Day of the Fiscal Quarter next ending. The
Lender’s internal records of applicable interest rates shall be determinative in the absence of manifest error. 

“Lien” means any security interest (including any ‘security interest’ (as defined in the PPS Law)), mortgage,
pledge, hypothecation, assignment, deposit arrangement, encumbrance, lien (statutory or otherwise), charge against or interest in property, or other priority or preferential arrangement of any kind or nature whatsoever, to secure payment of a debt
or performance of an obligation, but solely with respect to the Australian Subsidiaries, excluding a security interest referred to in s.12(3) of the PPS Law that does not in substance secure a payment or performance obligation. 

“Liquidation” means (a) a winding up, dissolution, liquidation, provisional liquidation, administration, bankruptcy or
other proceeding for which an External Administrator is appointed, or an analogous or equivalent event or proceeding in any jurisdiction, or (b) an arrangement, moratorium, assignment or composition with or for the benefit of creditors or any
class or group of them. 
 “Liquidity” means, at any time, an amount determined for the Borrower equal to the sum of
unrestricted cash-on-hand and Cash Equivalent Investments of the Borrower, to the extent held in a Controlled Account located in the United States. 

“Loan Documents” means, collectively, this Agreement, the Notes, the Security Agreement, the Royalty Agreement, the Mortgage,
the Australian Security Documents and each other agreement, pursuant to which the Lender is granted a Lien to secure the Obligations (including any agreements entered into pursuant to Section 7.8), the Guarantee, and each other
agreement, certificate, document or instrument delivered in connection with any Loan Document, whether or not specifically mentioned herein or therein. 

“Loan Request” means a Loan request and certificate duly executed by an Authorized Officer of the Borrower substantially in
the form of Exhibit B hereto. 
 “Loans” means the Initial Loan and each Delayed Draw Loan. 

“Material Adverse Effect” means a material adverse effect on (i) the business, condition (financial or otherwise),
operations, performance, properties or prospects of the Borrower or Holdings, the Borrower and the Subsidiaries taken as a whole, (ii) the rights and remedies of the Lender under any Loan Document or (iii) the ability of Holdings, the
Borrower or any Subsidiary to perform its Obligations under any Loan Document. 

  
 -14- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Material Agreements” means (i) each contract or agreement to which
Holdings, the Borrower or any Subsidiary is a party involving aggregate payments of more than $500,000, whether such payments are being made by Holdings, the Borrower or any Subsidiary to any Person that is not the Borrower or a Guarantor, except
for the types of contracts or agreements described in clause (ii) hereof; (ii) each employment and consulting agreement, capital equipment purchase agreement related to the facilities or production, agreement or purchase order with
suppliers of goods and services, including those related to the development and manufacture of Products, to which Holdings, the Borrower or any Subsidiary is a party involving aggregate payments of more than $1,500,000 annually to any Person that is
not the Borrower or a Guarantor, (iii) each contract or agreement to which Holdings, the Borrower or any Subsidiary is a party involving aggregate payments of more than $1,500,000 by any Person to Holdings, the Borrower or any Subsidiary,
(iv) the Hikma Agreements, (v) the Sanofi Agreements, and (vi) all other contracts or agreements, individually or in the aggregate, material to the business, operations, assets, prospects, conditions (financial or otherwise),
performance or liabilities of Holdings, the Borrower or any Subsidiary. 
 “Maturity Date” means March 12, 2020. 

“MedImmune Agreement” means that certain Master Development & Supply Agreement, dated November 1, 2013, between
MedImmune, LLC and the Borrower, as supplemented by Project Addendum No. 1, dated November 1, 2013, as amended, supplemented, restated or replaced from time to time. 

“Metro Bank” means Metro Bank (formerly known as Commerce Bank/Harrisburg, N.A.). 

“Metro Bank Business Loans” means collectively, (a) the loans made by Metro Bank to the Borrower evidenced by
(i) the Promissory Note of Integrated BioSciences, Inc., dated December 30, 2005, (ii) the Promissory Note of Integrated BioSciences, Inc., dated August 25, 2006, and (iii) the Promissory Note of Unilife Medical Solutions,
Inc., dated October 19, 2011, and (b) all loan agreements, security agreements, guarantees, pledge agreements and other agreements relating thereto. 

“Metro Bank Facility A” means the loan in the aggregate original principal amount of $14,250,000, made by Metro Bank to
Unilife Cross Farm LLC and designated Facility A in the Metro Bank Loan Agreement. 
 “Metro Bank Facility B” means the
loan in the aggregate original principal amount of $3,750,000, made by Metro Bank to Unilife Cross Farm LLC and designated Facility B in the Metro Bank Loan Agreement. 

  
 -15- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Metro Bank Loan Agreement” means the Loan Agreement, dated as of
October 20, 2010, between Metro Bank and Unilife Cross Farm LLC. 
 “Metro Bank Mortgage Loans” means the loans in the
aggregate original principal amount of $18,000,000, made by Metro Bank to Unilife Cross Farm LLC, pursuant the Metro Bank Loan Agreement, and all loan agreements, notes, mortgages, security agreements, guarantees, pledge agreements and other
agreements relating thereto. 
 “Metro Bank Reserve Account” means the debt reserve account maintained by Unilife Cross
Farm LLC in favor of Metro Bank relating to the Metro Bank Mortgage Loans and containing a balance of not more than $2.4 million in the aggregate. 

“Moody’s” means Moody’s Investors Service, Inc. 

“Mortgage” means the Open-End Mortgage and Security Agreement, dated as of the Closing Date, between Unilife Cross Farm LLC
and the Lender, substantially in the form of Exhibit F hereto, as amended, supplemented, amended and restated or otherwise modified from time to time. 

“Mortgaged Property” means the real property in Pennsylvania and owned by Unilife Cross Farm LLC, described more fully on
Schedule 1.01(a) hereto. 
 “Net Asset Sales Proceeds” means, with respect to the Disposition (other than Dispositions of
inventory permitted by Section 8.8(i)) after the Closing Date by the Borrower to any Person of any assets of Holdings, the Borrower or the Subsidiaries, the excess of gross cash proceeds received by Holdings, the Borrower or the
Subsidiaries from such Disposition over all reasonable and customary costs and expenses incurred in connection with such Disposition in excess of $500,000, individually or in the aggregate through the Termination Date, which have not been paid to
Affiliates of the Borrower in connection therewith. 
 “Net Casualty Proceeds” means, with respect to any Casualty Event,
the amount of any insurance proceeds or condemnation awards received by Holdings, the Borrower or any of the Subsidiaries in connection with such Casualty Event in excess of $500,000, individually or in the aggregate through the Termination Date
(net of all reasonable and customary collection expenses thereof, including any legal or professional fees), but excluding any proceeds or awards required to be paid to a creditor (other than the Lender) which holds a first priority Lien permitted
by Section 8.3(e) on the property which is the subject of such Casualty Event. 
 “Net Sales” has the meaning
given to such term in the Royalty Agreement. 
 “Non-Excluded Taxes” means any Taxes, including for the avoidance of doubt
Australian Withholding Taxes, other than the following Taxes imposed on or with respect to a recipient of any payment to be made by or on account of any Lender or required to be withheld or deducted from a payment to any Lender (i) net income,
branch profits and franchise Taxes imposed with 

  
 -16- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
respect to the Lender by any Governmental Authority under the laws of which the Lender is organized, its principal office is located in, or in which it maintains its applicable lending office,
(ii) Taxes imposed as a result of a present or former connection between such Lender and the jurisdiction imposing such Tax (other than connections arising from a Lender having executed, delivered, become a party to, performed its obligations
under, received payments under, received or perfected a security interest under, engaged in any other transactions pursuant to or enforced any Loan Document, except any such Taxes imposed with respect to an assignment of the Loans), (iii) Taxes
attributable to a Lender’s failure to comply with Section 4.3(e) or to the extent that such documentation fails to establish a complete exemption from applicable withholding Taxes, other than, in either case, due to a Change in Law after
the Closing Date, (iv) any U.S. federal withholding Taxes imposed under FATCA and (v) Other Taxes. 
 “Note”
means a promissory note of the Borrower payable to the Lender, in the form of Exhibit A hereto (as such promissory note may be amended, endorsed or otherwise modified from time to time), evidencing the aggregate Indebtedness of the Borrower
to the Lender resulting from the outstanding amount of the Loans, and also means all other promissory notes accepted from time to time in substitution therefor or renewal thereof. 

“Obligations” means all obligations (monetary or otherwise, whether absolute or contingent, matured or unmatured) of
Holdings, the Borrower and each Subsidiary arising under or in connection with a Loan Document and the principal of and premium, if any, and interest (including interest accruing during the pendency of any proceeding of the type described in
Section 9.1(i) or Section 9.1(j), whether or not allowed in such proceeding) on the Loans. 

“Observer” is defined in Section 7.14. 

“OFAC” means the Office of Foreign Assets Control of the United States Department of the Treasury. 

“Organic Document” means, relative to Holdings, the Borrower or any Subsidiary, its certificate of incorporation, certificate
of registration, constitution, by-laws, certificate of partnership, partnership agreement, certificate of formation, limited liability agreement, operating agreement and all shareholder agreements, voting trusts and similar arrangements applicable
to Holdings’, the Borrower’s or any Subsidiary’s Capital Securities. 
 “Other Administrative Proceeding”
means any administrative proceeding relating to a dispute involving a patent office or other relevant intellectual property registry which relates to validity, opposition, revocation, ownership or enforceability of the relevant Intellectual
Property. 
 “Other Taxes” means any and all stamp, documentary or similar Taxes, or any other excise or property Taxes or
similar levies that arise on account of any payment made or required to be made under any Loan Document or from the execution, delivery, registration, recording or enforcement of any Loan Document. 

  
 -17- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Party” and “Parties” have the meanings set forth in the
preamble hereto. 
 “Patent” means any patent, patent right, patent application or invention disclosure, including all
divisions, continuations, continuations in-part, provisionals, continued prosecution applications, substitutions, reissues, reexaminations, renewals, extensions, restorations, supplemental protection certificates and other additions in connection
therewith, whether in or related to the United States or any foreign country or other jurisdiction. 
 “Patent Security
Agreement” means any Patent Security Agreement executed and delivered by Holdings, the Borrower or any of the Subsidiaries in substantially the form of Exhibit A to the Security Agreement, as amended, supplemented, amended and restated or
otherwise modified from time to time. 
 “Pennsylvania Loan” means the loan, in the original principal amount of
$2,250,000, made by Keystone Redevelopment Group, LLC to Unilife Cross Farm, LLC, and all loan agreements, notes, mortgages, security agreements, guarantees, pledge agreements and other agreements relating thereto, including the Collateral
Assignment of Note and Mortgage and Other Loan Documents to the Commonwealth Financing Authority of the Commonwealth of Pennsylvania. 

“Permits” means all permits, licenses, registrations, certificates, orders, approvals, authorizations, consents, waivers,
franchises, variances and similar rights issued by or obtained from any Governmental Authority or any other Person, including, without limitation, those relating to Environmental Laws, but excluding all Patents. 

“Permitted Subordinated Indebtedness” means Indebtedness incurred after the Closing Date by Holdings, the Borrower or the
other Guarantors that is (i) subordinated to the Obligations and all other Indebtedness owing from Holdings, the Borrower or the Subsidiaries to the Lender pursuant to a written subordination agreement satisfactory to the Lender in its sole
discretion and (ii) in an amount and on terms approved by the Lender in its sole discretion. 
 “Person” means any
natural person, corporation, limited liability company, partnership, joint venture, association, trust or unincorporated organization, Governmental Authority or any other legal entity, whether acting in an individual, fiduciary or other capacity.

 “Personal Property Securities Register” means the register established under section 147 of the PPSA. 

“PPS Law” means (i) the PPSA and any regulation made at any time under the PPSA, including the PPS Regulations (each as
amended from time to time), and (ii) any amendment made at any time to any other legislation as a consequence of a law or regulation referred to in paragraph (i). 

“PPS Regulations” means the Personal Property Securities Regulations 2010 (Cth). 

  
 -18- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “PPSA” means the Personal Property Securities Act 2009 (Cth). 

“Privacy Laws” means all applicable security and privacy standards regarding protected health information under (i) the
Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, including the regulations promulgated thereunder (collectively “HIPAA”) and
(ii) any applicable state privacy Laws. 
 “Product” means any current or future service or product researched,
designed, developed, manufactured, licensed, marketed, sold, performed, distributed or otherwise commercialized by the Borrower or any of its Affiliates, including the research, manufacture, and supply of syringes and other injection and drug
delivery devices, and any such product in development or which may be developed. 
 “Product Agreement” means each
agreement, license, document, instrument, interest (equity or otherwise) or the like under which any of Borrower or its Affiliates grants or receives any right, title or interest with respect to any Product Development and Commercialization
Activities in respect of one or more Products specified therein or to exclude third parties from engaging in, or otherwise restricting any right, title or interest as to any Product Development and Commercialization Activities with respect thereto,
including each contract or agreement with suppliers, manufacturers, pharmaceutical companies, distributors, clinical research organizations, hospitals, group purchasing organizations, wholesalers, pharmacies or any other Person related to any such
entity. 
 “Product Authorizations” means any and all approvals, licenses, notifications, registrations or authorizations
of any Governmental Authority necessary for the manufacture, development, distribution, use, storage, import, export, transport, promotion, marketing, sale or other commercialization of a Product in any country or jurisdiction, including without
limitation registration and listing, IDEs, Device Approval Applications and BLAs or similar applications. 
 “Product Development
and Commercialization Activities” means, with respect to any Product, any combination of research, development, manufacture, import, use, sale, importation, storage, labeling, marketing, promotion, supply, distribution, testing, packaging,
purchasing or other commercialization activities, receipt of payment in respect of any of the foregoing, or like activities the purpose of which is to commercially exploit such Product. 

“Purchase Money Indebtedness” means Indebtedness (1) consisting of the deferred purchase price for equipment used in the
manufacture of Products incurred in connection with the acquisition of such equipment, where the amount of such Indebtedness does not exceed the greater of (a) the cost of the equipment being financed and (b) the fair market value of such
equipment; and (2) incurred to finance such acquisition by Holdings, the Borrower or a Guarantor of such equipment. 

  
 -19- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “QSRs” is defined in Section 6.18(a)(ii). 

“Qualified Capital Securities” shall mean any Capital Securities that are not Disqualified Capital Securities. 

“Receiving Party” means the Party receiving Confidential Information. 

“Recipient” is defined in Section 10.17. 

“Regulatory Agencies” means any Governmental Authority that is concerned with the use, control, safety, efficacy,
reliability, manufacturing, marketing, distribution, sale or other Product Development and Commercialization Activities relating to any Product of Holdings, the Borrower or any of the Subsidiaries, including CMS, FDA, and all similar agencies in
other jurisdictions, and includes Standard Bodies. 
 “Regulatory Authorizations” means all approvals, clearances,
notifications, authorizations, orders, exemptions, registrations, certifications, licenses and permits granted by, submitted to or filed with any Regulatory Agencies, including all Product Authorizations. 

“Related Parties” means the partners, directors, officers, employees, agents, trustees, administrators, managers, advisors
and representatives of Holdings, the Borrower and the Subsidiaries. 
 “Release” means any releasing, disposing,
discharging, injecting, spilling, leaking, leaching, pumping, pouring, dumping, depositing, emitting, escaping, emptying, seeping, dispersal, migrating or placing, including movement through, into or upon the environment or any natural or man-made
structure. 
 “Repayment Premium” means a premium of 6.0% of the principal amount of any prepayment or repayment of the
Borrower on any Loan. 
 “Restricted Assignee” means (i) any Person who competes with Holdings, the Borrower or any
Subsidiary in the field of injectable drug delivery systems or any similar business, and (ii) any pharmaceutical company that is a customer of the Borrower or could reasonably be expected to become a customer of the Borrower. 

“Restricted Payment” means (i) the declaration or payment of any dividend on, or the making of any payment or
distribution on account of, or setting apart assets for a sinking or other analogous fund for the purchase, redemption, defeasance, retirement or other acquisition of, any class of Capital Securities of Holdings, the Borrower or any Subsidiary or
any warrants, options or other right or obligation to purchase or acquire any such Capital Securities, whether now or hereafter outstanding, or (ii) the making of any other distribution in respect of such Capital Securities, in each case either
directly or indirectly, whether in cash, property or obligations of Holdings, the Borrower or any Subsidiary or otherwise. 

  
 -20- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Revenue Base” means, with respect to any period, the Net Sales (as defined
in the Royalty Agreement) for such period. 
 “ROS” means Royalty Opportunities S.à r.l, a Luxembourg
société à responsabilité limitée. 
 “Royalty Agreement” means the Royalty Agreement,
dated as of the date hereof, among the Borrower and ROS. 
 “S&P” means Standard & Poor’s Rating
Services, a division of The McGraw-Hill Companies, Inc. 
 “Sanctions” means any international economic sanction
administered or enforced by the United States Government (including, without limitation, OFAC), the United Nations Security Council, the European Union, Her Majesty’s Treasury or other relevant sanctions authority. 

“Sanofi Agreements” means each contract or agreement to which Holdings, the Borrower or any Subsidiary, on the one hand, and
Sanofi Winthrop Industrie or any of its Affiliates, on the other hand, is a party, including the Sanofi Supply Agreement. 
 “Sanofi
Supply Agreement” means that certain Supply Agreement, dated September 3, 2013, between the Borrower and Sanofi Winthrop Industrie. 

“SEC” means the Securities and Exchange Commission. 

“Security Agreement” means the Pledge and Security Agreement executed and delivered by each of the parties thereto,
substantially in the form of Exhibit E hereto, as amended, supplemented, amended and restated or otherwise modified from time to time. 

“Solvent” means: 

(a) with respect to any Person (other than an Australian Subsidiary) on a particular date, that on such date (i) the fair
value of the property of such Person is greater than the total amount of liabilities, including contingent liabilities, of such Person, (ii) the present fair saleable value of the assets of such Person is not less than the amount that will be
required to pay the probable liability of such Person on its debts as they become absolute and matured, (iii) such Person does not intend to, and does not believe that it will, incur debts or liabilities beyond its ability to pay as such debts
and liabilities mature, (iv) such Person is not engaged in a business or a transaction, and is not about to engage in a business or a transaction, for which the property of such Person would constitute an unreasonably small capital and
(v) such Person has not executed this Agreement or any other Loan Document, or made any transfer or incurred any obligations hereunder or thereunder, with actual intent to hinder, delay or defraud either present or future creditors. The amount
of contingent liabilities at any time shall be computed as the amount that, in light of all the facts and circumstances existing at such time, can reasonably be expected to become an actual or matured liability; or 

  
 -21- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) with respect to any Australian Subsidiary on a particular date, that on
such date such Person is solvent in accordance with section 95A of the Corporations Act and there are no grounds for suspecting that it will not continue to be able to pay all of its debts as and when they become due and payable immediately after
entering into the Loan Documents (and after incurring any other liability which it proposes to incur around the time it enters into them). 

“Standard Bodies” means any of the organizations that create, sponsor or maintain safety, quality or other standards,
including ISO, ANSI, CEN and SCC and the like. 
 “Subsidiary” means, (i) with respect to any Person, any other Person
of which more than 50% of the outstanding Voting Securities of such other Person (irrespective of whether at the time Capital Securities of any other class or classes of such other Person shall or might have voting power upon the occurrence of any
contingency) is at the time directly or indirectly owned or controlled by such Person, by such Person and one or more other Subsidiaries of such Person, or by one or more other Subsidiaries of such Person, and (ii) in addition and without
limiting (i), with respect to any Person incorporated in Australia, a subsidiary as defined in section 46 of the Corporations Act. Unless the context otherwise specifically requires, the term “Subsidiary” shall be a reference to a
Subsidiary of Holdings (other than the Borrower). 
 “Subsequent Agreement” means an agreement (or set of related
agreements) with a pharmaceutical or biotechnology company customer of the Borrower entered into after the date hereof by the Borrower that is designated in writing by the Lender as the “Subsequent Agreement” in its sole discretion. 

“Synthetic Lease” means, as applied to any Person, any lease (including leases that may be terminated by the lessee at any
time) of any property (whether real, personal or mixed) (i) that is not a capital lease in accordance with GAAP and (ii) in respect of which the lessee retains or obtains ownership of the property so leased for federal income tax purposes,
other than any such lease under which that Person is the lessor. 
 “Taxes” means all income, stamp, goods and services tax
or other taxes, duties, levies, imposts, charges, assessments, fees, deductions or withholdings, now or hereafter imposed, levied, collected, withheld or assessed by any Governmental Authority, and all interest, penalties or similar liabilities with
respect thereto. 
 “Tax Consolidated Group” means a ‘consolidated group’ or ‘MEC group’ (as defined in
the Income Tax Assessment Act 1936 (Cth) or the Income Tax Assessment Act 1997 (Cth) (as applicable)) of which a Credit Obligor is or becomes a member. 

  
 -22- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Termination Date” means the date on which all Obligations have been paid in
full in cash and the Commitment shall have terminated. 
 “Third Party” means any Person other than Holdings, the Borrower
or any of the Subsidiaries. 
 “Title Documents” means each certificate, confirmation, grant, assurance, conveyance, deed
and other document of title or evidencing title to, or rights to acquire, possess, use or dispose of, any collateral. 

“Trademark” means any trademark, service mark, trade name, logo, symbol, trade dress, domain name, corporate name or other
indicator of source or origin, and all applications and registrations therefor, together with all of the goodwill associated therewith. 

“Trademark Security Agreement” means any Trademark Security Agreement executed and delivered by Holdings, the Borrower or any
of the Subsidiaries substantially in the form of Exhibit B to the Security Agreement, as amended, supplemented, amended and restated or otherwise modified from time to time. 

“UCC” means the Uniform Commercial Code as in effect from time to time in the State of New York; provided that if,
with respect to any financing statement or by reason of any provisions of law, the perfection or the effect of perfection or non-perfection of the security interests granted to the Lender pursuant to the applicable Loan Document is governed by the
Uniform Commercial Code as in effect in a jurisdiction of the United States other than New York, then “UCC” means the Uniform Commercial Code as in effect from time to time in such other jurisdiction for purposes of the provisions of each
Loan Document and any financing statement relating to such perfection or effect of perfection or non-perfection. 
 “Unilife
France” means Unilife Medical Solutions France, an indirect Subsidiary of Holdings. 
 “United States” or
“U.S.” means the United States of America, its fifty states and the District of Columbia. 
 “U.S. Person”
means any Person that is a “United States Person” as defined in Section 7701(a)(30) of the Code. 
 “U.S.
Obligor” means any Credit Obligor that is organized in a state of the United States or in the District of Columbia. 

“U.S. Subsidiary” means any Subsidiary incorporated or organized under the laws of a state of the United States or in the
District of Columbia. 

  
 -23- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Voting Securities” means, with respect to any Person, Capital Securities of
any class or kind ordinarily having the power to vote for the election of directors, managers or other voting members of the governing body of such Person. 

“wholly owned Subsidiary” means any direct or indirect Subsidiaries of Holdings or the Borrower, all of the outstanding
Capital Securities of which (other than any director’s qualifying shares or investments by foreign nationals mandated by applicable laws) is owned directly or indirectly by Holdings. 

SECTION 1.2 Use of Defined Terms. Unless otherwise defined or the context otherwise requires, terms for which meanings are
provided in this Agreement shall have such meanings when used in each other Loan Document and the schedules attached hereto. 

SECTION 1.3 Cross-References. Unless otherwise specified, references in a Loan Document to any clause, Article or Section are
references to such clause, Article or Section of such Loan Document, and references in any Article, Section or definition to any clause are references to such clause of such Article, Section or definition. 

SECTION 1.4 Accounting and Financial Determinations. Unless otherwise specified, all accounting terms used in each Loan Document
shall be interpreted, and all accounting determinations and computations thereunder (including under Section 8.4 and the definitions used in such calculations) shall be made, in accordance with GAAP, as in effect from time to time;
provided that if either the Borrower or the Lender requests an amendment to any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or the application thereof on the operation of such provision,
regardless of whether any such notice is given before or after such change in GAAP or the application thereof, then such provision shall be interpreted on the basis of GAAP in effect and applied immediately before such change shall have become
effective until such request shall have been withdrawn or such provision amended in accordance herewith. Unless otherwise expressly provided, all financial covenants and defined financial terms shall be computed on a consolidated basis for Holdings,
the Borrower and the Subsidiaries, in each case without duplication. 
 SECTION 1.5 Interpretation. The parties have
participated jointly in the negotiation and drafting of the Loan Documents. In the event an ambiguity or question of intent or interpretation arises, the Loan Documents shall be construed as if drafted jointly by the parties and no presumption or
burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement. Except as otherwise expressly provided, the following rules of interpretation shall apply to the Loan Documents:
(a) the definitions of terms shall apply equally to the singular and plural forms of the terms defined; (b) wherever the context may require, any pronoun shall include the corresponding masculine, feminine, and neuter forms;
(c) “including” and “include” means including without limiting the generality of any description preceding such term, and, for purposes of each Loan Document, the parties hereto agree that the rule of ejusdem generis shall
not be applicable to limit a general statement, 

  
 -24- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
which is followed by or referable to an enumeration of specific matters, to matters similar to the matters specifically mentioned; (d) the word “will” shall be construed to have
the same meaning and effect as the word “shall”; (e) unless the context requires otherwise, any definition of or reference to any agreement, instrument, or other document herein shall be construed as referring to such agreement,
instrument, or other document as from time to time amended, restated, supplemented, or otherwise modified (subject to any restrictions on such amendments, supplements, or modifications set forth herein or therein) and shall include any appendices,
schedules, exhibits, clarification letters, side letters, and disclosure letters executed in connection therewith; (f) any reference to any Person shall be construed to include such Person’s successors and assigns to the extent permitted
under the applicable documentation; (g) any reference to any applicable law shall be construed as referring to such applicable law as amended from time to time; (h) “herein”, “hereof”, “hereto”,
“hereunder” and similar terms contained in any Loan Document refer to such Loan Document as a whole and not to any particular Section, paragraph or provision of such Loan Document; and (i) the words “asset” and
“property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts, and contract rights. 

SECTION 1.6 Conversion of Currencies. 

(a) If, for the purpose of obtaining judgment in any court, it is necessary to convert a sum owing hereunder from one currency
into another currency, each party hereto agrees, to the fullest extent that it may effectively do so, that the rate of exchange used shall be that at which in accordance with normal banking procedures in the relevant jurisdiction the first currency
could be purchased with such other currency on the Business Day immediately preceding the day on which final judgment is given. 

(b) The obligations of any Credit Obligor in respect of any sum due to any party hereto or any holder of the Obligations owing
hereunder or under the other Loan Documents (the “Applicable Creditor”) shall, notwithstanding any judgment or determination in a currency (the “Judgment Currency”) other than the currency in which such sum is
stated to be due hereunder (the “Agreement Currency”), be discharged only to the extent that, on the Business Day following receipt by the Applicable Creditor of any sum adjudged to be so due in the Judgment Currency, the Applicable
Creditor may in accordance with normal banking procedures in the relevant jurisdiction purchase the Agreement Currency with the Judgment Currency; if the amount of the Agreement Currency so purchased is less than the sum originally due to the
Applicable Creditor in the Agreement Currency, each Credit Obligor agrees, as a separate obligation and notwithstanding any such judgment, to indemnify the Applicable Creditor against such loss. The obligations of the Credit Obligors contained
in this Section 1.6(b) shall survive the termination of this Agreement and the payment of the Obligations. 

  
 -25- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE II 

COMMITMENT AND BORROWING PROCEDURES 

SECTION 2.1 Commitment. On the terms and subject to the conditions of this Agreement, the Lender agrees to make a term loan (the
“Initial Loan”) to the Borrower on the Closing Date in an amount equal to (but not less than) the Initial Commitment Amount. On the terms and subject to the conditions of this Agreement, the Lender agrees to make term loans (each, a
“Delayed Draw Loan”) to the Borrower on each Delayed Draw Closing Date in an amount equal to $10,000,000 (so that the aggregate amount of all such Delayed Draw Loans shall not exceed the Delayed Draw Commitment Amount). No amounts
paid or prepaid with respect to the Loans may be reborrowed. 
 SECTION 2.2 Borrowing Procedure. The Borrower shall irrevocably
request that the Initial Loan be made by delivering to the Lender a Loan Request prior to the proposed Closing Date. The Borrower shall irrevocably request that a Delayed Draw Loan be made by delivering to the Lender a Loan Request on or before
10:00 a.m. on a Business Day that is five Business Days prior to each Delayed Draw Closing Date. 
 SECTION 2.3 Funding.
After receipt of the Loan Request for the Initial Loan, the Lender shall, on the Closing Date and subject to the terms and conditions hereof, make the requested proceeds of the Initial Loan available to the Borrower by wire transfer to the account
the Borrower shall have specified in its Loan Request. The Lender shall, on each Delayed Draw Closing Date and subject to the terms and conditions hereof, make the Delayed Draw Loan in the amount equal to $10,000,000 available to the Borrower by
wire transfer to the account the Borrower shall have specified in its Loan Request. 
 SECTION 2.4 Reduction of the Commitment
Amounts. The Initial Commitment Amount shall automatically and permanently be reduced to zero on the Closing Date. The Delayed Draw Commitment Amount shall automatically and permanently be reduced (i) to $10,000,000 at the close of business
on December 15, 2014 and (ii) to zero at the close of business on June 15, 2015. 
 ARTICLE III 

REPAYMENTS, PREPAYMENTS, INTEREST AND FEES 

SECTION 3.1 Repayments and Prepayments; Application. The Borrower agrees that the Loans, and any fees or interest accrued or
accruing thereon, shall be repaid and prepaid solely in U.S. dollars pursuant to the terms of this Article III. 
 SECTION 3.2
Repayments and Prepayments. The Borrower shall repay in full the unpaid principal amount of the Loans (together with the Repayment Premium) on the Maturity Date. Prior thereto, payments and prepayments of the Loans shall be made as set forth
below. 
 (a) The Borrower shall have the right, with at least three Business Days’ written notice to the Lender, at any
time and from time to time to prepay any unpaid principal amount of the Loans, in whole or in part. 

  
 -26- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) Within five Business Days of receipt by Holdings, the Borrower, or any
Subsidiary of any (i) Net Casualty Proceeds or (ii) Net Asset Sales Proceeds, the Borrower shall notify the Lender thereof. If requested by the Lender, the Borrower shall within five Business Days of such request make a mandatory
prepayment of the Loans, in an amount equal to 100% of such proceeds (or such lesser amount as the Lender may specify on the date of such request), to be applied to the outstanding principal amount of the Loans and the Borrower shall concurrently
pay the accrued and unpaid interest on such amount; provided, however, that no such payment shall be required on account of Net Casualty Proceeds that are intended to be reinvested in the ordinary course of the Credit Obligors’
business within 180 days in replacement equipment or real property used or useful in their business, so long as such proceeds are held in a deposit account subject to a perfected security interest of Lender; provided, further, that if
such Net Casualty Proceeds have not in fact been so re-invested at the expiration of such 180 day period than any such Net Casualty Proceeds shall be paid to Lender as provided herein at such time. 

(c) The Borrower shall repay the Loans in full immediately upon any acceleration of the Maturity Date thereof pursuant to
Section 9.2 or Section 9.3, unless, pursuant to Section 9.3, only a portion of the Loans is so accelerated (in which case the portion so accelerated shall be so repaid). 

(d) Amounts repaid or prepaid in respect of the outstanding principal amount of the Loans shall be applied pro rata to the
Initial Loan and each Delayed Draw Loan. 
 SECTION 3.3 Interest Rate. During any applicable Interest Period, the outstanding
balance on the Loans shall accrue interest during such Interest Period at a rate per annum equal to the sum of (i) the Applicable Margin plus (ii) the higher of (x) the LIBO Rate for such Interest Period and (y) 1.00%. The
interest rate shall be recalculated and, if necessary, adjusted for each Interest Period, in each case pursuant to the terms hereof. 

SECTION 3.4 Default Rate. At all times commencing upon the date any Event of Default occurs, and continuing until such Event of
Default is no longer continuing, the Applicable Margin shall be increased by 5% per annum. 
 SECTION 3.5 Payment Dates.
Interest accrued on the Loans shall be payable in cash, without duplication: 
 (a) on the Maturity Date therefor; 

  
 -27- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) on the date of any payment or prepayment, in whole or in part, of
principal outstanding on such Loan on the principal amount so paid or prepaid; 
 (c) on the last day of each Fiscal Quarter;
provided that if such day is not a Business Day, then such payment shall be made on the next succeeding Business Day; and 

(d) on that portion of the Loans that is accelerated pursuant to Section 9.2 or Section 9.3,
immediately upon such acceleration. 
 Interest accrued on the Loans or other monetary Obligations after the date such amount is due and payable (whether on
the Maturity Date, upon acceleration or otherwise) shall be payable upon demand. 
 SECTION 3.6 Repayment Premium. Any repayment
or prepayment of any principal of the Loans shall be accompanied by the Repayment Premium (including any repayment of the Loans on the Maturity Date or upon any acceleration thereof pursuant to Article IX, except to the extent such prepayment
is required pursuant to Section 3.2(b)(i). 
 ARTICLE IV 

LIBO RATE AND OTHER PROVISIONS 

SECTION 4.1 Increased Costs, Etc. The Borrower agrees to reimburse the Lender for any increase in the cost to the Lender of, or
any reduction in the amount of any sum receivable by the Lender in respect of, the Lender’s Commitment and the making, continuation or maintaining of the Loans hereunder that may arise in connection with any Change in Law, except for such
changes with respect to increased capital costs and Taxes which are governed by Section 4.2 and Section 4.3, respectively. The Lender shall notify the Borrower in writing of the occurrence of any such event, stating the
reasons therefor and the additional amount required fully to compensate the Lender for such increased cost or reduced amount. Such additional amounts shall be payable by the Borrower directly to the Lender within five days of its receipt of such
notice, and such notice shall, in the absence of manifest error, be conclusive and binding on the Borrower; provided that the Borrower shall not be required to compensate Lender pursuant to this Section 4.1 for any increased costs
incurred or reductions suffered more than six months prior to the date that Lender notifies the Borrower of the Change in Law giving rise to such increased costs or reductions and of Lender’s intention to claim compensation therefor;
provided further that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the six-month period referred to above shall be extended to include the period of retroactive effect thereof. 

SECTION 4.2 Increased Capital Costs. If any Change in Law affects or would affect the amount of capital required or expected to be
maintained by the Lender or any Person controlling the Lender, and the Lender determines (in good faith but in its sole and absolute discretion) that 

  
 -28- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
the rate of return on its or such controlling Person’s capital as a consequence of the Commitment or the Loans made by it hereunder is reduced to a level below that which the Lender or such
controlling Person could have achieved but for the occurrence of any such circumstance, then upon notice from time to time by the Lender to the Borrower, the Borrower shall within five days following receipt of such notice pay directly to the Lender
additional amounts sufficient to compensate the Lender or such controlling Person for such reduction in rate of return; provided that the Borrower shall not be required to compensate Lender pursuant to this Section 4.2 for any reductions
suffered more than six months prior to the date that Lender notifies the Borrower of the Change in Law giving rise to such reduction and of Lender’s intention to claim compensation therefor; provided further that, if the Change in
Law giving rise to such reduction is retroactive, then the six-month period referred to above shall be extended to include the period of retroactive effect thereof. A statement of the Lender as to any such additional amount or amounts shall, in the
absence of manifest error, be conclusive and binding on the Borrower. In determining such amount, the Lender may use any method of averaging and attribution that it (in its sole and absolute discretion) shall deem applicable. 

SECTION 4.3 Taxes. The Borrower covenants and agrees as follows with respect to Taxes. 

(a) Any and all payments by the Borrower or any Guarantor under each Loan Document shall be made without setoff, counterclaim
or other defense, and free and clear of, and without deduction or withholding for or on account of, any Taxes. In the event that any Taxes are imposed and required to be deducted or withheld from any payment required to be made by the Borrower or
any Guarantor to or on behalf of the Lender under any Loan Document, then: 
 (i) if such Taxes are Non-Excluded Taxes, the
amount of such payment shall be increased as may be necessary so that such payment is made, after withholding or deduction for or on account of such Taxes, in an amount that is not less than the amount provided for in such Loan Document; and 

(ii) the Borrower or such Guarantor shall withhold the full amount of such Taxes from such payment (as increased pursuant to
clause (a)(i)) and shall pay such amount to the Governmental Authority imposing such Taxes in accordance with applicable law. 

(b) In addition, the Borrower shall pay all Other Taxes imposed to the relevant Governmental Authority imposing such Other
Taxes in accordance with applicable law. 
 (c) As promptly as practicable after the payment of any Taxes or Other Taxes, and
in any event within 45 days of any such payment being due, the Borrower shall furnish to the Lender a copy of an official receipt (or a certified copy thereof) evidencing the payment of such Taxes or Other Taxes. 

  
 -29- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) The Borrower shall indemnify the Lender for any Non-Excluded Taxes and
Other Taxes levied, imposed or assessed on (and whether or not paid directly by) the Lender whether or not such Non-Excluded Taxes or Other Taxes are correctly or legally asserted by the relevant Governmental Authority. Promptly upon having
knowledge that any such Non-Excluded Taxes or Other Taxes have been levied, imposed or assessed, and promptly upon notice thereof by the Lender, the Borrower shall pay such Non-Excluded Taxes or Other Taxes directly to the relevant Governmental
Authority (provided that the Lender shall not be under any obligation to provide any such notice to the Borrower). In addition, the Borrower shall indemnify the Lender for any incremental Taxes that may become payable by the Lender as a
result of any failure of the Borrower to pay any Taxes when due to the appropriate Governmental Authority or to deliver to the Lender, pursuant to clause (c), documentation evidencing the payment of Non-Excluded Taxes or Other Taxes. Such
indemnification shall be made within 30 days after the date the Lender makes written demand therefor and for the full USD value of such indemnified amounts (regardless of the currency used to levy and pay such Taxes). For the avoidance of doubt, the
indemnity to be provided by the Borrower shall ensure that the Lender receives an amount that is at least equal to the USD amounts payable under each Loan Document without any deduction (including for Non-Excluded Taxes and Other Taxes, but
excluding Excluded Taxes). The Borrower acknowledges that any payment made to the Lender or to any Governmental Authority in respect of the indemnification obligations of the Borrower provided in this clause shall constitute a payment in respect of
which the provisions of clause (a) and this clause shall apply. 
 (e) If the Lender is entitled to an exemption
from or reduction of withholding Tax with respect to payments made under any Loan Document shall deliver to the Borrower, at the time or times reasonably requested by the Borrower, such properly completed and executed documentation reasonably
requested by the Borrower as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, the Lender, if reasonably requested by the Borrower, shall deliver such other documentation prescribed by
applicable law or reasonably requested by the Borrower as will enable the Borrower to determine whether or not the Lender is subject to backup withholding or information reporting requirements. 

Without limiting the generality of the foregoing: 

(i) If the Lender is a U.S. Person it shall deliver to the Borrower on or prior to the date on which the Lender becomes a
Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower), executed originals of IRS Form W-9 certifying that the Lender is exempt from U.S. federal backup withholding tax; 

  
 -30- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (ii) If the Lender is not a U.S. Person it shall, to the extent it is legally
entitled to do so, deliver to the Borrower (in such number of copies as shall be requested by the Borrower) on or prior to the date on which the Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable
request of the Borrower), whichever of the following is applicable: 
 (1) in the case of a Lender claiming the benefits of an income tax
treaty to which the United States is a party (x) with respect to payments of interest under any Loan Document, executed originals of IRS Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the
“interest” article of such tax treaty and (y) with respect to any other applicable payments under any Loan Document, IRS Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the
“business profits” or “other income” article of such tax treaty; 
 (2) executed originals of IRS Form W-8ECI; 

(3) in the case of a Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Code, (x) a
certificate to the effect that such Lender is not a “bank” within the meaning of Section 881(c)(3)(A) of the Code, a “10 percent shareholder” of the Borrower within the meaning of Section 881(c)(3)(B) of the Code, or a
“controlled foreign corporation” described in Section 881(c)(3)(C) of the Code (a “U.S. Tax Compliance Certificate”) and (y) executed originals of IRS Form W-8BEN; or 

(4) to the extent a Lender is not the beneficial owner, executed originals of IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form
W-8BEN, a U.S. Tax Compliance Certificate, IRS Form W-9, and/or other certification documents from each beneficial owner, as applicable; provided that if the Lender is a partnership and one or more direct or indirect partners of such Foreign Lender
are claiming the portfolio interest exemption, such Foreign Lender may provide a U.S. Tax Compliance Certificate on behalf of each such direct and indirect partner; 

(iii) If the Lender is not a U.S. Person it shall, to the extent it is legally entitled to do so, deliver to the Borrower (in
such number of copies as shall be requested by the Borrower) on or prior to the date on which the Lender becomes a Lender under this Agreement (and from time to time thereafter upon the 

  
 -31- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
reasonable request of the Borrower), executed originals of any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly
completed, together with such supplementary documentation as may be prescribed by applicable law to permit the Borrower to determine the withholding or deduction required to be made; and 

(iv) If a payment made to the Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA
if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower at the time or times
prescribed by law and at such time or times reasonably requested by the Borrower such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably
requested by the Borrower as may be necessary for the Borrower to comply with their obligations under FATCA and to determine that the Lender has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and
withhold from such payment. Solely for purposes of this clause (iv), “FATCA” shall include any amendments made to FATCA after the date of this Agreement. 

(v) Each Lender agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in
any respect, it shall update such form or certification or promptly notify the Borrower in writing of its legal inability to do so. 

(f) If Lender determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to
which it has been indemnified pursuant to this Section 4.3 (including by the payment of additional amounts pursuant to Section 4.3(a)(1), it shall pay to the Borrower an amount equal to such refund (but only to the extent of indemnity
payments made under this Section with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of Lender and without interest (other than any interest paid by the relevant taxation authority with respect
to such refund). The Borrower, upon the request of Lender, shall repay to Lender the amount paid over pursuant to this Section 4.3(e) (plus any penalties, interest or other charges imposed by the relevant taxation authority) in the event that
Bank is required to repay such refund to such taxation authority. Notwithstanding anything to the contrary in this Section 4.3(e), in no event will Lender be required to pay any amount to the Borrower pursuant to this Section 4.3(e) the
payment of which would place Lender in a less favorable net after-Tax position than Lender would have been if the Tax subject to indemnification had not been deducted, withheld or otherwise imposed and the indemnification payments or additional
amounts giving rise to such refund had never been paid. This paragraph shall not be construed to require Lender to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the Borrower or any
other Person. 

  
 -32- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (g) Each party’s obligations under this Section 4.3 shall survive
any assignment of rights by, or the replacement of the Lender, termination of this Agreement and the payment in full of the Obligations. 

(h) For the purposes of this Section 4.3 the term “applicable law” includes FATCA. 

SECTION 4.4 Payments, Computations; Proceeds of Collateral, Etc. 

(a) Unless otherwise expressly provided in a Loan Document, all payments by the Borrower pursuant to each Loan Document shall
be made without setoff, deduction or counterclaim not later than 11:00 a.m. on the date due in same day or immediately available funds to such account as the Lender shall specify from time to time by notice to the Borrower. Funds received after
11:00 a.m. on any day shall be deemed to have been received by the Lender on the next succeeding Business Day. All interest and fees shall be computed on the basis of the actual number of days (including the first day but excluding the last day)
occurring during the period for which such interest or fee is payable over a year comprised of 360 days. Payments due on other than a Business Day shall be made on the next succeeding Business Day and such extension of time shall be included in
computing interest and fees in connection with that payment. 
 (b) All amounts received as a result of the exercise of
remedies under the Loan Documents (including from the proceeds of collateral securing the Obligations) or under applicable law shall be applied upon receipt to the Obligations as follows: (i) first, to the payment in full in cash of all
interest (including interest accruing after the commencement of a proceeding in bankruptcy, insolvency or similar law, whether or not permitted as a claim under such law) and fees owing under the Loan Documents, and all costs and expenses owing to
the Lender pursuant to the terms of the Loan Documents, until paid in full in cash, (ii) second, after payment in full in cash of the amounts specified in clause (b)(i), to the payment of the principal amount of the Loans then
outstanding, (iii) third, after payment in full in cash of the amounts specified in clauses (b)(i) and (b)(ii), to the payment of all other Obligations owing to the Lender, and (iv) fourth, after payment in full in cash of
the amounts specified in clauses (b)(i) through (b)(iii), and following the Termination Date, to the Borrower or any other Person lawfully entitled to receive such surplus. 

SECTION 4.5 Setoff. The Lender shall, upon the occurrence and during the continuance of any Default described in
clauses (i) through (iv) of Section 9.1(i) or Section 9.1(j) or, upon the occurrence and during the continuance of any other Event of Default, have the right to appropriate and apply to the
payment of the Obligations owing to it (whether or not then due), 

  
 -33- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
and (as security for such Obligations) the Borrower hereby grants to the Lender a continuing security interest in, any and all balances, credits, deposits, accounts or moneys of the Borrower then
or thereafter maintained with or on behalf of the Lender. The Lender agrees promptly to notify the Borrower after any such appropriation and application made by the Lender; provided that the failure to give such notice shall not affect the
validity of such setoff and application. The rights of the Lender under this Section are in addition to other rights and remedies (including other rights of setoff under applicable law or otherwise) which the Lender may have. 

SECTION 4.6 LIBO Rate Not Determinable. If prior to the commencement of any Interest Period, adequate and reasonable means do not
exist for ascertaining the LIBO Rate for such Interest Period, then the Lender shall give notice thereof to the Borrower as promptly as practicable. In the event of any such determination, the Loans shall, until the Lender has advised the Borrower
that the circumstances giving rise to such notice no longer exist, bear interest at the interest rate in effect for the immediately preceding Interest Period. 

ARTICLE V 
 CONDITIONS TO MAKING
THE LOANS 
 SECTION 5.1 Credit Extensions. The obligation of the Lender to make the Initial Loan shall be subject to the
execution and delivery of this Agreement by the parties hereto, the delivery of a Loan Request as requested pursuant to Section 2.3, and the satisfaction of each of the conditions precedent set forth below in this Article V (other than
Sections 5.25, 5.26, 5.27, 5.28 and 5.29). The obligation of the Lender to make each Delayed Draw Loan shall be subject to the prior making of the Initial Loan and the satisfaction (or waiver in writing by the
Lender) of each of the conditions precedent set forth below in Sections 5.4, 5.9 and 5.25. 
 SECTION 5.2
Secretary’s Certificate, Etc. The Lender shall have received: (a) from each U.S. Obligor, a copy of a good standing certificate, dated a date reasonably close to the Closing Date from its jurisdiction of formation, for each
such Person and (b) from each Credit Obligor party to a Loan Document, a certificate, dated as of the Closing Date, duly executed and delivered by such Person’s Director, Secretary or Assistant Secretary, managing member or general
partner, as applicable, as to (in its capacity as director or officer): 
 (a) resolutions of each such Person’s Board
of Directors (or other managing body, in the case of other than a corporation) then in full force and effect authorizing the execution, delivery and performance of each Loan Document to be executed by such Person and the transactions contemplated
hereby and thereby; 
 (b) the incumbency and signatures of those of its officers, managing member or general partner, as
applicable, authorized to act with respect to each Loan Document to be executed by such Person; and 
 (c) the full force and
validity of each Organic Document of such Person and copies thereof; 

  
 -34- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 upon which certificates the Lender may conclusively rely until it shall have received a further certificate
of the Director, Secretary, Assistant Secretary, managing member or general partner, as applicable, of any such Person canceling or amending the prior certificate of such Person. 

SECTION 5.3 Australian Requirements. The Lender shall have received a verification certificate for each of Unilife Medical
Solutions Pty Limited and Unitract Syringe Pty Ltd in form and substance satisfactory to the Lender properly completed and with all required attachments, duly signed by a director (in his or her capacity as director) and dated no earlier than
two Business Days before the Closing Date. 
 SECTION 5.4 Closing Certificate. The Lender shall have received a Closing
Certificate, dated as of the Closing Date or Delayed Draw Closing Date, as the case may be, and duly executed and delivered by an Authorized Officer of the Borrower, in which certificate the Borrower shall agree and acknowledge that the statements
made therein shall be deemed to be true and correct representations and warranties of the Borrower as of such date, and, at the time such certificate is delivered, such statements shall in fact be true and correct, and such statements shall include
that (i) the representations and warranties set forth in each Loan Document shall, in each case, be true and correct in all respects (in the case of any representation or warranty qualified by materiality or Material Adverse Effect) or in all
material respects (in the case of any representation or warranty not qualified by materiality or Material Adverse Effect), before and after giving effect to the making of the Initial Loan and to the application of the proceeds thereof, as though
made on and as of the date hereof, (ii) no Default shall have then occurred and be continuing, or would result from the Loan to be advanced on the Closing Date or Delayed Draw Closing Date, as the case may be, and (c) all of the conditions
set forth in this Article V have been satisfied. All documents and agreements required to be appended to the Closing Certificate, if any, shall be in form and substance reasonably satisfactory to the Lender, shall have been executed and
delivered by the requisite parties, and shall be in full force and effect. 
 SECTION 5.5 Payment of Outstanding Indebtedness,
Etc. All Indebtedness identified in Schedule 8.2(b), together with all interest, all prepayment premiums and all other amounts due and payable with respect thereto, shall have been paid in full from the proceeds of the Initial Loan and the
commitments in respect of such Indebtedness shall have been terminated, and all Liens securing payment of any such Indebtedness shall have been released and the Lender shall have received all Uniform Commercial Code Form UCC-3 termination statements
or other instruments (including customary payoff letters) as may be suitable or appropriate in connection therewith. 
 SECTION 5.6
Delivery of Note. The Lender shall have received a Note duly executed and delivered by an Authorized Officer of the Borrower. 

  
 -35- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 5.7 Financial Information, Etc. The Lender shall have received 

(a) audited consolidated financial statements of Holdings, the Borrower and the Subsidiaries for each of the fiscal years ended
June 30, 2011, June 30, 2012 and June 30, 2013. 
 (b) unaudited consolidated balance sheets of Holdings,
the Borrower and the Subsidiaries for each fiscal quarter ended after June 30, 2013, together with the related consolidated statement of operations, shareholder’s equity and cash flows for such quarter and fiscal year to date; and 

(c) such other financial information as to Holdings, the Borrower and the Subsidiaries and their respective businesses, assets
and liabilities as the Lender may reasonably request. 
 SECTION 5.8 Compliance Certificate. The Lender shall have received an
initial Compliance Certificate on a pro forma basis as if the Initial Loan had been made as of December 31, 2013, and as to such items therein as the Lender reasonably requests, dated the Closing Date, duly executed (and with all schedules
thereto duly completed) and delivered by the chief financial or accounting Authorized Officer of the Borrower. 
 SECTION 5.9
Solvency, Etc. The Lender shall have received a solvency certificate duly executed and delivered by the chief financial or accounting Authorized Officer of Holdings. the Borrower and each Subsidiary, dated as of the Closing Date or Delayed
Draw Closing Date, as the case may be, in form and substance satisfactory to the Lender. 
 SECTION 5.10 Guarantee. The Lender
shall have received executed counterparts of the Guarantee, dated as of the date hereof, duly executed and delivered by Holdings and each Australian Subsidiary and each U.S. Subsidiary. 

SECTION 5.11 Security Agreement. The Lender shall have received executed counterparts of the Security Agreement, dated as of the
date hereof, duly executed and delivered by Holdings, the Borrower and each relevant Subsidiary, together with: 
 (a)
certificates (in the case of Capital Securities that are securities (as defined in the UCC)) evidencing all of the issued and outstanding Capital Securities owned by Holdings, the Borrower or any Subsidiary in the Borrower and the Subsidiaries,
which certificates in each case shall be accompanied by undated instruments of transfer duly executed in blank, or, in the case of Capital Securities that are uncertificated securities (as defined in the UCC), confirmation and evidence satisfactory
to the Lender that the security interest therein has been transferred to and perfected by the Lender in accordance with Articles 8 and 9 of the UCC and all laws otherwise applicable to the perfection of the pledge of such Capital Securities; 

  
 -36- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) financing statements suitable in form for naming each U.S. Obligor and
each Australian Subsidiary as a debtor and the Lender as the secured party, or other similar instruments or documents to be filed under the UCC of all jurisdictions as may be necessary or, in the opinion of the Lender, desirable to perfect the
security interests of the Lender pursuant to the Security Agreement; 
 (c) UCC Form UCC-3 termination statements necessary
to release all Liens and other rights of any Person (i) in any assets of Holdings, the Borrower or any Subsidiary, and (ii) securing any of the Indebtedness identified in Schedule 8.2(b), in each case, other than the Liens described
in Section 8.3(c), together with such other UCC Form UCC-3 termination statements as the Lender may reasonably request from Holdings, the Borrower or any Subsidiary; 

(d) bailee letters in form and substance reasonably satisfactory to the Lender from Nypro (two locations) and the bailee with
respect to the 255 Marianne Drive, York, PA location; and 
 (e) evidence that all deposit accounts, lockboxes, disbursement
accounts, investment accounts or other similar accounts of Holdings, the Borrower and each Subsidiary (other than Excluded Accounts) are Controlled Accounts. 

SECTION 5.12 Intellectual Property Security Agreements. The Lender shall have received a Patent Security Agreement, a Copyright
Security Agreement and a Trademark Security Agreement, as applicable, each dated as of the Closing Date, duly executed and delivered by Holdings, the Borrower or any Subsidiary that, pursuant to the Security Agreement, is required to provide such
intellectual property security agreements to the Lender. 
 SECTION 5.13 Royalty Agreement. The Lender shall have received an
executed counterpart of the Royalty Agreement, dated as of the date hereof, executed and delivered by an Authorized Officer of the Borrower. 

SECTION 5.14 Australian Security Documents. The Lender shall have received executed counterparts of the General Security Deed,
dated as of the date hereof, duly executed and delivered by Holdings and each Australian Subsidiary, together with: 
 (a)
each Title Document in respect of the collateral. This includes original share certificates for all the issued share capital of Unilife Medical Solutions Pty Limited and Unitract Syringe Pty Ltd, together with executed undated blank transfer forms
for all shares; 
 (b) a certified copy of the share register maintained by each of Unilife Medical Solutions Pty Limited and
Unitract Syringe Pty Ltd in respect of all shares issued by it; and 

  
 -37- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (c) satisfactory results of all searches, enquires and requisitions on behalf
of the Lender with respect to Holdings, Unilife Medical Solutions Pty Limited and Unitract Syringe Pty Ltd and the collateral secured by the General Security Deed, including all searches of the Personal Property Securities Register in respect of
that collateral and Holdings, Unilife Medical Solutions Pty Limited and Unitract Syringe Pty Ltd. 
 SECTION 5.15 Opinions of
Counsel. The Lender shall have received opinions, dated the Closing Date and addressed to the Lender, from 
 (a) Pepper
Hamilton LLP, counsel to Holdings, the Borrower and the Subsidiaries, in form and substance reasonably satisfactory to the Lender; and 

(b) Minter Ellison, Australian counsel to the Lender, in form and substance reasonably satisfactory to the Lender. 

SECTION 5.16 Insurance. The Lender shall have received certified copies of the insurance policies (or binders in respect thereof),
from one or more insurance companies satisfactory to the Lender, evidencing coverage required to be maintained pursuant to each Loan Document, with the Lender named as loss payee or additional insured, as applicable. 

SECTION 5.17 Metro Bank and Pennsylvania Loans. The Lender shall have received: 

(a) lien releases, UCC Form UCC-3 termination statements and other documents and instruments necessary to release all Liens and
other rights of Metro Bank with respect to the Metro Bank Mortgage Loans, the Metro Bank Business Loans or otherwise in any assets of Holdings, the Borrower or any Subsidiary other than Liens on the Mortgaged Property (but not personal property
thereon or affixed thereto, or manufacturing or similar equipment that may be fixtures thereto) in favor of Metro Bank with respect to Metro Bank Facility A; 

(b) evidence satisfactory to the Lender that in relation to the guarantee by USDA in favor of Metro Bank, the USDA has
consented to transactions contemplated hereby (including the Liens provided by Holdings, the Borrower and the Subsidiaries in favor of the Lender); 

(c) an agreement with Metro Bank in form and substance satisfactory to the Lender to reflect the lien releases and transactions
described herein and contemplated hereby in form and substance satisfactory to the Lender; and 
 (d) an intercreditor
agreement, in form and substance satisfactory to the Lender, executed by Metro Bank, the Commonwealth Financing Authority of the Commonwealth of Pennsylvania and Keystone Redevelopment Group, LLC with respect to Metro Bank Facility A, the
Pennsylvania Loan and the Loans provided by the Lender. 

  
 -38- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 5.18 [Reserved]. 

SECTION 5.19 Acknowledgement Agreements. The Lender shall have received an executed acknowledgement agreement with respect to the
Sanofi Supply Agreement. 
 SECTION 5.20 Mortgaged Property. The Lender shall have received, in respect of the Mortgaged
Property, a Mortgage, dated as of the Closing Date, and duly executed and delivered by an Authorized Officer of Unilife Cross Farm LLC, which Mortgage shall be in the form of Exhibit F, and (i) evidence satisfactory to it that all charges for
mortgage recording tax, and all related expenses, if any, have been paid or duly provided for and (ii) legal opinions from local counsel in the jurisdiction where the Mortgaged Property is situated and from counsel in the jurisdiction where the
owner of the Mortgaged Property is organized relating to the matters described above, which opinions shall be in form and substance reasonably satisfactory to the Lender. 

SECTION 5.21 Flood Determinations; Flood Insurance. The Lender shall have received a completed Federal Emergency Management Agency
Standard Flood Hazard Determination certified to the Lender in respect of the Mortgaged Property and, if such Mortgaged Property is located in an area identified as an area having special flood hazards, a policy of flood insurance in amounts
reasonably acceptable to the Lender. 
 SECTION 5.22 Closing Fees, Expenses, Etc. The Lender shall have received for its own
account all fees, costs and expenses due and payable pursuant to Section 10.3. 
 SECTION 5.23 Anti-Terrorism Laws.
The Lender shall have received, as applicable, all documentation and other information required by bank regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including the U.S.A.
Patriot Act. 
 SECTION 5.24 Satisfactory Legal Form. All documents executed or submitted pursuant hereto by or on behalf of
Holdings, the Borrower or any Subsidiary shall be satisfactory in form and substance to the Lender and its counsel, and the Lender and its counsel shall have received all information, approvals, resolutions, opinions, documents or instruments as the
Lender or its counsel may reasonably request. 
 SECTION 5.25 Loan Request and Disclosure Schedules. The Borrower shall have
delivered a Loan Request to the Lender as required pursuant to Section 2.3, and immediately prior to each Delayed Draw Closing Date, the Borrower shall have delivered to the Lender updates to Schedules 6.15(a), 6.16 and 6.22, each such updated
Schedule to be complete and accurate in all material respects as of such Delayed Draw Closing Date. 
 SECTION 5.26 Post-Closing
Commitments. Within 90 days following the Closing Date, the Borrower shall provide the Lender with the following: 
 (a)
evidence that the Borrower and Hikma have entered into a definitive Supply Agreement and Quality Agreement (as referenced in the Hikma LDSA), which agreements are in form and substance reasonably satisfactory to the Lender; 

  
 -39- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) landlord access agreements for the King of Prussia facility in form and
substance reasonably satisfactory to the Lender; and 
 (c) evidence that the Holdings and the Borrower have entered into new
[four-year] employment agreements with Alan Shortall and Ramin Mojdeh, which agreements are in form and substance reasonably satisfactory to the Lender. 

SECTION 5.27 Mortgage Post-Closing Commitments. Within 45 days following the Closing Date, the Lender shall have received, in
respect of the Mortgaged Property, (i) a mortgagee’s title insurance policy or marked up unconditional binder for such insurance, effective as of the Closing Date, together with a current ALTA survey thereof and a surveyor’s
certificate, in form reasonably satisfactory to the Lender, provided that such policy shall (A) be in an amount not less than the fair market value of the Mortgaged Property covered thereby; (B) insure that, as of the Closing Date,
the Mortgage insured thereby creates a valid third Lien on such Mortgaged Property free and clear of all defects and encumbrances, except as disclosed in the Mortgage or otherwise permitted by Section 8.3; (C) name the Lender as the
insured thereunder; (D) be in form reasonably satisfactory to the Lender; (E) contain such endorsements, coinsurance, reinsurance and affirmative coverage as the Lender may reasonably request; and (F) be issued by First American Title
Insurance Company or such other national title company or companies reasonably satisfactory to the Lender (including any such title companies acting as co-insurers or reinsurers, at the option of the Lender); and (ii) evidence satisfactory to
it that all premiums in respect of such policy and all related expenses, if any, have been paid or duly provided for. 
 SECTION 5.28
MELF and Bank Account Post-Closing Commitments. Within 30 days following the Closing Date, the Lender shall have received: 

(a) lien releases, UCC Form UCC-3 termination statements and other documents and instruments necessary to release all Liens and
other rights and extinguish the Indebtedness of any Credit Obligor to the Commonwealth of Pennsylvania, acting by and through the Department of Community and Economic Development (other than, for the avoidance of doubt, the Pennsylvania Loan); and

 (b) evidence that the Metro Bank account relating to Safe in Common Inc. [***] has been closed. 

SECTION 5.29 Acknowledgement Agreements Post-Closing Commitments. Within 10 Business Days following the Closing Date, the Lender
shall have received (a) an executed acknowledgement agreement with respect to the Hikma LDSA and Hikma Security Agreement 

  
 -40- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
substantially in the form attached hereto as Exhibit G-1, and (b) an executed acknowledgement agreement with respect to the MedImmune Agreement substantially in the form attached
hereto as Exhibit G-2. 
 ARTICLE VI 

REPRESENTATIONS AND WARRANTIES 

In order to induce the Lender to enter into this Agreement and to make the Loans hereunder, the Borrower represents and warrants, in each case
(unless otherwise stated) on the Closing Date and on each Delayed Draw Closing Date, to the Lender as set forth in this Article VI. 

SECTION 6.1 Organization, Etc. (a) Each Credit Obligor is validly organized or registered and existing under the laws of the
jurisdiction of its incorporation or organization, (b) each U.S. Obligor (i) is in good standing under the laws of its jurisdiction of its incorporation or organization and (ii) is in good standing as a foreign entity in each
jurisdiction where the nature of its business requires qualification, except with respect to Section 6.1(b)(ii) where failure to do so would not reasonably be expected to have a Material Adverse Effect, (c) is duly qualified to do business
in each jurisdiction where the nature of its business requires such qualification, except where failure to do so would not reasonably be expected to have a Material Adverse Effect, and (d) has full power and authority and holds all requisite
governmental licenses, permits and other approvals to enter into and perform its Obligations under each Loan Document to which it is a party, to own and hold under lease its property and to conduct its business substantially as currently conducted
by it. 
 SECTION 6.2 Due Authorization, Non-Contravention, Etc. The execution, delivery and performance by Holdings, the
Borrower and each Subsidiary of each Loan Document executed or to be executed by it are in each case within such Person’s corporate or other powers, have been duly authorized by all necessary corporate or other action, and do not: 

(a) contravene (i) Holdings’, the Borrower’s or any Subsidiary’s Organic Documents, (ii) any court
decree or order binding on or affecting Holdings, the Borrower or any Subsidiary or (iii) any law or governmental regulation binding on or affecting Holdings, the Borrower or any Subsidiary; or 

(b) result in (i) or require the creation or imposition of any Lien on Holdings’, the Borrower’s or any
Subsidiary’s properties (except as permitted by this Agreement) or (ii) a default under any contract, agreement, or instrument binding on or affecting the Borrower or any Subsidiary. 

SECTION 6.3 Government Approval, Regulation, Etc. No authorization or approval or other action by, and no notice to or filing
with, any Governmental Authority or other Person (other than those that have been, or on the Closing Date will be, duly obtained or made and 

  
 -41- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
which are, or on the Closing Date will be, in full force and effect) is required for the due execution, delivery or performance by Holdings, the Borrower or any Subsidiary of any Loan Document to
which it is a party. 
 SECTION 6.4 Validity, Etc. Each Loan Document to which Holdings, the Borrower or any Subsidiary is a
party constitutes the legal, valid and binding obligations of such Person enforceable against such Person in accordance with its respective terms (except, in any case, as such enforceability may be limited by applicable bankruptcy, insolvency,
reorganization or similar laws affecting creditors’ rights generally and by principles of equity). 
 SECTION 6.5 Financial
Information. The financial statements of Holdings, the Borrower and the Subsidiaries furnished to the Lender pursuant to Sections 5.6 and 7.1 have been prepared in accordance with GAAP, consistently applied, and present fairly the
consolidated financial condition of the Persons covered thereby as at the dates thereof and the results of their operations for the periods then ended. 

SECTION 6.6 No Material Adverse Change. There has been no material adverse change in the business, financial performance or
condition, operations (including the results thereof), assets, properties or prospects of Holdings, the Borrower or any Subsidiary since June 30, 2013. 

SECTION 6.7 Litigation, Labor Matters and Environmental Matters. 

(a) Except as described on Schedule 6.7(a), there are no actions, suits or proceedings by or before any arbitrator or
Governmental Authority pending against or, to the knowledge of the Borrower, threatened against or affecting Holdings, the Borrower or any Subsidiary (i) as to which there is a reasonable likelihood of an adverse determination and that, if
adversely determined, would reasonably be expected, individually or in the aggregate, to result in liabilities in excess of $500,000 or (ii) that would reasonably be likely to adversely affect this Agreement or the transactions contemplated
hereby. 
 (b) There are no employee strikes, employee lockouts, labor arbitrations, unfair labor practice charges or other
labor disputes pending against or, to the knowledge of the Borrower, threatened against or affecting Holdings, the Borrower or any Subsidiary (i) that would reasonably be expected, individually or in the aggregate, to result in liabilities in
excess of $500,000 or (ii) that would reasonably be likely to adversely affect this Agreement or the transaction contemplated hereby. 

(c) Neither Holdings, the Borrower nor any Subsidiary (i) has failed to comply in all material respects with any
Environmental Law or to obtain, maintain or comply in all material respects with any Permit under or in connection with any Environmental Law (“Environmental Permit”), (ii) is or has been subject to any material claim under any
Environmental Liability, (iii) has received notice of any material claim 

  
 -42- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
under any Environmental Liability, or (iv) knows of any basis for any material claim under any Environmental Liability in each case, which has resulted or would be reasonably expected,
individually or in the aggregate, to result in liabilities in excess of $500,000. 
 SECTION 6.8 Subsidiaries. Holdings has no
Subsidiaries except those Subsidiaries which are identified in Schedule 6.8 (which Schedule also identifies the direct and indirect owners of the Capital Securities of such Subsidiaries) or which are permitted to have been organized or
acquired after the Closing Date in accordance with Section 8.5 or Section 8.7. 
 SECTION 6.9 Ownership of
Properties. Each of Holdings, the Borrower and each Subsidiary has (i) in the case of owned real property, good and marketable title in fee simple to, or valid leasehold interests in, all real property necessary or used in the ordinary
conduct of its business, except for such defects in title as could not, individually or in the aggregate, adversely interfere in any material respect with the value or use of such property, and (ii) in the case of owned personal property, good
and valid title to, or, in the case of leased real or personal property, valid leasehold interests (as the case may be) in, all of its properties and assets, tangible and intangible, of any nature whatsoever; in each case, free and clear of all
Liens or claims, except for Liens permitted pursuant to Section 8.3. 
 SECTION 6.10 Taxes. Each of Holdings, the
Borrower and each Subsidiary has filed all material Tax returns and reports required by law to have been filed by it and has paid all material Taxes due and owing, except any such Taxes which are being diligently contested in good faith by
appropriate proceedings and for which adequate reserves in accordance with GAAP shall have been set aside on its books. No Credit Obligor (other than the Australian Subsidiaries) is a member of a Tax Consolidated Group. No Credit Obligor (other than
the Australian Subsidiaries) is or has ever been a member of a GST Group. 
 SECTION 6.11 Benefit Plans, Etc. None of Holdings,
the Borrower or any of the Subsidiaries or any of their respective ERISA Affiliates sponsors, maintains, contributes to, is required to contribute to, or has any actual or potential liability with respect to, any Benefit Plan. None of Holdings, the
Borrower or any of the Subsidiaries, in their capacities as such, is a party to any collective bargaining agreement, and none of the employees of Holdings, the Borrower or any of the Subsidiaries are subject to any collective bargaining agreement.
Each “employee benefit plan” as defined in section 3(3) of ERISA that provides retirement benefits and that is sponsored by Holdings, the Borrower, any of the Subsidiaries or any of their ERISA Affiliates (or under which any of these
entities has any actual or potential liability) and is intended to be tax qualified under section 401 of the Code has a determination letter or opinion letter from the Internal Revenue Service on which it is entitled to rely, and no assets of any
such plan are invested in Capital Securities of Holdings. Each employee benefit plan, program or arrangement sponsored, maintained, contributed to or required to be contributed to by Holdings, the Borrower or any Subsidiary (or under which any of
these entities has any actual or potential liability) has complied in all material respects with its terms and applicable law except for non-compliance 

  
 -43- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
that would not reasonably (i) be expected, individually or in the aggregate, to result in liabilities in excess of $500,000 or (ii) be likely to adversely affect this Agreement or the
transaction contemplated hereby. Each employee benefit plan as defined in section 3(3) of ERISA that provides medical, dental, vision, or long-term disability benefits and that is sponsored by Holdings, the Borrower, any Subsidiary or any of their
ERISA Affiliates (or under which any of these entities has any actual or potential liability) is fully insured, except for the Borrower’s short-term disability program for salaried employees and health reimbursement accounts for all of its
employees, which are funded by the Borrower. 
 SECTION 6.12 Accuracy of Information. None of the information heretofore or
contemporaneously furnished in writing to the Lender by or on behalf of Holdings, the Borrower or any Subsidiary in connection with any Loan Document or any transaction contemplated hereby contains any untrue statement of a material fact, or omits
to state any material fact necessary to make statements and information therein, in light of the circumstances under which they were made, not misleading (after giving effect to all modifications and supplements to such written information and
written data, in each case, furnished after the date on which such written information or such written data was originally delivered and prior to the Closing Date); it being understood that for purposes of this Section 6.10, such written
information and written data shall not include projections, and Borrower represents only that such projections were prepared in good faith based upon assumptions believed to be reasonable at the time. 

SECTION 6.13 Regulations U and X. None of Holdings, the Borrower or any Subsidiary is engaged in the business of extending credit
for the purpose of buying or carrying margin stock, and no proceeds of the Loans will be used to purchase or carry margin stock or otherwise for a purpose which violates, or would be inconsistent with, F.R.S. Board Regulation U or Regulation X.
Terms for which meanings are provided in F.R.S. Board Regulation U or Regulation X or any regulations substituted therefor, as from time to time in effect, are used in this Section with such meanings. 

SECTION 6.14 Solvency. Each of the Credit Obligors, both before and after giving effect to the Loans, is Solvent. 

SECTION 6.15 Intellectual Property. 

(a) Schedule 6.15(a) sets forth a complete and accurate list as of the Closing Date or Delayed Draw Closing Date, as the
case may be, of all (i) Patents including any Patent applications and other material defined herein as Patents, (ii) registered and material unregistered Trademarks (including domain names whether or not such domain names are or might be a
Trademark) and any pending registrations for Trademarks, (iii) any other registered Intellectual Property and (iv) any commercially significant unregistered Intellectual Property, in each case owned (or is assignable pursuant to the terms
of the relevant contract) or licensed by Holdings, the Borrower or any of the Subsidiaries. For each item of Intellectual Property listed on Schedule 6.15(a), the 

  
 -44- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
Borrower has, where relevant, indicated on such schedule (A) the countries in each case in which such item is registered or pending registration, (B) the application numbers,
(C) the registration or patent or patent application numbers, (D) with respect to the Patents, the expected expiration date of the issued Patents, (E) the owner of such item of Intellectual Property and (F) with respect to
Intellectual Property owned by any Third Party, the agreement pursuant to which that Intellectual Property is licensed to Holdings, the Borrower or any Subsidiary. 

(b) With respect to all Intellectual Property listed on Schedule 6.15(a): 

(i) Holdings, the Borrower or a Subsidiary owns or has a valid license to such Intellectual Property free and clear of any and
all Liens other than Liens permitted pursuant to Section 8.3 and all such Intellectual Property are in full force and effect, and have not expired, lapsed or been forfeited, cancelled or abandoned; 

(ii) each of Holdings, the Borrower and the Subsidiaries, as applicable, has taken commercially reasonable actions to maintain
and protect such Intellectual Property and there are no unpaid maintenance or renewal fees payable by Holdings, the Borrower or any of the Subsidiaries that are currently overdue for any of such registered Intellectual Property; 

(iii) there is no proceeding that the Borrower has knowledge of challenging in any way the validity, scope or enforceability of
any such Intellectual Property, none of Holdings, the Borrower or any of the Subsidiaries is involved in any such proceeding with any Person and to the knowledge of the Borrower, none of the Intellectual Property is the subject of any Other
Administrative Proceeding; 
 (iv) (A) such Intellectual Property is valid, enforceable and subsisting and (B) no event
has occurred, and nothing has been done or omitted to have been done, that would affect the validity, scope or enforceability of such Intellectual Property; and 

(v) each of Holdings, the Borrower and each Subsidiary, as applicable, is the sole and exclusive owner of all right, title and
interest in and to all such Intellectual Property that is owned by it or licensed to it. 
 (c) To the knowledge of the
Borrower, no Third Party is committing any act of Infringement of any Intellectual Property listed on Schedule 6.15(a). 

(d) With respect to each license agreement listed on Schedule 6.15(a), such license agreement (i) is in full force
and effect and is binding upon and enforceable by or 

  
 -45- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
against Holdings, the Borrower and the Subsidiaries party thereto and all other parties thereto in accordance with its terms, (ii) has not been amended or otherwise modified and
(iii) has not suffered a default or breach thereunder. None of Holdings, the Borrower or any of the Subsidiaries has taken or omitted to take any action that would permit any other Person party to any such license agreement to have, and to the
knowledge of the Borrower, no such Person otherwise has, any defenses, counterclaims or rights of setoff thereunder. 
 (e)
Except as set forth on Schedule 6.15(e), none of Holdings, the Borrower or any of the Subsidiaries has received written notice from any Third Party alleging that the conduct of its business (including the development, manufacture, use, sale
or other commercialization of any Product) Infringes any Intellectual Property of that Third Party and, to the knowledge of the Borrower, the conduct of its business and the business of Holdings and the Subsidiaries (including the development,
manufacture, use, marketing, sale or other commercialization of any Product) does not Infringe any Intellectual Property of any Third Party. 

(f) Holdings, the Borrower and the Subsidiaries have used commercially reasonable efforts and precautions to protect their
respective commercially significant unregistered Intellectual Property. 
 SECTION 6.16 Material Agreements. Set forth on
Schedule 6.16 is a complete and accurate list as of the Closing Date or Delayed Draw Closing Date, as the case may be, of all Material Agreements of Holdings, the Borrower or any of the Subsidiaries, with an adequate description of the
parties thereto, and amendments and modifications thereto. Each such Material Agreement (i) is in full force and effect and is binding upon and enforceable against Holdings, the Borrower and the Subsidiaries party thereto and, to the knowledge
of the Borrower, all other parties thereto in accordance with its terms, and (ii) is not currently subject to any breach or default by Holdings, the Borrower, any Subsidiary, or, to the knowledge of the Borrower, any other party thereto. None
of Holdings, the Borrower or any of the Subsidiaries has taken or failed to take any action that would permit any other Person party to any Material Agreement to have, and, to the knowledge of the Borrower, no such Person otherwise has, any
defenses, counterclaims or rights of setoff thereunder. 
 SECTION 6.17 Permits. Holdings, the Borrower and the Subsidiaries
have all Permits, including Environmental Permits, necessary or required for the ownership, operation and conduct of their business and the distribution of the Products. All such Permits are validly held and there are no defaults thereunder. 

SECTION 6.18 Regulatory Matters. 

(a) The business of Holdings, the Borrower and the Subsidiaries has been, and currently is, being conducted in compliance with
all applicable U.S. federal, state, local 

  
 -46- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
or foreign laws, statutes, ordinances, rules, regulations, judgments, orders, injunctions, decrees, arbitration awards and Key Permits issued by any Governmental Authority (collectively,
“Laws”). 
 (i) The Products have been and are being researched, developed, designed, investigated, manufactured,
marketed, and distributed in compliance in all material respects with all applicable Laws, including the FDCA, the FTC Act, Privacy Laws and state laws; it being understood that the foregoing does not concern the research, development, design,
investigation, manufacture, marketing or distribution by customers of the Borrower or any of its Affiliates of any customer finished product that is a combination of any Product with any drugs or biologics of such customers, for which the Borrower
makes no representations or warranties in this Section 6.18(a)(i). 
 (ii) Without limitation of
Section 6.18(a)(i), (A) each Product has been, and currently is, being designed, manufactured, made, assembled, stored, packaged and labeled by Holdings, the Borrower or the Subsidiaries in all material respects in compliance with
all applicable Law, including cGMP, the FDA Quality System Regulations (“QSRs”), and (B) Holdings, the Borrower and the Subsidiaries are in compliance in all material respects with applicable Law governing reporting and
recordkeeping of Product modifications, adverse event reporting, reporting of corrections and removals, and recordkeeping for each Product. 

(b) To the Borrower’s knowledge, other than routine surveillance audits and inspections, no investigation by any
Governmental Authority with respect to Holdings, the Borrower or any Subsidiary is pending or threatened. None of Holdings, the Borrower or any Subsidiary has received any written communication from any Person (including any Governmental Authority)
of any noncompliance with any Laws or any written communication from any Governmental Authority or accrediting organization of any material issues, problems, or concerns regarding the quality or performance of the Products, except to the extent
identified in the quality complaint files (as described in 21 C.F.R. 820.198) and adverse event reports of such Obligor. 

(c) Holdings, the Borrower and each Subsidiary owns, free and clear of all Liens, except those permitted pursuant to
Section 8.3, all Key Permits, including all authorizations under the FD&C Act and state laws, necessary for the research and development and commercialization of the Products and to carry on Holdings’, the Borrower’s or
such Subsidiary’s business, as applicable. All such Key Permits are valid and in full force and effect and Holdings, the Borrower and each Subsidiary is in compliance with all terms and conditions of such Key Permits. None of Holdings, the
Borrower or any Subsidiary has received any written notice from any Governmental Authority that any Key Permits have been or are being revoked, withdrawn, suspended or challenged. 

  
 -47- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) The Borrower has made available to Lender all Key Permits and material
correspondence submitted to or received from FDA, CMS, or other Governmental Authority (including minutes and official contact reports relating to any material communications with any Governmental Authority) in Holdings’, the Borrower’s or
any Subsidiary’s possession or control. There has been no material untrue statement of fact and no fraudulent statement made by Holdings, the Borrower, any of the Subsidiaries, or any of their respective agents or representatives to the FDA,
CMS, or any other Governmental Authority, and there has been no failure to disclose any material fact required to be disclosed to the FDA or any other Governmental Authority. 

(e) No right of Holdings, the Borrower or any Subsidiary to receive reimbursements pursuant to any government program or
private program has ever been terminated or otherwise adversely affected as a result of any investigation or enforcement action, whether by any Governmental Authority or other Third Party. None of Holdings, the Borrower or any Subsidiary has been
the subject of any “for cause” inspection, investigation or audit by any Governmental Authority in connection with any alleged improper activity. 

(f) There is no arrangement relating to Holdings, the Borrower or any Subsidiary providing for any rebates, kickbacks or other
forms of compensation that are unlawful to be paid to any Person in return for the referral of business or for the arrangement for recommendation of such referrals. All billings by Holdings, the Borrower or any Subsidiary for its services have been
true and correct in all material respects and are in compliance in all material respects with all applicable Laws. 
 (g)
None of Holdings, the Borrower, any Subsidiary or, to the Borrower’s knowledge, any individual who is an officer, director, employee or manager of Holdings, the Borrower or any Subsidiary has been convicted of, charged with or, to the
Borrower’s knowledge, investigated for any federal or state health program-related offense or been excluded or suspended from participation in any such program; or, to the Borrower’s knowledge, within the past five (5) years, has been
convicted of, charged with or, to the Borrower’s knowledge, investigated for a violation of Laws related to fraud, theft, embezzlement, breach of fiduciary responsibility, financial misconduct, obstruction of an investigation or controlled
substances, or has been subject to any judgment, stipulation, order or decree of, or criminal or civil fine or penalty imposed by, any Governmental Authority related to fraud, theft, embezzlement, breach of fiduciary responsibility, financial
misconduct, obstruction of an investigation or controlled substances. None of Holdings, the Borrower, any Subsidiary or, to the Borrower’s knowledge, any individual who is an officer, director, employee or manager of Holdings, the Borrower or
any Subsidiary has been convicted of any crime or engaged in any conduct that has resulted 

  
 -48- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
or would reasonably be expected to result in a debarment or exclusion (i) under 21 U.S.C. Section 335a, or (ii) any similar applicable Law. No debarment proceedings or
investigations in respect of the business of the Borrower or any Subsidiary are pending or, to the Borrower’s knowledge, threatened against Holdings, the Borrower, any Subsidiary or any individual who is an officer, director, employee or
manager of Holdings, the Borrower or any Subsidiary. 
 (h) All studies, tests and preclinical and clinical trials conducted
relating to the Products, sponsored by Holdings, the Borrower and the Subsidiaries and, to the knowledge of the Borrower, their respective licensees, licensors and Third Party services providers and consultants, have been conducted, and are
currently being conducted, in accordance with all applicable Laws and IDEs, including procedures and controls pursuant to, where applicable, current good clinical practices and current good laboratory practices and other applicable laws, rules
regulations. All results of such studies, tests and trials, and all other material information related to such studies, tests and trials, have been made available to Lender. The summaries and descriptions of any of the foregoing provided to the
Lender are accurate and contain no material omissions. To the extent required by applicable Law, each of Holdings, the Borrower and each Subsidiary has obtained all necessary authorizations from Regulatory Authorities and IECs, including an IDE for
the conduct of any clinical investigations conducted by or on behalf of the Borrower or such Subsidiary. 
 (i) To the
Borrower’s knowledge, none of the clinical investigators in any clinical trial sponsored by Holdings, the Borrower or any Subsidiary has been or is disqualified or otherwise sanctioned by the FDA, the Department of Health and Human Services, or
any Governmental Authority and, to the Borrower’s knowledge, no such disqualification, or other sanction of any such clinical investigator is pending or threatened. None of Holdings, the Borrower, any of the Subsidiaries, or, to the knowledge
of the Borrower, any of their respective licensees, licensors or Third Party services providers or consultants, has received from the FDA or other applicable Governmental Authority any notices or correspondence requiring or threatening the
termination, suspension, material modification or clinical hold of any studies, tests or clinical trials with respect to or in connection with the Products. 

(j) The transactions contemplated by the Loan Documents (or contemplated by the conditions to effectiveness of any Loan
Document) will not impair Holdings’, the Borrower’s or any of the Subsidiaries’ ownership of or rights under (or the license or other right to use, as the case may be) any Regulatory Authorizations relating to the Products in any
material manner. 
 SECTION 6.19 Transactions with Affiliates. Except as set forth on Schedule 6.19, none of Holdings,
the Borrower or any Subsidiary has entered into, renewed, extended or been a party to any transaction or agreement (including the purchase, sale, lease, transfer or exchange of 

  
 -49- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
property or assets of any kind or the rendering of services of any kind) with any of its Affiliates during the five-year period immediately prior to the Closing Date, and none of Holdings, the
Borrower or any Subsidiary is a party to any such transaction or agreement as of the Closing Date. 
 SECTION 6.20 Investment
Company Act. None of Holdings, the Borrower or any Subsidiary is an “investment company” or is “controlled” by an “investment company,” as such terms are defined in, or subject to regulation under, the Investment
Company Act of 1940, as amended. 
 SECTION 6.21 OFAC. None of Holdings, the Borrower, any Subsidiary or, to the knowledge of
the Borrower, any Related Party (a) is currently the subject of any Sanctions, (b) is located, organized or residing in any Designated Jurisdiction, or (c) is or has been (within the previous five (5) years) engaged in any
transaction with any Person who is now or was then the subject of Sanctions or who is located, organized or residing in any Designated Jurisdiction. No Loan, nor the proceeds from any Loan, has been or will be used, directly or indirectly, to lend,
contribute or provide to, or has been or will be otherwise made available to fund, any activity or business in any Designated Jurisdiction or to fund any activity or business of any Person located, organized or residing in any Designated
Jurisdiction or who is the subject of any Sanctions, or in any other manner that will result in any violation by any Person (including the Lender and its Affiliates) of Sanctions. 

SECTION 6.22 Deposit and Disbursement Accounts. Set forth on Schedule 6.22 is a complete and accurate list as of the
Closing Date or Delayed Draw Closing Date, as the case may be, of all banks and other financial institutions at which Holdings, the Borrower or any Subsidiary maintains deposit accounts, lockboxes, disbursement accounts, investment accounts or other
similar accounts, such Schedule correctly identifies the name, address and telephone number of each bank or financial institution, the name in which each such account is held, the type of each such account, and the complete account number for each
such account, and each such account (other than Excluded Accounts) is a Controlled Account. 
 SECTION 6.23 Customer and Trade
Relations. There exists no actual or, to the knowledge of the Borrower, overtly threatened termination or cancellation of, or any material adverse modification or change in (a) the business relationship of Holdings, the Borrower or any
Subsidiary with any customer or group of customers whose purchases during the preceding 12 calendar months caused such customer or group of customers to be ranked among the ten largest customers of Holdings, the Borrower or such Subsidiary, as
applicable, or (b) the business relationship of Holdings, the Borrower or any Subsidiary with any supplier essential to its operations. 

  
 -50- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 6.24 Holding Companies; Excluded Subsidiary. 

(a) Holdings is a passive holding company with no operations (other than such operations as are incidental to its status as a
holding company, including maintaining its corporate existence and participating in tax, accounting and other administrative activities as the parent of the consolidated group of companies), no assets (other than ownership of Capital Securities of
the Borrower or other Subsidiaries and such immaterial assets as are incidental to its status as a holding company) and no liabilities (other than the Obligations under the Loan Documents and such immaterial liabilities as are incidental to its
status as a holding company, including payment of annual listing fees to ASX and fees for quotation of new securities on ASX). 

(b) Each of Unilife Medical Solutions Pty Limited and Unitract Syringe Pty Ltd has no operations (other than such operations as
are incidental to owning Intellectual Property and licensing Intellectual Property to its Affiliates and incidental to its status as a holding company including maintaining its corporate existence and the existence of Intellectual Property rights),
no assets (other than ownership of Intellectual Property and such immaterial assets as are incidental to its status as a holding company) and no liabilities (other than the Obligations under the Loan Documents including ongoing patent maintenance
fees in Australia and any royalties or payments required to be made under the IP Licensing Arrangements and such immaterial liabilities as are incidental to its status as a holding company). 

(c) Unilife Cross Farm LLC has no operations (other than such operations as are incidental to owning real property and
incidental to owning real property including maintaining its corporate existence and the real property and rights related thereto), no assets (other than real property, the Metro Bank Reserve Account, and such immaterial assets as are incidental to
owning real property) and no liabilities (other than the Obligations under the Loan Documents, obligations under the Metro Bank Reserve Account, obligations under the first priority Metro Bank Mortgage Loans and the Pennsylvania Loan and such
immaterial liabilities as are incidental to owning real property). 
 (d) Unilife France is a dormant Subsidiary with no
assets, no operations and no liabilities. 
 SECTION 6.25 Hikma Collateral. None of the Hikma Collateral is used, or held for
use, for the research, design, development, manufacturing, licensing, marketing, sale, distribution or other commercialization of Products for any customers of any Credit Obligor other than Hikma Pharmaceuticals, LLC; except that (i) Hikma
Collateral is used in the development of Intellectual Property, and (ii) certain inventory of the type included in the Hikma Collateral consists of components that are also of the same type or kind used or held for use for customers other than
Hikma (and such inventory used or held for use for such other customers is not Hikma Collateral). 

  
 -51- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE VII 

AFFIRMATIVE COVENANTS 
 The
Borrower covenants and agrees with the Lender that until the Termination Date has occurred, the Borrower and Holdings will, and will cause the Subsidiaries to, perform or cause to be performed the obligations set forth below. 

SECTION 7.1 Financial Information, Reports, Notices, Etc. The Borrower will furnish the Lender copies of the following financial
statements, reports, notices and information: 
 (a) as soon as available and in any event within 30 days after the end of
each calendar month, in each case with supporting detail and certified as complete and correct by the chief financial or accounting Authorized Officer of Holdings (subject to normal year-end audit adjustments), (i) unaudited reports of the
Liquidity of the Borrower at the end of such calendar month and (ii) beginning with the calendar month of February 2014, unaudited reports of the Liquidity of the Borrower for the corresponding calendar month in the preceding Fiscal Year, in
comparative form; 
 (b) as soon as available and in any event within 45 days after the end of each of the first three
Fiscal Quarters of each Fiscal Year, an unaudited consolidated balance sheet of Holdings, the Borrower and the Subsidiaries as of the end of such Fiscal Quarter, consolidated statements of income and cash flow of Holdings, the Borrower and the
Subsidiaries for such Fiscal Quarter and for the period commencing at the end of the previous Fiscal Year and ending with the end of such Fiscal Quarter and the Revenue Base for such Fiscal Quarter and for the period commencing at the end of the
previous Fiscal Year and ending with the end of such Fiscal Quarter, and including in comparative form the figures for the corresponding Fiscal Quarter in, and the year to date portion of, the immediately preceding Fiscal Year, certified as complete
and correct by the chief financial or accounting Authorized Officer of the Borrower (subject to normal year-end audit adjustments); 

(c) as soon as available and in any event within 90 days after the end of each Fiscal Year, (i) a copy of the consolidated
balance sheet of Holdings, the Borrower and the Subsidiaries, and the related consolidated statements of income and cash flow of Holdings, the Borrower and the Subsidiaries for such Fiscal Year, setting forth in comparative form the figures for the
immediately preceding Fiscal Year, audited (without any Impermissible Qualification) by independent public accountants acceptable to the Lender, which shall include a calculation of the financial covenants set forth in Section 8.4 and
stating that, in performing the examination necessary to deliver the audited financial statements of Holdings, no knowledge was obtained of any Event of Default, and (ii) the Revenue Base for the Fiscal Quarter then ending and such Fiscal Year
and including in comparative form the figures for the corresponding Fiscal Quarter in the immediately preceding Fiscal Year and the immediately preceding Fiscal Year; 

  
 -52- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) concurrently with the delivery of the financial information pursuant to
clauses (a), (b) and (c), a Compliance Certificate, executed by the chief financial or accounting Authorized Officer of the Borrower, (i) showing compliance with the financial covenants set forth in
Section 8.4 and stating that no Default has occurred and is continuing (or, if a Default has occurred, specifying the details of such Default and the action that Holdings, the Borrower or any of the Subsidiaries has taken or proposes to
take with respect thereto), (ii) stating that no Subsidiary has been formed or acquired since the delivery of the last Compliance Certificate (or, if a Subsidiary has been formed or acquired since the delivery of the last Compliance
Certificate, a statement that such Subsidiary has complied with Section 7.8) and (iii) stating that no real property has been acquired by Holdings, the Borrower or any of the Subsidiaries since the delivery of the last Compliance
Certificate (or, if any real property has been acquired since the delivery of the last Compliance Certificate, a statement that the Borrower has complied with Section 7.8 with respect to such real property); 

(e) as soon as available and in any event within 90 days after the end of each Fiscal Year, an annual operating plan for
Holdings, the Borrower and the Subsidiaries for the following Fiscal Year, in form reasonably satisfactory to the Lender, which (i) includes a statement of all material assumptions on which such plan is based, (ii) includes an annual
budget (by quarter) for the following Fiscal Year, and (iii) integrates sales, gross profits, operating expenses, operating profit and cash flow projections, all prepared on the same basis and in similar detail as that on which the operating
results are reported (and in the case of cash flow projections, representing management’s good faith estimates of future financial performance based on historical performance), and including plans for personnel, capital expenditures and
facilities; 
 (f) as soon as possible and in any event within five Business Days after the Borrower obtains knowledge of the
occurrence of a Default, a statement of an Authorized Officer of the Borrower setting forth details of such Default and the action which Holdings, the Borrower or any of the Subsidiaries has taken or proposes to take with respect thereto; 

(g) as soon as possible and in any event within five Business Days after the Borrower obtains knowledge of (i) the
occurrence of any material adverse development with respect to any litigation, action, proceeding or labor controversy described in Schedule 6.7(a) or (ii) the commencement of any litigation, action, proceeding or labor controversy of
the type and materiality described in Section 6.7, notice thereof and, to the extent the Lender requests, copies of all documentation relating thereto; 

(h) as soon as possible and in any event within five Business Days after the Borrower obtains knowledge of any return,
recovery, dispute or claim related to Product or inventory that involves more than $500,000. 

  
 -53- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (i) as soon as possible and in any event within three days after the Borrower
obtains knowledge of (i) any claim that Holdings, the Borrower, any of the Subsidiaries or one of their ERISA Affiliates has actual or potential liability under a Benefit Plan, (ii) any effort to unionize the employees of the Borrower or
any Subsidiary, (iii) correspondence from the Internal Revenue Service asserting the failure of a retirement plan intended to be qualified under Section 401(a) of the Code to meet the requirements for such qualification, or (iv) any
employee benefit plan as defined in section 3(3) of ERISA that provides medical, dental, vision, or long-term disability benefits and that is sponsored by Holdings, the Borrower, any Subsidiary or any of their ERISA Affiliates (or under which any of
these entities has any actual or potential liability) becoming self-insured; 
 (j) promptly after the sending or filing
thereof, copies of all reports, notices, prospectuses and registration statements which Holdings, the Borrower or any of the Subsidiaries files with the SEC or any national securities exchange that are not immediately publicly available on the ASX
platform or the SEC’s EDGAR system; 
 (k) promptly upon receipt thereof, copies of all “management letters”
(or equivalent) submitted to Holdings, the Borrower or any of the Subsidiaries by the independent public accountants referred to in clause (b) in connection with each audit made by such accountants; 

(l) promptly upon receipt thereof, copies of all subpoenas, requests for information and other notices regarding any active or
potential investigation of, or claim or litigation against, Holdings, the Borrower or any of the Subsidiaries by any Governmental Authority, and the findings of any inspections of any manufacturing facilities of Holdings, the Borrower or any of the
Subsidiaries or any Third Party suppliers of Holdings, the Borrower or any of the Subsidiaries by any Governmental Authority (including any Form 483s and warning letters); 

(m) as soon as practicable and in any event within five Business Days after (i) the Borrower enters into a new Material
Agreement; and (ii) an existing Material Agreement is amended or terminated; and 
 (n) such other financial and other
information as the Lender may from time to time reasonably request (including copies of any documents requested and information and reports in such detail as the Lender may request with respect to the terms of and information provided pursuant to
the Compliance Certificate). 
 The Borrower will furnish the Lender, together with the delivery of any reports of Revenue Base pursuant to clause
(b) or (c) above, supporting detail (including, account-level detail regarding the sources of cash collected to comprise Net Sales, and, to the extent Net Sales are not recognized as GAAP revenue in the period pursuant to clause
(b) or (c) above, a description of 

  
 -54- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
when and how such Net Sales are anticipated to be recognized as GAAP revenue) and a reconciliation of the cash based determination of Revenue Base to Holdings’ GAAP, accrual based, financial
statements, in form reasonably satisfactory to the Lender. 
 SECTION 7.2 Maintenance of Existence; Compliance with Contracts, Laws,
Etc. Each of Holdings, the Borrower and each of the Subsidiaries will preserve and maintain its legal existence (except as otherwise permitted by Section 8.7), perform in all material respects its obligations under Material
Agreements to which Holdings, the Borrower or any of the Subsidiaries is a party, take all actions to ensure that all Material Agreements remain in full force and effect, and comply in all material respects with all applicable laws, rules,
regulations and orders (including all Laws), including the payment (before the same become delinquent), of all Taxes, imposed upon Holdings, the Borrower or any of the Subsidiaries or upon their property except to the extent being diligently
contested in good faith by appropriate proceedings and for which adequate reserves in accordance with GAAP have been set aside on the books of Holdings, the Borrower or any of the Subsidiaries, as applicable. None of Holdings, the Borrower or any of
the Subsidiaries will become a member of a Tax Consolidated Group or GST Group (other than the Australian Subsidiaries may be members of a Tax Consolidated Group or GST Group in which they are the only two members). 

SECTION 7.3 Maintenance of Properties. Each of Holdings, the Borrower and each of the Subsidiaries will maintain, preserve,
protect and keep its and their respective properties in good repair, working order and condition (ordinary wear and tear excepted and obligations of the landlords of any leased real property excepted), and make necessary repairs, renewals and
replacements (or, with respect to any leased real property, cause landlord to do so) so that the business carried on by Holdings, the Borrower or any of the Subsidiaries may be properly conducted at all times, unless Holdings, the Borrower or any of
the Subsidiaries determines in good faith that the continued maintenance of such property is no longer economically desirable, necessary or useful to the business of Holdings, the Borrower or any of the Subsidiaries or the Disposition of such
property is otherwise permitted by Section 8.7 or Section 8.8. 
 SECTION 7.4 Insurance. Each of
Holdings, the Borrower and each of the Subsidiaries will maintain: 
 (a) insurance on its property with financially sound
and reputable insurance companies against business interruption, loss and damage in at least the amounts (and with only those deductibles) customarily maintained, and against such risks as are typically insured against in the same general area, by
Persons of comparable size engaged in the same or similar business as Holdings, the Borrower and the Subsidiaries; and 
 (b)
all worker’s compensation, employer’s liability insurance or similar insurance as may be required under the laws of any state or jurisdiction in which it may be engaged in business. 

  
 -55- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 Without limiting the foregoing, all insurance policies required pursuant to this Section shall (i) name
the Lender as mortgagee and loss payee (in the case of property insurance) and additional insured (in the case of liability insurance), as applicable, and provide that no cancellation of the policies will be made without 30 days’ prior written
notice to the Lender and (ii) be in addition to any requirements to maintain specific types of insurance contained in the other Loan Documents. 

SECTION 7.5 Books and Records. Each of Holdings, the Borrower and each of the Subsidiaries will keep books and records in
accordance with GAAP which accurately reflect all of its business affairs and transactions and permit the Lender or any of its representatives, at reasonable times and intervals upon reasonable notice to the Borrower, to visit Holdings’, the
Borrower’s or any of the Subsidiaries’ offices, to discuss Holdings’, the Borrower’s or any of the Subsidiaries’ financial or other matters with its officers and employees, and its independent public accountants (and the
Borrower hereby authorizes such independent public accountant to discuss Holdings’, the Borrower’s and any of the Subsidiaries’ financial and other matters with the Lender or its representatives whether or not any representative of
Holdings, the Borrower or any of the Subsidiaries is present) and to examine (and photocopy extracts from) any of its books and records all at Borrower’s expense; provided that, only one such visit and inspection in each calendar year shall be
at the Borrower’s expense, other than and visits and inspections during the time that an Event of Default has occurred and is continuing. 

SECTION 7.6 Environmental Law Covenant. Each of Holdings, the Borrower and each of the Subsidiaries will (i) use and operate
all of its and their businesses, facilities and properties in material compliance with all Environmental Laws, and keep and maintain all Environmental Permits and remain in compliance therewith, and (ii) promptly notify the Lender of, and
provide the Lender with copies of all material claims, complaints, notices or inquiries relating to, any actual or alleged non-compliance with any Environmental Laws or Environmental Permits or any actual or alleged Environmental Liabilities.
Holdings, the Borrower and each of the Subsidiaries will, to the extent required by applicable Environmental Laws, promptly resolve, remedy and mitigate any such non-compliance or Environmental Liabilities, and shall keep the Lender informed as to
the progress of same. 
 SECTION 7.7 Use of Proceeds. The Borrower will apply the proceeds of the Loans according to the sources
and uses table in Schedule 7.7. 
 SECTION 7.8 Future Guarantors, Security, Etc. Each of Holdings, the Borrower and each
of the Subsidiaries will execute any documents, financing statements, agreements and instruments, and take all further action that may be required under applicable law, or that the Lender may reasonably request, in order to effectuate the
transactions contemplated by the Loan Documents and in order to grant, preserve, protect and perfect the validity and priority (subject to Liens permitted by Section 8.3) of the Liens created or intended to be created by the Loan
Documents, subject to any limitations, terms and requirements set forth in the Security Agreement or the Australian Security Agreements (including provisions that only require certain 

  
 -56- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
actions to be taken on a quarterly basis). Prior to or upon acquiring, incorporating or organizing any new Subsidiary, the Borrower will cause such Subsidiary to execute a supplement (in form and
substance satisfactory to the Lender) to the Guarantee, the Security Agreement and each other applicable Loan Document in favor of the Lender and shall enter into such other security agreements and take such other actions as may be required or
reasonably requested for the Lender to have a valid Lien with the priority intended to be created on and security interest in all of the assets of such Subsidiary, subject to no other Liens (other than Liens permitted by Section 8.3)
subject to any limitations and requirements set forth in the Security Agreement or the Australian Security Agreements (including provisions that only require certain actions to be taken on a quarterly basis). Prior to or upon any of Holdings, the
Borrower and the Subsidiaries entering into a new lease with respect to real property, the Borrower will cause the lessor thereof to enter into a landlord access agreement reasonably acceptable to the Lender. The Borrower shall cause the lessor of
the Radnor, Pennsylvania premises to enter into a landlord access agreement reasonably acceptable to the Lender if any Collateral is placed or installed on such premises (it being understood that on the date hereof such premises are vacant and no
Collateral is placed or installed on such premises). The Borrower will promptly notify the Lender of any subsequently acquired real property and will provide the Lender with a description of such real property, the acquisition date thereof and the
purchase price therefor. In addition, from time to time, each of Holdings, the Borrower and each of the Subsidiaries will, at its cost and expense, secure the Obligations by pledging or creating, or causing to be pledged or created, perfected Liens
with respect to such of its assets and properties as the Lender shall designate, it being agreed that it is the intent of the parties that the Obligations shall be secured by, among other things, substantially all the assets of Holdings, the
Borrower and the Subsidiaries (including real property and personal property acquired subsequent to the Closing Date). Such Liens will be created under the Loan Documents in form and substance satisfactory to the Lender, and Holdings, the Borrower
and each of the Subsidiaries shall deliver or cause to be delivered to the Lender all such instruments and documents (including mortgages, legal opinions, title insurance policies and lien searches) as the Lender shall reasonably require to evidence
compliance with this Section subject to any limitations and requirements set forth in the Security Agreement or the Australian Security Agreements (including provisions that only require certain actions to be taken on a quarterly basis). 

SECTION 7.9 Obtaining of Permits, Etc. With respect to Products, each of Holdings, the Borrower and each of the Subsidiaries will
obtain, maintain and preserve, and take all necessary action to timely renew all Permits and accreditations that are necessary and material to the proper conduct of its business. 

SECTION 7.10 Product Licenses. Each of Holdings, the Borrower and each of the Subsidiaries shall maintain each Permit, including
each Key Permit, from, or file any notice or registration in, each jurisdiction in which Holdings, the Borrower or any of the Subsidiaries are required to obtain any Permit or Regulatory Authorization or to file any notice or registration that are
necessary and material for the sale and distribution of the Products, it being understood that this Section 7.10 does not concern Permits required to be maintained by customers of 

  
 -57- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
Borrower or any of its Affiliates for any research, development, design, investigation, manufacture, marketing or distribution conducted or sponsored by such customer of the Borrower or any of
its Affiliates of any finished product that is a combination of any Product with any drugs or biologics of such customers. 

SECTION 7.11 Maintenance of Regulatory Authorizations, Contracts, Intellectual Property, Etc. With respect to the Products, each
of Holdings, the Borrower and each of the Subsidiaries will (i) maintain in full force and effect all Regulatory Authorizations, contract rights, authorizations or other rights necessary and material for the operations of its business, and
comply with the terms and conditions applicable to the foregoing excluding the maintenance of Regulatory Authorizations that in the commercially reasonable business judgment of the Borrower are not necessary or material for the conduct of the
business of Holdings, the Borrower or any Subsidiary; (ii) notify the Lender, promptly after learning thereof, of any product recalls, safety alerts, withdrawals, marketing suspensions, removals or the like conducted, to be undertaken or
issued, by Holdings, the Borrower, any of the Subsidiaries or their respective suppliers whether or not at the request, demand or order of any Governmental Authority or otherwise with respect to any Product, or any basis for undertaking or issuing
any such action or item; (iii) design, manufacture, store and label all Products in compliance in all material respects with cGMP, QSRs and other applicable Laws; (iv) conduct all studies, tests and preclinical and clinical trials relating
to the Products sponsored by Borrower in accordance in all material respects with all IDEs, current good clinical practices, current good laboratory practices, and other applicable Laws; (v) maintain in full force and effect, not permit to
expire, lapse, be forfeited, be lost, be cancelled or be abandoned prior to the maximum expect legal life of, or pursue the prosecution of, as the case may be, and pay all costs and expenses relating to, all Intellectual Property owned or controlled
by Holdings, the Borrower or any of the Subsidiaries and all Material Agreements, excluding the maintenance of Intellectual Property that in the commercially reasonable business judgment of the Borrower is not necessary or material for the conduct
of the business of Holdings, the Borrower or any Subsidiary; (vi) notify the Lender, promptly after learning thereof, of any Infringement or other violation by any Person of its Intellectual Property; (vii) pursue and maintain in full
force and effect legal protection for all Intellectual Property, including Patents, developed or controlled by Holdings, the Borrower or any of the Subsidiaries; and (viii) notify the Lender, promptly after learning thereof, of any claim by any
Person that the conduct of Holdings’, the Borrower’s or any of the Subsidiaries’ business (including the development, manufacture, use, sale or other commercialization of any Product) Infringes any Intellectual Property of that Person
and, if requested by the Lender, use commercially reasonable efforts to resolve such claim. 
 SECTION 7.12 Inbound Licenses.
Each of Holdings, the Borrower and each of the Subsidiaries will, promptly after entering into or becoming bound by any inbound license or agreement (other than over-the-counter software that is commercially available to the public):
(i) provide written notice to the Lender of the material terms of such license or agreement with a description of its anticipated and projected impact on Holdings’, the Borrower’s and the Subsidiaries’ business and financial
condition; and (ii) take such commercially reasonable 

  
 -58- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
actions as the Lender may reasonably request to obtain the consent of, or waiver by, any Person whose consent or waiver is necessary for the Lender to be granted and perfect a valid security
interest in such license or agreement and to fully exercise its rights under any of the Loan Documents in the event of a disposition or liquidation of the rights, assets or property that is the subject of such license or agreement. 

SECTION 7.13 Cash Management. Each of Holdings, the Borrower and each of the Subsidiaries will: 

(a) maintain a current and complete list of all accounts (of the type initially set forth on Schedule 6.22) and promptly
deliver any updates to such list to the Lender; execute and maintain an account control agreement for each such account (other than Excluded Accounts), in form and substance reasonably acceptable to the Lender (each such account, a
“Controlled Account”); and maintain each such account as a cash collateral account, with all cash, checks and other similar items of payment in such account securing payment of the Obligations (and in which Holdings, the Borrower
and the Subsidiaries shall have granted a Lien to the Lender); 
 (b) deposit promptly, and in any event no later than five
Business Days after the date of receipt thereof, all cash, checks, drafts or other similar items of payment relating to or constituting payments made in respect of any and all accounts and other rights and interests into Controlled Accounts; and

 (c) at any time after the occurrence and during the continuance of an Event of Default, at the request of the Lender,
promptly cause all payments constituting proceeds of accounts to be directed into lockbox accounts under agreements in form and substance satisfactory to the Lender. 

SECTION 7.14 Subsequent Agreement. From and after the date hereof, until such time as the Lender has designated a Subsequent
Agreement pursuant to the definition thereof, the Borrower shall provide written notice to the Lender of its entry into each agreement with a pharmaceutical or biotechnology company, together with a copy of the applicable agreement. Within 30 days
of the Lender’s delivery to the Borrower of written notification of its designation of any agreement or set of related agreements as the Subsequent Agreement, the Borrower shall deliver to the Lender an acknowledgement agreement executed by the
applicable pharmaceutical or biotechnology company, in form and substance satisfactory to the Lender and generally consistent with those executed in connection herewith (other than any agreement with Hikma). 

  
 -59- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE VIII 

NEGATIVE COVENANTS 
 The Borrower
covenants and agrees with the Lender that until the Termination Date has occurred, Holdings, the Borrower and the Subsidiaries will perform or cause to be performed the obligations set forth below. 

SECTION 8.1 Business Activities. None of Holdings, the Borrower or any of the Subsidiaries will engage in any line of business or
activity except those business lines and activities engaged in on the date of this Agreement and business or activities substantially similar, ancillary, incidental, complementary or related to, or a reasonable extension, development or expansion
thereto. 
 SECTION 8.2 Indebtedness. None of Holdings, the Borrower or any of the Subsidiaries will create, incur, assume or
permit to exist any Indebtedness, other than: 
 (a) Indebtedness in respect of the Obligations; 

(b) until the Closing Date, Indebtedness that is to be repaid in full as further identified in Schedule 8.2(b); 

(c) Indebtedness existing as of the Closing Date which is identified in Schedule 8.2(c), and refinancing of such
Indebtedness in a principal amount not in excess of that which is outstanding on the Closing Date (as such amount has been reduced following the Closing Date); 

(d) unsecured Indebtedness in respect of performance, surety or appeal bonds provided in the ordinary course of business in an
aggregate amount at any time outstanding not to exceed $1,000,000; 
 (e) Purchase Money Indebtedness and Capitalized Lease
Liabilities not to exceed $10,000,000 in the aggregate, including of any outstanding Purchase Money Indebtedness and Capitalized Lease Liabilities permitted by Section 8.2(c); 

(f) Permitted Subordinated Indebtedness; 

(g) Indebtedness of any Guarantor or the Borrower owing to the Borrower or any Guarantor; and 

(h) other Indebtedness of Holdings, the Borrower and the other Guarantors in an aggregate amount at any time outstanding not to
exceed $1,000,000; 

  
 -60- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 provided that no Indebtedness otherwise permitted by clauses (c), (e), (f),
(g) or (h) shall be assumed, created or otherwise incurred if a Default has occurred and is then continuing or would result therefrom. 

SECTION 8.3 Liens. None of Holdings, the Borrower or any of the Subsidiaries will create, incur, assume or permit to exist any
Lien upon any of its property (including Capital Securities of any Person), revenues or assets, whether now owned or hereafter acquired, except: 

(a) Liens securing payment of the Obligations; 

(b) until the Closing Date, Liens securing payment of Indebtedness of the type described in Section 8.2(b); 

(c) Liens existing as of the Closing Date and disclosed in Schedule 8.3(c) securing Indebtedness described in
Section 8.2(c), and refinancings of such Indebtedness; provided that no such Lien shall encumber any additional property and the amount of Indebtedness secured by such Lien is not increased from that existing on the Closing Date
(as such Indebtedness may have been permanently reduced subsequent to the Closing Date); 
 (d) Liens securing Indebtedness
of Holdings, the Borrower or the other Guarantors permitted pursuant to Section 8.2(e) (provided that (i) such Liens shall be created within 180 days of the acquisition of the assets financed with such Indebtedness and
(ii) such Liens do not at any time encumber any property other than the property so financed); 
 (e) Liens in favor of
carriers, warehousemen, mechanics, materialmen and landlords (including security deposits) granted in the ordinary course of business for amounts not overdue for a period of more than thirty (30) days or being diligently contested in good faith
by appropriate proceedings and for which adequate reserves in accordance with GAAP shall have been set aside on its books; 

(f) Liens incurred or deposits made in the ordinary course of business in connection with worker’s compensation,
unemployment insurance or other forms of governmental insurance or benefits, or to secure performance of tenders, statutory obligations, bids, leases or other similar obligations (other than for borrowed money) entered into in the ordinary course of
business or to secure obligations on surety, stay, customs, appeal or performance bonds; 
 (g) judgment Liens in existence
for less than 60 days after the entry thereof or with respect to which execution has been stayed or the payment of which is covered in full (subject to a customary deductible) by insurance maintained with responsible insurance companies and
which do not otherwise result in an Event of Default under Section 9.1(g); 

  
 -61- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (h) easements, rights-of-way, zoning restrictions, minor defects or
irregularities in title, restrictions and other similar encumbrances on the use of real property not interfering in any material respect with the value or use of the property to which such Lien is attached and with respect to the real property
leased by Holdings, the Borrower or the Subsidiaries pursuant to any capital lease or other real estate lease, such Liens existing or of record of which shall be hereinafter placed on the fee interest of such real property by parties other than
Holdings, the Borrower or the Subsidiaries, including mortgages, deeds of trust, UCC security interest filings and similar encumbrances; 

(i) Liens for Taxes not at the time delinquent or thereafter payable without penalty or being diligently contested in good
faith by appropriate proceedings and for which adequate reserves in accordance with GAAP shall have been set aside on its books; 

(j) Liens arising in the ordinary course of business by virtue of any contractual, statutory or common law provision relating
to banker’s Liens, rights of set-off or similar rights and remedies covering deposit or securities accounts (including funds or other assets credited thereto) or other funds maintained with a depository institution or securities intermediary,
in each case incurred in the ordinary course of business; 
 (k) the interests of lessors under operating leases and
non-exclusive licensors under license agreements; and 
 (l) non-exclusive licenses or covenants not to sue of patents,
trademarks, copyrights and other intellectual property rights in the ordinary course of business. 
 SECTION 8.4 Financial
Covenants. 
 (a) Minimum Revenue Base. The Revenue Base for each calendar year set forth below shall not be less
than the amount set forth below for such calendar year: 
  

					
	 Calendar Year Ended
	  	Minimum
Revenue Base	 
	 December 31, 2014
	  	$	40,000,000	  
	 December 31, 2015
	  	$	54,100,000	  
	 December 31, 2016
	  	$	67,400,000	  
	 December 31, 2017
	  	$	78,400,000	  
	 December 31, 2018
	  	$	84,000,000	  
	 December 31, 2019
	  	$	84,000,000	  

 (b) Minimum Liquidity. The Liquidity of the Borrower shall not at any time be less than
$5,000,000. The Borrower shall maintain an amount equal to the amount required under this Section 8.4(b), along with its other cash and Cash Equivalent Investments, in a Controlled Account. 

  
 -62- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 8.5 Investments. None of Holdings, the Borrower or any of the
Subsidiaries will purchase, make, incur, assume or permit to exist any Investment in any other Person, except: 
 (a)
Investments existing on the Closing Date and identified in Schedule 8.5(a); 
 (b) Cash Equivalent Investments;
provided that any Investment which when made complies with the requirements of the definition of the term “Cash Equivalent Investment” may continue to be held notwithstanding that such Investment if made thereafter would not comply with
such requirements; 
 (c) Investments received in connection with the bankruptcy or reorganization of, or settlement of
delinquent accounts and disputes with, customers and suppliers, in each case in the ordinary course of business; 
 (d)
Investments consisting of any deferred portion of the sales price received by Holdings, the Borrower or any of the Subsidiaries in connection with any Disposition permitted under Section 8.8; 

(e) Investments constituting (i) accounts receivable arising, (ii) trade debt granted, or (iii) deposits made in
connection with the purchase price of goods or services, in each case in the ordinary course of business; 
 (f) other
Investments in an amount not to exceed $100,000 over the term of this Agreement, provided that no Investment otherwise permitted by this clause (f) shall be permitted to be made if any Default has occurred and is continuing or would
result therefrom; and 
 (g) Investments in the form of Capital Contributions and the ownership of Capital Stock made by one
Credit Obligor in another Credit Obligor that is its direct Subsidiary; and 
 (h) loans permitted under Section 8.2(g).

 SECTION 8.6 Restricted Payments, Etc. None of Holdings, the Borrower or any of the Subsidiaries will declare or make a
Restricted Payment, or make any deposit for any Restricted Payment, other than Restricted Payments made by the Borrower or any of the Subsidiaries to the Borrower or any Guarantor. 

SECTION 8.7 Consolidation, Merger; Permitted Acquisitions, Etc. None of Holdings, the Borrower or any of the Subsidiaries will
liquidate or dissolve, consolidate with, or merge into 

  
 -63- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
or with, any other Person, or purchase or otherwise acquire all or substantially all of the assets of any Person (or any division thereof), except that, so long as no Event of Default has
occurred and is continuing (or would occur as a result), any Subsidiary may liquidate or dissolve voluntarily into, and may merge with and into, the Borrower or any Guarantor that is organized or incorporated in the same jurisdiction as such
Subsidiary (provided that Persons organized in different states of the United States shall be deemed to be organized in the same jurisdiction for purposes of this Section 8.7). 

SECTION 8.8 Permitted Dispositions. None of Holdings, the Borrower or any of the Subsidiaries will Dispose of any of its assets
(including accounts receivable and Capital Securities of the Borrower or Subsidiaries) to any Person in one transaction or a series of transactions unless such Disposition (i) is inventory or obsolete, damaged, worn out or surplus property
Disposed of in the ordinary course of its business, or (ii) is permitted by Section 8.7. 
 SECTION 8.9
Modification of Certain Agreements. None of Holdings, the Borrower or any of the Subsidiaries will consent to any amendment, supplement, waiver or other modification of, or enter into any forbearance from exercising any rights with respect
to, the terms or provisions contained in (i) any Organic Documents of Holdings, the Borrower or any of the Subsidiaries, if the result would have an adverse effect on the rights or remedies of the Lender, (ii) any agreement governing any
Permitted Subordinated Indebtedness, if the result would shorten the maturity date thereof or advance the date on which any cash payment is required to be made thereon or would otherwise change any terms thereof in a manner adverse to the Lender,
(iii) any intracompany license agreement between or among Holdings, the Borrower or any Subsidiary, including those agreements listed on Schedule 8.9, (iv) all documents relating to the Metro Bank Mortgage Loan and the Pennsylvania Loan,
(v) the Hikma Security Agreement, (vi) the Hikma LDSA and the definitive separate Supply Agreement and Quality Agreement (as referenced in the Hikma LDSA), the Sanofi Supply Agreement, the MedImmune Agreement and any other Covered
Agreement, in each case of this clause (vi), if any such amendment, supplement, waiver or other modification is adverse in any material respect to the interests of the Lender. 

SECTION 8.10 Transactions with Affiliates. None of Holdings, the Borrower or any of the Subsidiaries will enter into or cause or
permit to exist any arrangement, transaction or contract (including for the purchase, lease or exchange of property or the rendering of services) with, or make any payment to, any of its Affiliates, unless such arrangement, transaction, contract or
payment (i) is between or among the Borrower or any Guarantor, (ii) is on fair and reasonable terms no less favorable to Holdings, the Borrower or any Subsidiary than it could obtain in an arm’s-length transaction with a Person that
is not one of its Affiliates and (ii) is of the kind which would be entered into by a prudent Person in its position with a Person that is not one of its Affiliates. 

SECTION 8.11 Restrictive Agreements, Etc. None of Holdings, the Borrower or any of the Subsidiaries will enter into any agreement
prohibiting (i) the creation or assumption of any 

  
 -64- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
Lien upon its properties, revenues or assets, whether now owned or hereafter acquired, (ii) the ability of Holdings, the Borrower or any of the Subsidiaries to amend or otherwise modify any
Loan Document, or (iii) the ability of the Borrower or any Subsidiary to make any payments, directly or indirectly, to the Borrower or any Guarantor, including by way of dividends, advances, repayments of loans, reimbursements of management and
other intercompany charges, expenses and accruals or other returns on investments. The foregoing prohibitions shall not apply to restrictions contained (x) in any Loan Document, or (y) in the case of clause (i), any agreement
governing any Indebtedness permitted by Section 8.2(e) as to the assets financed with the proceeds of such Indebtedness. 

SECTION 8.12 Sale and Leaseback. None of Holdings, the Borrower or any of the Subsidiaries will directly or indirectly enter into
any agreement or arrangement providing for the sale or transfer by it of any property (now owned or hereafter acquired) to a Person and the subsequent lease or rental of such property or other similar property from such Person. 

SECTION 8.13 Product Agreements. None of Holdings, the Borrower or any of the Subsidiaries will enter into any amendment with
respect to any existing Product Agreement or enter into any new Product Agreement that contains (a) any provision which restricts or penalizes a security interest in, or the assignment of, any Product Agreements, upon the sale, merger or other
disposition of all or a material portion of a Product to which such Product Agreement relates, or (b) any other provision that has or is likely to adversely effect, in any material respect, any Product to which such agreement relates or to the
Lender’s rights hereunder; provided, however, nothing in this Section 8.13 shall limit the rights of Holdings, the Borrower or any of the Subsidiaries to enter into any amendment with respect to any existing Product
Agreement or enter into any new Product Agreement that contain provisions consistent with past practices, including the provisions set forth in the Covered Agreements. 

SECTION 8.14 Change in Name, Location or Executive Office or Executive Management; Change in Fiscal Year. None of Holdings, the
Borrower or any of the Subsidiaries will (i) change its legal name or any trade name used to identify it in the conduct of its business or ownership of its properties, (ii) change its jurisdiction of organization or registration or legal
structure, (iii) relocate its chief executive office, principal place of business or any office in which it maintains books or records relating to its business (including the establishment of any new office or facility) without the prior
written consent of the Lender, which consent shall not be unreasonably withheld, (iv) change its federal taxpayer identification number or organizational number (or equivalent) without 10 days’ prior written notice to the Lender,
(v) replace its chief executive officer or chief financial officer without written notification to the Lender within 30 days thereafter, or (vi) change its Fiscal Year or any of its Fiscal Quarters. 

SECTION 8.15 Benefit Plans and Agreements. None of Holdings, the Borrower or any Subsidiary will (i) become the sponsor of,
incur any responsibility to contribute to or otherwise incur actual or potential liability with respect to, any Benefit Plan, (ii) allow any “employee benefit plan” as defined in section 3(3) of ERISA that provides retirement benefits
and that is 

  
 -65- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
sponsored by Holdings, the Borrower, any Subsidiary or any of their ERISA Affiliates (or under which any of these entities has any actual or potential liability) and is intended to be tax
qualified under section 401 of the Code to be disqualified, (iii) allow the assets of any tax qualified retirement plan to become invested in Capital Securities of the Borrower or any Subsidiary, (iv) allow any employee benefit plan,
program or arrangement sponsored, maintained, contributed to or required to be contributed to by Holdings, the Borrower or any Subsidiary (or under which any of these entities has any actual or potential liability) to fail to comply in all material
respects with its terms and applicable law except for non-compliance that would not reasonably (x) be expected, individually or in the aggregate, to result in liabilities in excess of $500,000 or (y) be likely to adversely affect this
Agreement or the transaction contemplated hereby, or (v) allow any employee benefit plan as defined in section 3(3) of ERISA that provides medical, dental, vision or long-term disability benefits and that is sponsored by Holdings, the Borrower,
any Subsidiary or any of their ERISA Affiliates (or under which any of these entities has any actual or potential liability) to become self-insured, except to the extent already self-insured with respect to the Borrower’s short-term disability
program for salaried employees and health reimbursement accounts for all of its employees. None of Holdings, the Borrower or any Subsidiary will enter into any employment, severance or tax gross-up agreement or grant any equity awards other than in
the course of ordinary business or consistent with past practice; provided that this sentence shall not restrict Holdings’ ability to allow the assets of any tax qualified retirement plan to become invested in Capital Securities of
Holdings. 
 SECTION 8.16 Holding Companies. 

(a) Holdings shall not have any operations (other than such operations as are incidental to its status as a holding company,
including maintaining its corporate existence and participating in tax, accounting and other administrative activities as the parent of the consolidated group of companies), own any assets (other than ownership of Capital Securities of the Borrower
or other Subsidiaries and such immaterial assets as are incidental to its status as a holding company) or incur any liabilities (other than the Obligations under the Loan Documents and such immaterial liabilities as are incidental to its status as a
holding company, including payment of annual listing fees to ASX and fees for quotation of new securities on ASX). 
 (b)
Neither Unilife Medical Solutions Pty Limited nor Unitract Syringe Pty Ltd shall have any operations (other than such operations as are incidental to owning Intellectual Property and licensing Intellectual Property to its Affiliates or other
Subsidiaries and incidental to its status as a holding company, including maintaining its corporate existence and the existence of Intellectual Property rights), own any assets (other than ownership of Intellectual Property, Capital Securities of
the Borrower and such immaterial assets as are incidental to its status as a holding company) or incur any liabilities (other than the Obligations under the Loan Documents including ongoing patent maintenance fees in Australia and any royalties or
payments required to be made under the IP Licensing Arrangements and such immaterial liabilities as are incidental to its status as a holding company). 

  
 -66- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (c) Unilife Cross Farm LLC shall not have any operations (other than such
operations as are incidental to owning real property, including maintaining its corporate existence and the existence of Intellectual Property rights), own any assets (other than real property, the Metro Bank Reserve Account and such immaterial
assets as are incidental to owning real property) or incur any liabilities (other than the Obligations under the Loan Documents, the obligations under the Metro Bank Reserve Account, obligations under the first priority Metro Bank Mortgage Loans and
the Pennsylvania Loan and such immaterial liabilities as are incidental to owning real property). 
 (d) Unilife France shall
remain dormant and shall not have any operations, own any assets or incur any liabilities. 
 SECTION 8.17 Hikma Collateral.
Except with the consent of the Lender, none of the Hikma Collateral will be used, or held for use, for the research, design, development, manufacturing, licensing, marketing, sale, distribution or other commercialization of Products for any
customers of any Credit Obligor other than Hikma Pharmaceuticals, LLC; except that (i) Hikma Collateral may be used in the development of Intellectual Property, and (ii) certain inventory of the type included in the Hikma Collateral
consists of components that are also of the same type or kind used or held for use for customers other than Hikma (and such inventory used or held for use for such other customers is not Hikma Collateral). 

ARTICLE IX 
 EVENTS OF DEFAULT 

SECTION 9.1 Listing of Events of Default. Each of the following events or occurrences described in this Article IX shall
constitute an “Event of Default”. 
 (a) Non-Payment of Obligations. The Borrower shall default in
the payment or prepayment when due of (i) any principal of or interest on any Loan, or (ii) any fee described in Article III or any other monetary Obligation, and in the case of clause (ii) such default shall continue
unremedied for a period of two Business Days after such amount was due. 
 (b) Breach of Warranty. Any representation
or warranty made or deemed to be made by Holdings, the Borrower or any of the Subsidiaries in any Loan Document (including any certificates delivered pursuant to Article V) is or shall be incorrect when made or deemed to have been made in any
material respect. 
 (c) Non-Performance of Certain Covenants and Obligations. Holdings, the Borrower or any
Subsidiary shall default in the due performance or observance of any of its obligations under Section 5.26, Section 5.27, Section 5.28, Section 5.29, Section 7.1, Section 7.7,
or Article VIII. 

  
 -67- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) [Reserved]. 

(e) Non-Performance of Other Covenants and Obligations. Holdings, the Borrower or any Subsidiary shall default in the
due performance and observance of any other covenant, obligation or agreement contained in any Loan Document executed by it, and such default shall continue unremedied for a period of 30 days after the earlier to occur of (i) notice
thereof given to the Borrower by the Lender or (ii) the date on which Holdings, the Borrower or any Subsidiary has knowledge of such default. 

(f) Default on Other Indebtedness. Holdings, the Borrower or any Subsidiary shall fail to pay any amount when due
(subject to any applicable grace period), whether by acceleration or otherwise, of any principal or stated amount of, or interest or fees on, any Indebtedness of Holdings, the Borrower or any of the Subsidiaries having a principal or stated amount,
individually or in the aggregate, in excess of $1,000,000, or a default shall occur in the performance or observance of any obligation or condition with respect to such Indebtedness if the effect of such default is to accelerate the maturity of any
such Indebtedness or such default shall continue unremedied for any applicable period of time sufficient to permit the holder or holders of such Indebtedness, or any trustee or agent for such holders, to cause or declare such Indebtedness to become
due and payable or to require such Indebtedness to be prepaid, redeemed, purchased or defeased, or require an offer to purchase or defease such Indebtedness to be made, prior to its expressed maturity. 

(g) Judgments. Any judgment or order for the payment of money individually or in the aggregate in excess of $1,000,000
(exclusive of any amounts fully covered by insurance (less any applicable deductible) and as to which the insurer has acknowledged its responsibility to cover such judgment or order) shall be rendered against Holdings, the Borrower or any of the
Subsidiaries and such judgment shall not have been vacated or discharged or stayed or bonded pending appeal within 30 days after the entry thereof or enforcement proceedings shall have been commenced by any creditor upon such judgment or order.

 (h) Change in Control. Any Change in Control shall occur. 

(i) Bankruptcy, Insolvency, Etc. Holdings, the Borrower or any of the Subsidiaries shall 

(i) become insolvent or generally fail to pay, or admit in writing its inability or unwillingness generally to pay, debts as
they become due; 

  
 -68- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (ii) apply for, consent to, or acquiesce in the appointment of a trustee,
receiver, sequestrator or other custodian for any substantial part of the property of any thereof, or make a general assignment for the benefit of creditors; 

(iii) in the absence of such application, consent or acquiescence in or permit or suffer to exist the appointment of a trustee,
receiver, sequestrator or other custodian for a substantial part of the property of any thereof, and such trustee, receiver, sequestrator or other custodian shall not be discharged within 60 days; provided that Holdings, the Borrower and
each Subsidiary hereby expressly authorizes the Lender to appear in any court conducting any relevant proceeding during such 60-day period to preserve, protect and defend its rights under the Loan Documents; 

(iv) permit or suffer to exist the commencement of any bankruptcy, reorganization, debt arrangement or other case or proceeding
under any bankruptcy or insolvency law or any dissolution, winding up or liquidation proceeding, in respect thereof, and, if any such case or proceeding is not commenced by Holdings, the Borrower or any Subsidiary, such case or proceeding shall be
consented to or acquiesced in by Holdings, the Borrower or such Subsidiary, as the case may be, or shall result in the entry of an order for relief or shall remain for 60 days undismissed; provided that Holdings, the Borrower and each
Subsidiary hereby expressly authorizes the Lender to appear in any court conducting any such case or proceeding during such 60-day period to preserve, protect and defend its rights under the Loan Documents; or

 (v) take any action authorizing, or in furtherance of, any of the foregoing. 

(j) Insolvency Event. An Insolvency Event occurs with respect to any Australian Subsidiary. 

(k) Impairment of Security, Etc. Any Loan Document or any Lien granted thereunder shall (except in accordance with its
terms), in whole or in part, terminate, cease to be effective or cease to be the legally valid, binding and enforceable obligation of Holdings, the Borrower or any Subsidiary thereto; Holdings, the Borrower, any Subsidiary or any other party shall,
directly or indirectly, contest in any manner such effectiveness, validity, binding nature or enforceability; or, except as permitted under any Loan Document, any Lien securing any Obligation shall, in whole or in part, cease to be a perfected first
priority Lien. 
 (l) Key Permit Events. Any Key Permit or any of Holdings’, the Borrower’s or any
Subsidiary’s material rights or interests thereunder is terminated or amended in any manner adverse to Holdings, the Borrower or any Subsidiary in any material respect; 

  
 -69- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
provided, however, the foregoing shall not apply to any Key Permit the Borrower allows to lapse for Products that are not material to the Credit Obligors and the Credit Obligors no
longer market or sell and have determined, in their reasonable business judgment, not to continue to market or sell. 
 (m)
Material Adverse Change. Any circumstance occurs that could reasonably be expected to have a Material Adverse Effect. 

(n) Key Person Event. If either or both of Alan Shortall and Dr. Ramin Mojdeh (or any replacement therefor
appointed in accordance with this Section 9.1(n)) ceases to be employed full time by the Borrower and Holdings and actively working as Chairman, CEO, President or Chief Operating Officer, unless within 90 days after such individual ceases to be
employed full time and actively working the Borrower and Holdings hire a replacement acceptable to the Lender (such acceptance not to be unreasonably withheld). 

(o) Regulatory Matters. If any of the following occurs: (i) the FDA, CMS, EMA or any other Governmental Authority
(A) issues a letter or other communication asserting that any Product lacks a required Regulatory Authorization, (B) initiates an enforcement action against, or issues a warning letter or takes any other action with respect to, Holdings,
the Borrower or any of the Subsidiaries, or any of their Products or the manufacturing facilities therefor, that causes Holdings, the Borrower or such Subsidiary to discontinue marketing or withdraw any of its Products, or causes a delay in the
manufacture or offering of any of its Products, which discontinuance, withdrawal or delay could reasonably be expected to last for more than 45 days, or (C) withdraws, or requires the withdrawal of, any Product for safety or effectiveness
reasons, or otherwise imposes restrictions on the distribution or use of any Product, which restrictions on distribution or use would reasonably be expected to significantly impact commercial sales of such Product; (ii) a recall which could
reasonably be expected to result in liability to the Borrower and the Subsidiaries in excess of $1,000,000; or (iii) the Borrower or any of the Subsidiaries enters into a settlement agreement with the FDA, CMS, EMA or any other Governmental
Authority that results in aggregate liability as to any single or related series of transactions, incidents or conditions in excess of $1,000,000. 

(p) Covered Agreements. (i) Any individual Covered Agreement terminates or otherwise ceases to be valid and
binding on any party thereto, (ii) any breach by Holdings, the Borrower or any Subsidiary occurs under any of the Covered Agreements, which permits (or could be reasonably expected to permit) the counterparty to terminate a Covered Agreement if
such breach is not cured within the applicable cure period, and such breach continues uncured for more than the applicable cure period specified in the relevant agreement, or (iii) Hikma takes an enforcement action against the collateral
pledged under the Hikma Security Agreement. 

  
 -70- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 9.2 Action if Bankruptcy. If any Event of Default described in clauses
(i) through (iv) of Section 9.1(i) or Section 9.1(j) with respect to the Borrower shall occur, the Commitments (if not theretofore terminated) shall automatically terminate and the outstanding principal amount of
the Loans and all other Obligations shall automatically be and become immediately due and payable, without notice or demand to any Person. 

SECTION 9.3 Action if Other Event of Default. If any Event of Default (other than any Event of Default described in clauses
(i) through (iv) of Section 9.1(i) or Section 9.1(j)) shall occur for any reason, whether voluntary or involuntary, and be continuing, the Lender may, by notice to the Borrower declare all or any portion of the
outstanding principal amount of the Loans and other Obligations to be due and payable and/or the Commitments (if not theretofore terminated) to be terminated, whereupon the full unpaid amount of the Loans and other Obligations which shall be so
declared due and payable shall be and become immediately due and payable, without further notice, demand or presentment, and the Commitments shall terminate. 

ARTICLE X 
 MISCELLANEOUS
PROVISIONS 
 SECTION 10.1 Waivers, Amendments, Etc. The provisions of each Loan Document may from time to time be amended,
modified or waived, if such amendment, modification or waiver is in writing and consented to by the Lender and the Borrower. No failure or delay on the part of the Lender in exercising any power or right under any Loan Document shall operate as a
waiver thereof, nor shall any single or partial exercise of any such power or right preclude any other or further exercise thereof or the exercise of any other power or right. No notice to or demand on Holdings, the Borrower or any of the
Subsidiaries in any case shall entitle it or any of them to any notice or demand in similar or other circumstances. No waiver or approval by the Lender under any Loan Document shall, except as may be otherwise stated in such waiver or approval, be
applicable to subsequent transactions. No waiver or approval hereunder shall require any similar or dissimilar waiver or approval thereafter to be granted hereunder. 

SECTION 10.2 Notices; Time. All notices and other communications provided under any Loan Document shall be in writing or by
facsimile and addressed, delivered or transmitted, if to the Borrower or the Lender, to the applicable Person at its address or facsimile number set forth on Schedule 10.2 hereto, or at such other address or facsimile number as may be
designated by such party in a notice to the other parties, and a copy of all notices shall be given by email at the email address for a party set forth therein, if any, or at such other email address as designated by such party to the other parties.
Any notice, if mailed and properly addressed with postage prepaid or if properly addressed and sent by pre-paid courier service, shall be deemed given when received; any notice, if transmitted by facsimile, shall be deemed given when the
confirmation of transmission thereof is received by the transmitter. Unless otherwise indicated, all references to the time of a day in a Loan Document shall refer to New York City time. 

  
 -71- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 10.3 Payment of Costs and Expenses. The Borrower agrees to pay on demand
all expenses of the Lender (including the fees and out-of-pocket expenses of Covington & Burling LLP, counsel to the Lender, and of local counsel, if any, who may be retained by or on behalf of the Lender) in connection with: 

(a) the negotiation, preparation, execution and delivery of each Loan Document, including schedules and exhibits, and any
amendments, waivers, consents, supplements or other modifications to any Loan Document as may from time to time hereafter be required, whether or not the transactions contemplated hereby are consummated; 

(b) the filing or recording of any Loan Document (including any financing statements) and all amendments, supplements,
amendment and restatements and other modifications to any thereof, searches made following the Closing Date in jurisdictions where financing statements (or other documents evidencing Liens in favor of the Lender) have been recorded and any and all
other documents or instruments of further assurance required to be filed or recorded by the terms of any Loan Document; and 

(c) the preparation and review of the form of any document or instrument relevant to any Loan Document. 

The Borrower also agrees to reimburse the Lender upon demand for all reasonable out-of-pocket expenses (including reasonable attorneys’ fees and legal
expenses of counsel to the Lender) incurred by the Lender in connection with (x) the negotiation of any restructuring or “work-out” with the Borrower, whether or not consummated, of any Obligations and (y) the enforcement of any
Obligations. 
 SECTION 10.4 Indemnification. In consideration of the execution and delivery of this Agreement by the Lender,
the Borrower hereby indemnifies, agrees to defend, exonerates and holds the Lender (as agent or lender), ROS, any “Receiver” (as defined in any Australian Security Document), any “Attorney” (as defined in any Australian Security
Document) and each of its officers, directors, employees and agents (collectively, the “Indemnified Parties”) free and harmless from and against any and all actions, causes of action, suits, losses, costs, liabilities, obligations
and damages, and expenses incurred in connection therewith (irrespective of whether any such Indemnified Party is a party to the action for which indemnification hereunder is sought), including reasonable attorneys’ and professionals’ fees
and disbursements, whether incurred in connection with actions between the parties hereto or the parties hereto and third parties (collectively, the “Indemnified Liabilities”), including, without limitation, Indemnified Liabilities
arising out of or relating to (i) the entering into and performance of any Loan Document by any of the Indemnified Parties (including any action brought by or on behalf of the Borrower as the result of any determination by the Lender pursuant
to Article V not to fund any Loan), (ii) a Credit Obligor failing to pay or perform the Obligations on time, (iii) an Insolvency Event in relation to a Credit Obligor, (iv) any Obligations (or money which would be Obligations

  
 -72- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
if it were recoverable) not being recoverable from a Credit Obligor, or a liability or obligation to pay any Obligations not being enforceable against a Credit Obligor, (v) enforcing a Loan
Document, or exercising, enforcing or protecting a Power, or attempting to do so, (vi) maintaining, preserving or protecting any collateral secured by any Loan Document, (vii) an indemnity given by the Lender (as agent or lender) or ROS to
a Receiver or administrator of a Credit Obligor, and (viii) any Environmental Liability, but excluding any Indemnified Liabilities for any Indemnified Party to the extent that they arise from such Indemnified Party’s gross negligence or
willful misconduct. If and to the extent that the foregoing indemnification may be unenforceable for any reason, the Borrower agrees to make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities which is
permissible under applicable law. This Section 10.4 shall not apply with respect to Taxes other than any Taxes that represent actions, causes of action, suits, losses, costs, liabilities, obligations and damages and expenses arising from any
third party claim or other non-Tax claim. 
 SECTION 10.5 Survival. The obligations of the Borrower under
Section 4.1, Section 4.2, Section 4.3, Section 10.3 and Section 10.4, shall in each case survive any assignment by the Lender and the occurrence of the Credit Agreement Termination Date and
the Termination Date. The representations and warranties made by the Borrower in each Loan Document shall survive the execution and delivery of such Loan Document. 

SECTION 10.6 Severability. Any provision of any Loan Document which is prohibited or unenforceable in any jurisdiction shall, as
to such provision and such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions of such Loan Document or affecting the validity or enforceability of such provision in any
other jurisdiction. 
 SECTION 10.7 Headings. The various headings of each Loan Document are inserted for convenience only and
shall not affect the meaning or interpretation of such Loan Document or any provisions thereof. 
 SECTION 10.8 Execution in
Counterparts, Effectiveness, Etc. This Agreement may be executed by the parties hereto in several counterparts, each of which shall be an original and all of which shall constitute together but one and the same agreement. This Agreement shall
become effective when counterparts hereof executed on behalf of the Borrower and the Lender, shall have been received by the Lender. Delivery of an executed counterpart of a signature page to this Agreement by email (e.g. “pdf” or
“tiff”) or telecopy shall be effective as delivery of a manually executed counterpart of this Agreement. 
 SECTION 10.9
Governing Law; Entire Agreement. EACH LOAN DOCUMENT (OTHER THAN THE AUSTRALIAN SECURITY DOCUMENTS) AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO
THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT CONTEMPLATED HEREBY AND 

  
 -73- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
THEREBY (OTHER THAN THE AUSTRALIAN SECURITY DOCUMENTS) SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR SUCH PURPOSE SECTIONS
5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK). The Loan Documents constitute the entire understanding among the parties hereto with respect to the subject matter thereof and supersede any prior agreements, written or
oral, with respect thereto. 
 SECTION 10.10 Successors and Assigns. This Agreement shall be binding upon and shall inure to the
benefit of the parties hereto and their respective successors and assigns; provided that the Borrower may not, directly or indirectly, assign or transfer its rights or obligations hereunder without the consent of the Lender; provided,
further, that the Lender may not, directly or indirectly, assign or transfer its rights or obligations hereunder or under the other Loan Documents to a Restricted Assignee or any Person that controls a Restricted Assignee without the prior
written consent of the Borrower, not to be unreasonably withheld or delayed, except such consent shall not be required in the case that an Event of Default has occurred and is continuing. 

SECTION 10.11 Other Transactions. Nothing contained herein shall preclude the Lender, from engaging in any transaction, in
addition to those contemplated by the Loan Documents, with the Borrower or any of its Affiliates in which the Borrower or such Affiliate is not restricted hereby from engaging with any other Person. 

SECTION 10.12 Forum Selection and Consent to Jurisdiction. ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER, OR IN CONNECTION
WITH, ANY LOAN DOCUMENT, OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER ORAL OR WRITTEN) OR ACTIONS OF THE LENDER OR THE BORROWER IN CONNECTION HEREWITH OR THEREWITH SHALL BE BROUGHT AND MAINTAINED IN THE COURTS OF THE BOROUGH OF
MANHATTAN IN THE CITY OF NEW YORK IN THE STATE OF NEW YORK OR IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK; PROVIDED THAT ANY SUIT SEEKING ENFORCEMENT AGAINST ANY COLLATERAL OR OTHER PROPERTY MAY BE
BROUGHT, AT THE LENDER’S OPTION, IN THE COURTS OF ANY JURISDICTION WHERE SUCH COLLATERAL OR OTHER PROPERTY MAY BE FOUND. THE BORROWER IRREVOCABLY CONSENTS TO THE SERVICE OF PROCESS BY REGISTERED MAIL, POSTAGE PREPAID, OR BY PERSONAL SERVICE
WITHIN OR WITHOUT THE STATE OF NEW YORK AT THE ADDRESS FOR NOTICES SPECIFIED IN SECTION 10.2. THE BORROWER HEREBY EXPRESSLY AND IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH IT MAY HAVE OR HEREAFTER MAY
HAVE TO THE LAYING OF VENUE OF ANY SUCH LITIGATION BROUGHT IN ANY SUCH COURT REFERRED TO ABOVE AND ANY CLAIM THAT ANY SUCH LITIGATION HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. TO THE EXTENT THAT THE

  
 -74- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
BORROWER HAS OR HEREAFTER MAY ACQUIRE ANY IMMUNITY FROM JURISDICTION OF ANY COURT OR FROM ANY LEGAL PROCESS (WHETHER THROUGH SERVICE OR NOTICE, ATTACHMENT PRIOR TO JUDGMENT, ATTACHMENT IN AID OF
EXECUTION OR OTHERWISE) WITH RESPECT TO ITSELF OR ITS PROPERTY, THE BORROWER HEREBY IRREVOCABLY WAIVES TO THE FULLEST EXTENT PERMITTED BY LAW SUCH IMMUNITY IN RESPECT OF ITS OBLIGATIONS UNDER THE LOAN DOCUMENTS. 

SECTION 10.13 Waiver of Jury Trial. THE LENDER AND THE BORROWER HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE TO THE
FULLEST EXTENT PERMITTED BY LAW ANY RIGHTS THEY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER, OR IN CONNECTION WITH, EACH LOAN DOCUMENT, OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS
(WHETHER ORAL OR WRITTEN) OR ACTIONS OF THE LENDER OR THE BORROWER IN CONNECTION THEREWITH. THE BORROWER ACKNOWLEDGES AND AGREES THAT IT HAS RECEIVED FULL AND SUFFICIENT CONSIDERATION FOR THIS PROVISION (AND EACH OTHER PROVISION OF EACH OTHER LOAN
DOCUMENT TO WHICH IT IS A PARTY) AND THAT THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE LENDER ENTERING INTO THE LOAN DOCUMENTS. 

SECTION 10.14 Confidential Information. Subject to the provisions of Section 10.15, at all times prior to the second
anniversary of the Credit Agreement Termination Date, the Receiving Party shall keep confidential and shall not publish or otherwise disclose any Confidential Information furnished to it by the Disclosing Party, except to those of the Receiving
Party’s employees, advisors or consultants’ who have a need to know such information to assist such Party in the performance of such Party’s obligations or in the exercise of such Party’s rights hereunder and who are subject to
reasonable obligations of confidentiality (collectively, “Recipients”). Notwithstanding anything to the contrary set forth herein, (a) the Lender may disclose this Agreement and the terms and conditions hereof and any
information related hereto, to (i) its Affiliates, (ii) potential and actual assignees of any of the Lender’s rights hereunder and (iii) potential and actual investors in, or lenders to, the Lender (including, in each of the
foregoing cases, such Person’s employees, advisors or consultants); provided that in each case, each such Recipient shall be subject to reasonable obligations of confidentiality; and (b) the Borrower may disclose this Agreement and
the terms and conditions hereof and information related hereto to the extent that this Agreement, such terms, condition or information, as applicable, are publicly available on the U.S. Securities and Exchange Commission EDGAR website, to potential
or actual permitted acquirers or assignees, collaborators and other (sub)licensees, permitted subcontractors, investment bankers, investors, lenders (including, in each of the foregoing cases, such Person’s employees, advisors or consultants
who have a need to receive and review such information); provided that in each case, each such Recipient shall be subject to reasonable obligations of confidentiality. In addition to the foregoing, the Receiving Party may disclose
Confidential Information belonging to the Disclosing Party to the extent (and 

  
 -75- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
only to the extent) such disclosure is reasonably necessary in order to comply with applicable laws (including any securities law or regulation or the rules of a securities exchange) and with
judicial process, if in the reasonable opinion of the Receiving Party’s counsel, such disclosure is necessary for such compliance, provided that the Receiving Party (x) will only disclose those portions of the Confidential
Information that are necessary or required to be so disclosed, and (y) will notify the Disclosing Party of the Receiving Party’s intent to make any disclosure pursuant thereto sufficiently prior to making such disclosure so as to allow the
Disclosing Party time to take whatever action it may deem appropriate to protect the confidentiality of the information to be disclosed. 

SECTION 10.15 Exceptions to Confidentiality. The Receiving Party’s obligations set forth in this Agreement shall not extend
to any Confidential Information of the Disclosing Party: 
 (a) that is or hereafter becomes part of the public domain (other
than as a result of a disclosure by the Receiving Party or its Recipients in violation of this Agreement); 
 (b) that is
received from a Third Party without restriction on disclosure and without, to the knowledge of the Receiving Party, breach of any agreement between such Third Party and the Disclosing Party; 

(c) that the Receiving Party can demonstrate by competent evidence was already in its possession without any limitation on
disclosure prior to its receipt from the Disclosing Party; 
 (d) that is generally made available to third parties by the
Disclosing Party without restriction on disclosure; or 
 (e) that the Receiving Party can demonstrate by competent evidence
was independently developed by the Receiving Party without use of or reference to the Confidential Information. 
 [Signature Page
Follows] 

  
 -76- 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their
respective officers thereunto duly authorized as of the day and year first above written. 
  

					
	UNILIFE MEDICAL SOLUTIONS, INC.,
	as the Borrower
		
	By:	 	 /s/ Alan Shortall

		 	Name:	 	Alan Shortall
		 	Title:	 	Chairman and CEO
	
	 ROS ACQUISITION OFFSHORE LP,
 as the
Lender

		
	By	 	OrbiMed Advisors, LLC,
	its investment manager
		
	By:	 	 /s/ Sven Borho

		 	Name:	 	Sven Borho
		 	Title:	 	Managing Member

 Signature Page to Credit Agreement 

  

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT A 

FORM OF PROMISSORY NOTE 
  

			
	Up to $60,000,000	  	March 12, 2014

 FOR VALUE RECEIVED, UNILIFE MEDICAL SOLUTIONS, INC., a Delaware
corporation (the “Borrower”), hereby promises to pay to the order of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (together with its Affiliates, successors, transferees and assigns, the
“Lender”), on the Maturity Date the principal sum of FORTY MILLION DOLLARS ($40,000,000) or, if Delayed Draw Loans in the aggregate principal amount of $20,000,000 are made to the Borrower, SIXTY MILLION DOLLARS ($60,000,000) or, in
each case if less, the aggregate unpaid principal amount of the Loans (and any continuation thereof) made (or continued) by the Lender pursuant to the Credit Agreement, dated as of March 12, 2014 (as amended, supplemented or otherwise modified
from time to time, the “Credit Agreement”), by and between the Borrower and the Lender. Unless otherwise defined herein or the context otherwise requires, terms used in this Note have the meanings provided in the Credit Agreement.

 The Borrower also promises to pay interest on the unpaid principal amount hereof from time to time outstanding from the date hereof until
maturity (whether by acceleration or otherwise) and, after maturity upon demand, until paid in full, at the rates per annum and on the dates specified in the Credit Agreement, as well as any other amounts that may be due to the Lender upon maturity
(whether by acceleration or otherwise) under or in respect of this Note. 
 Payments of both principal and interest are to be made in U.S.
Dollars in same day or immediately available funds to the account designated by the Lender. 
 This Note is referred to in, and evidences
Indebtedness incurred under, the Credit Agreement, to which reference is made for a description of the security and guarantee for this Note and for a statement of the terms and conditions on which the Borrower is permitted and required to make
prepayments and repayments of the unpaid principal amount of the Indebtedness evidenced by this Note and on which such Indebtedness may be declared to be immediately due and payable. Any prepaid principal of this Note may not be reborrowed. 

All parties hereto, whether as makers, endorsers or otherwise, severally waive presentment for payment, demand, protest and notice of
dishonor. 
 THIS NOTE HAS BEEN DELIVERED IN NEW YORK, NEW YORK AND SHALL BE DEEMED TO BE A CONTRACT MADE UNDER AND GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK). 

  
 A-1 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 [ Signature Page Follows ] 

  
 A-2 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
			
	UNILIFE MEDICAL SOLUTIONS, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  
 A-3 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT B 

FORM OF LOAN REQUEST 
 [DATE] 

ROS Acquisition Offshore LP 
 C/O Walkers Corporate Services
Limited 
 Walker House, 87 Mary Street 
 George Town, Grand
Cayman KY 1-9005, Cayman Islands 
 Attention: Board of Directors 

with a copy to: 
 OrbiMed Advisors LLC 

601 Lexington Avenue, 54th Floor 
 New York, NY 10022 

Attention: Tadd Wessel and Matthew Rizzo 
 Ladies and Gentlemen:

 Reference is hereby made to that certain Credit Agreement, dated as of
[—], 2014 (as amended, supplemented or otherwise modified from time to time and in effect on the date hereof, the “Credit Agreement”), by and between
UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the “Borrower”), and ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (together with its Affiliates, successors, transferees and assignees, the
“Lender”). 
 Unless otherwise defined herein or the context otherwise requires, terms used herein have the meanings
provided in the Credit Agreement. 
 Pursuant to the provisions of Section 2.2 of the Credit Agreement, the Borrower hereby requests
[an Initial ][a Delayed Draw ]Loan of $[        ] to be made on                 , 201     (the
“Proposed Disbursement Date”), which Loan shall be evidenced by that certain Promissory Note dated as of [     ], 2014 in the aggregate original principal amount of up to $60,000,000.00. 

The undersigned hereby represent(s) and warrant(s) to the Lender that: 

(a) the proceeds of the proposed Loan are to be used for the purposes set forth in Section 7.7 of the Credit Agreement; 

(b) bank account details and wire transfer instructions for disbursement of the proceeds of the proposed Loan are set forth on Schedule
A hereto (and Lender is hereby directed to disburse the proceeds of the proposed Loan to the recipients and in the amounts set forth on Schedule A); 

  
 B-1 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (c) no Default has occurred and is continuing or would result from the proposed Loan; 

(d) all conditions required to be satisfied, as set forth in Article V of the Credit Agreement, as applicable, as of the Proposed
Disbursement Date for the making of the Loan requested hereby have been, and are, fully satisfied; and 
 (e) the representations and
warranties contained in Article VI of the Credit Agreement and in the other Loan Documents are true and correct in all respects (in the case of any representation or warranty qualified by materiality or Material Adverse Effect) or in all material
respects (in the case of any representation or warranty not qualified by materiality or Material Adverse Effect), before and after giving effect to the making of the proposed Loan and to the application of the proceeds thereof, as though made on and
as of the date hereof. 
 The officer signing below is an Authorized Officer of the undersigned and is authorized to request the Loan
contemplated hereby and issue this Loan Request on behalf of the undersigned. 
 [ Signature Page Follows ] 

  
 B-2 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 Very truly yours, 

 

					
	UNILIFE MEDICAL SOLUTIONS, INC.,
	
	as the Borrower
		
	By:	 	
			
		 	Name:	 	[—]
		 	Title:	 	[—]

  
 B-3 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 Schedule A 

Disbursement / Wire Instructions 

  
 B-4 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT C 

FORM OF COMPLIANCE CERTIFICATE 

UNILIFE MEDICAL SOLUTIONS, INC. 

COMPUTATION DATE:                  ,
201     
 This Compliance Certificate (this “Certificate”) is delivered pursuant to [Section
5.8][Section 7.1(d)] of the Credit Agreement, dated as of [—], 2014 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”),
by and between UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the “Borrower”), and ROS ACQUISITION OFFSHORE, LP, a Cayman Islands exempted limited partnership (together with its Affiliates, successors, transferees and
assignees, the “Lender”). Unless otherwise defined herein or the context otherwise requires, terms used in this Certificate have the meanings provided in the Credit Agreement. 

This Certificate relates to the [calendar month][Fiscal Quarter][Fiscal Year] commencing on
                 , 201     and ending on                  ,
201     (such latter date being the “Computation Date”). 
 The undersigned is duly authorized to
execute and deliver this Certificate on behalf of the Borrower. By executing this Certificate, the undersigned hereby certifies to the Lender that as of the Computation Date: 

(a) [Attached hereto as Annex I are (i) unaudited reports of the Liquidity of the Borrower at the end of such
calendar month and (ii) beginning with the calendar month of February 2014, unaudited reports of the Liquidity of the Borrower for the corresponding calendar month in the preceding Fiscal Year, in comparative form.]1 
 [Attached hereto as Annex I are an unaudited consolidated balance
sheet of Holdings, the Borrower and the Subsidiaries as of the end of such Fiscal Quarter, consolidated statements of income and cash flow of Holdings, the Borrower and the Subsidiaries for such Fiscal Quarter and for the period commencing at the
end of the previous Fiscal Year and ending with the end of such Fiscal Quarter and the Revenue Base for such Fiscal Quarter and for the period commencing at the end of the previous Fiscal Year and ending with the end of such Fiscal Quarter, and
including (in each case) in comparative form the figures for the corresponding Fiscal Quarter in, and the year to date portion of, the immediately preceding Fiscal Year, certified as complete and correct by the chief financial or accounting
Authorized Officer of the Borrower (subject to normal year-end audit adjustments).]2 

 
  

	1 	INCLUDE FOR MONTHLY FINANCIAL DELIVERABLES. 

	2 	INCLUDE FOR QUARTERLY FINANCIAL DELIVERABLES. 

  
 C-1 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 [Attached hereto as Annex I are (i) a copy of the consolidated
balance sheet of Holdings, the Borrower and the Subsidiaries, and the related consolidated statements of income and cash flow of Holdings, the Borrower and the Subsidiaries for such Fiscal Year, setting forth in comparative form the figures for the
immediately preceding Fiscal Year, audited (without any Impermissible Qualification) by independent public accountants acceptable to the Lender, which shall include a calculation of the financial covenants set forth in Section 8.4 of the
Credit Agreement and stating that, in performing the examination necessary to deliver the audited financial statements of Holdings, no knowledge was obtained of any Event of Default, and (ii) the Revenue Base for the Fiscal Quarter then ending
and such Fiscal Year and including in comparative form the figures for the corresponding Fiscal Quarter in the immediately preceding Fiscal Year and the immediately preceding Fiscal Year.]3 

(b) The financial statements delivered with this Certificate in accordance with Section 7.1(a), (b) and (c) of
the Credit Agreement fairly present in all material respects the financial condition of Holdings, the Borrower and the Subsidiaries (subject to the absence of footnotes and to normal year-end audit adjustments in the case of unaudited financial
statements). 
 (c) [Attached hereto as Annex II is/are (i) a list of the applications for the registration of any
Intellectual Property Collateral filed with the United States Patent and Trademark Office, the United States Copyright Office or any similar office or agency in any other country or any political subdivision thereof by any Credit Obligor or any of
its agents, employees, designees or licensees subsequent to the date of the most recent Compliance Certificate submitted by the undersigned pursuant to Section 7.1(d) of the Credit Agreement, and (ii) executed [Patent Security Agreement],
[Trademark Security Agreement], and/or [Copyright Security Agreement], in the form(s) attached to the Security Agreement, relating to an interest in any Intellectual Property obtained by any Credit Obligor or a Credit Obligor filing (or any of its
agents, employees, designees or licensees filing on behalf of a Credit Obligor) an application for the registration of any Intellectual Property Collateral (as defined in the Security Agreement) subsequent to the date of the most recent Compliance
Certificate submitted by the undersigned pursuant to Section 7.1(d) of the Credit Agreement and any other document reasonably required to evidence the Lender’s interest in any part of such item of Intellectual Property in connection with
the obligations of the Borrowers under Sections 4.5(c) and 4.5(e) of the Security Agreement.]4 

 

	3 	INCLUDE FOR ANNUAL FINANCIAL DELIVERABLES. 

	4	INCLUDE FOR QUARTERLY FINANCIAL DELIVERABLES. ALSO REQUIRED 45 DAYS AFTER THE END OF EACH FISCAL YEAR. 

  
 C-2 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) As of the Computation Date, Holdings, the Borrower and the Subsidiaries
are in compliance in all respects with the financial covenants set forth in Section 8.4 of the Credit Agreement. Set forth on Attachment 1 hereto are calculations showing compliance with such financial covenants as of the Computation
Date. 
 (e) No Default has occurred and is continuing [except as set forth on Attachment [2] hereto, which includes a
description of the nature and period of existence of such Default and what action Holdings, the Borrower or any of the Subsidiaries has taken, is taking, or proposes to take with respect thereto]. 

(f) Subsequent to the date of the most recent Compliance Certificate submitted by the undersigned pursuant to
Section 7.1(d) of the Credit Agreement, none of Holdings, the Borrower or any Subsidiary has formed or acquired any new Subsidiary [ except as set forth on Attachment [2] hereto, in which case such new Subsidiary has complied with the
requirements of Section 7.8 of the Credit Agreement]. 
 (g) Subsequent to the date of the most recent Compliance
Certificate submitted by the undersigned pursuant to Section 7.1(d) of the Credit Agreement, none of Holdings, the Borrower or any Subsidiary has acquired any ownership interest in any real property [except as set forth on Attachment [2]
hereto, in which case the Borrower has complied with the requirements of Section 7.8 of the Credit Agreement with respect to such real property]. 

[ Signature Page Follows ] 

  
 C-3 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the undersigned has caused this Certificate to be executed and delivered,
and the certification and warranties contained herein to be made, by its chief financial or accounting Authorized Officer as of the date first above written. 

 

					
	UNILIFE MEDICAL SOLUTIONS, INC.
		
	 By:
	 	  

		 	 Name:
	 	
		 	 Title:
	 	

  
 C-4 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 [Annex 1] 

  
 C-5 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 [Annex 2] 

  
 C-6 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 [Attachment 1] 

  
 C-7 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 [Attachment 2] 

  
 C-8 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT D 

FORM OF GUARANTEE 
 This
GUARANTEE, dated as of March 12, 2014 (as amended, supplemented or otherwise modified from time to time, this “Guarantee”), is made by UNILIFE CORPORATION, a Delaware corporation (“Holdings”), Unilife Cross
Farm LLC, a Delaware limited liability company (“Cross Farm”), UNILIFE MEDICAL SOLUTIONS PTY LIMITED, a company registered in South Australia with ACN 008 071 403 (“Solutions”) and UNITRACT SYRINGE PTY LTD, a
company registered in Western Australia with ACN 101 059 723 (“Syringe”); and together with Holdings, Cross Farm and Solutions and any additional Persons named pursuant to Section 5.5, each a “Guarantor”
and collectively the “Guarantors”), in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (together with its Affiliates, successors, transferees and assignees, “ROS Acquisition”) and
ROYALTY OPPORTUNITIES S.À R.L, a Luxembourg société à responsabilité limitée (together with its Affiliates, successors, transferees and assignees, “ROS”, and together with ROS Acquisition,
the “Lender”). 

W I T N E S S E T H: 

WHEREAS, pursuant to the Credit Agreement, dated as of March 12, 2014 (as amended, supplemented or otherwise modified from time to time,
the “Credit Agreement”), by and between Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”) and ROS Acquisition, ROS Acquisition has extended a Commitment to make Loans to the Borrower; and 

WHEREAS, as a condition precedent to the making of the Initial Loan under the Credit Agreement, the Guarantors are required to execute and
deliver this Guarantee; 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, and in order to induce ROS Acquisition to make the Loans to the Borrower and to enter into and to make other financial accommodations to the Obligors under the Loan Documents, each Guarantor hereby agrees, for the benefit of the
Lender, as follows. 
 ARTICLE I 

DEFINITIONS 
 SECTION 1.1.
Certain Terms. The following terms (whether or not underscored) when used in this Guarantee, including its preamble and recitals, shall have the following meanings (such definitions to be equally applicable to the singular and
plural forms thereof): 
 “Borrower” is defined in the first recital. 

“Credit Agreement” is defined in the first recital. 

  
 D-1 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Guarantor” is defined in the preamble. 

“Guarantee” is defined in the preamble. 

“Lender” is defined in the preamble. 

“Obligor” is defined in Section 2.1(a). 

“ROS” is defined in the preamble. 

“ROS Acquisition” is defined in the preamble. 

SECTION 1.2. Credit Agreement Definitions. Unless otherwise defined herein or the context otherwise requires, terms used in this
Guarantee, including its preamble and recitals, have the meanings provided in the Credit Agreement. 
 SECTION 1.3. Interpretation

 SECTION 1.4. The provisions of Section 1.5 of the Credit Agreement are incorporated in, and apply to, this Guarantee as if set out
in full with any necessary amendments. 
 ARTICLE II 

GUARANTEE PROVISIONS 
 SECTION
2.1. Guarantee. Each Guarantor jointly and severally, absolutely, unconditionally and irrevocably: 
 (a)
guarantees the full and punctual payment when due, whether at stated maturity, by required prepayment, declaration, acceleration, demand or otherwise, and performance of all Obligations of Holdings, the Borrower and the Subsidiaries party to any
Loan Document (each, an “Obligor”) now or hereafter existing, whether for principal, interest (including interest accruing at the then applicable default rate as provided in Section 3.4 of the Credit Agreement, whether or not a
claim for post-filing or post-petition interest is allowed under applicable law following the institution of a proceeding under bankruptcy, insolvency or similar laws), fees, expenses or otherwise (including all such amounts which would become due
but for the operation of the automatic stay under Section 362(a) of the United States Bankruptcy Code, 11 U.S.C. §362(a), and the operation of Sections 502(b) and 506(b) of the United States Bankruptcy Code, 11 U.S.C. §502(b) and
§506(b)) and includes money and amounts which a Person would be liable to pay but for an Insolvency Event in respect of that Person; and 

(b) indemnifies and holds harmless the Lender for any and all costs and expenses (including the reasonable fees and
out-of-pocket expenses of counsel to the Lender) incurred by the Lender in enforcing any rights under this Guarantee, except to the extent such amounts arise or are incurred as a consequence of the Lender’s own gross negligence or willful
misconduct; 

  
 D-2 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 provided, that each Guarantor (other than an Australian Subsidiary) shall only be liable under this
Guarantee for the maximum amount of such liability that can be hereby incurred without rendering this Guarantee, as it relates to such Guarantor, voidable under applicable law relating to fraudulent conveyance or fraudulent transfer, and not for any
greater amount. This Guarantee constitutes a guarantee of payment when due as if the Guarantor was the principal obligor and not of collection, and each Guarantor specifically agrees that it shall not be necessary or required that the Lender
exercise any right, assert any claim or demand or enforce any remedy whatsoever against such Guarantor or any other Person before or as a condition to the obligations of such Guarantor becoming due hereunder. This agreement to immediate recourse
(and associated waiver) applies irrespective of any law or any provision of a Loan Document to the contrary. 
 SECTION 2.2.
Reinstatement, Etc. Each Guarantor agrees that this Guarantee shall continue to be effective or be reinstated (including on or after the Termination Date), as the case may be, if at any time any payment (in whole or in part) of, or any
transaction relating to, any of the Obligations is invalidated, declared to be fraudulent or preferential, set aside, rescinded, void, voidable, unenforceable or defective for any reason or must otherwise be restored by the Lender, including upon
the occurrence of any Event of Default set forth in Sections 9.1(i) or 9.1(j) of the Credit Agreement or otherwise, all as though such payment had not been made. This Section 2.2 survives any termination or full or partial discharge or release
of any Loan Document. 
 SECTION 2.3. Guarantee Absolute, Etc. This Guarantee shall in all respects be a continuing, absolute,
unconditional and irrevocable guarantee of payment, and shall remain in full force and effect until (unless reinstated pursuant to Section 2.2 above) the Termination Date has occurred. Each Guarantor guarantees that the Obligations shall
be paid strictly in accordance with the terms of each Loan Document under which they arise, regardless of any law, regulation or order now or hereafter in effect in any jurisdiction affecting any of such terms or the rights of the Lender with
respect thereto. The liability of each Guarantor under this Guarantee shall be absolute, unconditional and irrevocable irrespective of: 

(a) any lack of validity, legality or enforceability of any Loan Document; 

(b) the failure of the Lender (i) to assert any claim or demand or to enforce any right or remedy against such Guarantor
or any other Person (including any other guarantor) under the provisions of any Loan Document or otherwise, or (ii) to exercise any right or remedy against any other guarantor (including such Guarantor and any other Guarantor) of, or collateral
securing, any Obligations; 
 (c) any change in the time, manner or place of payment of, or in any other term of, all or any
part of the Obligations, or any other extension, compromise or renewal of any Obligation, or any amendment to, rescission, waiver, or other modification of, or any consent to or departure from, any of the terms of any Loan Document; 

  
 D-3 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) any reduction, limitation, impairment or termination of any Obligations
for any reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to (and each Guarantor hereby waives any right to or claim of) any defense or setoff, counterclaim (other than a defense of payment
or performance), recoupment or termination whatsoever by reason of the invalidity, illegality, irregularity, compromise, unenforceability of, or any other event or occurrence affecting, any Obligations or otherwise; 

(e) any addition, exchange or release of any collateral, or of any Person that is (or will become) a guarantor of the
Obligations, or any surrender or non-perfection of any collateral, or any amendment to, or waiver or release of, or addition to, or consent to or departure from, any other guarantee held by the Lender securing any of the Obligations; 

(f) the occurrence of an Insolvency Event in respect of an Obligor or another Person or any judgment or order being obtained or
made against, or the conduct of any proceedings by, an Obligor or another Person; or 
 (g) any other circumstance which
might otherwise constitute a defense available to, or a legal or equitable discharge of, any Obligor, any surety or any guarantor (including any Guarantor). 

SECTION 2.4. Setoff. Each Guarantor hereby irrevocably authorizes the Lender, without the requirement that any notice be given to such
Guarantor (such notice being expressly waived by such Guarantor), upon the occurrence and during the continuance of any Event of Default, to appropriate and apply to the payment of the Obligations owing to it (whether or not then due), and (as
security for such Obligations) each Guarantor hereby grants to the Lender a continuing security interest in, any and all balances, credits, deposits, accounts or moneys of such Guarantor then or thereafter maintained with or on behalf of the Lender.
The Lender agrees to notify such Guarantor after any such set-off and application made by the Lender; provided, that the failure to give such notice shall not affect the validity of such setoff and application. The rights of the Lender under
this Section are in addition to other rights and remedies (including other rights of setoff under applicable law or otherwise) which the Lender may have. 

SECTION 2.5. Waiver, Etc. Each Guarantor waives promptness, diligence, notice of acceptance and any other notice with respect to any of
the Obligations and this Guarantee and any requirement that the Lender protect, secure, perfect or insure any Lien, or any property subject thereto, or exhaust any right or take any action against any Obligor or any other Person (including any
Guarantor) or entity or any collateral securing the Obligations, as the case may be. This waiver applies irrespective of any law or any provision of a Loan Document to the contrary. 

  
 D-4 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 2.6. Postponement of Subrogation, Etc. Each Guarantor agrees that it will not
claim or exercise any rights which it may acquire by way of rights of subrogation under any Loan Document to which it is a party, nor shall such Guarantor seek or be entitled to seek any contribution or reimbursement from the Borrower or any other
Obligor or Guarantor, in respect of any payment made under any Loan Document or otherwise, until following the Termination Date. Any amount paid to such Guarantor on account of any such subrogation rights prior to the Termination Date shall be held
in trust for the benefit of the Lender and shall immediately be paid and turned over to the Lender in the exact form received by such Guarantor (duly endorsed in favor of the Lender, if required), to be credited and applied against the Obligations,
whether matured or unmatured, in accordance with Section 2.7; provided, that if such Guarantor has made payment to the Lender of all or any part of the Obligations and the Termination Date has occurred, then, at such
Guarantor’s request, the Lender will, at the expense of such Guarantor, execute and deliver to such Guarantor appropriate documents (without recourse and without representation or warranty) necessary to evidence the transfer by subrogation to
such Guarantor of an interest in the Obligations resulting from such payment. In furtherance of the foregoing, at all times prior to the Termination Date, such Guarantor shall refrain from taking any action or commencing any proceeding against the
Borrower or any other Obligor or Guarantor (or their successors or assigns, whether in connection with a bankruptcy proceeding, Liquidation or otherwise) to recover any amounts in respect of payments made under this Guarantee to the Lender. 

SECTION 2.7. Payments; Application. Each Guarantor agrees that all obligations of such Guarantor hereunder shall be paid solely in U.S.
Dollars to the Lender in immediately available funds, without set-off, counterclaim or other defense and in accordance with Sections 3.2, 4.3 and 4.4 of the Credit Agreement, free and clear of and without deduction for any Non-Excluded Taxes, such
Guarantor hereby agreeing to comply with and be bound by the provisions of Sections 3.2, 4.3 and 4.4 of the Credit Agreement in respect of all payments and application of such payments made by it hereunder and the provisions of which Sections are
hereby incorporated into and made a part of this Guarantee by this reference as if set forth herein; provided, that references to the “Borrower” in such Sections shall be deemed to be references to such Guarantor, and references to
“this Agreement” in such Sections shall be deemed to be references to this Guarantee. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES 

In order to induce ROS Acquisition to enter into the Credit Agreement and make the Loans thereunder, each Guarantor represents and warrants to
the Lender as set forth below. 
 SECTION 3.1. Credit Agreement Representations and Warranties. The representations and warranties
contained in Article VI of the Credit Agreement and Article III of the Royalty Agreement, insofar as the representations and warranties contained therein are applicable to such 

  
 D-5 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
Guarantor and its properties, are true and correct in all material respects as of the Closing Date and each Delayed Draw Closing Date, if applicable, each such representation and warranty set
forth in such Articles (insofar as applicable as aforesaid) and all other terms of the Credit Agreement and the Royalty Agreement to which reference is made therein, together with all related definitions and ancillary provisions, being hereby
incorporated into this Guarantee by this reference as though specifically set forth in this Article. 
 SECTION 3.2. Financial Condition,
Etc. Each Guarantor has knowledge of the Borrower’s and each other Guarantor’s financial condition and affairs and has adequate means to obtain from each such Person on an ongoing basis information relating thereto and to each such
Person’s ability to pay and perform the Obligations, and agrees to assume the responsibility for keeping, and to keep, so informed for so long as this Guarantee is in effect. Each Guarantor acknowledges and agrees that the Lender shall have no
obligation to investigate the financial condition or affairs of the Borrower or any other Guarantor for the benefit of such Guarantor nor to advise such Guarantor of any fact respecting, or any change in, the financial condition or affairs of each
such Person that might become known to the Lender at any time, whether or not the Lender knows or believes or has reason to know or believe that any such fact or change is unknown to such Guarantor, or might (or does) materially increase the risk of
such Guarantor as guarantor, or might (or would) affect the willingness of such Guarantor to continue as a guarantor of the Obligations. 

SECTION 3.3. Best Interests. It is in the best interests, and for the commercial benefit, of each Guarantor to execute this Guarantee
inasmuch as each Guarantor will, as a result of being an Affiliate of the Borrower, derive substantial direct and indirect benefits from the Loans made to the Borrower by ROS Acquisition pursuant to the Credit Agreement, and each Guarantor agrees
that ROS Acquisition is relying on this representation in agreeing to make the Loans to the Borrower. 
 ARTICLE IV 

COVENANTS, ETC. 
 SECTION 4.1.
Covenants. Each Guarantor covenants and agrees that, at all times prior to the Termination Date, it will perform, comply with and be bound by all of the agreements, covenants and obligations contained in the Credit Agreement (including
Articles VII and VIII of the Credit Agreement) and the Royalty Agreement (including Article IV of the Royalty Agreement) which are applicable to such Guarantor or its properties, each such agreement, covenant and obligation contained in the Credit
Agreement and the Royalty Agreement and all other terms of the Credit Agreement and the Royalty Agreement to which reference is made in this Article, together with all related definitions and ancillary provisions, being hereby incorporated into this
Guarantee by this reference as though specifically set forth in this Article. 

  
 D-6 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE V 

MISCELLANEOUS PROVISIONS 
 SECTION
5.1. Loan Document. This Guarantee is a Loan Document executed pursuant to the Credit Agreement and shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions
thereof, including Article X thereof. 
 SECTION 5.2. Binding on Successors, Transferees and Assigns; Assignment. This
Guarantee shall remain in full force and effect until, subject to Section 2.2, the Termination Date has occurred, shall be binding upon each Guarantor and its successors, transferees and assigns and shall inure to the benefit of and be
enforceable by the Lender; provided, that such Guarantor may not (unless otherwise permitted under the terms of the Credit Agreement) assign any of its obligations hereunder without the prior written consent of the Lender. Without limiting
the generality of the foregoing, the Lender may assign or otherwise transfer (in whole or in part) its Commitment, the Note, the Loans and its other rights under the Loan Documents held by it to any other Person, and such other Person shall
thereupon become vested with all rights and benefits in respect thereof granted to the Lender under each Loan Document (including this Guarantee) or otherwise. 

SECTION 5.3. Amendments, Etc. No amendment to or waiver of any provision of this Guarantee, nor consent to any departure by any
Guarantor from its obligations under this Guarantee, shall in any event be effective unless the same shall be in writing and signed by the Lender and then such waiver or consent shall be effective only in the specific instance and for the specific
purpose for which given. 
 SECTION 5.4. Notices. All notices and other communications provided for hereunder shall be given or
made as set forth in Section 10.2 of the Credit Agreement. 
 SECTION 5.5. Additional Guarantors. Upon the execution and
delivery by any other Person of a supplement in the form of Annex I hereto, such Person shall become a “Guarantor” hereunder with the same force and effect as if it were originally a party to this Guarantee and named as a
“Guarantor” hereunder. The execution and delivery of such supplement shall not require the consent of any other Guarantor hereunder, and the rights and obligations of each Guarantor hereunder shall remain in full force and effect
notwithstanding the addition of any new Guarantor as a party to this Guarantee. 
 SECTION 5.6. No Waiver; Remedies. In addition
to, and not in limitation of, Section 2.3 and Section 2.5, no failure on the part of the Lender to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof, nor shall any single or partial
exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right. The remedies herein provided are cumulative and not exclusive of any remedies provided by law. 

  
 D-7 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 5.7. Further Assurances. Each Guarantor agrees, upon the written request of
the Lender, to execute and deliver to the Lender, from time to time, any additional instruments or documents deemed to be reasonably necessary by the Lender to cause this Guarantee to be, become or remain valid and effective in accordance with its
terms. 
 SECTION 5.8. Section Captions. Section captions used in this Guarantee are for convenience of reference only and shall
not affect the construction of this Guarantee. 
 SECTION 5.9. Severability. Any provision of this Guarantee which is prohibited
or unenforceable in any jurisdiction shall, as to such provision and such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions of this Guarantee or affecting the validity or
enforceability of such provision in any other jurisdiction. 
 SECTION 5.10. Governing Law, Entire Agreement, Etc. THIS GUARANTEE AND
ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS GUARANTEE OR ANY OTHER LOAN DOCUMENT (OTHER THAN THE AUSTRALIAN SECURITY DOCUMENTS) CONTEMPLATED HEREBY
SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK). This Guarantee, along with the other
Loan Documents, constitutes the entire understanding among the parties hereto with respect to the subject matter hereof and supersedes any prior agreements, written or oral, with respect hereto. 

SECTION 5.11. Forum Selection and Consent to Jurisdiction. ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER, OR IN CONNECTION
WITH, THIS GUARANTEE, OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER ORAL OR WRITTEN) OR ACTIONS OF THE LENDER OR ANY GUARANTOR IN CONNECTION HEREWITH SHALL BE BROUGHT AND MAINTAINED IN THE COURTS OF THE BOROUGH OF MANHATTAN IN THE
CITY OF NEW YORK IN THE STATE OF NEW YORK OR IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK; PROVIDED THAT ANY SUIT SEEKING ENFORCEMENT AGAINST ANY COLLATERAL OR OTHER PROPERTY MAY BE BROUGHT, AT THE
LENDER’S OPTION, IN THE COURTS OF ANY JURISDICTION WHERE SUCH COLLATERAL OR OTHER PROPERTY MAY BE FOUND. THE LENDER BY ACCEPTANCE OF THIS GUARANTEE AND EACH GUARANTOR IRREVOCABLY CONSENTS TO THE SERVICE OF PROCESS BY REGISTERED MAIL, POSTAGE
PREPAID, OR BY PERSONAL SERVICE WITHIN OR WITHOUT THE STATE OF NEW YORK AT THE ADDRESS FOR NOTICES SPECIFIED IN SECTION 10.2 OF THE CREDIT AGREEMENT. THE LENDER BY ACCEPTANCE OF THIS GUARANTEE AND EACH GUARANTOR HEREBY EXPRESSLY AND IRREVOCABLY
WAIVES, TO THE 

  
 D-8 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH IT MAY HAVE OR HEREAFTER MAY HAVE TO THE LAYING OF VENUE OF ANY SUCH LITIGATION BROUGHT IN ANY SUCH COURT REFERRED TO ABOVE AND ANY CLAIM THAT
ANY SUCH LITIGATION HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. TO THE EXTENT THAT THE LENDER BY ACCEPTANCE OF THIS GUARANTEE OR ANY GUARANTOR HAS OR HEREAFTER MAY ACQUIRE ANY IMMUNITY FROM JURISDICTION OF ANY COURT OR FROM ANY LEGAL PROCESS (WHETHER
THROUGH SERVICE OR NOTICE, ATTACHMENT PRIOR TO JUDGMENT, ATTACHMENT IN AID OF EXECUTION OR OTHERWISE) WITH RESPECT TO ITSELF OR ITS PROPERTY, THE LENDER BY ACCEPTANCE OF THIS GUARANTEE AND SUCH GUARANTOR, EACH ON ITS OWN BEHALF, HEREBY IRREVOCABLY
WAIVES TO THE FULLEST EXTENT PERMITTED BY LAW SUCH IMMUNITY IN RESPECT OF ITS OBLIGATIONS UNDER THIS GUARANTEE. 
 SECTION 5.12.
Counterparts. This Guarantee may be executed by the parties hereto in several counterparts, each of which shall be an original and all of which shall constitute together but one and the same agreement. This Guarantee shall become
effective when counterparts hereof executed on behalf of each Guarantor shall have been received by the Lender. Delivery of an executed counterpart of a signature page to this Guarantee by email (e.g. “pdf” or “tiff”) or telecopy
shall be effective as delivery of a manually executed counterpart of this Guarantee. 
 SECTION 5.13. Waiver of Jury Trial. THE
LENDER BY ACCEPTANCE OF THIS GUARANTEE AND EACH GUARANTOR HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE TO THE FULLEST EXTENT PERMITTED BY LAW ANY RIGHTS THEY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR ARISING
OUT OF, UNDER, OR IN CONNECTION WITH, THIS GUARANTEE, OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER ORAL OR WRITTEN) OR ACTIONS OF THE LENDER OR ANY GUARANTOR IN CONNECTION HEREWITH. EACH GUARANTOR ACKNOWLEDGES AND AGREES THAT IT
HAS RECEIVED FULL AND SUFFICIENT CONSIDERATION FOR THIS PROVISION (AND EACH OTHER PROVISION OF EACH OTHER LOAN DOCUMENT TO WHICH IT IS A PARTY) AND THAT THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE LENDER TO ENTER INTO THE LOAN DOCUMENTS. 

[ Signature Page Follows ] 

  
 D-9 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, each Guarantor has caused this Guarantee to be duly executed and
delivered by its Authorized Officer as of the date first above written. 
 EXECUTED as a deed by each Australian Subsidiary. 

 

			
	UNILIFE CORPORATION
		
	By:	 	  

		 	Name:
		 	Title:
	
	UNILIFE CROSS FARM LLC
		
	By:	 	  

		 	Name:
		 	Title:

  

					
			
	Executed by Unilife Medical Solutions Pty	 		 	
	Limited in accordance with Section 127 of the Corporations Act 2001	 		 	
			
	  
	 		 	  

	Signature of director	 		 	Signature of director/company secretary
		 		 	(Please delete as applicable)
			
	  
	 		 	  

	Name of director (print)	 		 	Name of director/company secretary (print)

  
 D-10 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

					
	Executed by Unitract Syringe Pty Ltd in accordance with Section 127 of the Corporations Act 2001	 		 	
			
	  
	 		 	  

	Signature of director	 		 	Signature of director/company secretary
		 		 	(Please delete as applicable)
			
	  
	 		 	  

	Name of director (print)	 		 	Name of director/company secretary (print)

  
 D-11 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ANNEX I 

to Guarantee 
 SUPPLEMENT TO 

GUARANTEE 
 This
SUPPLEMENT, dated as of                  ,         (this “Supplement”), is to the Guarantee, dated as of
March 12, 2014 (as amended, supplemented, amended and restated or otherwise modified from time to time, the “Guarantee”), by the Guarantors (such term, and other terms used in this Supplement, to have the meanings set forth in
Article I of the Guarantee) from time to time party thereto, in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (together with its Affiliates, successors, transferees and assignees, “ROS
Acquisition”) and ROYALTY OPPORTUNITIES S.À R.L, a Luxembourg société à responsabilité limitée (collectively with ROS Acquisition, with their Affiliates, successors, transferees and assignees, the
“Lender”). 
 W I T N E S S E T H : 

WHEREAS, pursuant to a Credit Agreement, dated as of March 12, 2014 (as amended, supplemented, or otherwise modified from time to time,
the “Credit Agreement”), by and between Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”) and ROS Acquisition, ROS Acqusition has extended a Commitment to make the Loans to the Borrower; 

WHEREAS, pursuant to the provisions of Section 5.5 of the Guarantee, each of the undersigned is becoming a Guarantor under the Guarantee;
and 
 WHEREAS, each of the undersigned desires to become a “Guarantor” under the Guarantee in order to induce the Lender to
continue to extend Loans under the Credit Agreement and to make other financial accommodations to the Obligors under the Loan Documents; 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each of the undersigned
agrees, for the benefit of the Lender, as follows. 
 SECTION 1. Party to Guarantee, Etc. In accordance with the terms of the
Guarantee, by its signature below, each of the undersigned hereby irrevocably agrees to become a Guarantor under the Guarantee with the same force and effect as if it were an original signatory thereto and each of the undersigned hereby
(a) agrees to be bound by and comply with all of the terms and provisions of the Guarantee applicable to it as a Guarantor and (b) represents and warrants that the representations and warranties made by it as a Guarantor thereunder are
true and correct as of the date hereof, unless stated to relate solely to an earlier date, in which case such representations and warranties shall be true and correct as of such earlier date. In furtherance of the foregoing, each reference to a
“Guarantor” and/or “Guarantors” in the Guarantee shall be deemed to include each of the undersigned. 

  
 D-12 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 2. Representations. Each of the undersigned Guarantors hereby represents and
warrants that this Supplement has been duly authorized, executed and delivered by it and that this Supplement and the Guarantee constitute its legal, valid and binding obligation, enforceable against it in accordance with its terms. 

SECTION 3. Full Force of Guarantee. Except as expressly supplemented hereby, the Guarantee shall remain in full force and effect in
accordance with its terms. 
 SECTION 4. Severability. Wherever possible each provision of this Supplement shall be interpreted in
such manner as to be effective and valid under applicable law, but if any provision of this Supplement shall be prohibited by or invalid under such law, such provision shall be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provision or the remaining provisions of this Supplement or the Guarantee. 
 SECTION 5. Governing
Law, Entire Agreement, Etc. THIS SUPPLEMENT AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS SECURITY AGREEMENT OR ANY DOCUMENT CONTEMPLATED HEREBY
SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW
YORK). This Supplement, along with the other Loan Documents, constitutes the entire understanding among the parties hereto with respect to the subject matter thereof and supersedes any prior agreements, written or oral, with respect thereto. 

SECTION 6. Effective. This Supplement shall become effective when a counterpart hereof executed by the Guarantor shall have been
received by the Lender. Delivery of an executed counterpart of a signature page to this Agreement by email (e.g. “pdf” or “tiff”) or telecopy shall be effective as delivery of a manually executed counterpart of this Agreement.

 [ Signature Page Follows ] 

  
 D-13 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, each of the parties hereto has caused this Supplement to be duly executed
and delivered by its Authorized Officer as of the date first above written. 
  

			
	[NAME OF ADDITIONAL SUBSIDIARY]
		
	By:	 	  

		 	Name:
		 	Title:
	
	[NAME OF ADDITIONAL SUBSIDIARY]
		
	By:	 	  

		 	Name:
		 	Title:

  
 D-14 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT E 

PLEDGE AND SECURITY AGREEMENT 

This PLEDGE AND SECURITY AGREEMENT, dated as of March 12, 2014 (as amended, supplemented or otherwise modified from time to time, this
“Security Agreement”), is made by UNILIFE MEDICAL SOLUTIONS, INC., a Delaware corporation (the “Borrower”), UNILIFE CORPORATION, a Delaware corporation (“Holdings”), Unilife Cross Farm LLC, a
Delaware limited liability company (“Cross Farm”), UNILIFE MEDICAL SOLUTIONS PTY LIMITED, a company registered in South Australia with ACN 008 071 403 (“Solutions”) and UNITRACT SYRINGE PTY LTD, a company registered
in Western Australia with ACN 101 059 723 (“Syringe”; and together with the Borrower, Holdings, Cross Farm and Solutions, and any other entity that may become a party hereto as provided herein, each a “Grantor” and,
collectively, the “Grantors”) in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (together with its successors, transferees and assignees, the “Lender”), for itself and as agent
for ROYALTY OPPORTUNITIES S.À R.L, a Luxembourg société à responsabilité limitée (together with its successors, transferees and assignees, “ROS”) and the other parties to which the Grantors
may owe any Obligations (together with the Lender and ROS, the “Secured Parties” and each, a “Secured Party”). 

W I T N E S S E T H : 

WHEREAS, pursuant to the Credit Agreement, dated as of the date hereof (as the same may be amended, supplemented or otherwise modified from
time to time, the “Credit Agreement”), by and between the Borrower and the Lender, the Lender has extended a Commitment to make Loans to the Borrower; and 

WHEREAS, as a condition precedent to the making of the Initial Loan under the Credit Agreement and entering into the other Loan Documents,
each Grantor is required to execute and deliver this Security Agreement; 
 NOW, THEREFORE, for good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, each Grantor agrees, for the benefit of the Lender, as follows: 
 ARTICLE I 

DEFINITIONS 
 SECTION 1.1.
Certain Terms. The following terms (whether or not underscored) when used in this Security Agreement, including its preamble and recitals, shall have the following meanings (such definitions to be equally applicable to the singular and plural
forms thereof): 
 “Borrower” is defined in the preamble. 

  
 E-1 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Collateral” is defined in Section 2.1. 

“Collateral Accounts” is defined in Section 4.3(b). 

“Computer Hardware and Software Collateral” means (a) all of the Grantors’ computer and other electronic data
processing hardware, integrated computer systems, central processing units, memory units, display terminals, printers, features, computer elements, card readers, tape drives, hard and soft disk drives, cables, electrical supply hardware, generators,
power equalizers, accessories and all peripheral devices and other related computer hardware, including all operating system software, utilities and application programs in whatsoever form; (b) all software programs (including both source code,
object code and all related applications and data files) designed for use on the computers and electronic data processing hardware described in clause (a) above; (c) all firmware associated therewith; (d) all documentation
(including flow charts, logic diagrams, manuals, guides, specifications, training materials, charts and pseudo codes) with respect to such hardware, software and firmware described in the preceding clauses (a) through (c); and
(e) all rights with respect to all of the foregoing, including copyrights, licenses, options, warranties, service contracts, program services, test rights, maintenance rights, support rights, improvement rights, renewal rights and
indemnifications and any substitutions, replacements, improvements, error corrections, updates, additions or model conversions of any of the foregoing. 

“Control Agreement” means an authenticated record in form and substance reasonably satisfactory to the Lender, that provides
for the Lender to have “control” (as defined in the UCC) over certain Collateral. 
 “Copyright Collateral” means
all copyrights of the Grantors, whether statutory or common law, whether registered or unregistered and whether published or unpublished, now or hereafter in force throughout the world including all of the Grantors’ rights, titles and interests
in and to all copyrights registered in the United States Copyright Office or anywhere else in the world, including the copyrights referred to in Item A of Schedule V, and registrations and recordings thereof and all applications for
registration thereof, whether pending or in preparation, all copyright licenses, including each copyright license referred to in Item B of Schedule V, the right to sue for past, present and future infringements of any of the foregoing,
all rights corresponding thereto, all extensions and renewals of any thereof and all Proceeds of the foregoing, including licenses, royalties, income, payments, claims, damages and Proceeds of suit, which are owned or licensed by the Grantors. 

“Credit Agreement” is defined in the first recital. 

“Distributions” means all dividends paid on Capital Securities, liquidating dividends paid on Capital Securities, shares (or
other designations) of Capital Securities resulting from (or in connection with the exercise of) stock splits, reclassifications, warrants, options, non-cash dividends, mergers, consolidations, and all other
distributions (whether similar or dissimilar to the foregoing) on or with respect to any Capital Securities constituting Collateral. 

  
 E-2 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Filing Statements” is defined in Section 3.7(b). 

“General Intangibles” means all “general intangibles” and all “payment intangibles”, each as defined in
the UCC, and shall include all interest rate or currency protection or hedging arrangements, all tax refunds, all licenses, permits, concessions and authorizations and all Intellectual Property Collateral (in each case, regardless of whether
characterized as general intangibles under the UCC). 
 “Grantor” and “Grantors” are defined in the
preamble. 
 “Hikma Collateral” has the meaning given such term in the Security Agreement, between Hikma
Pharmaceuticals LLC, the Borrower and Syringe, attached hereto as Exhibit D. 
 “Intellectual Property Collateral”
means, collectively, the Computer Hardware and Software Collateral, the Copyright Collateral, the Patent Collateral, the Trademark Collateral, the Trade Secrets Collateral, Product Agreements and Regulatory Authorizations. 

“Intercompany Note” means any promissory note evidencing loans made by any Grantor to any other Grantor. 

“Investment Property” means, collectively, (a) all “investment property” as such term is defined in
Section 9-102(a)(49) of the UCC and (b) whether or not constituting “investment property” as so defined, all Pledged Notes. 

“Lender” is defined in the preamble. 

“Patent Collateral” means: 

(a) all of the Grantors’ (i) inventions and discoveries, whether patentable or not, and (ii) letters patent and
applications for letters patent throughout the world, including all patent applications in preparation for filing and each patent and patent application referred to in Item A of Schedule III; 

(b) all reissues, divisions, continuations,
continuations-in-part, extensions, renewals and reexaminations of any of the items described in clause (a); 

(c) all patent licenses, and other agreements providing any Grantor with the right to use any items of the type referred to in
clauses (a) and (b) above, including each patent license referred to in Item B of Schedule III; and 

(d) all Proceeds of, and rights associated with, the foregoing (including licenses, royalties income, payments, claims, damages
and Proceeds of infringement suits) and the right to sue third parties for past, present or future infringements of any patent or patent application and for breach or enforcement of any patent license. 

  
 E-3 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 “Permitted Liens” means all Liens permitted by Section 8.3 of the
Credit Agreement. 
 “Pledged Notes” means all promissory notes listed on Item J of Schedule II (as such
schedule may be amended or supplemented from time to time), all Intercompany Notes at any time issued to any Grantor and all other promissory notes issued to or held by any Grantor. 

“ROS” is defined in the preamble. 

“Securities Act” is defined in Section 6.2(a). 

“Security Agreement” is defined in the preamble. 

“Trade Secrets Collateral” means all of the Grantors’ common law and statutory trade secrets and all other confidential,
proprietary or useful information, and all know-how obtained by or used in or contemplated at any time for use in the business of any Grantor (all of the foregoing being collectively called a “Trade
Secret”), whether or not such Trade Secret has been reduced to a writing or other tangible form, including all documents and things embodying, incorporating or referring in any way to such Trade Secret, all Trade Secret licenses, including
each Trade Secret license referred to in Schedule VI, and including the right to sue for and to enjoin and to collect damages for the actual or threatened misappropriation of any Trade Secret and for the breach or enforcement of any such
Trade Secret license. 
 “Trademark Collateral” means: 

(a) (i) all of the Grantors’ trademarks, trade names, corporate names, company names, business names, fictitious business
names, trade styles, service marks, certification marks, collective marks, logos and other source or business identifiers, and all goodwill of the business associated therewith, now existing or hereafter adopted or acquired including those referred
to in Item A of Schedule IV, whether currently in use or not, all registrations and recordings thereof and all applications in connection therewith, whether pending or in preparation for filing, including registrations, recordings and
applications in the United States Patent and Trademark Office or in any office or agency of the United States of America, or any State thereof or any other country or political subdivision thereof or otherwise, and all
common-law rights relating to the foregoing, and (ii) the right to obtain all reissues, extensions or renewals of the foregoing (collectively referred to as the “Trademarks”); 

  
 E-4 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) all Trademark licenses for the grant by or to any Grantors of any right
to use any Trademark, including each Trademark license referred to in Item B of Schedule IV; and 
 (c) all of
the goodwill of the business connected with the use of, and symbolized by the items described in, clause (a), and to the extent applicable clause (b); 

(d) the right to sue third parties for past, present and future infringements of any Trademark Collateral described in
clause (a) and, to the extent applicable, clause (b); and 
 (e) all Proceeds of, and rights associated
with, the foregoing, including any claim by any Grantor against third parties for past, present or future infringement or dilution of any Trademark, Trademark registration or Trademark license, or for any injury to the goodwill associated with the
use of any such Trademark or for breach or enforcement of any Trademark license and all rights corresponding thereto throughout the world. 

SECTION 1.2. Credit Agreement Definitions. Unless otherwise defined herein or the context otherwise requires, terms used in this
Security Agreement, including its preamble and recitals, have the meanings provided in the Credit Agreement. 
 SECTION 1.3. UCC
Definitions. When used herein the terms “Account”, “Certificate of Title”, “Certificated Securities”, “Chattel Paper”, “Commercial Tort Claim”, “Commodity Account”, “Commodity
Contract”, “Deposit Account”, “Document”, “Electronic Chattel Paper”, “Equipment”, “Goods”, “Instrument”, “Inventory”, “Letter-of-Credit Rights”, “Payment
Intangibles”, “Proceeds”, “Promissory Notes”, “Securities Account”, “Security Entitlement”, “Supporting Obligations” and “Uncertificated Securities” have the meaning provided in
Article 8 or Article 9, as applicable, of the UCC. “Letters of Credit” has the meaning provided in Section 5-102 of the UCC. 

SECTION 1.4. Interpretation. The provisions of Section 1.5 of the Credit Agreement are incorporated in, and apply to, this
Agreement as if set out in full with any necessary amendments. 
 ARTICLE II 

SECURITY INTEREST 
 SECTION 2.1.
Grant of Security Interest. Each Grantor hereby grants to the Lender, for its benefit, a continuing security interest in all of such Grantor’s right, title and interest in and to the following property, whether now or hereafter existing,
owned or acquired by such Grantor, and wherever located, (collectively, the “Collateral”): 
 (a) Accounts;

  
 E-5 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) Chattel Paper; 

(c) Commercial Tort Claims listed on Item I of Schedule II (as such schedule may be amended or supplemented from
time to time); 
 (d) Deposit Accounts; 

(e) Documents; 

(f) General Intangibles; 

(g) Goods (including Goods held on consignment with third parties); 

(h) Instruments; 

(i) Investment Property; 

(j) Letter-of-Credit Rights and Letters of Credit; 

(k) Supporting Obligations; 

(l) all books, records, writings, databases, information and other property relating to, used or useful in connection with,
evidencing, embodying, incorporating or referring to, any of the foregoing in this Section (collectively, “Collateral Records”); 

(m) all Proceeds of the foregoing and, to the extent not otherwise included, (A) all payments under insurance (whether or
not the Lender is the loss payee thereof) in respect of Collateral and (B) all tort claims; and 
 (n) all other
property and rights of every kind and description and interests therein. 
 Notwithstanding the foregoing, the term “Collateral”
shall not include the following “Excluded Property”: 
 (i) any General Intangibles or other rights arising
under any contracts, instruments, licenses or other documents as to which the grant of a security interest would (A) constitute a violation of a valid and enforceable restriction in favor of a third party on such grant, unless and until any
required consents shall have been obtained, or (B) give any other party to such contract, instrument, license or other document the right to terminate its obligations thereunder; 

  
 E-6 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (ii) trademark applications filed in the United States Patent and Trademark
Office on the basis of such Grantor’s “intent to use” such trademark, unless and until acceptable evidence of use of the Trademark has been filed with the United States Patent and Trademark Office pursuant to Section 1(c) or
Section 1(d) of the Lanham Act (15 U.S.C. 1051, et seq.), to the extent that granting a Lien in such Trademark application prior to such filing would adversely affect the enforceability or validity of such Trademark application; 

(iii) any asset, the granting of a security interest in which would be void or illegal under any applicable governmental law,
rule or regulation, or pursuant thereto would result in, or permit the termination of, such asset; 
 (iv) any asset subject
to a Permitted Lien (other than Liens in favor of the Lender) securing obligations permitted under the Credit Agreement to the extent that the grant of other Liens on such asset (A) would result in a breach or violation of, or constitute a
default under, the agreement or instrument governing such Permitted Lien, (B) would result in the loss of use of such asset or (C) would permit the holder of such Permitted Lien to terminate the Grantor’s use of such asset; 

(v) the accounts described in paragraphs (ii) and (iv) of the definition of Excluded Accounts; or 

(vi) any Hikma Collateral, until such time, with respect to any such Collateral, as such Collateral no longer secures any
obligations owing to Hikma Pharmaceuticals LLC; 
 provided, that the property described in paragraphs (i), (iii) and
(iv) above shall only be excluded from the term “Collateral” to the extent the conditions stated in such paragraphs are not rendered ineffective pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the UCC or any other applicable law
and the term “Excluded Property” shall not include any proceeds, products, substitutions or replacements of Excluded Property (unless such proceeds, products, substitutions or replacements would otherwise constitute Excluded Property).

 SECTION 2.2. Security for Obligations. This Security Agreement and the Collateral in which the Lender is granted a security
interest hereunder by the Grantors secure the payment and performance of all of the Obligations. 
 SECTION 2.3. Grantors Remain
Liable. Anything herein to the contrary notwithstanding: 
 (a) the Grantors will remain liable under the contracts and
agreements included in the Collateral to the extent set forth therein, and will perform all of their duties and obligations under such contracts and agreements to the same extent as if this Security Agreement had not been executed; 

  
 E-7 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) the exercise by the Lender of any of its rights hereunder will not
release any Grantor from any of its duties or obligations under any such contracts or agreements included in the Collateral; and 

(c) the Lender will not have any obligation or liability under any contracts or agreements included in the Collateral by reason
of this Security Agreement, nor will the Lender be obligated to perform any of the obligations or duties of any Grantor thereunder or to take any action to collect or enforce any claim for payment assigned hereunder. 

SECTION 2.4. Distributions on Capital Securities; Payments on Pledged Notes. In the event that any (a) Distribution with respect
to any Capital Securities or (b) payment with respect to any Pledged Notes, in each case pledged hereunder, is permitted to be paid (in accordance with Section 8.6 of the Credit Agreement), such Distribution or payment may be paid directly
to the applicable Grantor. If any Distribution or payment is made in contravention of Section 8.6 of the Credit Agreement, such Grantor shall hold the same segregated and in trust for the Lender until paid to the Lender in accordance with
Section 4.1.5. 
 SECTION 2.5. Security Interest Absolute, Etc. This Security Agreement shall in all respects be a
continuing, absolute, unconditional and irrevocable grant of security interest, and shall remain in full force and effect until the Termination Date. All rights of the Lender and the security interests granted to the Lender hereunder, and all
obligations of the Grantors hereunder, shall, to the fullest extent permitted by applicable law, in each case, be absolute, unconditional and irrevocable irrespective of: 

(a) any lack of validity, legality or enforceability of any Loan Document (other than this Security Agreement); 

(b) the failure of the Lender (i) to assert any claim or demand or to enforce any right or remedy against Holdings, the
Borrower or any of the Subsidiaries or any other Person (including any other Grantor) under the provisions of any Loan Document or otherwise, or (ii) to exercise any right or remedy against any other guarantor (including any other Grantor) of,
or Collateral securing, any Obligations; 
 (c) any change in the time, manner or place of payment of, or in any other term
of, all or any part of the Obligations, or any other extension, compromise or renewal of any Obligations; 
 (d) any
reduction, limitation, impairment or termination of any Obligations for any reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to (and each Grantor hereby waives, until payment

  
 E-8 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
of all Obligations, any right to or claim of) any defense or setoff, counterclaim, recoupment or termination whatsoever by reason of the invalidity, illegality, nongenuineness, irregularity,
compromise, unenforceability of, or any other event or occurrence affecting, any Obligations or otherwise; 
 (e) any
amendment to, rescission, waiver, or other modification of, or any consent to or departure from, any of the terms of any Loan Document; 

(f) any addition, exchange or release of any Collateral or of any Person that is (or will become) a Grantor (including the
Grantors hereunder), or any surrender or non-perfection of any Collateral, or any amendment to or waiver or release or addition to, or consent to or departure from, any other guaranty held by the Lender securing any of the Obligations; or 

(g) any other circumstance which might otherwise constitute a defense available to, or a legal or equitable discharge of
Holdings, the Borrower or any of the Subsidiaries, any surety or any guarantor. 
 SECTION 2.6. Postponement of Subrogation. Each
Grantor agrees that it will not exercise any rights against another Grantor which it may acquire by way of rights of subrogation under any Loan Document to which it is a party until following the Termination Date. No Grantor shall seek or be
entitled to seek any contribution or reimbursement from Holdings, the Borrower or any of the Subsidiaries, in respect of any payment made under any Loan Document or otherwise, until following the Termination Date. Any amount paid to any Grantor on
account of any such subrogation rights prior to the Termination Date shall be held in trust for the benefit of the Lender and shall immediately be paid and turned over to the Lender in the exact form received by such Grantor (duly endorsed in favor
of the Lender, if required), to be credited and applied against the Obligations, whether matured or unmatured, in accordance with Section 6.1(b); provided that if such Grantor has made payment to the Lender of all or any part of
the Obligations and the Termination Date has occurred, then at such Grantor’s request, the Lender will, at the expense of such Grantor, execute and deliver to such Grantor appropriate documents (without recourse and without representation or
warranty) necessary to evidence the transfer by subrogation to such Grantor of an interest in the Obligations resulting from such payment. In furtherance of the foregoing, at all times prior to the Termination Date, such Grantor shall refrain from
taking any action or commencing any proceeding against Holdings, the Borrower or any of the Subsidiaries (or their successors or assigns, whether in connection with a bankruptcy proceeding or otherwise) to recover any amounts in respect of payments
made under this Security Agreement to the Lender. 

  
 E-9 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE III 

REPRESENTATIONS AND WARRANTIES 

In order to induce the Lender to enter into the Credit Agreement and make the Loans thereunder, the Grantors represent and warrant to the
Lender as set forth below. 
 SECTION 3.1. As to Capital Securities of the Subsidiaries, Investment Property. 

(a) With respect to any U.S. Subsidiary of any Grantor that is 

(i) a corporation, business trust, joint stock company or similar Person, all Capital Securities issued by such Subsidiary
(including the Borrower) are duly authorized and validly issued, fully paid and non-assessable, and represented by a certificate or certificates; and 

(ii) a partnership or limited liability company, no Capital Securities issued by such Subsidiary (A) are dealt in or
traded on securities exchanges or in securities markets, (B) expressly provides that such Capital Securities is a security governed by Article 8 of the UCC or (C) is held in a Securities Account, except, with respect to this clause
(a)(ii), Capital Securities (x) for which the Lender is the registered owner or (y) with respect to which the issuer has agreed in an authenticated record with such Grantor and the Lender to comply with any instructions of the Lender
without the consent of such Grantor. 
 (b) Each Grantor has delivered all Certificated Securities constituting Collateral
held by such Grantor in a Subsidiary (including the Borrower) on the Closing Date (or the date such Grantor becomes a party to this Security Agreement, as applicable) to the Lender, together with duly executed undated blank stock powers, or other
equivalent instruments of transfer acceptable to the Lender. 
 (c) With respect to Uncertificated Securities constituting
Collateral owned by any Grantor in a Subsidiary (including the Borrower) on the Closing Date (or the date such Grantor becomes a party to this Security Agreement, as applicable), such Grantor has caused the issuer thereof either to (i) register
the Lender as the registered owner of such security or (ii) agree in an authenticated record with such Grantor and the Lender that such issuer will comply with instructions with respect to such security originated by the Lender without further
consent of such Grantor. 
 (d) The percentage of the issued and outstanding Capital Securities of each Subsidiary (including
the Borrower) pledged on the Closing Date by each Grantor hereunder is as set forth on Schedule I. All shares of such Capital Securities have been duly and validly issued and are fully paid and nonassessable. 

  
 E-10 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (e) Each of the Intercompany Notes constitutes the legal, valid and binding
obligation of the obligor with respect thereto, enforceable in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting
creditors’ rights generally, general equitable principles (whether considered in a proceeding in equity or at law) and an implied covenant of good faith and fair dealing. 

SECTION 3.2. Grantor Name, Location, Etc. In each case as of the date hereof: 

(a) (i) The jurisdiction in which each Grantor is located for purposes of Sections
9-301 and 9-307 of the UCC and (ii) the address of each Grantor’s executive office and principal place of business is set forth in Item A of Schedule
II. 
 (b) The Grantors do not have any trade names other than those set forth in Item C of Schedule II
hereto. 
 (c) During the twelve months preceding the date hereof (or preceding the date such Grantor becomes a party to this
Security Agreement, as applicable), no Grantor has been known by any legal name different from the one set forth on the signature page hereto, nor has such Grantor been the subject of any merger or other corporate reorganization, except as set forth
in Item D of Schedule II hereto. 
 (d) Each Grantor’s federal taxpayer identification number (or foreign
equivalent) is (and, during the twelve months preceding the date hereof, such Grantor has not had a federal taxpayer identification number (or equivalent) different from that) set forth in Item E of Schedule II hereto. 

(e) No Grantor is a party to any federal, state or local government contract except as set forth in Item F of
Schedule II hereto. 
 (f) No Grantor maintains any Deposit Accounts, Securities Accounts or Commodity Accounts with
any Person, in each case, except as set forth on Item G of Schedule II. 
 (g) No Grantor is the beneficiary of
any Letters of Credit, except as set forth on Item H of Schedule II. 
 (h) No Grantor has Commercial Tort
Claims except as set forth on Item I of Schedule II. 
 (i) The name set forth on the signature page attached
hereto is the true and correct legal name (as defined in the UCC) of each Grantor. 

  
 E-11 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 3.3. Ownership, No Liens, Etc. Each Grantor owns its Collateral free and clear
of any Lien, except for any security interest (a) created by this Security Agreement and (b) Permitted Liens. No effective UCC financing statement or other filing similar in effect covering all or any part of the Collateral is on file in
any recording office, except those filed in favor of the Lender relating to this Security Agreement, Permitted Liens or as to which a duly authorized termination statement relating to such UCC financing statement or other instrument has been
delivered to the Lender on the Closing Date. 
 SECTION 3.4. Possession of Inventory, Control, Etc. 

(a) Each Grantor has, and agrees that it will maintain, exclusive possession of its Documents, Instruments, Promissory Notes,
Goods, Equipment and Inventory, other than (i) Equipment and Inventory that is in transit in the ordinary course of business, (ii) Equipment and Inventory that in the ordinary course of business is in the possession or control of a
warehouseman, bailee agent or other Person (other than a Person controlled by or under common control with such Grantor) that has been notified of the security interest created in favor of the Lender pursuant to this Security Agreement and has
authenticated a record acknowledging that it holds possession of such Collateral for the Lender’s benefit and waives any Lien held by it against such Collateral, (iii) Inventory that is in the possession of a consignee in the ordinary
course of business, (iv) Instruments or Promissory Notes that have been delivered to the Lender pursuant to Section 3.5, and (v) Equipment and Inventory at any single location which does not meet the requirements of
sub-sections (i), (ii), (iii) or (iv) above, but the value of such Equipment and Inventory at such location is not in an aggregate amount of more than $100,000. In the case of Equipment or Inventory described in clause
(ii) above, no lessor or warehouseman of any premises or warehouse upon or in which such Equipment or Inventory is located has (w) issued any warehouse receipt or other receipt in the nature of a warehouse receipt in respect of any
such Equipment or Inventory, (x) issued any Document for any such Equipment or Inventory, or (y) received notification of the Lender’s interest (other than the security interest granted hereunder) in any such Equipment or Inventory or
(z) any Lien on any such Equipment or Inventory. All Collateral Records of the Grantors are maintained at or accessible from the locations set forth in Item A of Schedule II. 

(b) Each Grantor is the sole entitlement holder of its Deposit Accounts (other than the Excluded Accounts) and no other Person
(other than the Lender pursuant to this Security Agreement or any other Person with respect to Permitted Liens) has control or possession of, or any other interest in, any of its Deposit Accounts (other than the Excluded Accounts) or any other
securities or property credited thereto. 
 SECTION 3.5. Negotiable Documents, Instruments and Chattel Paper. Each Grantor has
delivered to the Lender possession of all originals of all Documents, Instruments, Promissory Notes, and tangible Chattel Paper (other than any Document, Instrument, Promissory Note or tangible Chattel Paper not exceeding $20,000 in principal
amount) owned or held by such Grantor on the Closing Date. 

  
 E-12 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 3.6. Intellectual Property Collateral. Except as disclosed on Schedules
III through VI, with respect to any Intellectual Property Collateral: 
 (a) any Intellectual Property Collateral
owned by any Grantor is valid, subsisting, unexpired ahead of its natural expiration or term, and enforceable and has not been abandoned by the Grantor or adjudged invalid or unenforceable, in whole or in part; 

(b) such Grantor is the sole and exclusive owner of the entire and unencumbered right, title and interest in and to all
Intellectual Property Collateral owned by such Grantor and to the knowledge of such Grantor, no claim has been made that the use of such Intellectual Property Collateral by such Grantor does or may, conflict with, infringe, misappropriate, dilute,
misuse or otherwise violate in any material respect, any of the rights of any third party; 
 (c) such Grantor has made all
necessary filings and recordations to protect its interest in any Intellectual Property Collateral owned by such Grantor to the extent such filing or recordation is necessary for the conduct of the business substantially in the manner presently
conducted, including recordations of all of its interests in the Patent Collateral and Trademark Collateral in the United States Patent and Trademark Office (or foreign equivalent), and its claims to the Copyright Collateral in the United States
Copyright Office (or foreign equivalent), and, to the extent necessary, has used proper statutory notice in connection with its use of any material Patent, Trademark and Copyright in any of the Intellectual Property Collateral; 

(d) such Grantor has taken reasonable steps to safeguard its Trade Secrets and to its knowledge (A) none of the Trade
Secrets of such Grantor has been used, divulged, disclosed or appropriated for the benefit of any other Person other than such Grantor; (B) no employee, independent contractor or agent of such Grantor has misappropriated any Trade Secrets of
any other Person in the course of the performance of his or her duties as an employee, independent contractor or agent of such Grantor; and (C) no employee, independent contractor or agent of such Grantor is in default or breach of any material
term of any employment agreement, non-disclosure agreement, assignment of inventions agreement or similar agreement or contract relating in any material way to the protection, ownership, development, use or transfer of such Grantor’s
Intellectual Property Collateral; 
 (e) to such Grantor’s knowledge, no third party is infringing upon any Intellectual
Property owned or used by such Grantor in any material respect; 

  
 E-13 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (f) no settlement or consents, covenants not to sue, nonassertion assurances,
or releases have been entered into by such Grantor or to which such Grantor is bound that adversely affects its rights to own or use any Intellectual Property; 

(g) such Grantor has not made a previous assignment, sale, transfer or agreement constituting a present or future assignment,
sale or transfer of any Intellectual Property for purposes of granting a security interest or as Collateral that has not been terminated or released except the security interest granted to Hikma Pharmaceuticals LLC in the Hikma Collateral; 

(h) such Grantor has executed and delivered to the Lender Intellectual Property Collateral security agreements for all
Copyrights, Patents and Trademarks owned by such Grantor, including all Copyrights, Patents and Trademarks on Schedule III through VI (as such schedules may be amended or supplemented from time to time by notice by such Grantor to the
Lender); 
 (i) such Grantor uses commercially reasonable standards of quality in the manufacture, distribution, and sale of
all products sold and in the provision of all services rendered under or in connection with all Trademarks and has taken commercially reasonable action necessary to insure that all licensees of the Trademarks owned by such Grantor use such adequate
standards of quality; 
 (j) the consummation of the transactions contemplated by the Credit Agreement and this Security
Agreement will not result in the termination or material impairment of any of the Intellectual Property Collateral; and 

(k) to such Grantor’s knowledge, such Grantor owns or is entitled to use by license, lease or other agreement, all
Patents, Trademarks, Trade Secrets, Copyrights, mask works, licenses, technology, know-how, processes and rights with respect to any of the foregoing as necessary to conduct the business and operations of such
Grantor substantially in the manner presently conducted. 
 SECTION 3.7. Validity, Etc. 

(a) This Security Agreement creates a valid security interest in the Collateral securing the payment of the Obligations to the
extent such security interest may be created pursuant to Article 9 of the UCC. 
 (b) As of the Closing Date, each Grantor
has filed or will cause to be filed all UCC-1 financing statements in the filing office for each Grantor’s jurisdiction of organization listed in Item A of Schedule II (collectively, the “Filing Statements”) (or
has delivered to the Lender the Filing Statements suitable for timely and proper filing in such offices) and has taken all other actions required by the Lender for the Lender to obtain control (either itself or through an agent) of the Collateral as
provided in Sections 9-104, 9-105, 9-106 and 9-107 of the UCC. 

  
 E-14 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (c) Upon the filing of the Filing Statements with the appropriate agencies
therefor the security interests created under this Security Agreement shall constitute a perfected security interest in the Collateral described on such Filing Statements in favor of the Lender to the extent that a security interest therein may be
perfected by filing a financing statement pursuant to the relevant UCC, prior to all other Liens, except for Permitted Liens (in which case such security interest shall have such priority of right contemplated by the Loan Documents and subject only
to the Permitted Liens until the obligations secured by such Permitted Liens have been satisfied, except as expressly specified in the Loan Documents). 

SECTION 3.8. Authorization, Approval, Etc. Except as have been obtained or made and are in full force and effect, no authorization,
approval or other action by, and no notice to or filing with, any Governmental Authority or any other third party is required either 

(a) for the grant by the Grantors of the security interest granted hereby or for the execution, delivery and performance of
this Security Agreement by the Grantors; 
 (b) for the perfection or maintenance of the security interests hereunder
including the first priority nature of such security interest (except with respect to the Filing Statements or, with respect to Intellectual Property Collateral, the recordation of any agreements with the United States Patent and Trademark Office or
the United States Copyright Office or, with respect to foreign Intellectual Property Collateral, the taking of appropriate action under applicable foreign law and, with respect to after-acquired Intellectual Property Collateral, any subsequent
filings in United States intellectual property offices) or the exercise by the Lender of its rights and remedies hereunder; or 

(c) for the exercise by the Lender of the voting or other rights provided for in this Security Agreement, except (i) with
respect to any securities issued by a Subsidiary of the Grantors, as may be required in connection with a disposition of such securities by laws affecting the offering and sale of securities generally, the remedies in respect of the Collateral
pursuant to this Security Agreement and (ii) any “change of control” or similar filings required by state licensing agencies. 

SECTION 3.9. Best Interests. It is in the best interests, and for the commercial benefit, of each Grantor (other than the Borrower) to
execute this Security Agreement inasmuch as such Grantor will, as a result of being an Affiliate of the Borrower, derive substantial direct and indirect benefits from the Loans made to the Borrower by the Lender pursuant to the Credit Agreement, and
each Grantor agrees that the Lender is relying on this representation in agreeing to make such Loans pursuant to the Credit Agreement to the Borrower. 

  
 E-15 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE IV 

COVENANTS 
 Each Grantor covenants
and agrees that, until the Termination Date, such Grantor will perform, comply with and be bound by the obligations set forth below. 

SECTION 4.1. As to Investment Property, Etc. 

SECTION 4.1.1. Capital Securities of Subsidiaries. No Grantor will allow any of its Subsidiaries (including the Borrower): 

(a) that is a corporation, business trust, joint stock company or similar Person, to issue Uncertificated Securities; 

(b) that is a partnership or limited liability company, to (i) issue Capital Securities that are to be dealt in or traded
on securities exchanges or in securities markets, (ii) expressly provide in its Organic Documents that its Capital Securities are securities governed by Article 8 of the UCC, or (iii) place such Subsidiary’s Capital Securities in a
Securities Account; and 
 (c) to issue Capital Securities in addition to or in substitution for the Capital Securities
pledged hereunder, except to such Grantor (and such Capital Securities are immediately pledged and delivered to the Lender pursuant to the terms of this Security Agreement). 

SECTION 4.1.2. Investment Property (other than Certificated Securities). 

(a) With respect to any Deposit Accounts, Securities Accounts, Commodity Accounts, Commodity Contracts or Security Entitlements
constituting Investment Property owned or held by any Grantor, such Grantor will cause (except for Excluded Accounts) the intermediary maintaining such Investment Property to execute a Control Agreement relating to such Investment Property pursuant
to which such intermediary agrees to comply with the Lender’s instructions with respect to such Investment Property without further consent by such Grantor. 

(b) With respect to any Uncertificated Securities (other than Uncertificated Securities credited to a Securities Account)
constituting Investment Property owned or held by any Grantor, such Grantor will cause the issuer of such securities to either (i) register the Lender as the registered owner thereof on the books and records of the issuer or (ii) execute a
Control Agreement relating to such Investment Property pursuant to which the issuer agrees to comply with the Lender’s instructions with respect to such Uncertificated Securities without further consent by such Grantor. Each party hereto that
is such an issuer of any Uncertificated Securities herby agrees that such party will comply with instructions with respect to such security originated by the Lender. 

  
 E-16 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 4.1.3. Certificated Securities (Stock Powers). Each Grantor agrees that all
Certificated Securities constituting Collateral, including the Capital Securities delivered by such Grantor pursuant to this Security Agreement, will be accompanied by duly executed undated blank stock powers, or other equivalent instruments of
transfer reasonably acceptable to the Lender. 
 SECTION 4.1.4. Continuous Pledge. Each Grantor will (subject to the terms of the
Credit Agreement) (a) deliver to the Lender all Investment Property and all Payment Intangibles to the extent that such Investment Property or Payment Intangibles are evidenced by a Document, Instrument, Promissory Note or Chattel Paper (other
than any Document, Instrument, Promissory Note or Chattel Paper not exceeding $20,000 in the principal amount), and (b) at all times keep pledged to the Lender pursuant hereto, on a first-priority,
perfected basis, security interest therein and in all interest and principal with respect to such Payment Intangibles, and all Proceeds and rights from time to time received by or distributable to such Grantor in respect of any of the foregoing
Collateral. Each Grantor agrees that it will, promptly following receipt thereof, deliver to the Lender possession of all originals of negotiable Documents, Instruments, Promissory Notes and Chattel Paper that it acquires following the Closing Date
(other than any Document, Instrument, Promissory Note or Chattel Paper not exceeding $20,000 in the principal amount). 
 SECTION 4.1.5.
Voting Rights, Dividends, Etc. Each Grantor agrees: 
 (a) upon receipt of notice of the occurrence and continuance of
an Event of Default from the Lender and without any request therefor by the Lender, so long as such Event of Default shall continue, to deliver (properly endorsed where required hereby or requested by the Lender) to the Lender all dividends and
Distributions with respect to Investment Property, all interest, principal, other cash payments on Payment Intangibles, and all Proceeds of the Collateral, in each case thereafter received by such Grantor, all of which shall be held by the Lender as
additional Collateral, except for payments made in accordance with Section 8.6 of the Credit Agreement; and 
 (b)
immediately upon the occurrence and during the continuance of an Event of Default and so long as the Lender has notified such Grantor of the Lender’s intention to exercise its voting power under this clause, 

(i) with respect to Collateral consisting of general partner interests or limited liability company interests, to promptly
modify its Organic Documents to admit the Lender as a general partner or member, as applicable; 
 (ii) that the Lender may
exercise (to the exclusion of such Grantor) the voting power and all other incidental rights of ownership with respect to any Investment Property constituting Collateral and such Grantor hereby grants the Lender an irrevocable proxy, exercisable
under such circumstances, to vote such Investment Property; and 
 (iii) to promptly deliver to the Lender such additional
proxies and other documents as may be necessary to allow the Lender to exercise such voting power. 

  
 E-17 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 All dividends, Distributions, interest, principal, cash payments, Payment Intangibles and Proceeds that may
at any time and from time to time be held by such Grantor, but which such Grantor is then obligated to deliver to the Lender, shall, until delivery to the Lender, be held by such Grantor separate and apart from its other property in trust for the
Lender. The Lender agrees that unless an Event of Default shall have occurred and be continuing and the Lender shall have given the notice referred to in clause (b), such Grantor will have the exclusive voting power with respect to any
Investment Property constituting Collateral and the Lender will, upon the written request of such Grantor, promptly deliver such proxies and other documents, if any, as shall be reasonably requested by such Grantor which are necessary to allow such
Grantor to exercise that voting power; provided that no vote shall be cast, or consent, waiver, or ratification given, or action taken by such Grantor that would impair any such Collateral or be inconsistent with or violate any provision of
any Loan Document. 
 SECTION 4.2. Change of Name, Etc. No Grantor will change its name or place of incorporation or organization or
federal taxpayer identification number except as otherwise permitted by the Credit Agreement. 
 SECTION 4.3. As to Accounts. 

(a) Each Grantor shall have the right to collect all Accounts so long as no Event of Default shall have occurred and be
continuing. 
 (b) Upon (i) the occurrence and continuance of an Event of Default and (ii) the delivery of notice
by the Lender to each Grantor, all Proceeds of Collateral received by such Grantor shall be delivered in kind to the Lender for deposit in a Deposit Account of such Grantor maintained with the Lender (together with any other Deposit Accounts or
Security Accounts pursuant to which any portion of the Collateral is deposited with the Lender, the “Collateral Accounts”), and such Grantor shall not commingle any such Proceeds, and shall hold separate and apart from all other
property, all such Proceeds in express trust for the benefit of the Lender until delivery thereof is made to the Lender. 

(c) Following the delivery of notice pursuant to clause (b)(ii), the Lender shall have the right to apply any amount in
the Collateral Account to the payment of any Obligations which are then due and payable. 

  
 E-18 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (d) With respect to each of the Collateral Accounts, it is hereby confirmed
and agreed that (i) deposits in such Collateral Account are subject to a security interest as contemplated hereby, (ii) such Collateral Account shall be under the control of the Lender and (iii) the Lender shall have the sole right of
withdrawal over such Collateral Account. 
 SECTION 4.4. As to Grantors’ Use of Collateral. 

(a) Subject to clause (b), each Grantor (i) may in the ordinary course of its business, at its own expense, sell, lease
or furnish under contracts of service any of the Inventory normally held by such Grantor for such purpose, and use and consume, in the ordinary course of its business, any raw materials, work in process or materials normally held by such Grantor for
such purpose, (ii) will, at its own expense, endeavor to collect, as and when due, all amounts due with respect to any of the Collateral, including the taking of such action with respect to such collection as the Lender may reasonably request
following the occurrence of an Event of Default or, in the absence of such request, as such Grantor may deem advisable, and (iii) may grant, in the ordinary course of business, to any party obligated on any of the Collateral, any rebate, refund or
allowance to which such party may be lawfully entitled, and may accept, in connection therewith, the return of Goods, the sale or lease of which shall have given rise to such Collateral. 

(b) At any time following the occurrence and during the continuance of an Event of Default, whether before or after the
maturity of any of the Obligations, the Lender may (i) revoke any or all of the rights of each Grantor set forth in clause (a), (ii) notify any parties obligated on any of the Collateral to make payment to the Lender of any amounts
due or to become due thereunder and (iii) enforce collection of any of the Collateral by suit or otherwise and surrender, release, or exchange all or any part thereof, or compromise or extend or renew for any period (whether or not longer than
the original period) any indebtedness thereunder or evidenced thereby. 
 (c) Upon the request of the Lender following the
occurrence and during the continuance of an Event of Default, each Grantor will, at its own expense, notify any parties obligated on any of the Collateral to make payment to the Lender of any amounts due or to become due thereunder. 

(d) At any time following the occurrence and during the continuation of an Event of Default, the Lender may endorse, in the
name of such Grantor, any item, howsoever received by the Lender, representing any payment on or other Proceeds of any of the Collateral. 

  
 E-19 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 4.5. As to Intellectual Property Collateral. Each Grantor covenants and agrees
to comply with the following provisions as such provisions relate to any Intellectual Property Collateral material to the operations or business of such Grantor: 

(a) such Grantor will not (i) do or fail to perform any act whereby any of the Patent Collateral may lapse or become
abandoned or dedicated to the public or unenforceable, (ii) permit any of its licensees to (A) fail to continue to use any of the Trademark Collateral in order to maintain all of the Trademark Collateral in full force free from any claim
of abandonment for non-use, (B) fail to maintain the quality of products and services offered under all of the Trademark Collateral at a level substantially consistent with the quality of products and
services offered under such Trademark as of the date hereof, (C) fail to employ all of the Trademark Collateral registered with any federal or state or foreign authority with an appropriate notice of such registration, (D) adopt or use any
other Trademark which is confusingly similar or a colorable imitation of any of the Trademark Collateral, (E) use any of the Trademark Collateral registered with any federal, state or foreign authority except for the uses for which registration
or application for registration of all of the Trademark Collateral has been made or (F) do or permit any act or knowingly omit to do any act whereby any of the Trademark Collateral may become invalid or unenforceable, or (iii) do or permit
any act or knowingly omit to do any act whereby any of the Copyright Collateral or any of the Trade Secrets Collateral may lapse or become invalid or unenforceable or placed in the public domain except upon expiration of the end of an unrenewable
term of a registration thereof, unless, in the case of any of the foregoing requirements in clauses (i), (ii) and (iii), such Grantor reasonably and in good faith determines that either (x) the further prosecution or
maintenance of such Intellectual Property Collateral is not economically justified in relation to the economic value, or potential or expected economic value to such Grantor or any other Credit Obligor, (y) the loss of such Intellectual
Property Collateral would not be material to such Grantor or any other Credit Obligor or (z) the Grantor, in its reasonable judgment, determines that further prosecution of such Intellectual Property Collateral is unlikely to result in an
allowance of exclusive patent rights; 
 (b) such Grantor shall promptly notify the Lender if it knows, or has reason to
know, that any application or registration relating to any material item of the Intellectual Property Collateral may, in the Grantor’s reasonable commercial judgment, become abandoned or dedicated to the public or placed in the public domain or
invalid or unenforceable, or of any adverse determination or development (including the institution of, or any such determination or development in, any proceeding in the United States Patent and Trademark Office, the United States Copyright Office
or any foreign counterpart thereof or any court) regarding such Grantor’s ownership of any of the Intellectual Property Collateral, its right to register the same or to keep and maintain and enforce the same; 

  
 E-20 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (c) at the times and with such frequency set forth in Section 4.5(e)
below, each Grantor shall notify the Lender of the filing of an application for the registration of any Intellectual Property Collateral with the United States Patent and Trademark Office, the United States Copyright Office or any similar office or
agency in any other country or any political subdivision thereof by such Grantor or any of its agents, employees, designees or licensees, and, upon request of the Lender (subject to the terms of the Credit Agreement), executes and delivers all
agreements, instruments and documents as the Lender may reasonably request to evidence the Lender’s security interest in such Intellectual Property Collateral; 

(d) such Grantor will take all reasonable and necessary steps, including in any proceeding before the United States Patent and
Trademark Office, the United States Copyright Office or any similar office or agency in any other country or any political subdivision thereof (subject to the terms of the Credit Agreement), to maintain and pursue any material application (and to
obtain the relevant registration) filed with respect to, and to maintain any registration of, material Intellectual Property Collateral, including the filing of applications for renewal, affidavits of use, affidavits of incontestability and
opposition, interference and cancellation proceedings and the payment of fees and taxes (except to the extent that dedication, abandonment or invalidation is permitted under the foregoing clause (a) or (b) or such Grantor
reasonably and in good faith determines that the failure to take any such step would not have a material adverse effect on the interests of the Lender in such Intellectual Property Collateral); and 

(e) such Grantor will within 45 days after the end of each Fiscal Quarter execute and deliver to the Lender (as applicable) a
Patent Security Agreement, Trademark Security Agreement and/or Copyright Security Agreement, as the case may be, in the forms of Exhibit A, Exhibit B and Exhibit C hereto following its obtaining an interest in any such
Intellectual Property or such Grantor filing (or any of its agents, employees, designees or licensees filing on behalf of a Grantor) an application for the registration of any Intellectual Property Collateral in accordance with Section 4.5(c)
above, and shall execute and deliver to the Lender any other document reasonably required to evidence the Lender’s interest in any part of such item of Intellectual Property Collateral unless such Grantor shall determine in good faith (with the
consent of the Lender) that any Intellectual Property Collateral is of negligible economic value to such Grantor. 
 SECTION 4.6. As to
Letter-of-Credit Rights. 
 (a) Each Grantor, by granting a security interest in its Letter-of-Credit Rights to the
Lender, intends to (and hereby does) collaterally assign to the Lender its rights (including its contingent rights ) to the Proceeds of all Letter-of-Credit Rights of which it is or hereafter becomes a beneficiary or assignee. 

  
 E-21 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) Upon the occurrence of an Event of Default, such Grantor will, promptly
upon request by the Lender, (i) notify (and such Grantor hereby authorizes the Lender to notify) the issuer and each nominated person with respect to each of the Letters of Credit that the Proceeds thereof have been assigned to the Lender
hereunder and any payments due or to become due in respect thereof are to be made directly to the Lender and (ii) arrange for the Lender to become the transferee beneficiary of such Letter of Credit. 

SECTION 4.7. As to Commercial Tort Claims. Each Grantor covenants and agrees that, until the payment in full of the Obligations and
termination of all Commitments, with respect to any Commercial Tort Claim hereafter arising, it shall deliver to the Lender a supplement in form and substance reasonably satisfactory to the Lender, together with all supplements to schedules thereto,
identifying such new Commercial Tort Claim. 
 SECTION 4.8. Electronic Chattel Paper and Transferable Records. If any Grantor at any
time holds or acquires an interest in any electronic chattel paper or any “transferable record,” as that term is defined in Section 201 of the U.S. Federal Electronic Signatures in Global and National Commerce Act, or in
Section 16 of the U.S. Uniform Electronic Transactions Act as in effect in any relevant jurisdiction, with a value in excess of $100,000, such Grantor shall promptly notify the Lender thereof and, at the request of the Lender, shall take such
action as the Lender may reasonably request to vest in the Lender control under Section 9-105 of the UCC of such electronic chattel paper or control under Section 201 of the Federal Electronic Signatures in Global and National Commerce Act
or, as the case may be, Section 16 of the Uniform Electronic Transactions Act, as so in effect in such jurisdiction, of such transferable record. The Lender agrees with such Grantor that the Lender will arrange, pursuant to procedures
satisfactory to the Lender and so long as such procedures will not result in the Lender’s loss of control, for the Grantor to make alterations to the electronic chattel paper or transferable record permitted under Section 9-105 of the UCC
or, as the case may be, Section 201 of the U.S. Federal Electronic Signatures in Global and National Commerce Act or Section 16 of the U.S. Uniform Electronic Transactions Act for a party in control to allow without loss of control, unless
an Event of Default has occurred and is continuing or would occur after taking into account any action by such Grantor with respect to such electronic chattel paper or transferable record. 

SECTION 4.9. Further Assurances, Etc. Each Grantor agrees that, from time to time at its own expense, it will, subject to the terms of
this Security Agreement, promptly execute and deliver all further instruments and documents, and take all further action, that may be necessary or that the Lender may reasonably request, in order to perfect, preserve and protect any security
interest granted or purported to be granted hereby or to enable the Lender to exercise and enforce its rights and remedies hereunder with respect to any Collateral. Without limiting the generality of the foregoing, such Grantor will 

(a) from time to time upon the request of the Lender, promptly deliver to the Lender such stock powers, instruments and similar
documents, reasonably satisfactory in form and substance to the Lender, with respect to such Collateral as the Lender may 

  
 E-22 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
request and will, from time to time upon the request of the Lender, after the occurrence and during the continuance of any Event of Default, promptly transfer any securities constituting
Collateral into the name of any nominee designated by the Lender; if any Collateral shall be evidenced by an Instrument, negotiable Document, Promissory Note or tangible Chattel Paper, deliver and pledge to the Lender hereunder such Instrument,
negotiable Document, Promissory Note or tangible Chattel Paper (other than any Instrument, negotiable Document, Promissory Note or tangible Chattel Paper in principal amount less than $20,000) duly endorsed and accompanied by duly executed
instruments of transfer or assignment, all in form and substance reasonably satisfactory to the Lender; 
 (b) file (and
hereby authorizes the Lender to file) such Filing Statements or continuation statements, or amendments thereto, and such other instruments or notices (including any assignment of claim form under or pursuant to the federal assignment of claims
statute, 31 U.S.C. § 3726, any successor or amended version thereof or any regulation promulgated under or pursuant to any version thereof), as may be necessary or that the Lender may reasonably request in order to perfect and preserve the
security interests and other rights granted or purported to be granted to the Lender hereby; 
 (c) at all times keep pledged
to the Lender pursuant hereto, on a first-priority, perfected basis, at the request of the Lender, all Investment Property constituting Collateral, all dividends and Distributions with respect thereto, and all
interest and principal with respect to Promissory Notes, and all Proceeds and rights from time to time received by or distributable to such Grantor in respect of any of the foregoing Collateral; 

(d) not take or omit to take any action the taking or the omission of which would result in any impairment or alteration of any
obligation of the maker of any Payment Intangible or other Instrument constituting Collateral, except as provided in Section 4.4; 

(e) not create any tangible Chattel Paper without placing a legend on such tangible Chattel Paper reasonably acceptable to the
Lender indicating that the Lender has a security interest in such Chattel Paper (provided that so long as no Event of Default is continuing, Chattel Paper and records relating to such Collateral for amounts in each case less than $20,000, need only
be marked upon Lender’s request); 
 (f) furnish to the Lender, from time to time at the Lender’s request,
statements and schedules further identifying and describing the Collateral and such other reports in connection with the Collateral (including any real property locations where material Collateral Records or Collateral in excess of $100,000 in
aggregate are located) as the Lender may request, all in reasonable detail (provided however, for so long as no Event of Default has occurred, Lender may not require such additional statements and schedules more than once per fiscal quarter); and

 (g) do all things reasonably requested by the Lender in accordance with this Security Agreement (including dollar
thresholds herein) in order to enable the Lender to have and maintain control over the Collateral consisting of Investment Property, Deposit Accounts, Letter-of-Credit-Rights and Electronic Chattel Paper. 

  
 E-23 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 With respect to the foregoing and the grant of the security interest hereunder, each Grantor
hereby authorizes the Lender to file one or more financing or continuation statements, and amendments thereto, relative to all or any part of the Collateral. Each Grantor agrees that a carbon, photographic or other reproduction of this Security
Agreement or any UCC financing statement covering the Collateral or any part thereof shall be sufficient as a UCC financing statement where permitted by law. Each Grantor hereby authorizes the Lender to file financing statements describing as the
collateral covered thereby “all of the debtor’s personal property or assets” or words to that effect, notwithstanding that such wording may be broader in scope than the Collateral described in this Security Agreement. Each Grantor
also agrees to promptly notify the Lender of any change in the location of any office in which it maintains Collateral Records or any office or facility at which Collateral is located (including the establishment of any such new office or facility).

 ARTICLE V 
 THE LENDER 

SECTION 5.1. Lender Appointed Attorney-in-Fact. Each
Grantor hereby irrevocably appoints the Lender as its attorney-in-fact, with full authority in the place and stead of such Grantor and in the name of such Grantor or
otherwise, from time to time in the Lender’s discretion, following the occurrence and during the continuance of an Event of Default, to take any action and to execute any instrument which the Lender may deem necessary or advisable to accomplish
the purposes of this Security Agreement, including: 
 (a) to ask, demand, collect, sue for, recover, compromise, receive and
give acquittance and receipts for moneys due and to become due under or in respect of any of the Collateral; 
 (b) to
receive, endorse, and collect any drafts or other Instruments, Documents and Chattel Paper, in connection with clause (a) above; and 

(c) to file any claims or take any action or institute any proceedings which the Lender may deem necessary or desirable for the
collection of any of the Collateral or otherwise to enforce the rights of the Lender with respect to any of the Collateral. 
 Each Grantor hereby
acknowledges, consents and agrees that the power of attorney granted pursuant to this Section is irrevocable and coupled with an interest. 

  
 E-24 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 5.2. Lender May Perform. If any Grantor fails to perform any agreement
contained herein, the Lender may itself perform, or cause performance of, such agreement, that the Lender deems necessary for the maintenance, preservation or protection of any of the Collateral or of its security interest therein to the extent
provided for herein, and the expenses of the Lender incurred in connection therewith shall be payable by such Grantor pursuant to Section 10.3 of the Credit Agreement. 

SECTION 5.3. Lender Has No Duty. The powers conferred on the Lender hereunder are solely to protect its interest in the Collateral and
shall not impose any duty on it to exercise any such powers. Except for reasonable care of any Collateral in its possession and the accounting for moneys actually received by it hereunder, the Lender shall have no duty as to any Collateral or
responsibility for 
 (a) ascertaining or taking action with respect to calls, conversions, exchanges, maturities, tenders or
other matters relative to any Investment Property, whether or not the Lender has or is deemed to have knowledge of such matters, or 

(b) taking any necessary steps to preserve rights against prior parties or any other rights pertaining to any Collateral. 

SECTION 5.4. Reasonable Care. The Lender is required to exercise reasonable care in the custody and preservation of any of the
Collateral in its possession; provided that the Lender shall be deemed to have exercised reasonable care in the custody and preservation of any of the Collateral, if it takes such action for that purpose as each Grantor reasonably requests in
writing at times other than upon the occurrence and during the continuance of any Event of Default, but failure of the Lender to comply with any such request at any time shall not in itself be deemed a failure to exercise reasonable care. 

SECTION 5.5. Lender as Agent for Other Secured Parties. 

(a) Each of the Lender and ROS hereby irrevocably appoints the Lender hereunder and under the other Loan Documents as its agent
and authorizes the Lender to take such actions on its behalf as collateral agent for all purposes hereunder and under the other Loan Documents pursuant to which any Grantor grants a Lien or other right in any collateral (including Collateral and any
“Collateral” howsoever described in any Australian Security Document)to secure the Obligations and for purposes of acquiring, holding and enforcing any and all Liens on any collateral (including Collateral and any “Collateral”
howsoever described in any Australian Security Document) granted by any Grantor to secure any of the Obligations, including execution of the other Loan Documents, and to exercise such powers as are delegated to the Lender by the terms of the Loan
Documents, together with such actions and powers as are reasonably incidental thereto. The provisions of this Section are solely for the benefit of the Lender and ROS, and no Grantor shall have rights as a third-party beneficiary of any of such
provisions. 

  
 E-25 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (b) The Person serving as the collateral agent shall have the same rights and
powers in its capacity as the Lender under the Credit Agreement and may exercise the same as though it were not the collateral agent. The Lender shall not have any duties or obligations except those expressly set forth in the Loan Documents, and its
duties thereunder shall be administrative in nature. The Lender shall not be liable for any action taken or not taken by it with the consent or at the request of ROS or in the absence of its own gross negligence or willful misconduct as determined
by a court of competent jurisdiction by final and nonappealable judgment. The Lender may appoint any co-agents, sub-agents or attorneys-in-fact in connection with the foregoing. 

(c) The Lender shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request,
certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise
authenticated by the proper Person. The Lender also may rely upon any statement made to it orally (including by telephone) and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. The Lender
may consult with legal counsel, independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts. If in accordance
with the terms of the applicable Loan Documents, any additional Person is assigned, granted or otherwise transferred all or any portion of the Obligations under the Loan Documents (each such new Person, an “Additional Secured Party”
and collectively, the “Additional Secured Parties”), such Additional Secured Party shall preserve all of its rights with respect to the security interests and Lien created pursuant to this Agreement, so that the security created by
hereunder shall be automatically transferred to the assignee, transferee or new creditor after novation. Notwithstanding the foregoing, each Additional Secured Party shall deliver a counterpart signature page to this Agreement and accept and
acknowledge its rights, duties and obligations as if it were a Secured Party to this Agreement as of the Closing Date (including the appointment of the Lender to act as its agent for the purposes of perfecting and maintaining the security interest
in the Collateral on its behalf). On and after the delivery of a counterpart signature page to this Agreement by an Additional Secured Party, all references in this Agreement or in the other Loan Documents to the secured parties in reference to the
Obligations shall mean, be and include a reference to such Additional Secured Party. 

  
 E-26 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ARTICLE VI 

REMEDIES 
 SECTION 6.1. Certain
Remedies. If any Event of Default shall have occurred and be continuing: 
 (a) The Lender may exercise in respect of the
Collateral, in addition to other rights and remedies provided for herein or otherwise available to it, all the rights and remedies of the Lender on default under the UCC (whether or not the UCC applies to the affected Collateral) and also may 

(i) take possession of any Collateral not already in its possession without demand and without legal process; 

(ii) require each Grantor to, and each Grantor hereby agrees that it will, at its expense and upon request of the Lender
forthwith, assemble all or part of the Collateral as directed by the Lender and make it available to the Lender at a place to be designated by the Lender that is reasonably convenient to both parties, 

(iii) enter onto the property where any Collateral is located and take possession thereof without demand and without legal
process; and 
 (iv) without notice except as specified below, lease, license, sell or otherwise dispose of the Collateral
or any part thereof in one or more parcels at any public or private sale, at any of the Lender’s offices or elsewhere, for cash, on credit or for future delivery, and upon such other terms as the Lender may deem commercially reasonable. Each
Grantor agrees that, to the extent notice of sale shall be required by law, at least ten (10) days’ prior notice to such Grantor of the time and place of any public sale or the time after which any private sale is to be made shall
constitute reasonable notification. The Lender shall not be obligated to make any sale of Collateral regardless of notice of sale having been given. The Lender may adjourn any public or private sale from time to time by announcement at the time and
place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned. 

(b) All cash Proceeds received by the Lender in respect of any sale of, collection from, or other realization upon, all or any
part of the Collateral shall be applied by the Lender against all or any part of the Obligations as set forth in Section 4.4(b) of the Credit Agreement. 

(c) The Lender may: 

(i) transfer all or any part of the Collateral into the name of the Lender or its nominee, with or without disclosing that
such Collateral is subject to the Lien hereunder, 
 (ii) notify the parties obligated on any of the Collateral to make
payment to the Lender of any amount due or to become due thereunder, 

  
 E-27 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 (iii) withdraw, or cause or direct the withdrawal, of all funds with respect
to the Collateral Account; 
 (iv) enforce collection of any of the Collateral by suit or otherwise, and surrender, release
or exchange all or any part thereof, or compromise or extend or renew for any period (whether or not longer than the original period) any obligations of any nature of any party with respect thereto, 

(v) endorse any checks, drafts, or other writings in any Grantor’s name to allow collection of the Collateral, 

(vi) take control of any Proceeds of the Collateral, and 

(vii) execute (in the name, place and stead of any Grantor) endorsements, assignments, stock powers and other instruments of
conveyance or transfer with respect to all or any of the Collateral. 
 SECTION 6.2. Securities Laws. If the Lender shall determine
to exercise its right to sell all or any of the Collateral that are Capital Securities pursuant to Section 6.1(a)(iv), each Grantor agrees that, upon request of the Lender, such Grantor will, at its own expense: 

(a) execute and deliver, and cause (or, with respect to any issuer which is not a Subsidiary of such Grantor, use its best
efforts to cause) each issuer of the Collateral contemplated to be sold and the directors and officers thereof to execute and deliver, all such instruments and documents, and do or cause to be done all such other acts and things, as may be necessary
or, in the opinion of the Lender, advisable to register such Collateral under the provisions of the Securities Act of 1933, as from time to time amended (the “Securities Act”), and cause the registration statement relating thereto
to become effective and to remain effective for such period as prospectuses are required by law to be furnished, and to make all amendments and supplements thereto and to the related prospectus which, in the opinion of the Lender, are necessary or
advisable, all in conformity with the requirements of the Securities Act and the rules and regulations of the SEC applicable thereto; 

(b) use its best efforts to exempt the Collateral under the state securities or “Blue Sky” laws and to obtain all
necessary governmental approvals for the sale of the Collateral, as requested by the Lender; 
 (c) cause (or, with respect
to any issuer that is not a Subsidiary of such Grantor, use its best efforts to cause) each such issuer to make available to its security holders, as soon as practicable, an earnings statement that will satisfy the provisions of Section 11(a)
of the Securities Act; and 
 (d) do or cause to be done all such other acts and things as may be necessary to make such sale
of the Collateral or any part thereof valid and binding and in compliance with applicable law. 

  
 E-28 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 Each Grantor acknowledges the impossibility of ascertaining the amount of damages that would be suffered by
the Lender by reason of the failure by such Grantor to perform any of the covenants contained in this Section and consequently agrees, to the fullest extent permitted by applicable law, that, if such Grantor shall fail to perform any of such
covenants, it shall pay, as liquidated damages and not as a penalty, an amount equal to the value (as determined by the Lender) of such Collateral on the date the Lender shall demand compliance with this Section. 

SECTION 6.3. Compliance with Restrictions. Each Grantor agrees that in any sale of any of the Collateral whenever an Event of Default
shall have occurred and be continuing, the Lender is hereby authorized to comply with any limitation or restriction in connection with such sale as it may be advised by counsel is necessary in order to avoid any violation of applicable law
(including compliance with such procedures as may restrict the number of prospective bidders and purchasers, require that such prospective bidders and purchasers have certain qualifications, and restrict such prospective bidders and purchasers to
Persons who will represent and agree that they are purchasing for their own account for investment and not with a view to the distribution or resale of such Collateral), or in order to obtain any required approval of the sale or of the purchaser by
any Governmental Authority or official, and such Grantor further agrees that such compliance shall not result in such sale being considered or deemed not to have been made in a commercially reasonable manner, nor shall the Lender be liable nor
accountable to such Grantor for any discount allowed by the reason of the fact that such Collateral is sold in compliance with any such limitation or restriction. 

SECTION 6.4. Protection of Collateral. The Lender may from time to time, at its option, perform any act which any Grantor fails to
perform after being requested in writing so to perform (it being understood that no such request need be given after the occurrence and during the continuance of an Event of Default) and the Lender may from time to time take any other action which
the Lender deems necessary for the maintenance, preservation or protection of any of the Collateral or of its security interest therein. 

ARTICLE VII 
 MISCELLANEOUS
PROVISIONS 
 SECTION 7.1. Loan Document. This Security Agreement is a Loan Document executed pursuant to the Credit Agreement and
shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions thereof, including Article X thereof. 

SECTION 7.2. Binding on Successors, Transferees and Assigns; Assignment. This Security Agreement shall remain in full force and effect
until the Termination Date has occurred, 

  
 E-29 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
shall be binding upon the Grantors and their successors, transferees and assigns and shall inure to the benefit of and be enforceable by the Lender; provided that no Grantor may assign any
of its obligations hereunder without the prior consent of the Lender. 
 SECTION 7.3. Amendments, Etc. No amendment or modification
to or waiver of any provision of this Security Agreement, nor consent to any departure by any Grantor from its obligations under this Security Agreement, shall in any event be effective unless the same shall be in writing and signed by the Lender
and the Grantors and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given. 

SECTION 7.4. Notices. All notices and other communications provided for hereunder shall be delivered or made as provided in
Section 10.2 of the Credit Agreement. 
 SECTION 7.5. Release of Liens. Upon (a) the Disposition of Collateral in
accordance with the Credit Agreement or (b) the occurrence of the Termination Date, the security interests granted herein shall automatically terminate with respect to (i) such Collateral (in the case of clause (a)) or (ii) all
Collateral (in the case of clause (b)). Upon any such Disposition or termination, the Lender will, at the Grantors’ sole expense, deliver to the Grantors, without any representations, warranties or recourse of any kind whatsoever, all
Collateral held by the Lender hereunder, and execute and deliver to the Grantors such documents as the Grantors shall reasonably request to evidence such termination. 

SECTION 7.6. Additional Grantors. Upon the execution and delivery by any other Person of a supplement in the form of Annex I
hereto, such Person shall become a “Grantor” hereunder with the same force and effect as if it were originally a party to this Security Agreement and named as a “Grantor” hereunder. The execution and delivery of such supplement
shall not require the consent of any other Grantor hereunder, and the rights and obligations of each Grantor hereunder shall remain in full force and effect notwithstanding the addition of any new Grantor as a party to this Security Agreement. 

SECTION 7.7. No Waiver, Remedies. In addition to, and not in limitation of Section 2.4, no failure on the part of the
Lender to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right.
The remedies herein provided are cumulative and not exclusive of any remedies provided by law. 
 SECTION 7.8. Severability. Any
provision of this Security Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such provision and such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining
provisions of this Security Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. 

  
 E-30 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 7.9. Governing Law, Entire Agreement, Etc. THIS SECURITY AGREEMENT AND ANY
CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS SECURITY AGREEMENT OR ANY DOCUMENT CONTEMPLATED HEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH,
THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK). This Security Agreement, along with the other Loan Documents, constitutes the entire
understanding among the parties hereto with respect to the subject matter thereof and supersedes any prior agreements, written or oral, with respect thereto 

SECTION 7.10. Counterparts. This Security Agreement may be executed by the parties hereto in several counterparts, each of which shall
be an original and all of which shall constitute together but one and the same agreement. This Security Agreement shall become effective when counterparts hereof executed on behalf of all of the signatories hereto, shall have been received by the
Lender. Delivery of an executed counterpart of a signature page to this Security Agreement by email (e.g. “pdf” or “tiff”) or telecopy shall be effective as delivery of a manually executed counterpart of this Security Agreement.

 SECTION 7.11. Australian Subsidiaries. Notwithstanding anything to the contrary herein, nothing herein shall apply to any
Collateral owned by an Australian Subsidiary and not located in the United States or any state or territory thereof (including the District of Columbia) or created pursuant to or governed by any United States federal law or the laws of state or
territory thereof (including the District of Columbia) (it being understood that all Intellectual Property (regardless of where registered), other than Intellectual Property registered in Australia, is deemed located in the United States for
purposes of this paragraph), which is in the subject of the General Security Deed executed by Holdings and the Australian Subsidiaries in favor of Lender and not this Agreement. 

[Signature Page Follows] 

  
 E-31 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, each of the parties hereto has caused this Security Agreement to be duly
executed and delivered by its Authorized Officer as of the date first above written. 
 EXECUTED as a deed by each Australian Subsidiary.

  

									
	UNILIFE MEDICAL SOLUTIONS, INC.	 		 	UNILIFE CORPORATION
					
	By:	 	  
	 		 	By:	 	  

		 	Name:	 		 		 	Name:
		 	Title:	 		 		 	Title:
				
		 		 		 	UNILIFE CROSS FARM LLC
					
		 		 		 	By:	 	  

		 		 		 		 	Name:
		 		 		 		 	Title:

  

					
	Executed by Unilife Medical Solutions Pty Limited in accordance with Section 127 of the Corporations Act 2001	 		 	
			
	  
	 		 	  

	Signature of director	 		 	Signature of director/company secretary
		 		 	(Please delete as applicable)
			
	  
	 		 	  

	Name of director (print)	 		 	Name of director/company secretary (print)

  
 E-32 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

					
	Executed by Unitract Syringe Pty Ltd in accordance with Section 127 of the Corporations Act 2001	 		 	
			
	  
	 		 	  

	Signature of director	 		 	 Signature of director/company secretary
 (Please
delete as applicable)

			
	  
	 		 	  

	Name of director (print)	 		 	Name of director/company secretary (print)

  
 E-33 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
			
	ROS ACQUISITION OFFSHORE LP,
	as the Lender, for itself and as agent
	By OrbiMed Advisors LLC,
	its investment manager
		
	By:	 	  

		 	Name:
		 	Title:
	
	ROYALTY OPPORTUNITIES S.À R.L, as
	Secured Party
	
	By OrbiMed Advisors LLC,
	its investment manager
		
	By:	 	  

		 	Name:
		 	Title:

  
 E-34 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE I 

to Security Agreement 
  

			
	Name of Grantor:	  	Interest:
		  	
		  	
		  	

  
 E-35 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE II 

to Security Agreement 
  

	Item A.	Location of each Grantor. 

  

					
	 Name of Grantor:
	  	 Location for purposes of UCC:
	  	 Address of executive office and principal place of
business:

		  		  	

  

	Item B.	Filing locations last five years. 

  

	Item C.	Trade names. 

  

			
	 Name of Grantor:
	  	 Trade Names:

		  	

  

	Item D.	Merger or other corporate reorganization. 

  

	Item E.	Grantor’s federal taxpayer ID numbers. 

  

			
	 Name of Grantor:
	  	 Taxpayer ID numbers:

		  	

  

	Item F.	Government Contracts. 

  

	Item G.	Deposit Accounts, Securities Accounts and Commodities Accounts. 

  

			
	 Name of Grantor:
	  	 Description of Deposit Accounts, Securities Accounts and Commodities Accounts:

		  	

  

	Item H.	Letter of Credit Rights. 

  
 E-36 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

	Item I.	Commercial Tort Claims. 

  

	Item J.	Pledged Notes. 

  

			
	 Name of Grantor:
	  	 Description of Pledged Notes:

		  	

  
 E-37 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE III 

to Security Agreement 
  

	Item A.	Patents 

  

	Item B.	Patent Licenses 

  
 E-38 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE IV 

to Security Agreement 
  

	Item A.	Trademarks 

  

	Item B.	Trademark Licenses 

  
 E-39 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE V 

to Security Agreement 
  

	Item A.	Copyrights/Mask Works 

  

	Item B.	Copyright/Mask Work Licenses 

  
 E-40 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE VI 

to Security Agreement 
 Trade
Secret or Know-How Licenses 

  
 E-41 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT A 

to Security Agreement 
 PATENT
SECURITY AGREEMENT 
 This PATENT SECURITY AGREEMENT, dated as of
                 , 20     (this “Agreement”), is made by [NAME OF GRANTOR], a
                                          (the
“Grantor”), in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership, for itself and as agent for the other parties to which the Grantor may owe any Obligations (together with its Affiliates,
successors, transferees and assignees, the “Lender”). 
 W I T N E S S
E T H : 
 WHEREAS, pursuant to a Credit Agreement, dated as of March 12, 2014 (as amended, supplemented or
otherwise modified from time to time, the “Credit Agreement”), by and between Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”) and the Lender, the Lender has extended a Commitment to make the
Loans to the Borrower; 
 WHEREAS, in connection with the Credit Agreement, the Grantor and its Affiliates have executed and delivered a
Pledge and Security Agreement in favor of the Lender, dated as of March 12, 2014 (as amended, supplemented or otherwise modified from time to time, the “Security Agreement”); 

WHEREAS, pursuant to the Credit Agreement and pursuant to clause (e) of Section 4.5 of the Security Agreement, the Grantor is
required to execute and deliver this Agreement and to grant to the Lender a continuing security interest in all of the Patent Collateral (as defined below) to secure all of the Obligations; and 

WHEREAS, the Grantor has duly authorized the execution, delivery and performance of this Agreement; 

  
 E-42 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the Grantor agrees, for the benefit of the Lender, as follows: 
 SECTION 1. Definitions. Unless otherwise
defined herein or the context otherwise requires, terms used in this Agreement, including its preamble and recitals, have the meanings provided (or incorporated by reference) in the Security Agreement. 

SECTION 2. Grant of Security Interest. The Grantor hereby grants to the Lender, for its benefit, a continuing security interest in all
of the Grantor’s right, title and interest in and to the following property, whether now or hereafter existing or acquired by the Grantor (the “Patent Collateral”): 

(a) all of its letters patent and applications for letters patent throughout the world, including each patent and patent
application referred to in Item A of Schedule I attached hereto; 
 (b) all reissues, divisions, continuations,
continuations-in-part, extensions, renewals and reexaminations of any of the items described in clause (a); 

(c) all patent licenses and other agreements providing the Grantor with the right to use any items of the type referred to in
clauses (a) and (b) above, including each patent license referred to in Item B of Schedule I attached hereto; and 

(d) all Proceeds of, and rights associated with, the foregoing (including licenses, royalties income, payments, claims, damages
and Proceeds of infringement suits) and the right to sue third parties for past, present or future infringements of any patent or patent application and for breach or enforcement of any patent license. 

SECTION 3. Security Agreement. This Agreement has been executed and delivered by the Grantor for the purpose of registering the
security interest of the Lender in the Patent Collateral with the United States Patent and Trademark Office. The security interest granted hereby has been granted in furtherance of, and not in limitation of, the security interest granted to the
Lender for its benefit under the Security Agreement. The Security Agreement (and all rights and remedies of the Lender thereunder) shall remain in full force and effect in accordance with its terms. 

SECTION 4. Release of Liens. Upon (i) the Disposition of Patent Collateral in accordance with the Credit Agreement or
(ii) the occurrence of the Termination Date, the security interests granted herein shall automatically terminate with respect to (A) such Patent Collateral (in the case of clause (i)) or (B) all Patent Collateral (in the case
of clause (ii)). Upon any such Disposition or termination, the Lender will, at the Grantor’s sole expense, deliver to the Grantor, without any representations, warranties or recourse of any kind whatsoever, all Patent Collateral held by
the Lender hereunder, and execute and deliver to the Grantor such documents as the Grantor shall reasonably request to evidence such termination. 

  
 E-43 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 5. Acknowledgment. The Grantor does hereby further acknowledge and affirm that
the rights and remedies of the Lender with respect to the security interest in the Patent Collateral granted hereby are more fully set forth in the Security Agreement, the terms and provisions of which (including the remedies provided for therein)
are incorporated by reference herein as if fully set forth herein. 
 SECTION 6. Loan Document. This Agreement is a Loan Document
executed pursuant to the Credit Agreement and shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions thereof, including Article X thereof. 

SECTION 7. Effective. This Agreement shall become effective when a counterpart hereof executed by the Grantor, shall have been received
by the Lender. Delivery of an executed counterpart of a signature page to this Agreement by email (e.g. “pdf” or “tiff”) or telecopy shall be effective as delivery of a manually executed counterpart of this Agreement. 

[Signature Page Follows] 

  
 E-44 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the Grantor hereto has caused this Agreement to be duly executed and
delivered by its Authorized Officer as of the date first above written. 
  

			
	[NAME OF GRANTOR]
		
	By:	 	  

		 	Name:
		 	Title:

  
 E-45 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE I 

to Patent Security Agreement 
  

	Item A.	Patents 

 Issued Patents 

 

									
	 Country
	 	 Patent No.
	 	 Issue Date
	 	 Inventor(s)
	 	 Title

		 		 		 		 	
		 		 		 		 	
		 		 		 		 	

 Pending Patent Applications 

 

									
	 Country
	 	 Serial No.
	 	 Filing Date
	 	 Inventor(s)
	 	 Title

		 		 		 		 	
		 		 		 		 	
		 		 		 		 	

 Patent Applications in Preparation 

 

									
	 Country
	 	 Docket No.
	 	 Expected Filing Date
	 	 Inventor(s)
	 	 Title

		 		 		 		 	
		 		 		 		 	
		 		 		 		 	

  

	Item B.	Patent Licenses 

  

											
	 Country or Territory
	 	 Licensor
	 	 Licensee
	 	 Effective Date
	 	 Expiration Date
	 	 Subject Matter

		 		 		 		 		 	
		 		 		 		 		 	
		 		 		 		 		 	

  
 E-46 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT B 

to Security Agreement 
 TRADEMARK
SECURITY AGREEMENT 
 This TRADEMARK SECURITY AGREEMENT, dated as of
                 , 20     (this “Agreement”), is made by [NAME OF GRANTOR], a
                                          (the
“Grantor”), in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership, for itself and as agent for the other parties to which the Grantor may owe any Obligations (together with its Affiliates,
successors, transferees and assignees, the “Lender”). 
 W I T N E S S
E T H : 
 WHEREAS, pursuant to a Credit Agreement, dated as of March 12, 2014 (as amended, supplemented, or
otherwise modified from time to time, the “Credit Agreement”), by and between Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”) and the Lender, the Lender has extended a Commitment to make the
Loans to the Borrower; 
 WHEREAS, in connection with the Credit Agreement, the Grantor and its Affiliates have executed and delivered a
Pledge and Security Agreement in favor of the Lender, dated as of March 12, 2014 (as amended, supplemented, or otherwise modified from time to time, the “Security Agreement”); 

WHEREAS, pursuant to the Credit Agreement and pursuant to clause (e) of Section 4.5 of the Security Agreement, the Grantor is
required to execute and deliver this Agreement and to grant to the Lender a continuing security interest in all of the Trademark Collateral (as defined below) to secure all of the Obligations; and 

WHEREAS, the Grantor has duly authorized the execution, delivery and performance of this Agreement; 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Grantor agrees, for the
benefit of each Lender, as follows: 
 SECTION 1. Definitions. Unless otherwise defined herein or the context otherwise requires,
terms used in this Agreement, including its preamble and recitals, have the meanings provided (or incorporated by reference) in the Security Agreement. 

  
 E-47 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 2. Grant of Security Interest. The Grantor hereby grants to the Lender, for
its benefit, a continuing security interest in all of Grantor’s right, title and interest in and to the following property, whether now or hereafter existing or acquired by the Grantor (the “Trademark Collateral”): 

(a) (i) all of its trademarks, trade names, corporate names, company names, business names, fictitious business names,
trade styles, service marks, certification marks, collective marks, logos and other source or business identifiers, and all goodwill of the business associated therewith, including those referred to in Item A of Schedule I hereto,
whether currently in use or not, all registrations and recordings thereof and all applications in connection therewith, whether pending or filed, including registrations, recordings and applications in the United States Patent and Trademark Office
or in any office or agency of the United States of America or any State thereof, and all common-law rights relating to the foregoing, and (ii) the right to obtain all reissues, extensions or renewals of
the foregoing (collectively referred to as the “Trademarks”); 
 (b) all Trademark licenses for the grant by
or to the Grantor of any right to use any Trademark, including each Trademark license referred to in Item B of Schedule I hereto; 

(c) all of the goodwill of the business connected with the use of, and symbolized by the items described in, clause (a),
and to the extent applicable, clause (b); 
 (d) the right to sue third parties for past, present and future
infringements of any Trademark Collateral described in clause (a) and, to the extent applicable, clause (b); and 

(e) all Proceeds of, and rights associated with, the foregoing, including any claim by the Grantor against third parties for
past, present or future infringement or dilution of any Trademark, Trademark registration or Trademark license, or for any injury to the goodwill associated with the use of any such Trademark or for breach or enforcement of any Trademark license and
all rights corresponding thereto throughout the world. 
 SECTION 3. Security Agreement. This Agreement has been executed and
delivered by the Grantor for the purpose of registering the security interest of the Lender in the Trademark Collateral with the United States Patent and Trademark Office. The security interest granted hereby has been granted in furtherance of, and
not in limitation of, the security interest granted to the Lender for its benefit under the Security Agreement. The Security Agreement (and all rights and remedies of the Lender thereunder) shall remain in full force and effect in accordance with
its terms. 
 SECTION 4. Release of Liens. Upon (i) the Disposition of Trademark Collateral in accordance with the Credit
Agreement or (ii) the occurrence of the Termination Date, the security interests granted herein shall automatically terminate with respect to (A) such Trademark Collateral (in the case of clause (i)) or (B) all Trademark
Collateral (in the case of clause (ii)). Upon any such Disposition or termination, the Lender will, at the Grantor’s sole expense, deliver to the Grantor, without any representations, warranties or recourse of any kind

  
 E-48 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
whatsoever, all Trademark Collateral held by the Lender hereunder, and execute and deliver to the Grantor such documents as the Grantor shall reasonably request to evidence such termination. 

SECTION 5. Acknowledgment. The Grantor does hereby further acknowledge and affirm that the rights and remedies of the Lender with
respect to the security interest in the Trademark Collateral granted hereby are more fully set forth in the Security Agreement, the terms and provisions of which (including the remedies provided for therein) are incorporated by reference herein as
if fully set forth herein. 
 SECTION 6. Loan Document. This Agreement is a Loan Document executed pursuant to the Credit Agreement
and shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions thereof, including Article X thereof. 

SECTION 7. Effective. This Agreement shall become effective when a counterpart hereof executed by the Grantor, shall have been received
by the Lender. Delivery of an executed counterpart of a signature page to this Agreement by email (e.g. “pdf” or “tiff”) or telecopy shall be effective as delivery of a manually executed counterpart of this Agreement. 

[Signature Page Follows] 

  
 E-49 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the Grantor hereto has caused this Agreement to be duly executed and
delivered by Authorized Officer as of the date first above written. 
  

			
	[NAME OF GRANTOR]
		
	By:	 	  

		 	Name:
		 	Title:

  
 E-50 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE I 

to Trademark Security Agreement 
  

							
	 Item A.    Trademarks

	
	Registered Trademarks
				
	 Country
	  	 Trademark
	  	 Registration No.
	  	 Registration Date

		  		  		  	
		  		  		  	
		  		  		  	
	
	Pending Trademark Applications
				
	 Country
	  	 Trademark
	  	 Serial No.
	  	 Filing Date

		  		  		  	
		  		  		  	
		  		  		  	

  

									
	Trademark Applications in Preparation
					
	 Country
	  	 Trademark
	  	 Docket No.
	  	 Expected
Filing Date
	  	 Products/
Services

		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  

											
	 Item B.     Trademark Licenses

						
	 Country or
Territory
	  	 Trademark
	  	 Licensor
	  	 Licensee
	  	 Effective
Date
	  	 Expiration
Date

		  		  		  		  		  	
		  		  		  		  		  	
		  		  		  		  		  	

  
 E-51 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT C 

to Security Agreement 
 COPYRIGHT
SECURITY AGREEMENT 
 This COPYRIGHT SECURITY AGREEMENT, dated as of         
    , 20    (this “Agreement”), is made by [NAME OF GRANTOR], a                     (the
“Grantor”), in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership, for itself and as agent for the other parties to which the Grantor may owe any Obligations (together with its Affiliates,
successors, transferees and assignees, the “Lender”). 
 W I T N E S S
E T H : 
 WHEREAS, pursuant to a Credit Agreement, dated as of March 12, 2014 (as amended, supplemented, or
otherwise modified from time to time, the “Credit Agreement”), among by and between Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”) and the Lender, the Lender has extended a Commitment to
make the Loans to the Borrower; 
 WHEREAS, in connection with the Credit Agreement, the Grantor and its Affiliates have executed and
delivered a Pledge and Security Agreement in favor of the Lender, dated as of March 12, 2014 (as amended, supplemented, or otherwise modified from time to time, the “Security Agreement”); 

WHEREAS, pursuant to the Credit Agreement and pursuant to clause (e) of Section 4.5 of the Security Agreement, the Grantor is
required to execute and deliver this Agreement and to grant to the Lender a continuing security interest in all of the Copyright Collateral (as defined below) to secure all of the Obligations; and 

WHEREAS, the Grantor has duly authorized the execution, delivery and performance of this Agreement; 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Grantor agrees, for the
benefit of the Lender, as follows: 
 SECTION 1. Definitions. Unless otherwise defined herein or the context otherwise requires,
terms used in this Agreement, including its preamble and recitals, have the meanings provided (or incorporated by reference) in the Security Agreement. 

SECTION 2. Grant of Security Interest. The Grantor hereby grants to the Lender, for its benefit, a continuing security interest in all
of the Grantor’s right, title and interest in and to the following (the “Copyright Collateral”), whether now or hereafter existing or acquired by the Grantor: all copyrights of the Grantor, whether statutory or common law,
whether registered or unregistered and whether published or unpublished, now or hereafter in force throughout the 

  
 E-52 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
world including all of the Grantor’s right, title and interest in and to all copyrights registered in the United States Copyright Office or anywhere else in the world including the
copyrights referred to in Item A of Schedule I hereto, and registrations and recordings thereof and all applications for registration thereof, whether pending or in preparation, all copyright licenses, including each copyright license
referred to in Item B of Schedule I hereto, the right to sue for past, present and future infringements of any of the foregoing, all rights corresponding thereto, all extensions and renewals of any thereof and all Proceeds of the
foregoing, including licenses, royalties, income, payments, claims, damages and Proceeds of suit. 
 SECTION 3. Security Agreement.
This Agreement has been executed and delivered by the Grantor for the purpose of registering the security interest of the Lender in the Copyright Collateral with the United States Copyright Office. The security interest granted hereby has been
granted in furtherance of, and not in limitation of, the security interest granted to the Lender for its benefit under the Security Agreement. The Security Agreement (and all rights and remedies of the Lender thereunder) shall remain in full force
and effect in accordance with its terms. 
 SECTION 4. Release of Liens. Upon (i) the Disposition of Copyright Collateral in
accordance with the Credit Agreement or (ii) the occurrence of the Termination Date, the security interests granted herein shall automatically terminate with respect to (A) such Copyright Collateral (in the case of clause (i)) or
(B) all Copyright Collateral (in the case of clause (ii)). Upon any such Disposition or termination, the Lender will, at the Grantor’s sole expense, deliver to the Grantor, without any representations, warranties or recourse of any
kind whatsoever, all Copyright Collateral held by the Lender hereunder, and execute and deliver to the Grantor such documents as the Grantor shall reasonably request to evidence such termination. 

SECTION 5. Acknowledgment. The Grantor does hereby further acknowledge and affirm that the rights and remedies of the Lender with
respect to the security interest in the Copyright Collateral granted hereby are more fully set forth in the Security Agreement, the terms and provisions of which (including the remedies provided for therein) are incorporated by reference herein as
if fully set forth herein. 
 SECTION 6. Loan Document. This Agreement is a Loan Document executed pursuant to the Credit Agreement
and shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and provisions thereof, including Article X thereof. 

SECTION 7. Effective. This Agreement shall become effective when a counterpart hereof executed by the Grantor, shall have been received
by the Lender. Delivery of an executed counterpart of a signature page to this Agreement by email (e.g. “pdf” or “tiff”) or telecopy shall be effective as delivery or a manually executed counterpart of this Agreement. 

[Signature Page Follows] 

  
 E-53 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the Grantor hereto has caused this Agreement to be duly executed and
delivered by its Authorized Officer as of the date first above written. 
  

			
	[NAME OF GRANTOR]
		
	By:	 	  

		 	Name:
		 	Title:

  
 E-54 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULE I 

to Copyright Security Agreement 
  

									
	 Item A.    Copyrights/Mask Works

	
	Registered Copyrights/Mask Works
					
	 Country
	  	 Registration No.
	  	 Registration Date
	  	 Author(s)
	  	 Title

		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  

									
	Copyright/Mask Work Pending Registration Applications
					
	 Country
	  	 Serial
No.
	  	 Filing
Date
	  	 Author(s)
	  	 Title

		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  

									
	Copyright/Mask Work Registration Applications in Preparation
					
	 Country
	  	 Docket No.
	  	 Expected

Filing Date
	  	 Author(s)
	  	 Title

		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  

											
	 Item B.     Copyright/Mask Work Licenses

					
	 Country or

Territory
	  	 Licensor
	  	 Licensee
	  	 Effective

Date
	  	 Expiration

Date

  
 E-55 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 ANNEX I 

to Security Agreement 
 SUPPLEMENT
TO 
 PLEDGE AND SECURITY AGREEMENT 

This SUPPLEMENT, dated as of              , 20    (this
“Supplement”), is to the Pledge and Security Agreement, dated as of March 12, 2014 (as amended, supplemented, amended and restated or otherwise modified from time to time, the “Security Agreement”), among the
Grantors (such term, and other terms used in this Supplement, to have the meanings set forth in Article I of the Security Agreement) from time to time party thereto, in favor of ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited
partnership, for itself and as agent for the other parties to which the undersigned may owe any Obligations (together with its Affiliates, successors, transferees and assignees, the “Lender”). 

W I T N E S S E T H : 

WHEREAS, pursuant to a Credit Agreement, dated as of March 12, 2014 (as amended, supplemented, or otherwise modified from time to time,
the “Credit Agreement”), by and between Unilife Medical Solutions, Inc., a Delaware corporation (the “Borrower”) and the Lender, the Lender has extended a Commitment to make the Loans to the Borrower; 

WHEREAS, pursuant to the provisions of Section 7.6 of the Security Agreement, each of the undersigned is becoming a Grantor under the
Security Agreement; and 
 WHEREAS, each of the undersigned desires to become a “Grantor” under the Security Agreement in order to
induce the Lender to continue to extend Loans under the Credit Agreement; 
 NOW, THEREFORE, for good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, each of the undersigned agrees, for the benefit of the Lender, as follows. 

SECTION 1. Party to Security Agreement, Etc. In accordance with the terms of the Security Agreement, by its signature below, each of
the undersigned hereby irrevocably agrees to become a Grantor under the Security Agreement with the same force and effect as if it were an original signatory thereto and each of the undersigned hereby (a) agrees to be bound by and comply with
all of the terms and provisions of the Security Agreement applicable to it as a Grantor and (b) represents and warrants that the representations and warranties made by it as a Grantor thereunder are true and correct as of the date hereof,
unless stated to relate solely to an earlier date, in which case such representations and warranties shall be true and correct as of such earlier date. In furtherance of the foregoing, each reference to a “Grantor” and/or
“Grantors” in the Security Agreement shall be deemed to include each of the undersigned. 

  
 E-56 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SECTION 2. Schedules. Each of the undersigned Grantors hereby authorizes the Lender to
add the information set forth on the Schedules to this Supplement to the correlative Schedules attached to the Security Agreement. 

SECTION 3. Representations. Each of the undersigned Grantors hereby represents and warrants that this Supplement has been duly
authorized, executed and delivered by it and that this Supplement and the Security Agreement constitute its legal, valid and binding obligation, enforceable against it in accordance with its terms. 

SECTION 4. Full Force of Security Agreement. Except as expressly supplemented hereby, the Security Agreement shall remain in full force
and effect in accordance with its terms. 
 SECTION 5. Severability. Wherever possible each provision of this Supplement shall be
interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Supplement shall be prohibited by or invalid under such law, such provision shall be ineffective to the extent of such prohibition or
invalidity, without invalidating the remainder of such provision or the remaining provisions of this Supplement or the Security Agreement. 

SECTION 6. Governing Law, Entire Agreement, Etc. THIS SUPPLEMENT AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN
CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS SECURITY AGREEMENT OR ANY DOCUMENT CONTEMPLATED HEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR
SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK). This Supplement, along with the other Loan Documents, constitutes the entire understanding among the parties
hereto with respect to the subject matter thereof and supersedes any prior agreements, written or oral, with respect thereto. 
 SECTION 7.
Effective. This Supplement shall become effective when a counterpart hereof executed by the Grantor shall have been received by the Lender. Delivery of an executed counterpart of a signature page to this Supplement by email (e.g.
“pdf” or “tiff”) or telecopy shall be effective as delivery of a manually executed counterpart of this Supplement. 

[Signature Page Follows] 

  
 E-57 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, each of the parties hereto has caused this Supplement to be duly executed
and delivered by its Authorized Officer as of the date first above written. 
  

			
	[NAME OF ADDITIONAL SUBSIDIARY]
		
	By:	 	  

		 	Name:
		 	Title:
	
	[NAME OF ADDITIONAL SUBSIDIARY]
		
	By:	 	  

		 	Name:
		 	Title:

  
 E-58 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 SCHEDULES 

  
 E-59 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT D 

to Security Agreement 
 Hikma
Security Agreement 
 [see attached] 

  
 E-60 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT F 

MORTGAGE 
 This instrument was prepared by

 and upon recording, return to: 
 Stefanie L.
Brennan, Esquire 
 Pepper Hamilton LLP 
 500 Grant Street,
Suite 5000 
 Pittsburgh, PA 15219 
 (412) 454-5059 

Parcel Number: 23-000-MH-0095G000000 
 250 Cross Farm Lane, York,
PA 
 OPEN-END COMMERCIAL MORTGAGE AND SECURITY AGREEMENT 

(SECURES FUTURE ADVANCES) 
 by 

UNILIFE CROSS FARM LLC, 

Mortgagor, 
 To 

ROS ACQUISITION OFFSHORE LP, 

Mortgagee, 
 for itself and as agent
for ROYALTY OPPORTUNITIES S.À R.L 
 For delivery on             , 2014

 Relating to premises located in Conewago Township, 

York County, Pennsylvania 
 THIS
IS AN OPEN-END MORTGAGE UNDER 42 PA.C.S. § 8143 WHICH SECURES FUTURE ADVANCES. THE MAXIMUM PRINCIPAL AMOUNT SECURED BY THIS MORTGAGE IS $60,000,000, PLUS ACCRUED UNPAID INTEREST, FEES, COSTS AND EXPENSES, AND ADVANCES MADE AS PROVIDED HEREIN.
THIS MORTGAGE FURTHER SECURES ALL ADVANCES AUTHORIZED UNDER 42 PA.C.S. § 8144. MORTGAGOR WAIVES AND RELEASES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHTS WHICH IT MAY HAVE TO SEND A WRITTEN NOTICE PURSUANT TO 42 PA.C.S. §8143(c).

  
 F-1 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 THIS INSTRUMENT COVERS GOODS THAT ARE OR ARE TO BECOME FIXTURES ON THE REAL PROPERTY
DESCRIBED HEREIN AND IS TO BE FILED FOR RECORD IN THE REAL ESTATE RECORDS WHERE MORTGAGES ON REAL PROPERTY ARE RECORDED. MORTGAGOR IS THE OWNER OF RECORD OF AN INTEREST IN THE REAL PROPERTY. THIS INSTRUMENT SHOULD BE APPROPRIATELY INDEXED, NOT ONLY
AS A MORTGAGE BUT ALSO AS A FIXTURE FILING AND FINANCING STATEMENT COVERING GOODS THAT ARE OR ARE TO BECOME FIXTURES ON THE REAL PROPERTY DESCRIBED HEREIN. THE MAILING ADDRESSES OF MORTGAGOR, AS DEBTOR, AND AGENT, AS SECURED PARTY, ARE SET FORTH IN
SECTION 24 OF THIS INSTRUMENT. 

  
 F-2 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 OPEN-END COMMERCIAL MORTGAGE AND SECURITY AGREEMENT 

(SECURES FUTURE ADVANCES) 

THIS OPEN END MORTGAGE AND SECURITY AGREEMENT executed on the date set forth on the notarial acknowledgement, for delivery on the
[    ][th/st] day of [            ], 2014, between UNILIFE CROSS FARM LLC, whose address is 250 Cross Farm Lane, York, Pennsylvania 17406 (the
“Mortgagor”), and ROS ACQUISITION OFFSHORE LP, a Cayman Islands exempted limited partnership (together with its Affiliates, successors, transferees and assignees, the “Mortgagee”), for itself and as agent for ROYALTY
OPPORTUNITIES S.À R.L, a Luxembourg société à responsabilité limitée (together with its Affiliates, successors, transferees and assignees, “ROS”). 

W I T N E S S E T H: 
 WHEREAS
Unilife Medical Solutions, Inc. (the “Borrower”), an affiliate of Mortgagor, has made, executed and delivered to Mortgagee a certain credit agreement (the “Credit Agreement”) pursuant to which Mortgagee has agreed to make loans
to the Borrower in the aggregate maximum principal amount of up to $60,000,000.00. The real and personal property described herein and any other collateral securing any of Mortgagor’s obligations under any of the Loan Documents are hereinafter
referred to collectively as “Collateral”. Capitalized terms used but not defined herein shall have the meaning given such terms in the Credit Agreement. 

NOW, THEREFORE, that in consideration of the aforesaid, and as security for payment to Mortgagee of the principal of the Note with interest,
together with all other sums payable to or recoverable by Mortgagee under the terms of the Loan Documents, together with all existing and future liabilities of Borrower and/or Mortgagor to Mortgagee under the Loan Documents, including the
Obligations, and any renewal(s), extension(s) and modification(s) thereof and substitution(s) therefor (said indebtedness, interest and all other sums and liabilities are hereinafter collectively referred to as the “Aggregate Debt”), and
as security for the due and timely performance by the Borrower and Mortgagor of all of the other provisions of the Loan Documents, and intending to be legally bound hereby, Mortgagor hereby GRANTS, BARGAINS, SELLS, CONVEYS, ASSIGNS, TRANSFERS,
RELEASES, PLEDGES AND MORTGAGES to Mortgagee all those certain tracts or parcels of real property located in York County, Pennsylvania, as more fully described in Exhibit A attached hereto and made a part hereof (“Real Property”): 

TOGETHER WITH all right, title and interest of Mortgagor in and to the following property, rights and interests, which Mortgagor hereby
assigns to Mortgagee until the Aggregate Debt is paid (the Real Property together with the following property being hereinafter collectively called the “Mortgaged Property”): 

A. all buildings and other improvements now or hereafter located on the Real Property (“Improvements”); 

  
 F-3 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 B. all streets, lanes, alleys, passages, ways, easements, rights, liberties, privileges,
tenements, hereditaments and appurtenances whatsoever thereunto belonging to or in any way made appurtenant hereafter, and the reversions and remainder, with respect thereto (“Appurtenances”); 

C. all machinery, apparatus, equipment, furniture, furnishings, fixtures, inventory, goods, appliances and other property of every kind and
nature whatsoever, together with replacements thereof and accessories, parts or accessions thereto, owned by Mortgagor or in which Mortgagor has or shall have an interest, and which are now or hereafter located on the Real Property and used or to be
used in connection therewith, and any and all proceeds of any of the foregoing (“Equipment”); 
 D. all building materials,
building machinery and building equipment delivered on site to the Real Property during the course of, or in connection with, the construction of, or reconstruction of, or remodeling of any building and improvements from time to time during the term
of this Open End Mortgage and Security Agreement (“Building Equipment”); 
 E. all general intangibles relating to the development
or use of the Real Property, including but not limited to all licenses, permits and agreements from or with all boards, agencies, departments, public utilities, governmental or otherwise, all names under which or by which the Real Property or
Improvements may at any time be operated or known and all rights to carry on business under any such names or any variations thereof, all trademarks and goodwill in any way relating to the Real Property, all special declarant’s rights, and all
documents of membership in any owners or members association or similar group having responsibility for managing or operating any portion or all of the Real Property (“Intangibles”); 

F. all awards or payments, including interest thereon, which may be made with respect to the Real Property and Improvements, whether from the
exercise of the right of eminent domain (including any transfer made in lieu of the exercise of said right), or for any other injury to or decrease in the value of the Real Property or Improvements including, without limitation, all awards or
payments of estimated compensation, all damages to the Real Property or Improvements resulting from any taking, all machinery and equipment dislocation expenses, all settlement amounts, all apportionments of taxes, reimbursement of attorneys and
engineers fees, all moving expenses and all business dislocation expenses (“Awards”); 
 G. all insurance policies covering the
Real Property or Improvements and all proceeds of any unearned premiums on any such insurance policies including, without limitation, the right to receive and apply the proceeds of any insurance, judgments, or settlements made in lieu thereof, for
damage to the Real Property or Improvements (“Insurance Policies”); 
 H. all leases and other agreements affecting the use or
occupancy of any portion or all of the Real Property or Improvements, whether heretofore or hereafter executed and all rights of Mortgagor to payment under any such lease or agreement (“Leases”), and all rents, receipts,

  
 F-4 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
issues, profits and other income of any and all kinds (including deposits) received or receivable and due or to become due from the lease of all or a portion of the Real Property or Improvements
(all of such proceeds, receipts and income are hereinafter referred to as the “Income and Rents” and all such rights are hereinafter referred to as the “Accounts Receivable”); 

I. any securities or guaranties held by Mortgagor with respect to any of the Intangibles, Awards, Leases or Accounts Receivable, and any
notes, drafts, acceptances, chattel paper, documents or other instruments evidencing the same (“Security”); and 
 J. the right,
in the name and on behalf of itself or Mortgagor, to appear in or defend any action or proceeding brought with respect to the Real Property or Improvements (including without limitation, any condemnation or arbitration proceedings) and to commence
any action or proceedings to protect the interest of Mortgagee in the Real Property and Improvements. 
 TO HAVE AND TO HOLD the Mortgaged
Property unto Mortgagee, its successors and assigns forever. All right, title and interest of Mortgagor in and to all extensions, improvements, betterments, renewals, substitutes and replacements of, and all additions and appurtenances to the
Mortgaged Property hereafter acquired by, or released to, Mortgagor or constructed, assembled or placed by Mortgagor on the Premises, and all conversions of the security constituted thereby, immediately upon such acquisition, release, construction,
assembling, placement or conversion, as the case may be, and in each such case, without any further mortgage, pledge, conveyance, assignment or other act by Mortgagor, shall become subject to the lien of this Open End Mortgage and Security Agreement
as fully and completely, and with the same effect, as though now owned by Mortgagor and specifically described herein. Notwithstanding the foregoing, Mortgagor shall, at its own cost, make, execute, acknowledge, deliver and record any and all such
further acts, deeds, conveyances, mortgages, notices of assignment, transfers, assurances and other documents as Mortgagee shall from time to time require for better assuring, conveying, assigning, transferring and confirming unto Mortgagee of the
Mortgaged Property and the other rights hereby conveyed or assigned or intended now or hereafter so to be, or which Mortgagor may be or may hereafter become bound to convey or assign for carrying out the intention of facilitating the performance of
the terms of this Open End Mortgage and Security Agreement. 
 PROVIDED ALWAYS, and these presents are upon this express condition, that if
Mortgagor or its successors or assigns shall well and truly pay or cause to be paid unto Mortgagee, its successors or assigns, the Aggregate Debt secured by this Open End Mortgage and Security Agreement, and otherwise perform Mortgagor’s
obligations under the Loan Documents, then this Open End Mortgage and Security Agreement, and the estate hereby granted, shall cease, determine and be void, and Mortgagee shall furnish to Mortgagor a satisfaction of this Open End Mortgage and
Security Agreement in proper form for recording, but Mortgagee shall not be required to bear any expense or cost in connection with such satisfaction or the recording thereof. 

  
 F-5 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 THIS IS AN OPEN END MORTGAGE AND SECURITY AGREEMENT pursuant to 42 Pa.C.S. §8143, and
secures, inter alia, present and future advances made by Mortgagee pursuant to the Loan Documents. The priority of such future advances shall relate back to the date of this Mortgage, or to such later date as required by applicable law. This
Mortgage also secures advances made by Mortgagee pursuant to 42 Pa.C.S. §8144, for the payment of taxes, assessments, maintenance charges, insurance premiums and other costs incurred by Mortgagee for the protection of the Mortgaged Property or
the lien of this Mortgage, and expenses incurred by Mortgagee by reason of the occurrence of an Event of Default, and the priority of such advances, costs and expenses shall also relate back to the date of this Mortgage, or to such later date as
required by applicable law. Mortgagor specifically acknowledges that Mortgagee shall have no liability for any failure to make an advance pursuant to the Note upon receipt of any third party’s notice of lien pursuant to 42 Pa.C.S.A.
Section 8143(d) or receipt of the Mortgagor’s limitation of indebtedness pursuant to 42 Pa.C.S.A. Section 8143(c). All notices provided pursuant to 42 Pa.C.S.A. Sections 8143(c) and (d) must be provided in accordance with the
notice provisions contained herein. THE MAXIMUM AMOUNT OF INDEBTEDNESS SECURED BY THIS MORTGAGE SHALL NOT EXCEED $60,000,000.00, PLUS ALL ACCRUED AND UNPAID INTEREST, PLUS ALL COSTS AND EXPENSES INCURRED OR ASSUMED BY MORTGAGEE, INCLUDING ADVANCES
MADE WITH RESPECT TO THE MORTGAGED PROPERTY, FOR THE PAYMENT OF TAXES, ASSESSMENTS, MAINTENANCE CHARGES, INSURANCE PREMIUMS, OR COSTS INCURRED FOR THE PROTECTION OF THE MORTGAGED PROPERTY OR THE LIEN OF THIS MORTGAGE, OR EXPENSES INCURRED BY
MORTGAGEE BY REASON OF DEFAULT BY MORTGAGOR UNDER THIS MORTGAGE. 
 MORTGAGOR REPRESENTS AND WARRANTS TO AND COVENANTS WITH Mortgagee as
follows: 
 1. Title. As of the date hereof (a) Mortgagor has good and marketable title in and to the Mortgaged Property subject
to no lien, charge or encumbrance except for the encumbrances described on the attached Exhibit B and easements, rights-of-way, zoning restrictions, minor defects or irregularities in title, restrictions and other similar encumbrances on the use of
real property not interfering in any material respect with the value or current use of the property to which such Lien is attached (the “Permitted Encumbrances”); (b) this Open End Mortgage and Security Agreement is and shall remain a
valid and enforceable lien on the Mortgaged Property subject only to the matters referred to in subparagraph (a) hereof and Permitted Encumbrances; and (c) Mortgagor shall preserve such title, and all of its rights in and to the Mortgaged
Property, and shall forever warrant and defend the validity and priority of the lien hereof against the claims of all persons and entities whomsoever, subject only to the matters referred to in subparagraph (a) hereof. 

2. Payment and Performance. Mortgagor shall punctually pay or cause to be paid the Aggregate Debt, in the amounts and at the times and
places that the same may be due, and perform and comply with all of the terms, covenants, conditions and obligations contained in the Loan Documents. 

  
 F-6 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 3. Taxes and Other Charges. Mortgagor shall pay or cause to be paid all taxes of every
kind and nature (including real and personal property, income, gross receipts, franchise, profits, sales and withholding taxes), all general and special assessments, water and sewer rents and charges, and all levies, permits, inspection and license
fees and other public charges now or hereafter levied or assessed against the Mortgaged Property as liens or assessments (hereinafter individually called a “Tax” and collectively the “Taxes”) as the same shall become due and
payable from time to time and before interest or penalties accrue thereon; provided, however, that Mortgagor shall not be required to pay any Tax to the extent that nonpayment thereof is permitted while the validity thereof is being contested, so
long as (a) Mortgagor notifies Mortgagee in writing of intention to contest the validity thereof, (b) the validity thereof is being contested in good faith by Mortgagor and (c) Mortgagor deposits with Mortgagee if Mortgagee so
requests an amount deemed sufficient to make such payment if the contest is unsuccessful. Notwithstanding the foregoing, Mortgagor shall under no circumstances permit the Mortgaged Property to be sold or advertised for sale for nonpayment of any
Tax. Subject to Mortgagor’s right to contest any Tax as hereinabove provided, Mortgagor shall deliver to Mortgagee receipts evidencing the payment of such Tax on or before the last day on which any Tax may be paid without interest or penalties
or as soon thereafter as such receipts are available. 
 4. Insurance. Mortgagor shall carry or cause to be carried appropriate
insurance and keep the Improvements and the Equipment continuously insured against loss or damage by fire (with extended coverage), theft, vandalism, malicious mischief, and such other hazards as Mortgagee shall from time to time reasonably require.
Mortgagor shall also carry comprehensive liability insurance (including bodily injury and property damage) covering all operations of Mortgagor on the Mortgaged Property in such amounts as may be reasonably required by Mortgagee. 

5. Tax and Insurance Escrow. Upon the request of Mortgagee, but only on the occurrence of an Event of Default, Mortgagor shall pay or
cause to be paid to Mortgagee on the first day of each month a sum equal to one-twelfth (1/12) of the amount of (a) all real estate taxes, water and sewer charges and assessments, if any, as estimated from time to time by Mortgagee,
becoming due with respect to the Mortgaged Property on the next succeeding date upon which the same shall be due and payable and (b) all premiums, computed on an annual basis, for the insurance required to be carried pursuant to paragraph 4
hereof. All such amounts (hereinafter, the “Escrows”) shall be held by Mortgagee in such manner as it sees fit without any obligation to invest the same or (if invested) to account for any income or loss resulting therefrom; provided
however, that if and to the extent that Mortgagee is required under applicable law to invest the escrows for the benefit of Mortgagor, Mortgagee shall also have the right to charge a reasonable service fee in connection therewith unless prohibited
under such law. The Escrows shall be applied to the payment of the respective items in respect of which the Escrows are deposited, or at Mortgagee’s option, to the payment of any such items in such order

  
 F-7 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
of priority as Mortgagee shall determine. If, as the same become due and payable, the amount of Escrows then on deposit therefor shall be insufficient to pay such item, Mortgagor within five
(5) days after demand is made therefor shall deposit the amount of such deficiency with Mortgagee. If there is an event of default hereunder, Mortgagee may at its option apply the Escrows or any part thereof in payment of any unpaid portion of
the Aggregate Debt. If, when making any assignment of this Open End Mortgage and Security Agreement, the then Mortgagee shall pay over to its assignee the then balance of the Escrows, such assigning Mortgagee shall have no further obligation to
Mortgagor with respect to such deposits. 
 6. Casualty Loss. Mortgagor shall notify Mortgagee in writing immediately upon the
occurrence of any loss affecting the Mortgaged Property in excess of $100,000. Mortgagor hereby directs any insurer to pay directly to Mortgagee any moneys in excess of $100,000 payable under any policy, and Mortgagor hereby appoints Mortgagee as
attorney-in-fact to endorse any draft therefor. If an event(s) of default has occurred and is continuing, sums paid to Mortgagee by any insurer may be retained and applied by Mortgagee at its sole election toward payment of the Aggregate Debt
(whether or not any portion thereof may then be due and payable) in such priority and proportions as Mortgagee in its discretion shall deem proper. Otherwise, Mortgagee shall make any such sums in excess of $100,000 available to Mortgagor for
repairing the damaged property, provided that Mortgagor shall deposit with Mortgagee prior to the commencement of such repairs an amount equal to the difference between the cost to repair the damaged property and the sums made available by Mortgagee
on account of such insurance. The determination of the cost to repair the damaged property shall be made by Mortgagee. If Mortgagee retains such insurance money and applies the same toward payment of the Aggregate Debt, the lien of this Open End
Mortgage and Security Agreement shall be reduced only by the amount thereof retained by Mortgagee and actually applied by Mortgagee in reduction of the Aggregate Debt. Any funds retained by Mortgagee pursuant to this Section 6 that are used
towards the aggregate debt shall not incur a prepayment under the Loan Agreement. 
 7. Condemnation. In the event that the whole or
any part of the Mortgaged Property secured by this Open End Mortgage and Security Agreement is condemned or taken for any period of time, or there is any other injury to or decrease in value of the Mortgaged Property as a result of any public or
quasi-public authority or corporation exercising the power of eminent domain or otherwise, all sums awarded as damages for such condemnation or taking to which Mortgagor is entitled shall be paid over immediately to Mortgagee. Upon the receipt
thereof, Mortgagee may deduct and withhold from the amount actually received any costs, charges or fees incurred by Mortgagee in connection with the recovery of such award (hereinafter, “Mortgagee’s Costs”). If an event(s) of default
has occurred and is continuing, Mortgagee may apply all or any portion of the balance to the discharge of the Aggregate Debt. Otherwise, Mortgagee shall pay over any sums not so applied to Mortgagor for the purpose of restoring or repairing the
Mortgaged Property or for any purpose or object satisfactory to Mortgagee, in which event the Aggregate Debt shall not be reduced by that amount. Mortgagor hereby irrevocably appoints Mortgagee as attorney-in-fact for Mortgagor for the purpose of
collection of any or all proceeds available in connection with the condemnation of the Mortgaged Property. If 

  
 F-8 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
the Mortgaged Property is transferred, through foreclosure or otherwise, prior to the receipt by Mortgagee of such award of payment, Mortgagee shall have the right, whether or not a deficiency
judgment on the Notes shall have been sought, recovered or denied, to receive such award or payment, or a portion thereof sufficient to pay the Aggregate Debt, whichever is less. 

8. Preservation of Lien. Mortgagor shall pay or cause to be paid, from time to time as and when the same shall become due, all claims
and demands of any persons or entities which, if unpaid, might result in or permit the creation of a lien on the Mortgaged Property or any part thereof, and in general shall do or cause to be done everything necessary so that the lien hereof shall
be fully preserved and so that there shall not be created, permitted or suffered to exist any lien, encumbrance or charge affecting the Mortgaged Property superior or equal to the lien of this mortgage other than those matters referred to in
paragraph 1(a) hereof which have been approved in writing by Mortgagee, all at the sole cost of Mortgagor. At Mortgagee’s election, Mortgagee may make but is not obligated to make, any payments which Mortgagor has failed to make under any prior
lien, but such payment by Mortgagee shall not release Mortgagor from Mortgagor’s obligations or constitute a waiver of Mortgagor’s default hereunder. Mortgagee shall provide concurrent written notice to Mortgagor of any such payment(s).
Any sum so expended by Mortgagee shall be secured by this Open End Mortgage and Security Agreement, together with interest thereon at the rate stipulated in the Note from the date such payment is made by Mortgagee until the date of repayment by
Mortgagor. Notwithstanding the foregoing, Mortgagor shall have the right, at its sole cost and expense, to contest in good faith by any lawful means any such claims and demands, provided that it notifies Mortgagee in writing of its intention to do
so and deposits with Mortgagee, if Mortgagee so requests, an amount deemed sufficient by Mortgagee to satisfy such claims and demands if it is ultimately determined that Mortgagor is responsible therefor. 

9. Maintenance and Repair; Compliance with Laws and Regulations. Mortgagor shall cause the Mortgaged Property to be maintained in good
condition and repair, reasonable wear and tear excepted. None of the Improvements, Equipment or Building Equipment shall be removed, demolished, materially altered or sold (except for normal replacement of the Equipment), without the prior written
consent of Mortgagee. Mortgagor shall promptly comply with all laws, orders, ordinances, regulations, restrictions and requirements of governmental authorities, of courts and of insurance companies applicable to Mortgagor or affecting the Mortgaged
Property, or the use thereof. Mortgagor shall promptly repair, replace or rebuild any part of the Mortgaged Property which may be damaged or destroyed by any casualty or which may be affected by any condemnation or eminent domain proceeding. 

10. Assignment of Leases and Rents. As further security for payment of the indebtedness and performance of the obligations, covenants
and agreements secured hereby, Mortgagor assigns to Mortgagee, to be effective immediately but exercisable on default hereof, all leases applicable to the Mortgaged Property already in existence and to be created in the future, together with all
rents to become due under existing or future leases, all of which leases are and shall be subordinate to this Mortgage. In any such case, Mortgagor hereby confers on 

  
 F-9 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
Mortgagee the exclusive power, to be used or not in its sole discretion, to act as agent, or to appoint a third person to act as agent for Mortgagor, with power to take possession of, and collect
all rents arising from, the Mortgaged Property and apply such rents, at the option of Mortgagee, to the payment of the mortgage debt, taxes, costs of maintenance, repairs, expenses incident to managing and other expenses, in such order or priority
as Mortgagee may in its sole discretion determine, and to turn any balance remaining over to Mortgagor; but such collection of rents shall not independently from other provisions hereof operate as an affirmance of the tenant or lease in the event
Mortgagor’s title to the Mortgaged Property should be acquired by Mortgagee. Mortgagee shall be liable to account only for rents and profits actually received by Mortgagee. In exercising any of the powers of this paragraph, Mortgagee may also
take possession of, and for these purposes use, any and all personal property contained in the Mortgaged Property and used by Mortgagor in the rental or leasing thereof. All Leases are and shall be subject and subordinate to the provisions and lien
of this Mortgage and to all renewals, modifications, consolidations, replacements and extensions thereof to the full extent of the principal sum secured thereby and interest thereon, and the lien of this Mortgage is and shall be prior in lien to the
lien of the Leases. 
 11. Required Notice. Mortgagor shall give Mortgagee prompt written notice of any action or proceeding
purporting to affect the Mortgaged Property of which it has actual knowledge including, without limitation, the following: (a) a fire or other casualty causing damage to the Mortgaged Property; (b) receipt of notice of condemnation of the
Mortgaged Property or any part thereof; (c) receipt of notice from any governmental authority relating to the structure, use or occupancy of the Mortgaged Property; (d) receipt of any notice from any tenant of all or any portion of the
Mortgaged Property; (e) any change in the occupancy of the Mortgaged Property; (f) receipt of any notice from the holder of any lien or security interest in the Mortgaged Property; or (g) commencement of any litigation affecting the
Mortgaged Property. Mortgagee shall have the right to appear in or defend any such action or proceeding to the same extent as Mortgagor. Furthermore, Mortgagee shall have the right to bring any action or proceeding, in the name and on behalf of
itself or Mortgagor, which Mortgagee, in its discretion, feels should be brought to protect its interest in the Mortgaged Property or any part thereof. 

12. Mortgagee’s Right to Cure. Mortgagee shall have the right, but not the obligation, at Mortgagee’s election, to cure any
default by Mortgagor under any of the Loan Documents or under any mortgage or with respect to any security interest, lien or encumbrance which is senior in lien and position to this Open End Mortgage and Security Agreement. Mortgagee shall provide
concurrent written notice to Mortgagor of any such payment(s). Any payments made or expenses incurred by Mortgagee in the exercise of such right shall not release Mortgagor from Mortgagor’s obligation or constitute a waiver of Mortgagor’s
default hereunder. Any such payments made or expenses incurred by Mortgagee shall be repayable on demand by Mortgagee, together with interest thereon at the rate specified in the Note from the date such payment was made or such expense was incurred,
and the aggregate amount thereof, including such interest, shall become part of the Aggregate Debt and shall be secured by the lien of this Open End Mortgage and Security Agreement. 

  
 F-10 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 13. Certificate of No Offsets. Within five (5) days after being requested to do
so by Mortgagee, Mortgagor shall furnish to Mortgagee or any proposed assignee of this Open End Mortgage and Security Agreement a statement, duly executed, acknowledged and certified by Mortgagor, setting forth the remaining unpaid amount of the
Aggregate Debt and whether there exist any uncured defaults, offsets or defenses thereto. 
 14. Right to Inspect. Mortgagor shall
permit Mortgagee and its agents to enter and inspect the Mortgaged Property or any part thereof at all reasonable times, subject to the terms of the leases. 

15. Revenue, Tax or Other Stamps. Mortgagor shall pay or cause to be paid the cost of any revenue, tax or other stamps now or hereafter
required by the laws of the Commonwealth of Pennsylvania or the United States to be affixed to the Note or this Open End Mortgage and Security Agreement and if any taxes are imposed under the laws of the Commonwealth of Pennsylvania or the United
States with respect to evidences of indebtedness so secured, Mortgagor shall pay or reimburse Mortgagee upon demand the amount of such taxes without credit against any indebtedness evidenced by the Note. If Mortgagor does not do so, Mortgagee may at
its option accelerate the indebtedness evidenced by the Note to maturity as in the case of default by Mortgagor. 
 16. Security
Agreement. This Mortgage constitutes a security agreement under the Uniform Commercial Code and creates a security interest in all that property (and the proceeds thereof) of Mortgagor included in the Mortgaged Property which might otherwise be
deemed “personal property.” Mortgagor shall execute, deliver, file and refile any financing statements, continuation statements or other security agreements Mortgagee may require from time to time to confirm the lien of this Mortgage with
respect to such property. Without limiting the foregoing, Mortgagor hereby irrevocably appoints Mortgagee attorney-in-fact for Mortgagor to execute, deliver and file such instruments for and on behalf of Mortgagor. All costs of such filing and
refiling shall be paid by Mortgagor. Notwithstanding any release of any or all of that property included in the Mortgaged Property which is deemed “real property,” any proceedings to foreclose this Mortgage or its satisfaction of record,
the terms hereof shall survive as a security agreement with respect to the security interest created hereby and referred to above until the repayment or satisfaction in full of the obligations of Mortgagor as are now or hereafter evidenced by the
Note. 
 Notwithstanding the filing of a financing statement covering any of the Mortgaged Property in the records normally pertaining to
personal property, all of the Mortgaged Property, for all purposes and in all proceedings, legal or equitable, shall be regarded, at Mortgagee’s option (to the extent permitted by law), as part of the Real Property whether or not any such item
is physically attached to the Real Property or Improvements or serial numbers are used for the 

  
 F-11 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
better identification of certain items. The mention in any such financing statement of any of the Mortgaged Property shall never be construed as in any way altering any of the rights of Mortgagee
or adversely affecting the priority of the lien granted hereby or by any other Loan Document, but such mention in the financing statement is hereby declared to be for the protection of Mortgagee in the event any court shall at any time hold that
notice of Mortgagee’s priority of interest, to be effective against any third party, including the federal government and any authority or agency thereof, must be filed in the Uniform Commercial Code records. A carbon, photographic or other
reproduction of this Mortgage or of any financing statement signed by Mortgagor in connection herewith shall be sufficient as a financing statement and may be filed to perfect the security interest created hereby. 

The Mortgaged Property includes goods which are or are to become fixtures and this Mortgage is intended to serve as a fixture filing under the
Pennsylvania Uniform Commercial Code. 
 17. Events of Default. The occurrence of an Event of Default (as defined in the Credit
Agreement) shall constitute an event of default hereunder. It shall also be an “Event of Default” if Mortgagee receives written notice pursuant to 42 Pa.C.S. §8143(b), (c) or (d) from Mortgagor or any party claiming the
right to send such notice, whether or not such notice is effective under 42 Pa.C.S. §8143(b), (c) or (d). 
 18. Remedies;
Confession of Judgment. Upon the occurrence of any Event of Default: 
 a. The Aggregate Debt shall, at the option of Mortgagee, become
due and payable immediately without presentment, demand, notice of nonpayment, protest, notice of protest or other notice of dishonor, all of which are hereby expressly waived by Mortgagor. 

b. Mortgagee may institute appropriate proceedings at law or equity to collect the amount of the Aggregate Debt then due (by acceleration or
otherwise), or for specific performance of any of the covenants of Mortgagor under any of the Loan Documents (and Mortgagor acknowledges that all such covenants may be specifically enforced by Mortgagee by injunction or other appropriate equitable
remedy), or to recover damages for any breach thereof, or to institute an action of mortgage foreclosure against the Mortgaged Property, or take such other action at law or in equity for the enforcement of this Open End Mortgage and Security
Agreement and realization on the mortgage security or any other security herein or elsewhere provided for, and proceed therein to final judgment and execution for the Aggregate Debt, together with interest, costs and expenses. 

c. THE FOLLOWING PARAGRAPH SETS FORTH A WARRANT OF ATTORNEY TO CONFESS JUDGMENT AGAINST MORTGAGOR. IN GRANTING THE WARRANT OF ATTORNEY,
MORTGAGOR HEREBY KNOWINGLY, INTENTIONALLY, VOLUNTARILY AND (ON THE ADVICE OF ITS SEPARATE COUNSEL) 

  
 F-12 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
UNCONDITIONALLY WAIVES ALL RIGHTS WITH RESPECT TO SUCH WARRANT, AND WITH RESPECT TO ANY JUDGMENT ENTERED PURSUANT THERETO OR ANY EXECUTION THEREON, THAT MORTGAGOR MAY HAVE, UNDER THE CONSTITUTION
AND LAWS OF THE UNITED STATES AND THE COMMONWEALTH OF PENNSYLVANIA, TO NOTICE AND AN OPPORTUNITY FOR A HEARING PRIOR TO BEING DEPRIVED OF POSSESSION OF THE MORTGAGED PROPERTY OR ANY PART THEREOF. 

d. FOR THE PURPOSE OF PROCURING POSSESSION OF THE MORTGAGED PROPERTY IN THE EVENT OF ANY DEFAULT HEREUNDER OR UNDER ANY OTHER LOAN DOCUMENT,
MORTGAGOR HEREBY AUTHORIZES AND EMPOWERS ANY ATTORNEY OF ANY COURT OF RECORD IN THE COMMONWEALTH OF PENNSYLVANIA OR ELSEWHERE, AS ATTORNEY FOR MORTGAGOR AND ALL PERSONS CLAIMING UNDER OR THROUGH MORTGAGOR, TO APPEAR FOR MORTGAGOR AND CONFESS
JUDGMENT PURSUANT TO APPLICABLE LAW AGAINST MORTGAGOR, AND ALL PERSONS CLAIMING UNDER OR THROUGH MORTGAGOR, FOR THE RECOVERY BY MORTGAGEE OF POSSESSION OF THE MORTGAGED PROPERTY, WITHOUT ANY STAY OF EXECUTION, FOR WHICH THIS MORTGAGE, OR A COPY
HEREOF VERIFIED BY AFFIDAVIT, SHALL BE A SUFFICIENT WARRANT; AND THEREUPON A WRIT OF POSSESSION MAY BE ISSUED FORTHWITH, WITHOUT ANY PRIOR WRIT OR PROCEEDING WHATSOEVER. MORTGAGOR HEREBY RELEASES MORTGAGEE FROM ALL ERRORS AND DEFECTS WHATSOEVER IN
ENTERING SUCH JUDGMENT AND IN CAUSING SUCH WRIT OR WRITS TO BE ISSUED, AND HEREBY AGREES THAT NO WRIT OF ERROR, APPEAL, PETITION TO OPEN OR STRIKE OFF JUDGMENT, OR OTHER OBJECTION SHALL BE FILED OR MADE WITH RESPECT THERETO. IF FOR ANY REASON AFTER
SUCH JUDGMENT HAS BEEN CONFESSED THE SAME SHALL BE DISCONTINUED OR POSSESSION OF THE MORTGAGED PROPERTY SHALL REMAIN IN OR BE RESTORED TO MORTGAGOR, MORTGAGEE SHALL HAVE THE RIGHT FOR THE SAME DEFAULT OR ANY SUBSEQUENT DEFAULT TO BRING ONE OR MORE
FURTHER JUDGMENTS BY CONFESSION AS ABOVE PROVIDED TO RECOVER POSSESSION OF THE MORTGAGED PROPERTY. MORTGAGEE MAY ENTER SUCH JUDGMENT BEFORE OR AFTER THE INSTITUTION OF FORECLOSURE PROCEEDINGS UPON THIS MORTGAGE, OR AFTER JUDGMENT THEREON OR ON THE
LOAN AGREEMENT OR ANY OF THE NOTES, OR AFTER A SALE OF THE MORTGAGED PROPERTY BY THE SHERIFF. 
 e. With or without demand upon Mortgagor
for the surrender of possession, Mortgagee may enter upon and take possession of the Mortgaged Property, breaking locks if necessary and without liability for trespass, damages or otherwise and, upon so doing, Mortgagee may, in its discretion and in
addition to any of its other rights, as Mortgagee in possession, alter, improve, complete or repair the Mortgaged Property (and in so doing Mortgagee shall have the right to use the Mortgaged Property and to expend such amount for that purpose as
Mortgagee 

  
 F-13 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
shall deem best, all of which, with interest thereon at the rate specified in the Note from date of payment, shall be repayable by Mortgagor on demand and shall be secured hereby), and operate,
rent, sell or lease the same in the name of Mortgagor or Mortgagee upon such terms and conditions as Mortgagee shall deem appropriate, and Mortgagor hereby irrevocably appoints Mortgagee attorney-in-fact for Mortgagor for all such purposes. 

f. Mortgagee may further, by summary proceedings, initiate an action for possession or otherwise. If Mortgagor remains in possession after
demand by Mortgagee for surrender of possession of the Mortgaged Property, such continued possession by Mortgagor shall be as tenant of Mortgagee, and Mortgagor agrees to pay monthly in advance to Mortgagee such rent for the Mortgaged Property so
occupied as Mortgagee may demand, and in default of so doing, Mortgagor may also be dispossessed by summary proceedings or otherwise. In case of the appointment of a receiver of the rents, the foregoing agreement of Mortgagor to pay rent shall inure
to the benefit of such receiver. 
 Upon the occurrence of any Event of Default, Mortgagor irrevocably authorizes and empowers any attorney
of record, or the Prothonotary, Clerk or similar officer, of any court in the Commonwealth of Pennsylvania or elsewhere, as attorney for Mortgagor, as well as for the persons claiming under, by or through Mortgagor, to sign an agreement for entering
therein an appropriate amicable action in ejectment for possession of the Mortgaged Property (without the necessity of filing any bond and without any stay of execution or appeal) against Mortgagor and all persons claiming under, by or through
Mortgagor, and therein confess judgment for the recovery by Mortgagee of possession of the Mortgaged Property for which this instrument (or a copy thereof verified by affidavit) shall be a sufficient warrant; whereupon a writ of possession of the
Mortgaged Property may be issued forthwith, without any prior writ or proceeding whatsoever, Mortgagor hereby releasing and agreeing to release Mortgagee and any such attorney from all procedural errors and defects whatsoever in entering such action
or judgment or in causing such writ or process to be issued or in any proceeding thereon or concerning the same, provided that Mortgagee shall have filed in such action an affidavit made on Mortgagee’s behalf setting forth the facts necessary
to authorize the entry of such judgment according to the terms of this instruments, of which facts such affidavit shall be prima facie evidence. It is hereby expressly agreed that if for any reason after any such action has been commenced, the same
shall be discontinued, marked satisfied of record or be terminated, or possession of the Mortgaged Property remain in or be restored to Mortgagor or anyone claiming under, by or through Mortgagor, Mortgagee may, whenever and as often as Mortgagee
shall have the right to take possession again of the Mortgaged Property, bring one or more further amicable actions in the manner hereinbefore set forth to recover possession of the Mortgaged Property and to confess judgment therein as hereinabove
provided, and the authority and power above given to any such attorney shall extend to all such further amicable actions in ejectment and confession of judgment therein as hereinabove provided whether before or after an action of mortgage
foreclosure is brought or other proceedings in execution are instituted upon this Open End Mortgage and Security Agreement or the Note, and after judgment thereon or therein and after a judicial sale of the Mortgaged Property. 

  
 F-14 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 g. With or without taking possession of the Mortgaged Property, Mortgagee may collect and
receive all the income and rents and, after deducting the cost of all alterations, improvements, repairs, completion, partial completion, operation, sale, rental, leasing commissions and charges, including, but not limited to, reasonable counsel
fees, incurred by Mortgagee, apply the net income to the sums secured hereby in such manner as Mortgagee in its discretion shall determine. Mortgagee shall be liable to account only for the income and rents actually received. 

h. If Mortgagee shall so elect, Mortgagor shall not resist or contest but shall join in any petition to any court by Mortgagee for the
appointment of a receiver or receivers of the Mortgaged Property or any part thereof, and of all the income and rents therefrom, with such powers as the court making such appointment shall confer, and Mortgagor hereby appoints Mortgagee
attorney-in-fact of Mortgagor for all such purposes. 
 i. All deposits held in connection with the rental, lease, license or use of space
or other facilities on the Mortgaged Property at the time of the occurrence of such Event of Default, all interest of Mortgagor in all premiums for, or dividends upon, any insurance for the Mortgaged Property, and all refunds or rebates of taxes and
assessments upon the Mortgaged Property, are hereby assigned to Mortgagee as further security for the payment of the Aggregate Debt during the continuance of any such event of default. 

j. To the extent now or hereafter permitted by law and subject to such grace periods and notice requirements thereby imposed, Mortgagee may
cause a judicial sale of the Mortgaged Property in accordance with this subparagraph (j). Such sale may be made without demand on Mortgagor at the time and place fixed in the notice of such sale, and such sale may be of the Mortgaged Property as a
whole or in separate lots, and in such order as Mortgagee may determine, at public auction to the highest bidder for cash in lawful money of the United States, payable at time of sale. Such sale of the Mortgaged Property may be postponed by public
announcement at the time and place of sale, and may be further postponed from time to time thereafter by public announcement at the time fixed by the preceding postponement. Any person or entity including Mortgagee, may purchase at such sale. After
deducting all costs, fees, and expenses of Mortgagee, including cost of evidence of title in connection with such sale, the proceeds of sale shall be applied to payment of the Aggregate Debt. The Mortgaged Property may be sold as aforesaid either
before, after or during the pendency of any proceedings for the enforcement of the provisions of this Open End Mortgage and Security Agreement, and such power and right of sale shall not be affected by any entry hereunder, or by the exercise of any
other right, remedy or power with respect to the enforcement of the provisions of any of the Loan Documents or the collection of the amount of the Aggregate Debt. The provisions of this subparagraph (j) are not intended to and shall not
adversely affect Mortgagee’s rights to conduct a nonjudicial sale of such portions of the Mortgaged Property as constitute personal property. 

k. Mortgagee may exercise such rights as may be available to a secured party under the Uniform Commercial Code, including the right to sell or
otherwise dispose of any 

  
 F-15 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
personal property included in the Mortgaged Property at one or more public or private sales without advertisement or notice except as required by law (it being understood that notice of any
intended public or private sale or other disposition shall be deemed to have been reasonably made if delivered or mailed, postage prepaid, to Mortgagor at the address of Mortgagor maintained with the records of Mortgagee at least fifteen
(15) days prior to the date of public sale or the date after which the private sale or other disposition is to be consummated). 
 l.
Mortgagee shall have the right to set off all or any part of any amount due by Mortgagor to Mortgagee under the Note, this Mortgage or otherwise, against any indebtedness, liabilities or obligations owing by Mortgagee for any reason and in any
capacity to Mortgagor with respect to the Mortgaged Property, including any obligation to disburse to Mortgagor or its designee any funds or other property on deposit with or otherwise in the possession, control or custody of Mortgagee. 

19. Remedies Cumulative. etc. 

a. No right or remedy conferred upon or reserved to Mortgagee under any of the Loan Documents or with respect to any Collateral, or now or
hereafter existing at law or in equity or by statute or other legislative enactment, is intended to be exclusive of any other such right or remedy and each and every such right or remedy shall be cumulative and concurrent, and shall be pursued
separately, concurrently, successively or otherwise, at the sole discretion of Mortgagee, and shall not be exhausted by any one exercise thereof but may be exercised as often as occasion therefor shall occur. No act of Mortgagee shall be deemed or
construed as an election to proceed under any one such right or remedy to the exclusion of any other such right or remedy; furthermore, each such right or remedy of Mortgagee shall be separate, distinct and cumulative and none shall be given effect
to the exclusion of any other. The failure to exercise or delay in exercising any such right or remedy, or the failure to insist upon strict performance of any term of any of the Loan Documents, shall not be construed as a waiver or release of the
same, or of any Event of Default thereunder, or of any obligation or liability of Mortgagor thereunder. 
 b. The recovery of any judgment
by Mortgagee or the levy of execution under any judgment upon the Mortgaged Property shall not affect in any manner, or to any extent, the lien of this Open End Mortgage and Security Agreement upon the Mortgaged Property, or any security interest in
any other Collateral, or any rights, remedies or powers of Mortgagee under any of the Loan Documents or with respect to any Collateral, but such lien and such security interest and such rights, remedies and powers of Mortgagee shall continue
unimpaired as before. Further, the entry of any judgment by Mortgagee shall not affect in any way the interest payable hereunder or under any of the other Loan Documents on any amounts due to Mortgagee, but interest shall continue to accrue on such
amount at the rate provided in the Note after the entry of any judgment and continuing until distribution of the proceeds of any Sheriffs sale. 

  
 F-16 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 c. Except to the extent required under the Loan Documents, Mortgagor hereby waives
presentment, demand, notice of nonpayment, protest, notice of protest or other notice of dishonor, and any and all other notices in connection with any default in the payment of, or any enforcement of the payment of, the Aggregate Debt. To the
extent permitted by law, Mortgagor waives the right to any stay of execution and the benefit of all exemption laws now or hereinafter in effect. 

d. Mortgagor agrees that Mortgagee may release, compromise, forbear with respect to, waive, suspend, extend or renew any of the terms of the
Loan Documents (and Mortgagor hereby waives any notice of any of the foregoing), and that the Loan Documents may be amended, supplemented or modified by Mortgagee and the other signatory parties and the Mortgagee may resort to any Collateral in such
order and manner as it may think fit, or accept the assignment, substitution, exchange or pledge of any other collateral in place of, or release for such consideration, or none as it may require, all or any portion of any Collateral, without in any
way affecting the validity of its lien over or other security interest in the remainder of any such Collateral (or the priority thereof or the position of any subordinate holder of any lien or other security interest with respect thereto) and any
action taken by Mortgagee pursuant to any of the foregoing shall in no way be construed as a waiver or release of any right or remedy of Mortgagee, or of any event of default, or of any liability or obligation of Mortgagor, under any of the Loan
Documents. 
 e. To the extent permitted by law, Mortgagor shall not at any time insist upon, or plead, or in any manner whatever claim or
take any benefit or advantage of any stay or extension or moratorium law, or any exemption from execution or sale of the Mortgaged Property, wherever enacted, now or at any time hereafter in force, which may affect the covenants and terms of
performance of this Open End Mortgage and Security Agreement, nor claim, take, or insist upon any benefit or advantage of any law now or hereafter in force providing for the valuation or appraisal of the Mortgaged Property, prior to any sale of any
of Mortgagor’s interest therein; nor, after any such sale or sales, claim or exercise any right under any statute heretofore or hereafter enacted to redeem the Real Property so sold or any part thereof, and Mortgagor hereby expressly waives all
benefit or advantage of any such law or laws, and covenants not to hinder, delay, or impede the execution of any power herein granted to Mortgagee but to suffer and permit the execution of every power as though now such law or laws had been made or
enacted. Mortgagor further waives and releases all procedural errors, defects and imperfections in any proceeding instituted by Mortgagee under any of the Loan Documents. 

f. Mortgagor, for itself and for all persons hereafter claiming through or under it or who may at any time hereinafter become holders of liens
junior to the lien of this Open End Mortgage and Security Agreement, hereby expressly waives and releases all rights to direct the order in which any of the Mortgaged Property shall be sold in the event of any sale or sales pursuant hereto and to
have any of the Mortgaged Property and/or any other property now or hereafter constituting security for the Aggregate Debt marshalled upon any foreclosure of this Open End Mortgage and Security Agreement or of any other security for any of the
Aggregate Debt. 

  
 F-17 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 g. Mortgagor agrees that any action or proceeding against it to enforce the Open End Mortgage
and Security Agreement may be commenced in any state or federal court in Pennsylvania, and Mortgagor waives personal service of process and agrees that a summons and complaint commencing an action or proceeding in any such court shall be properly
served and shall confer personal jurisdiction if served by registered or certified mail in accordance with the notice provisions set forth herein. 

20. Environmental Compliance. Except as disclosed in writing to Mortgagee heretofore or concurrently herewith, no pollutant or other
toxic or hazardous substance, including any solid, liquid, gaseous or thermal irritant or contaminant, including smoke, vapor, soot, fumes, acids, alkalis, chemicals and waste (including materials to be recycled, reconditioned or reclaimed) has been
discharged or shall be discharged, dispersed, released, stored, treated, generated, disposed or allowed to escape by Mortgagor, or by any predecessor in interest of Mortgagor, in violation of any applicable environmental laws, rules or regulations
now or hereafter in effect. Mortgagor, for itself and its successors and assigns, hereby agrees to defend, indemnify and hold harmless Mortgagee, its directors, officers, employees, agents, contractors, subcontractors, licensees, invitees,
successors and assigns, from and against any and all claims, demands, judgments, damages, actions, causes of action, injuries, administrative orders, consent agreements and orders, liabilities, penalties, costs, and expenses of any kind whatsoever,
past, present and future, including claims arising out of loss of life, injury to persons, property or business and/or damage to natural resources in connection with the activities of Mortgagor or its predecessors or successors in interest or
tenants, or third parties who have trespassed on its or their property, or any of them; or which (1) arises out of the actual, alleged or threatened discharge, dispersal, release, storage, treatment, generation, disposal or escape or pollutants
or other toxic or hazardous substances, including any solid, liquid, gaseous or thermal irritant or contaminant, including smoke, vapor, soot fumes, acids, alkalis, chemicals and waste (including materials to be recycled, reconditioned or
reclaimed), and (2) arises out of the actual or alleged use, specification or inclusion of any product, material or process containing chemicals, the failure to detect the existence or proportion of chemicals in the soil, air, surface water or
ground water, or the performance or failure to perform the abatement of any pollution source or the replacement or removal of any soil, water, surface water or ground water containing chemicals. Mortgagor, its successors and assigns, shall bear, pay
and discharge when and as the same become due and payable, any and all such judgments, liabilities, or claims against Mortgagee unless Mortgagee is found or determined to have caused such occurrences set forth herein and shall assume the burden and
expense of defending all suits, administrative proceedings and negotiations of any description with any and all persons, political subdivisions or government agencies arising out of any of the occurrences set forth herein. 

21. Severability and Savings Clauses. If any provision of this Mortgage is held to be invalid or unenforceable by a court of competent
jurisdiction, the other provisions of this 

  
 F-18 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
Mortgage shall remain in full force and effect and shall be liberally construed in favor of Mortgagee in order to effect the provisions of this Mortgage. In addition, in no event shall the rate
of interest under the Note exceed the maximum rate of interest permitted to be charged by the applicable law (including the choice of law rules) and any interest paid in excess of the permitted rate shall be refunded to Mortgagor. Such refund shall
be made by application of the excessive amount of interest paid against any sums outstanding under the Note and shall be applied in such order as Mortgagee may determine. If the excessive amount of interest paid exceeds the sums outstanding under
the Note the portion exceeding the said sums outstanding under the Note shall be refunded in cash by Mortgagee. Any such crediting or refund shall not cure or waive any default by Mortgagor hereunder or under the Note. Mortgagor agrees, however,
that in determining whether or not any interest payable under the Note or this Mortgage exceeds the highest rate permitted by law, any non-principal payment (except payments specifically stated in the Note to be “interest”), including
without limitation prepayment premiums and late charges, shall be deemed to the extent permitted by law, to be an expense, fee, premium or penalty rather than interest. 

22. Costs and Expenses. Following the occurrence of any event of default under any of the Loan Documents, Mortgagor shall pay upon
demand all costs and expenses (including reasonable attorneys’ fees and all amounts paid to accountants, real estate brokers and other advisors employed by Mortgagee and to any contractors for labor and materials), incurred by Mortgagee in the
exercise of any of its rights, remedies or powers under any of the Loan Documents or with respect to any Collateral with respect to such event of default, and any amount thereof not paid promptly following demand therefor, together with interest
thereon at the rate provided in the Note from the date of such demand, shall become part of the Aggregate Debt and shall be secured by the lien of this Open End Mortgage and Security Agreement. In connection with and as part of the foregoing, in the
event that any of the Loan Documents is placed in the hands of any attorney for the collection of any sum payable thereunder, Mortgagor agrees to pay reasonable attorneys’ fees for the collection of the amount being claimed under such Loan
Documents, as well as all costs, disbursements and allowances provided by law, and the payment of such fees and costs, disbursements and allowances shall also be secured by the lien of this Open End Mortgage and Security Agreement. Nothing in this
paragraph 22 shall limit the obligation of Mortgagor to pay costs and expenses of Mortgagee for which Mortgagor is otherwise liable under the Loan Documents. 

23. Successors and Assigns. This Open End Mortgage and Security Agreement inures to the benefit of Mortgagee and binds Mortgagor, and
their respective successors and assigns. Mortgagee may assign or otherwise transfer this Open End Mortgage and Security Agreement and any or all of the Loan Documents to any other person, and such other person shall thereupon become vested with all
of the benefits in respect thereof granted to Mortgagee herein or otherwise. 
 24. Notices. All notices and other communications
provided under this Open End Mortgage and Security Agreement shall be in writing or by facsimile and addressed, delivered or 

  
 F-19 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
transmitted, if to Mortgagor or Mortgagee, to the applicable Person at its address or facsimile number set forth on the signature pages hereto, or at such other address or facsimile number as may
be designated by such party in a notice to the other parties, and a copy of all notices shall be given by email at the email address for a party set forth below, if any, or at such other email address as designated by such party to the other
parties. Any notice, if mailed and properly addressed with postage prepaid or if properly addressed and sent by pre-paid courier service, shall be deemed given when received; any notice, if transmitted by facsimile, shall be deemed given when the
confirmation of transmission thereof is received by the transmitter. 
  

			
	Mortgagee:	  	C/O Walkers Corporate Services Limited
		  	Walker House, 87 Mary Street
		  	George Town, Grand Cayman KY 1-9005
		  	Cayman Islands
		  	Attention: Neil Gray
		
		  	With duplicate notice sent to:
		
		  	OrbiMed Advisors LLC
		  	601 Lexington Avenue, 54th Floor
		  	New York, NY 10022
		  	Email: WesselT@OrbiMed.com;
		  	            RizzoM@OrbiMed.com
		  	Attention: Tadd Wessel and Matthew Rizzo
		
	Mortgagor:	  	Unilife Cross Farm LLC
		  	Attn: Chief Executive Officer
		  	250 Cross Farm Lane
		  	York Pennsylvania 17406
		  	Email:
		
		  	With copies to:
		  	Unilife Cross Farm LLC
		  	Attn: General Counsel
		  	250 Cross Farm Lane
		  	York Pennsylvania 17406
		  	Email: chris.naftzger@unilife.com
		
	with a copy to:	  	Pepper Hamilton LLP
		  	Attn: William R. Wagner
		  	The New York Times Building
		  	620 Eighth Avenue, 37th Floor
		  	New York, NY 10018-1405
		  	Email: wagnerw@pepperlaw.com

  
 F-20 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 All notices given by Mortgagor to Mortgagee pursuant to 42 Pa.C.S. § 8143(c) shall be
given as set forth herein. The preceding sentence shall not be deemed an authorization to give a notice pursuant to 42 Pa.C.S. § 8143(c). Mortgagor waives and relinquishes any rights which it may have to file or send a notice pursuant to 42
Pa.C.S. §§8143(c), to the extent that such waiver and relinquishment is permissible under applicable law. 
 All notices pursuant
to 42 Pa.C.S. §8143(b) or (d) must be addressed to Mortgagee in the manner set forth herein. The preceding sentence shall not be deemed an authorization to give a notice pursuant to 42 Pa.C.S. § 8143(b) or (d). With respect to any
lien placed on the Mortgaged Property (other than the lien of this Mortgage), the holder of the lien, whether or not consented to by Mortgagee, by acceptance of such lien and without any further act or documentation being required by it, waives and
relinquishes any rights which it may have to send a notice pursuant to 42 Pa.C.S. §§8143(b) and (d), to the extent that such waiver and relinquishment is permissible under applicable law. 

25. Definitions: Number and Gender. In the event Mortgagor consists of more than one person or entity, the obligations and liabilities
hereunder of each of such persons and entities shall be joint and several and the word “Mortgagor” shall mean all or some or any of them. For purposes of this Open End Mortgage and Security Agreement, the singular shall be deemed to
include the plural and the neuter shall be deemed to include the masculine and feminine, as the context may require. The words “Open End Mortgage and Security Agreement” and “Note” shall include any supplements to or any
amendments of or restatements thereof or thereto. 
 26. Incorporation by Reference. All of the terms and provisions of the Note and
the Loan Documents are hereby incorporated herein by reference. 
 27. Captions. The captions or heading of the paragraphs of this
Open End Mortgage and Security Agreement are for convenience only and shall not control or affect the meaning or construction of any of the terms or provisions of this Open End Mortgage and Security Agreement. 

28. As contemplated by 42 Pa.C.S. §8143, the indebtedness secured hereby is to be advanced pursuant to the Credit Agreement, the terms
and conditions of which are incorporated herein by this reference with the same force and effect as if hereinafter more fully set forth. It is understood and agreed that this Mortgage covers present and future advances, in the aggregate amount of
the obligations secured hereby, made by Mortgagee to or for the benefit of Mortgagor pursuant to the Credit Agreement and that the lien of such future advances shall relate back to the date of this Mortgage. 

  
 F-21 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 29. As contemplated by 42 Pa.C.S. §8144, this Mortgage secures, and the Obligations
Secured include, the unpaid balances of any advances made with respect to the Mortgaged Property for the payment of taxes, assessments, maintenance charges, insurance premiums or costs incurred for the protection of the Mortgaged Property or the
lien of this Mortgage and expenses incurred by Mortgagee by reason of default by Mortgagor under this Mortgage. 
 30. MORTGAGOR AND
MORTGAGEE RESERVE THE RIGHT TO MODIFY THIS MORTGAGE OR THE OBLIGATIONS IT SECURES, AND THIS MORTGAGE AS SO MODIFIED WILL RETAIN PRIORITY EVEN IF THE MODIFICATION IS MATERIALLY PREJUDICIAL TO THE HOLDERS OF JUNIOR INTERESTS IN THE MORTGAGED PROPERTY.
MORTGAGOR AND MORTGAGEE AGREE THAT CHANGES IN INTEREST RATE, AMORTIZATION AND MATURITY DATE, ALONE OR IN COMBINATION, WILL NOT BE MATERIALLY PREJUDICIAL TO THE HOLDERS OF JUNIOR INTERESTS IN THE MORTGAGED PROPERTY. BY ACCEPTING, ACQUIRING OR HOLDING
A JUNIOR INTEREST IN THE MORTGAGED PROPERTY, THE HOLDER THEREOF AGREES TO BE BOUND BY THIS PARAGRAPH. 
 [Remainder of Page Intentionally
Left Blank] 
 [Signature Page to Follow] 

  
 F-22 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, Mortgagor has executed this Mortgage and Security Agreement as of the day
and year first above written. 
  

							
	WITNESS ATTEST	 		 	UNILIFE CROSS FARM LLC
				
	  
	 		 	By:	 	  

  
 F-23 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

					
	COMMONWEALTH OF PENNSYLVANIA	  		  	
		  	:	  	SS.
	COUNTY OF	  	:	  	

 On this, the [    ][th/st] day of [    ], 2014, before me, a Notary
Public in and for said County and Commonwealth personally appeared [    ] who, being duly sworn, acknowledged the foregoing instrument to be the voluntary act and deed of UNILIFE CROSS FARM LLC, and that
[    ], as the [    ] of UNILIFE CROSS FARM LLC, being authorized to do so, executed the foregoing instrument for the purposes therein contained. 

IN WITNESS WHEREOF, I hereunto set my hand and official seal. 

 

	
	  

	Notary Public

 My commission expires: 

  
 F-24 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 Exhibit A 

Description of Property 

  
 F-25 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 Exhibit B 

Permitted Encumbrances 

  
 F-26 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT G-1 

ACKNOWLEDGEMENT AND AGREEMENT 

This Acknowledgement and Agreement (this “Agreement”) is dated as of March     , 2014 and entered into by
HIKMA PHARMACEUTICALS LLC (“Hikma”), ROS ACQUISITION OFFSHORE LP (“ROS”) and ROYALTY OPPORTUNITIES S.A.R.L. (together with ROS and their successors and assigns, “OrbiMed”). 

RECITALS: 

WHEREAS, Hikma and Unilife Medical Solutions, Inc. (“Unilife”) are parties to that certain Binding License,
Development and Supply Agreement, dated November 18, 2013 (the “LDSA”), relating to Unilife’s development and exclusive supply of customized devices to be filled with Hikma’s drugs and sold worldwide by Hikma as drug-device
combination products; 
 WHEREAS, Hikma, Unilife and Unitract Syringe Pty Ltd (“Unitract”) have entered into a Security
Agreement dated 18 December 2013 (as amended and restated, supplemented or otherwise modified from time to time) (the “Hikma Security Agreement”) pursuant to which Unilife and Unitract have granted to Hikma a valid and perfected first
priority security interest in certain of their assets (the “Hikma Collateral,” it being understood and agreed that the scope of the Hikma Collateral shall not be expanded from that set forth in the Hikma Security Agreement, as of
18 December 2013, without giving effect to any amendments, supplements, restatements or other modifications thereto) as contemplated by the LDSA (collectively, together with the LDSA, the “Hikma Agreements”); 

WHEREAS, OrbiMed has entered or will enter into that certain Credit Agreement (as amended, amended and restated, supplemented or
otherwise modified from time to time, together with the other Loan Documents (as defined therein), the “Credit Agreement”), by and between Unilife and OrbiMed, pursuant to which Unilife and its affiliates have executed security
agreements and other collateral documents in relation to the Credit Agreement (collectively, together with the Credit Agreement, the “OrbiMed Credit Documents”) and Unilife and its affiliates have granted to OrbiMed a security
interest in substantially all of their assets excluding the Hikma Collateral (the “OrbiMed Collateral”); 
 WHEREAS,
OrbiMed has requested that Hikma execute this Agreement as a condition to the extension of credit to Unilife under the Credit Agreement; 

WHEREAS, Hikma has agreed to enter into this Agreement in good faith and without negotiating, being party to, or having any obligations
under the OrbiMed Credit Documents; 

  
 G1-1 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 WHEREAS, Hikma and OrbiMed desire to set forth in this Agreement their respective
rights with respect to the Hikma Collateral and the OrbiMed Collateral. 
 NOW, THEREFORE, in consideration of the premises and for other
good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereby agree as follows: 

1. Hikma certifies that (a) the Hikma Agreements are in full force and effect and have not been amended, modified or supplemented,
(b) to the knowledge of Hikma, there is no defense, offset, claim, or counterclaim by or in favor of Hikma against Unilife, or by or in favor of Unilife against Hikma, under the Hikma Agreements, and (c) no notice of breach or default has
been given under or in connection with the Hikma Agreements which has not been cured, and Hikma has no knowledge of the occurrence of any other breach or default by Unilife or Hikma under or in connection with the Hikma Agreements. 

2. The parties acknowledge and agree that, as between Hikma and OrbiMed: 

 

	 	a.	the security interests of Hikma in the Hikma Collateral shall be exclusive to Hikma and OrbiMed hereby disclaims any and all interest, lien, claim or other right to the Hikma Collateral, until such time as the Hikma
Collateral no longer secures any obligations of Unilife or its affiliates owing or that might become owing to Hikma; 

  

	 	b.	the security interests of OrbiMed in the OrbiMed Collateral shall be exclusive to OrbiMed; 

  

	 	c.	nothing in this Agreement or the OrbiMed Credit Documents shall impair, supersede, cancel or nullify, or constitute a waiver of, any right, interest or remedy of Hikma under any of the Hikma Agreements.

 3. All notices and other communications provided under this Agreement shall be in writing or by facsimile and addressed,
delivered or transmitted to the applicable Person at its address or facsimile number set forth on the signature pages hereto, or at such other address or facsimile number as may be designated by such party in a notice to the other parties, and a
copy of all notices shall be given by email at the email address for a party set forth below, if any, or at such other email address as designated by such party to the other parties. Any notice, if mailed and properly addressed with postage prepaid
or if properly addressed and sent by pre-paid courier service, shall be deemed given when received; any notice, if transmitted by facsimile, shall be deemed given when the confirmation of transmission thereof is received by the transmitter. 

4. The provisions of this Agreement shall continue in effect until the earlier of: 

 

	 	a.	the expiry or termination in accordance with its terms of the LDSA; and 

  

	 	b.	the expiry or termination in accordance with its terms of the Credit Agreement; 

  
 G1-2 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 and each of Hikma and OrbiMed agrees to provide promptly to the other written notice of the expiry or
termination of the LDSA or the Credit Agreement respectively. 
 5. This Acknowledgement and the rights and obligations of the parties
hereunder shall be governed by, and shall be construed and enforced in accordance with, the internal laws of the State of New York, without regard to its conflicts of laws principles. 

[ Signature Pages Follow ] 

  
 G1-3 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first set
forth above. 
  

			
	HIKMA PHARMACEUTICALS, LLC
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	ADDRESS
	CITY, ST

  
 G1-4 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 
			
	ROS Acquisition Offshore LP, as Lender
	By ROS Acquisition Offshore GP Ltd.,
	its General Partner
	By OrbiMed Advisors LLC,
	its investment manager
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	C/O Walkers Corporate Services Limited
	Walker House, 87 Mary Street
	George Town, Grand Cayman KY 1-9005
	Cayman Islands
	Attention: Neil Gray
	
	With duplicate notice sent to:
	
	OrbiMed Advisors LLC
	601 Lexington Avenue, 54th Floor
	New York, NY 10022
	Email:	 	WesselT@OrbiMed.com;
		 	RizzoM@OrbiMed.com
	Attention: Tadd Wessel and Matthew Rizzo

  
 G1-5 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 EXHIBIT G-2 

ACKNOWLEDGEMENT AND AGREEMENT 

This Acknowledgement and Agreement (this “Acknowledgement”) is dated as of
[—], 2014 and entered into by MEDIMMUNE, LLC (“MedImmune”), to and for the benefit of ROS ACQUISITION OFFSHORE LP (in its capacity as Lender
under the Credit Agreement described below, “Lender”). 
 RECITALS: 

WHEREAS, MedImmune and Unilife Medical Solutions, Inc. (“Unilife”) are parties to that certain Master Development and
Supply Agreement, dated November 1, 2013, as amended by that certain Project Addendum No. 1, dated November 1, 2013 (the “Agreement”), relating to the development and supply of a customized subcutaneous bolus injector
device; 
 WHEREAS, MedImmune understands that Lender has entered or will enter into that certain Credit Agreement (as amended,
amended and restated, supplemented or otherwise modified from time to time, together with the other Loan Documents (as defined therein), the “Credit Agreement”), by and between Unilife and Lender, pursuant to which Unilife and its
Affiliates have executed security agreements and other collateral documents in relation to the Credit Agreement and Unilife has granted to Lender a security interest in all its assets; 

WHEREAS, Lender has requested that MedImmune execute this Acknowledgement as a condition to the extension of credit to Unilife under
the Credit Agreement. 
 NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the
receipt, sufficiency and adequacy of which are hereby acknowledged, MedImmune hereby represents and warrants to, and covenants and agrees with, Lender as follows: 

1. MedImmune certifies that (a) the Agreement is in full force and effect and has not been amended, modified or supplemented except as
set forth on Exhibit A annexed hereto, (b) to the knowledge of MedImmune, there is no defense, offset, claim, or counterclaim by or in favor of MedImmune against Unilife, or by or in favor of Unilife against MedImmune, under the
Agreement, and (c) no notice of breach or default has been given under or in connection with the Agreement which has not been cured, and MedImmune has no knowledge of the occurrence of any other breach or default by Unilife or MedImmune under
or in connection with the Agreement. 
 2. MedImmune shall send to Lender a copy of any notice of breach or default under the Agreement sent
by MedImmune to Unilife. 

  
 G2-1 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 3. If Lender gives MedImmune written notice (with a written plan to address the breach,
including a commercially reasonable timeline for curing such breach) prior to the termination of any cure period of Unilife under the Agreement, then Lender shall have an additional cure period of 60 days from the end of such time period or such
longer period of time that is mutually agreed by Lender and MedImmune to cure the breach or default, or cause Unilife to cure the breach or default, so long as Lender is using commercially reasonable efforts during such additional period to cure, or
cause Unilife to cure, such breach or default. Lender shall be under no obligation to cure any breach or default of Unilife under the Agreement. No action by Lender pursuant to this Acknowledgement shall be deemed to be an assumption by Lender of
any obligation under the Agreement, and Lender shall not have any obligation to MedImmune. 
 4. All notices and other communications
provided under this Acknowledgement shall be in writing or by facsimile and addressed, delivered or transmitted, if to MedImmune or the Lender, to the applicable Person at its address or facsimile number set forth on the signature pages hereto, or
at such other address or facsimile number as may be designated by such party in a notice to the other parties, and a copy of all notices shall be given by email at the email address for a party set forth below, if any, or at such other email address
as designated by such party to the other parties. Any notice, if mailed and properly addressed with postage prepaid or if properly addressed and sent by pre-paid courier service, shall be deemed given when received; any notice, if transmitted by
facsimile, shall be deemed given when the confirmation of transmission thereof is received by the transmitter. 
 5. The provisions of this
Acknowledgement shall continue in effect until MedImmune shall have received Lender’s written certification that (a) all Obligations (as defined in the Credit Agreement) under the Credit Agreement have been indefeasibly paid in full and
(b) Lender has no obligation to make any further advances or extensions of credit under the Credit Agreement. 
 6. This
Acknowledgement and the rights and obligations of the parties hereunder shall be governed by, and shall be construed and enforced in accordance with, the internal laws of the State of New York, without regard to its conflicts of laws principles.

 [ Signature Pages Follow ] 

  
 G2-2 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 IN WITNESS WHEREOF, MedImmune has caused this Acknowledgement to be executed and
delivered by its duly authorized representative as of the date first set forth above. 
  

			
	MEDIMMUNE, LLC
		
	By:	 	  

	Name:	 	Gail Wasserman
	Title:	 	Senior Vice President
	
	MedImmune
	One MedImmune Way
	Gaithersburg, MD 20878
	
	With a copy to:
	Legal Affairs
	MedImmune
	One MedImmune Way
	Gaithersburg, MD 20878

  
 G2-3 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 By its acceptance hereof, as of the date first set forth above, Lender agrees to be bound by
the provisions hereof. 
  

			
	ROS Acquisition Offshore LP, as Lender
	By ROS Acquisition Offshore GP Ltd.,
	its General Partner
	By OrbiMed Advisors LLC,
	its investment manager
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	C/O Walkers Corporate Services Limited
	Walker House, 87 Mary Street
	George Town, Grand Cayman KY 1-9005
	Cayman Islands
	Attention: Neil Gray
	
	With duplicate notice sent to:
	
	OrbiMed Advisors LLC
	601 Lexington Avenue, 54th Floor
	New York, NY 10022
	Email:	 	WesselT@OrbiMed.com;
		 	RizzoM@OrbiMed.com
	Attention: Tadd Wessel and Matthew Rizzo

  
 G2-4 

 Exhibit 10.1 

CONFIDENTIAL TREATMENT 

REQUESTED PURSUANT TO RULE 24b-2 

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of
1934, as amended. The omitted materials have been filed separately with the Securities and Exchange Commission. 
  

 Exhibit A 

See attached document. 

  
 G2-5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}]]